Researcher Profile and Settings

Researcher

• Name

  SAITOH Takayuki

Affiliation

• Laboratory Science, Professor

Profile and Settings

• Name

  Saitoh, Takayuki

Alternate Names

• Saitoh T
• Takeshi Saito
• Saito T
• T Saito
• SAITO TAKAYUKI
• Takayuki Saito
• Tatsuhiro Saito
• 齋 藤 貴 之
• Takashi Saito

Foreign language

• Use in presentation

  English

• Use in publication

  English

Affiliation

• Affiliation

  Graduate School of Gealth Science

• Job title

  Professor

Education

• 1991, Gunma University, Faculty of Medicine, School of Medicine
• 1991, Gunma University, Faculty of Medicine

Degree

• Doctor of Medicine
• Doctor of Medicine
• Doctor of Medicine
• Doctor of Medicine
• Doctor of Medicine
• Doctor of Medicine, Gunma University

Research Experience

• 2016, 9999, Gunma University, Graduate School of Health Science, Prof lv
• 2012, 2016, Gunma University, Graduate School of Health Science, Associate prof lecturer lv
• 2008, 2012, Gunma University, University Hospital, Oncology Center
• 2004, 2008, Gunma University
• 2001, 2004, University of California, Los Angeles
• 1999, 2001
• UCLA Hem/Onco CSMC Post-doc fellow
• Apr. 2023, 9999, Gunma University, Health Science, Dean, Executive

Research Activities

Research Areas

• Life sciences, Hematology and oncology
• Other, Other, Laboratory medicine

Research Interests

• patient safety
• data science
• leukemia
• DNA repair
• multiple myeloma
• IPE
• Polymorphism

Research Themes

• Polymorpshism study in Hematology, Polymorpshism, Personal, Hematology, 0135 (Japanese Only)

Published Papers

• Propensity-score matched analysis of the efficacy of maintenance/continuous therapy in newly diagnosed patients with multiple myeloma: a multicenter retrospective collaborative study of the Japanese Society of Myeloma., Shuji Ozaki; Hiroshi Handa; Hiromi Koiso; Takayuki Saitoh; Kazutaka Sunami; Tadao Ishida; Kenshi Suzuki; Tomoko Narita; Shinsuke Iida; Yuichi Nakamura; Kazuhito Suzuki; Noriko Nishimura; Hirokazu Murakami; Kazuyuki Shimizu, 02 Jun. 2021, Journal of cancer research and clinical oncology, 148, 1, 191, 203, Scientific journal

  DOI
• Clonal evolution detected with conventional cytogenetic analysis is a potent prognostic factor in adult patients with relapsed Philadelphia chromosome-negative acute lymphoblastic leukemia., Hiroaki Shimizu; Akihiko Yokohama; Takuma Ishizaki; Nahoko Hatsumi; Satoru Takada; Takayuki Saitoh; Toru Sakura; Hiroshi Handa, Apr. 2021, Leukemia research, 103, 106535, 106535, Scientific journal

  DOI
• IDO2 rs10109853 polymorphism affects the susceptibility to multiple myeloma, Tetsuhiro Kasamatsu; Nao Hashimoto; Nao Sakaya; Maaya Awata-Shiraiwa; Rei Ishihara; Yuki Murakami; Yuta Masuda; Nanami Gotoh; Kazue Nagai; Tsukasa Oda; Akihiko Yokohama; Takayuki Saitoh; Hiroshi Handa; Norifumi Tsukamoto; Kunihiko Hayashi; Hirokazu Murakami, 12 Mar. 2021, Clinical and Experimental Medicine, 21, 2, 323, 329, Scientific journal

  DOI
• DNA-double strand breaks enhance the expression of major histocompatibility complex class II through the ATM-NF-κΒ-IRF1-CIITA pathway, Tsukasa Oda; Ruri Nakamura; Tetsuhiro Kasamatsu; Nanami Gotoh; Keiko Okuda; Takayuki Saitoh; Hiroshi Handa; Hirokazu Murakami; Takayuki Yamashita, 22 Feb. 2021, Cancer Gene Therapy, 29, 2, 225, 240, Scientific journal

  DOI
• DNA Damage Response in Multiple Myeloma: The Role of the Tumor Microenvironment., Takayuki Saitoh; Tsukasa Oda, 28 Jan. 2021, Cancers, 13, 3, 1, 22, Scientific journal

  DOI
• SF3A1 Gene Polymorphism Affects Clinical Features, but not Susceptibility to Myelodysplastic Syndromes, Yuuju Kanayama; Tetsuhiro Kasamatsu; Maaya Awata; Rei Ishihara; Yuki Murakami; Yuta Masuda; Nanami Gotoh; Hiroshi Handa; Takayuki Saitoh; Hirokazu Murakami, 01 Nov. 2020, The Kitakanto Medical Journal, 70, 4, 315, 323, Scientific journal

  DOI
• Long Noncoding RNA PVT1 Is Regulated by Bromodomain Protein BRD4 in Multiple Myeloma and Is Associated with Disease Progression., Hiroshi Handa; Kazuki Honma; Tsukasa Oda; Nobuhiko Kobayashi; Yuko Kuroda; Kei Kimura-Masuda; Saki Watanabe; Rei Ishihara; Yuki Murakami; Yuta Masuda; Ken-Ichi Tahara; Hisashi Takei; Tetsuhiro Kasamatsu; Takayuki Saitoh; Hirokazu Murakami, 27 Sep. 2020, International journal of molecular sciences, 21, 19, 1, 17, Scientific journal

  DOI
• Stepwise Discriminant Function Analysis for Differentiation of Idiopathic Cytopenia of Undetermined Significance from Myelodysplastic Syndrome or Aplastic Anemia Using Sysmex XE-5000 Parameters., INOUE Madoka; KASAMATSU Tetsuhiro; HANDA Hiroshi; SHIZUKA Reiko; HAYAKAWA Masaki; SAITOH Takayuki; MURAKAMI Masami; HAYASHI Kunihiko; MURAKAMI Hirokazu, Jul. 2020, The official journal of Japanese Society of Laboratory Medicine, 68, 7, 604, 609, Scientific journal
• PARP1 V762A polymorphism affects the prognosis of myelodysplastic syndromes., Nanami Gotoh; Yusuke Minato; Takayuki Saitoh; Noriyuki Takahashi; Tetsuhiro Kasamatsu; Kana Souma; Tsukasa Oda; Takumi Hoshino; Toru Sakura; Takuma Ishizaki; Hiroaki Shimizu; Makiko Takizawa; Akihiko Yokohama; Norifumi Tsukamoto; Hiroshi Handa; Hirokazu Murakami, Jun. 2020, European journal of haematology, 104, 6, 526, 537, Scientific journal

  DOI
• IgG4-related Disease with a Cardiac Mass., Ikuko Matsumura; Takeki Mitsui; Kenichi Tahara; Hiroaki Shimizu; Kunio Yanagisawa; Takuma Ishizaki; Hiromi Koiso; Makiko Takizawa; Akihiko Yokohama; Takayuki Saitoh; Junko Hirato; Hirokazu Murakami; Hiroshi Handa; Norifumi Tsukamoto, 01 May 2020, Internal medicine (Tokyo, Japan), 59, 9, 1203, 1209, Scientific journal

  DOI
• Integrin α7 and Extracellular Matrix Laminin 211 Interaction Promotes Proliferation of Acute Myeloid Leukemia Cells and Is Associated with Granulocytic Sarcoma., Nobuhiko Kobayashi; Tsukasa Oda; Makiko Takizawa; Takuma Ishizaki; Norifumi Tsukamoto; Akihiko Yokohama; Hisashi Takei; Takayuki Saitoh; Hiroaki Shimizu; Kazuki Honma; Kei Kimura-Masuda; Yuko Kuroda; Rei Ishihara; Yuki Murakami; Hirokazu Murakami; Hiroshi Handa, 05 Feb. 2020, Cancers, 12, 2, Scientific journal

  DOI
• PDCD1 and PDCD1LG1 polymorphisms affect the susceptibility to multiple myeloma., Tetsuhiro Kasamatsu; Maaya Awata; Rei Ishihara; Yuki Murakami; Nanami Gotoh; Morio Matsumoto; Morio Sawamura; Akihiko Yokohama; Hiroshi Handa; Norifumi Tsukamoto; Takayuki Saitoh; Hirokazu Murakami, Feb. 2020, Clinical and experimental medicine, 20, 1, 51, 62, Scientific journal

  DOI
• Molecular biology of multiple myeloma and treatment strategy, SAITOH Takayuki, Feb. 2020, Journal of The Japanese Society for Laboratory Hematology
• Effects of overseas study tour on international posture: A report on the ninth US study tour for physical and occupational therapy students at Gunma University, 下 田 佳央莉; 久留利 菜菜; 齋 藤 貴 之, Feb. 2020, 1, 2, 35, 40, Research institution
• Human telomerase reverse transcriptase expression in a CD34-positive hematopoietic progenitor of myelodysplastic syndrome and acute myelogenous leukemia., Hiroshi Handa; Natsumi Nishimoto; Madoka Inoue; Akihiko Yokohama; Norifumi Tsukamoto; Takayuki Saitoh; Hirokazu Murakami, Oct. 2019, Hematological oncology, 37, 4, 520, 522

  DOI
• The Evaluation of an International Symposium using Skype, Kaori Shimoda; Bulganchimeg Sanjmyatav; Maika Murano; Masaaki Sakamoto; Fusae Tozato; Yosie Mori; Gaalan Khulan; Senichiro Kikuchi; Kenji Tsuchiya; Naoto Noguchi; Takako Ochi; Takayuki Saitoh, 01 Aug. 2019, The Kitakanto Medical Journal, 69, 3, 195, 203, Scientific journal

  DOI
• 群馬大学医学部における学生国際交流, 齋藤貴之; 岸美紀子; 鯉淵典之; 小山洋; 坂本雅昭; 石崎泰樹, Aug. 2019, 69, 3
• Key factors affecting the integration of interprofessional education into human resources for health reform: a Lao People’s Democratic Republic case study, Bumsuk Lee; Ketkesone Phrasisombath; Hiromitsu Shinozaki; Phouthone Vangkonevilay; Ketsomsouk Bouphavanh; Khamphanh Prabouasone; Outhip Sounthavong; Yoshiharu Tokita; Takatoshi Makino; Hiroki Matsui; Takayuki Saitoh; Fusae Tozato; Akinori Kama; Hideomi Watanabe, 04 Jul. 2019, Journal of Interprofessional Care, 33, 4, 356, 360, Scientific journal

  DOI
• Evaluation of the Revised International Staging System (R-ISS) in Japanese patients with multiple myeloma., Shuji Ozaki; Hiroshi Handa; Takayuki Saitoh; Hirokazu Murakami; Mitsuhiro Itagaki; Hideki Asaoku; Kenshi Suzuki; Atsushi Isoda; Morio Matsumoto; Morio Sawamura; Kazutaka Sunami; Naoki Takezako; Shotaro Hagiwara; Yoshiaki Kuroda; Takaaki Chou; Eiichi Nagura; Kazuyuki Shimizu, Jul. 2019, Annals of hematology, 98, 7, 1703, 1711, Scientific journal

  DOI
• Activin A: a novel urinary biomarker of renal impairment in multiple myeloma., Hirono Iriuchishima; Akito Maeshima; Shunsuke Takahashi; Takuma Ishizaki; Akihiko Yokohama; Norifumi Tsukamoto; Takayuki Saitoh; Hirokazu Murakami; Hiroshi Handa, 31 May 2019, Bioscience reports, 39, 5, Scientific journal

  DOI
• 分娩を契機に甲状腺クリーゼと溶血の悪化を認めた自己免疫性溶血性貧血, 杉崎 真人; 石埼 卓馬; 入内島 裕乃; 清水 啓明; 柳沢 邦雄; 小川 孔幸; 横濱 章彦; 斉藤 貴之; 塚本 憲史; 半田 寛, Apr. 2019, 60, 8
• Human telomerase reverse transcriptase expression in a CD34-positive hematopoietic progenitor of myelodysplastic syndrome and acute myelogenous leukemia., Handa H; Nishimoto N; Inoue M; Yokohama A; Tsukamoto N; Saitoh T; Murakami H, Apr. 2019, Hematol Oncol.
• Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation., Hiroyuki Takamatsu; Takeshi Yamashita; Shingo Kurahashi; Takayuki Saitoh; Tadakazu Kondo; Takeshi Maeda; Hideyuki Nakazawa; Makoto Murata; Tomoko Narita; Junya Kuroda; Hisako Hashimoto; Koji Kawamura; Toshihiro Miyamoto; Sumihisa Honda; Tatsuo Ichinohe; Yoshiko Atsuta; Kazutaka Sunami, Mar. 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 25, 3, 474, 479, Scientific journal

  DOI
• Distribution of three isoforms of antimicrobial peptide, chrysophsin-1, -2 and -3, in the red sea bream, Pagrus (Chrysophrys) major., Takayuki Saitoh; Yasumitsu Seto; Yukichi Fujikawa; Noriaki Iijima, 01 Feb. 2019, Analytical biochemistry, 566, 13, 15, Scientific journal

  DOI
• Prognostic impact of trisomy 21 in follicular lymphoma., Takeki Mitsui; Akihiko Yokohama; Hiromi Koiso; Akio Saito; Kohtaro Toyama; Hiroaki Shimizu; Takuma Ishizaki; Hiroyuki Irisawa; Makiko Takizawa; Takayuki Saitoh; Kayoko Murayama; Morio Matsumoto; Hiroshi Handa; Junko Hirato; Masaru Kojima; Hirokazu Murakami; Norifumi Tsukamoto, Feb. 2019, British journal of haematology, 184, 4, 570, 577, Scientific journal

  DOI
• Malignancy-Associated Hypercalcemia Related with Receptor Activator of NF-κB Ligand (RANKL) Expression in T-Cell Acute Lymphoblastic Leukemia., Tahara K; Koiso H; Osaki YH; Sekigami T; Yokohama A; Saitoh T; Tsukamoto N; Murakami H; Abe M; Handa H, Feb. 2019, Acta Haematol., 141, 3
• Prognostic impact of trisomy 21 in follicular lymphoma., Mitsui T; Yokohama A; Koiso H; Saito A; Toyama K; Shimizu H; Ishizaki T; Irisawa H; Takizawa M; Saitoh T; Murayama K; Matsumoto M; Handa H; Hirato J; Kojima M; Murakami H; Tsukamoto N, Feb. 2019, Br J Haematol., 184, 4
• Tumor long-axis diameter and SUVmax predict long-term responders in 90Y-ibritumomab tiuxetan monotherapy., Norifumi Tsukamoto; Akihiko Yokohama; Tetsuya Higuchi; Takeki Mitsui; Hiromi Koiso; Makiko Takizawa; Hiroaki Shimizu; Takuma Ishizaki; Morio Matsumoto; Kohtaro Toyama; Tohru Sakura; Hidemi Ogura; Takayuki Saitoh; Fumihiro Ishida; Hirokazu Murakami; Yoshito Tsushima; Hiroshi Handa, Jan. 2019, International journal of hematology, 109, 1, 91, 97, Scientific journal

  DOI
• Tumor long-axis diameter and SUVmax predict long-term responders in 90Y-ibritumomab tiuxetan monotherapy., Tsukamoto N; Yokohama A; Higuchi T; Mitsui T; Koiso H; Takizawa M; Shimizu H; Ishizaki T; Matsumoto M; Toyama K; Sakura T; Ogura H; Saitoh T; Ishida F; Murakami H; Tsushima Y; Handa H, Jan. 2019, Int J Hematol., 109, 1
• Malignancy-Associated Hypercalcemia Related with Receptor Activator of NF-κB Ligand (RANKL) Expression in T-Cell Acute Lymphoblastic Leukemia., Kenichi Tahara; Hiromi Koiso; Yo-Hei Osaki; Tomomi Sekigami; Akihiko Yokohama; Takayuki Saitoh; Norifumi Tsukamoto; Hirokazu Murakami; Masahiro Abe; Hiroshi Handa, 2019, Acta haematologica, 141, 3, 135, 137

  DOI
• [Thyroid storm and exacerbation of autoimmune hemolytic anemia following childbirth]., Manato Sugisaki; Takuma Ishizaki; Hirono Iriuchishima; Hiroaki Shimizu; Kunio Yanagisawa; Yoshiyuki Ogawa; Akihiko Yokohama; Takayuki Saitoh; Norifumi Tsukamoto; Hiroshi Handa, 2019, [Rinsho ketsueki] The Japanese journal of clinical hematology, 60, 8, 924, 928, Scientific journal

  DOI
• Tumor long-axis diameter and SUVmax predict long-term responders in 90Y-ibritumomab tiuxetan monotherapy, Tsukamoto, Norifumi;Yokohama, Akihiko;Higuchi, Tetsuya;Mitsui, Takeki;Koiso, Hiromi;Takizawa, Makiko;Shimizu, Hiroaki;Ishizaki, Takuma;Matsumoto, Morio;Toyama, Kohtaro;Sakura, Tohru;Ogura, Hidemi;Saitoh, Takayuki;Ishida, Fumihiro;Murakami, Hirokazu;Tsushima, Yoshito;Handa, Hiroshi, 2019, INTERNATIONAL JOURNAL OF HEMATOLOGY, 109, 1, 91, 97

  DOI
• Prognostic impact of trisomy 21 in follicular lymphoma, Mitsui, Takeki;Yokohama, Akihiko;Koiso, Hiromi;Saito, Akio;Toyama, Kohtaro;Shimizu, Hiroaki;Ishizaki, Takuma;Irisawa, Hiroyuki;Takizawa, Makiko;Saitoh, Takayuki;Murayama, Kayoko;Matsumoto, Morio;Handa, Hiroshi;Hirato, Junko;Kojima, Masaru;Murakami, Hirokazu;Tsukamoto, Norifumi, 2019, BRITISH JOURNAL OF HAEMATOLOGY, 184, 4, 570, 577

  DOI
• Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation, Takamatsu, Hiroyuki;Yamashita, Takeshi;Kurahashi, Shingo;Saitoh, Takayuki;Kondo, Tadakazu;Maeda, Takeshi;Nakazawa, Hideyuki;Murata, Makoto;Narita, Tomoko;Kuroda, Junya;Hashimoto, Hisako;Kawamura, Koji;Miyamoto, Toshihiro;Honda, Sumihisa;Ichinohe, Tatsuo;Atsuta, Yoshiko;Sunami, Kazutaka, 2019, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 25, 3, 474, 479

  DOI
• Evaluation of the Revised International Staging System (R-ISS) in Japanese patients with multiple myeloma, Ozaki, Shuji;Handa, Hiroshi;Saitoh, Takayuki;Murakami, Hirokazu;Itagaki, Mitsuhiro;Asaoku, Hideki;Suzuki, Kenshi;Isoda, Atsushi;Matsumoto, Morio;Sawamura, Morio;Sunami, Kazutaka;Takezako, Naoki;Hagiwara, Shotaro;Kuroda, Yoshiaki;Chou, Takaaki;Nagura, Eiichi;Shimizu, Kazuyuki, 2019, ANNALS OF HEMATOLOGY, 98, 7, 1703, 1711

  DOI
• Key factors affecting the integration of interprofessional education into human resources for health reform: a Lao People's Democratic Republic case study, Lee, Bumsuk;Phrasisombath, Ketkesone;Shinozaki, Hiromitsu;Vangkonevilay, Phouthone;Bouphavanh, Ketsomsouk;Prabouasone, Khamphanh;Sounthavong, Outhip;Tokita, Yoshiharu;Makino, Takatoshi;Matsui, Hiroki;Saitoh, Takayuki;Tozato, Fusae;Kama, Akinori;Watanabe, Hideomi, 2019, JOURNAL OF INTERPROFESSIONAL CARE, 33, 4, 356, 360

  DOI
• Initial extramedullary myeloma impacts overall survival via affecting post progression survival, Takei, Hisashi;Koiso, Hiromi;Matsumoto, Morio;Murayama, Kayoko;Shimizu, Hiroaki;Ishizaki, Takuma;Saitoh, Takayuki;Saito, Akio;Kobayashi, Nobuhiko;Iriuchishima, Hirono;Ishikawa, Tetsuya;Miyazawa, Yuri;Takizawa, Makiko;Yokohama, Akihiko;Tsukamoto, Norifumi;Murakami, Hirokazu;Handa, Hiroshi, 2019, CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 19, 10, E194, E195
• Human telomerase reverse transcriptase expression in a CD34-positive hematopoietic progenitor of myelodysplastic syndrome and acute myelogenous leukemia, Handa, Hiroshi;Nishimoto, Natsumi;Inoue, Madoka;Yokohama, Akihiko;Tsukamoto, Norifumi;Saitoh, Takayuki;Murakami, Hirokazu, 2019, HEMATOLOGICAL ONCOLOGY, 37, 4, 520, 522

  DOI
• Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma., Tetsuhiro Kasamatsu; Shuji Ozaki; Takayuki Saitoh; Jun Konishi; Kazutaka Sunami; Mitsuhiro Itagaki; Hideki Asaoku; Takaaki Cho; Hiroshi Handa; Shotaro Hagiwara; Toshio Wakayama; Akiko Negoro; Naoki Takezako; Naoko Harada; Yoshiaki Kuroda; Chiaki Nakaseko; Takaaki Miyake; Nobumasa Inoue; Hiroyuki Hata; Chihiro Shimazaki; Tatsuharu Ohno; Junya Kuroda; Tohru Murayama; Takahiro Kobayashi; Masahiro Abe; Tadao Ishida; Eiich Nagura; Kazuyuki Shimizu, Dec. 2018, Hematological oncology, 36, 5, 792, 800, Scientific journal

  DOI
• Association between OGG1 S326C CC genotype and elevated relapse risk in acute myeloid leukemia., Nanami Gotoh; Takayuki Saitoh; Noriyuki Takahashi; Tetsuhiro Kasamatsu; Yusuke Minato; Alkebsi Lobna; Tsukasa Oda; Takumi Hoshino; Toru Sakura; Hiroaki Shimizu; Makiko Takizawa; Hiroshi Handa; Akihiko Yokohama; Norifumi Tsukamoto; Hirokazu Murakami, Sep. 2018, International journal of hematology, 108, 3, 246, 253, Scientific journal

  DOI
• 白血病細胞の眼内浸潤を認めた成人T細胞白血病の1例, 島内 陽子; 馬郡 幹也; 鈴木 康太; 細貝 真弓; 戸所 大輔; 齋藤 貴之; 秋山 英雄, Sep. 2018, 72, 9
• A case of adult T-cell leukemia with intraocular infiltration of leukemic cells, Yoko Shimauchi-Anzai; Mikiya Magori; Kota Suzuki; Mayumi Hosogai; Daisuke Todokoro; Takayuki Saitoh; Hideo Akiyama, Sep. 2018, Japanese Journal of Clinical Ophthalmology, 72, 9, 1235, 1239, Scientific journal
• MTH1 V83M多型VV型は骨髄異形成症候群の発症リスクとなる, 倉持 真留美; 齋藤 貴之; 坂元 亜衣; 塩田 みのり; 後藤 七海; 相馬 佳奈; 須永 征伸; 山根 瑛子; 粟田 真彩; 石原 領; 大圃 真純; 金井 敬海; 村上 有希; 村田 圭祐; 渡辺 早貴; 小田 司; 笠松 哲光; 半田 寛; 村上 博和, Aug. 2018, 68, 3, 200, 201
• 多発性骨髄腫細胞株におけるmicroRNA-29、34 familyの発現制御機構, 村上 有希; 小田 司; 石原 領; 渡辺 早貴; 増田 裕太; 須永 征伸; 山根 瑛子; 小林 宣彦; 武井 寿史; 田原 研一; 大崎 洋平; 石埼 卓馬; 清水 啓明; 後藤 七海; 笠松 哲光; 齋藤 貴之; 村上 博和; 半田 寛, Aug. 2018, 68, 3, 201, 201
• Th1サイトカインTNF-α-857C/Tは急性骨髄性白血病の発症リスク、臨床背景、予後に関与する, 相馬 佳奈; 齋藤 貴之; 後藤 七海; 須永 征伸; 山根 瑛子; 村上 有希; 石原 領; 渡邉 早貴; 金井 敬海; 村田 圭祐; 粟田 真彩; 大圃 真純; 笠松 哲光; 半田 寛; 村上 博和, Aug. 2018, 68, 3, 209, 209
• 多発性骨髄腫における髄外形質細胞腫とMatrix metalloproteinase(MMP)及びtissue inhibitor of metalloproteinases(TIMP)の発現, 石原 領; 小田 司; 渡辺 早貴; 村上 有希; 増田 裕太; 須永 征伸; 山根 瑛子; 小林 宣彦; 武井 寿史; 田原 研一; 大崎 洋平; 石埼 卓馬; 清水 啓明; 後藤 七海; 笠松 哲光; 齋藤 貴之; 村上 博和; 半田 寛, Aug. 2018, 68, 3, 213, 213
• 多発性骨髄腫におけるlong non-cording RNA MALAT1とNEAT1およびNEAT1_2の発現, 渡辺 早貴; 小田 司; 石原 領; 村上 有希; 増田 裕太; 須永 征伸; 山根 瑛子; 小林 宣彦; 武井 寿史; 田原 研一; 大崎 洋平; 石埼 卓馬; 清水 啓明; 後藤 七海; 笠松 哲光; 齋藤 貴之; 村上 博和; 半田 寛, Aug. 2018, 68, 3, 213, 213
• Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302)., Tachibana T; Kanda J; Machida S; Saito T; Tanaka M; Najima Y; Koyama S; Miyazaki T; Yamamoto E; Takeuchi M; Morita S; Kanda Y; Kanamori H; Okamoto S; Kanto Study; Group for Cell Therapy; KSGCT, May 2018, International journal of hematology, 107, 5, 578, 585, Scientific journal

  DOI
• Short-term administration of recombinant human erythropoietin decreases B cell number in human peripheral blood., Tomomi Nagashima; Akihiko Yokohama; Kie Nagai; Tetsuhiro Kasamatsu; Nanami Gotoh; Hirono Iriuchishima; Tomomi Sekigami; Takayuki Saitoh; Hiroshi Handa; Norifumi Tsukamoto; Hirokazu Murakami, Apr. 2018, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 57, 2, 208, 214, Scientific journal

  DOI
• Clinical management and outcomes of completely resected stage I follicular lymphoma., Akihiko Yokohama; Yoko Hashimoto; Makiko Takizawa; Hiroaki Shimizu; Yuri Miyazawa; Akio Saitoh; Kohtaro Toyama; Takuma Ishizaki; Takeki Mitsui; Takayuki Saitoh; Kayoko Murayama; Morio Matsumoto; Morio Sawamura; Hirokazu Murakami; Junko Hirato; Masaru Kojima; Yoshihisa Nojima; Hiroshi Handa; Norifumi Tsukamoto, 16 Mar. 2018, Journal of clinical and experimental hematopathology : JCEH, 58, 1, 10, 16, Scientific journal

  DOI
• Health science students’ attitudes towards healthcare teams: A comparison between two universities, Takatoshi Makino; Bumsuk Lee; Hiroki Matsui; Yoshiharu Tokita; Hiromitsu Shinozaki; Shiomi Kanaizumi; Yumiko Abe; Takayuki Saitoh; Fusae Tozato; Ayako Igarashi; Mika Sato; Shigeki Ohtake; Noriko Tabuchi; Michiko Inagaki; Akinori Kama; Hideomi Watanabe, 04 Mar. 2018, Journal of Interprofessional Care, 32, 2, 196, 202, Scientific journal

  DOI
• PDCD1 and CTLA4 polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia, Tetsuhiro Kasamatsu; Rumi Ino; Noriyuki Takahashi; Nanami Gotoh; Yusuke Minato; Makiko Takizawa; Akihiko Yokohama; Hiroshi Handa; Takayuki Saitoh; Norifumi Tsukamoto; Hirokazu Murakami, Mar. 2018, British Journal of Haematology, 180, 5, 705, 714, Scientific journal

  DOI
• 保健学研究科 国際保健推進室の取り組み ーなぜ、 保健学は国際化が必要かー, 齋藤貴之; 岡美智代; 篠崎博光; 金泉志保美; 辻村弘美; 齊尾征直; 時田佳治; 坂本雅昭; 久留利菜菜; 中澤理恵; 李範爽; 今井忠則; 土屋謙仕; 川島智幸, Mar. 2018
• Clinical management and outcomes of completely resected stage I follicular lymphoma., Yokohama A; Hashimoto Y; Takizawa M; Shimizu H; Miyazawa Y; Saitoh A; Toyama K; Ishizaki T; Mitsui T; Hiromi; Koiso; Saitoh T; Murayama K; Matsumoto M; Sawamura M; Murakami H; Hirato J; Kojima M; Nojima Y; Handa H; Tsukamoto N, Mar. 2018, J Clin Exp Hematop, 58, 1
• PDCD1 and CTLA4 polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia., Kasamatsu T; Ino R; Takahashi N; Gotoh N; Minato Y; Takizawa M; Yokohama A; Handa H; Saitoh T; Tsukamoto N; Murakami H, Mar. 2018, Br J Haematol, 180, 5
• IL17A and IL23R gene polymorphisms affect the clinical features and prognosis of patients with multiple myeloma, Tetsuhiro Kasamatsu; Mari Kimoto; Noriyuki Takahashi; Yusuke Minato; Nanami Gotoh; Makiko Takizawa; Morio Matsumoto; Morio Sawamura; Akihiko Yokohama; Hiroshi Handa; Norifumi Tsukamoto; Takayuki Saitoh; Hirokazu Murakami, Feb. 2018, Hematological Oncology, 36, 1, 196, 201, Scientific journal

  DOI
• Clonal evolution detected with conventional cytogenetic analysis is a potent prognostic factor in adult patients with relapsed AML, Hiroaki Shimizu; Akihiko Yokohama; Takuma Ishizaki; Nahoko Hatsumi; Satoru Takada; Takayuki Saitoh; Toru Sakura; Yoshihisa Nojima; Hiroshi Handa, Feb. 2018, Hematological Oncology, 36, 1, 252, 257, Scientific journal

  DOI
• Health science students’ attitudes towards healthcare teams: A comparison between two universities, Makino, T.; Lee, B.; Matsui, H.; Tokita, Y.; Shinozaki, H.; Kanaizumi, S.; Abe, Y.; Saitoh, T.; Tozato, F.; Igarashi, A.; Sato, M.; Ohtake, S.; Tabuchi, N.; Inagaki, M.; Kama, A.; Watanabe, H., 2018, Journal of Interprofessional Care, 32, 2, Scientific journal

  DOI
• A rare case of chronic active Epstein-Barr virus (EBV) infection accompanied by the infiltration of EBV-infected CD8 + T cells into the muscle, Nobuhiko Kobayashi; Takeki Mitsui; Yoshiyuki Ogawa; Hirono Iriuchishima; Makiko Takizawa; Akihiko Yokohama; Takayuki Saitoh; Hiromi Koiso; Norifumi Tsukamoto; Hirokazu Murakami; Yoshihisa Nojima; Hiroshi Handa, 2018, Journal of Pediatric Hematology/Oncology, 40, 3, e171, e175, Scientific journal

  DOI
• Efficacy and safety of intermediate dose etoposide for mobilization of peripheral blood stem cells in hematopoietic tumors, Takuma Ishizaki; Akihiko Yokohama; Hiroaki Shimizu; Kunio Yanagisawa; Yoshiyuki Ogawa; Takeki Mitsui; Hiromi Koiso; Makiko Takizawa; Takayuki Saitoh; Norifumi Tsukamoto; Hirokazu Murakami; Hiroshi Handa, 2018, Kitakanto Medical Journal, 68, 1, 43, 47, Scientific journal

  DOI
• Clonal evolution detected with conventional cytogenetic analysis is a potent prognostic factor in adult patients with relapsed AML, Shimizu, Hiroaki;Yokohama, Akihiko;Ishizaki, Takuma;Hatsumi, Nahoko;Takada, Satoru;Saitoh, Takayuki;Sakura, Toru;Nojima, Yoshihisa;Handa, Hiroshi, 2018, HEMATOLOGICAL ONCOLOGY, 36, 1, 252, 257

  DOI
• A Rare Case of Chronic Active Epstein-Barr Virus (EBV) Infection Accompanied by the Infiltration of EBV-infected CD8(+) T Cells into the Muscle, Kobayashi, Nobuhiko;Mitsui, Takeki;Ogawa, Yoshiyuki;Iriuchishima, Hirono;Takizawa, Makiko;Yokohama, Akihiko;Saitoh, Takayuki;Koiso, Hiromi;Tsukamoto, Norifumi;Murakami, Hirokazu;Nojima, Yoshihisa;Handa, Hiroshi, 2018, JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 40, 3, E171, E175

  DOI
• Health science students' attitudes towards healthcare teams: A comparison between two universities, Makino, Takatoshi;Lee, Bumsuk;Matsui, Hiroki;Tokita, Yoshiharu;Shinozaki, Hiromitsu;Kanaizumi, Shiomi;Abe, Yumiko;Saitoh, Takayuki;Tozato, Fusae;Igarashi, Ayako;Sato, Mika;Ohtake, Shigeki;Tabuchi, Noriko;Inagaki, Michiko;Kama, Akinori;Watanabe, Hideomi, 2018, JOURNAL OF INTERPROFESSIONAL CARE, 32, 2, 196, 202

  DOI
• Clinical Significance of Clonal Cytogenetic Heterogeneity (CCH) at Diagnosis in Adult Patients with Acute Lymphoblastic Leukemia (ALL), Shimizu, Hiroaki;Hatsumi, Nahoko;Takada, Satoru;Ishizaki, Takuma;Yokohama, Akihiko;Saitoh, Takayuki;Sakura, Toru;Handa, Hiroshi, 2018, BLOOD, 132

  DOI
• Matrix Metalloproteinase and Tissue Inhibitor of Metalloproteinases Is Associated with Multiple Myeloma Progression, Prognosis and Extramedullary Plasmacytoma, Ishihara, Rei;Murakami, Yuki;Homma, Kazuki;Watanabe, Saki;Oda, Tsukasa;Sunaga, Masanobu;Yamane, Eiko;Kobayashi, Nobuhiko;Osaki, Yohei;Ishizaki, Takuma;Shimizu, Hiroaki;Iriuchishima, Hirono;Koiso, Hiromi;Tsukamoto, Norifumi;Yokohama, Akihiko;Nanami, Gotoh;Ino, Rumi;Saitoh, Takayuki;Murakami, Hirokazu;Handa, Hiroshi, 2018, BLOOD, 132

  DOI
• Polymorphism of IL-10 receptor β affects the prognosis of multiple myeloma patients treated with thalidomide and/or bortezomib, Tetsuhiro Kasamatsu; Takayuki Saitoh; Rumi Ino; Nanami Gotoh; Takeki Mitsui; Hiroaki Shimizu; Morio Matsumoto; Morio Sawamura; Akihiko Yokohama; Hiroshi Handa; Norifumi Tsukamoto; Hirokazu Murakami, Dec. 2017, Hematological Oncology, 35, 4, 711, 718, Scientific journal

  DOI
• Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma, Hiroshi Handa; Yuko Kuroda; Kei Kimura; Yuta Masuda; Hikaru Hattori; Lobna Alkebsi; Morio Matsumoto; Tetsuhiro Kasamatsu; Nobuhiko Kobayashi; Ken Ichi Tahara; Makiko Takizawa; Hiromi Koiso; Takuma Ishizaki; Hiroaki Shimizu; Akihiko Yokohama; Norifumi Tsukamoto; Takayuki Saito; Hirokazu Murakami, Nov. 2017, British Journal of Haematology, 179, 3, 449, 460, Scientific journal

  DOI
• 群馬大学のInterprofessional education (IPE)の取り組み, 外里 冨佐江; 篠﨑 博光; 金泉 志保美; 牧野 孝俊; 齋藤 貴之; 安部 由美子; 吉田 朋美; 松井 弘樹; 時田 佳治; 山路 雄彦; 佐藤 江奈; 李 範爽; 川島 智幸; 鎌田 英男; 岸 美紀子; 蒲 章則; 渡邊 秀臣, Oct. 2017, 10, 2
• アルキル化薬とステロイド, 村上 博和; 笠松 哲光; 齋藤 貴之; 半田 寛, Oct. 2017, 120, 4
• Recurrent alterations of the WW domain containing oxidoreductase gene spanning the common fragile site FRA16D in multiple myeloma and monoclonal gammopathy of undetermined significance., Handa H; Sasaki Y; Hattori H; Alkebsi L; Kasamatsu T; Saitoh T; Mitsui T; Yokohama A; Tsukamoto N; Matsumoto M; Murakami H, Oct. 2017, Oncol Lett., 14, 4
• The bridge treatment selected at the decision for transplantation did not affect the outcomes in patients with MDS, Shinichi Kako; Yoshinobu Kanda; Jun Kato; Wataru Yamamoto; Seiko Kato; Makoto Onizuka; Akira Yokota; Raine Tatara; Hiroki Yokoyama; Maki Hagihara; Kensuke Usuki; Moritaka Gotoh; Reiko Watanabe; Nobutaka Kawai; Takayuki Saitoh; Heiwa Kanamori; Satoshi Takahashi; Shinichiro Okamoto, Sep. 2017, Hematological Oncology, 35, 3, 341, 349, Scientific journal

  DOI
• Overexpression of B-cell lymphoma 6 alters gene expression profile in a myeloma cell line and is associated with decreased DNA damage response, Kenichi Tahara; Makiko Takizawa; Arito Yamane; Yohei Osaki; Takuma Ishizaki; Takeki Mitsui; Akihiko Yokohama; Takayuki Saitoh; Norifumi Tsukamoto; Morio Matsumoto; Hirokazu Murakami; Yoshihisa Nojima; Hiroshi Handa, Aug. 2017, Cancer Science, 108, 8, 1556, 1564, Scientific journal

  DOI
• DNA修復に着眼した多発性骨髄腫の耐性機構の解明, 齋藤 貴之, Aug. 2017, 32, 9
• 多発性骨髄腫における免疫チェックポイント分子の意義, 笠松 哲光; 齋藤 貴之; 村上 博和, Aug. 2017, 32, 9
• The cytokine polymorphisms affecting Th1/Th2 increase the susceptibility to, and severity of, chronic ITP, Noriyuki Takahashi; Takayuki Saitoh; Nanami Gotoh; Yasuhiro Nitta; Lobna Alkebsi; Tetsuhiro Kasamatsu; Yusuke Minato; Akihiko Yokohama; Norifumi Tsukamoto; Hiroshi Handa; Hirokazu Murakami, 16 May 2017, BMC Immunology, 18, 1, Scientific journal

  DOI
• Successful Treatment of Hepatocellular Carcinoma Complicated by Fanconi Anemia., Takahashi K; Suzuki E; Yokoyama M; Inoue M; Wakamatsu T; Saito T; Kusakabe Y; Ogasawara S; Ooka Y; Tawada A; Nagao Y; Nakaseko C; Chiba T, Jan. 2017, Case reports in gastroenterology, 11, 1, 29, 35, Scientific journal

  DOI
• Recurrent alterations of the WW domain containing oxidoreductase gene spanning the common fragile site FRA16D in multiple myeloma and monoclonal gammopathy of undetermined significance, Hiroshi Handa; Yoshiko Sasaki; Hikaru Hattori; Lobna Alkebsi; Tetsuhiro Kasamatsu; Takayuki Saitoh; Takeki Mitsui; Akihiko Yokohama; Norifumi Tsukamoto; Morio Matsumoto; Hirokazu Murakami, 2017, Oncology Letters, 14, 4, 4372, 4378, Scientific journal

  DOI
• XRCC1 Arg194Trp and XRCC1 Arg399Gln polymorphisms affect clinical features and prognosis of M yelodysplastic syndromes, Batchimeg Norjmaa; Takayuki Saitoh; Tetsuhiro Kasamatsu; Yusuke Minato; Hirokazu Murakami, 2017, Kitakanto Medical Journal, 67, 1, 93, 94, Scientific journal

  DOI
• XRCC1 Arg194Trp and XRCC1 Arg399Gln polymorphisms affect clinical features and prognosis of M yelodysplastic syndromes, Batchimeg Norjmaa; Takayuki Saitoh; Tetsuhiro Kasamatsu; Yusuke Minato; Hirokazu Murakami, 2017, Kitakanto Medical Journal, 67, 1, 93, 94, Scientific journal

  DOI
• Chromosome 16q genes CDH1, CDH13 and ADAMTS18 are correlated and frequently methylated in human lymphoma, Lobna Alkebsi; Hiroshi Handa; Akihiko Yokohama; Takayuki Saitoh; Norifumi Tsukamoto; Hirokazu Murakami, Nov. 2016, Oncology Letters, 12, 5, 3523, 3530, Scientific journal

  DOI
• A plan for embedding an interprofessional education initiative into an existing programme in a Southeast Asian university, Bumsuk Lee; Hiromitsu Shinozaki; Ketsomsouk Bouphavanh; Yoshiharu Tokita; Takatoshi Makino; Hiroki Matsui; Takayuki Saitoh; Fusae Tozato; Hideomi Watanabe, 03 May 2016, Journal of Interprofessional Care, 30, 3, 401, 403, Scientific journal

  DOI
• Reduced frequency treatment with bortezomib plus dexamethasone for elderly patients with relapsed and/or refractory multiple myeloma: a phase 2 study of the Japanese Myeloma Study Group (JMSG-0902), Shuji Ozaki; Hiroyuki Hata; Masahiro Abe; Takayuki Saitoh; Ichiro Hanamura; Hiroki Yano; Kazutaka Sunami; Hiroshi Kosugi; Morio Sawamura; Tomonori Nakazato; Taro Masunari; Mayumi Mori; Toshiyuki Takagi; Hirokazu Murakami; Kazuyuki Shimizu, 01 May 2016, Annals of Hematology, 95, 6, 921, 929, Scientific journal

  DOI
• III. Treatment of relapsed/refractory multiple myeloma, Hirokazu Murakami; Takayuki Saitoh; Tetsuhiro Kasamatsu, May 2016, Japanese Journal of Cancer and Chemotherapy, 43, 5, 539, 544, Scientific journal
• 多発性骨髄腫診断基準と病期分類の変遷と展望．多発性骨髄腫学―最新の臨床と基礎研究―, 齋藤 貴之; 笠松 哲光; 村上 博和, May 2016, 74
• 血液・リンパ系腫瘍 再発・難治性造血器腫瘍の治療―新規・追加承認薬とその位置づけ―Ⅲ．多発性骨髄腫, 村上 博和; 齋藤 貴之; 笠松 哲光, May 2016, 43, 5
• Aberrant epigenome and miRNA of multiple myeloma, 半田 寛; 斉藤 貴之; 村上 博和, May 2016, 72, 5, 684, 690
• Professional identity acquisition process model in interprofessional education using structural equation modelling: 10-year initiative survey, Nana Kururi; Fusae Tozato; Bumsuk Lee; Hiroko Kazama; Shiori Katsuyama; Maiko Takahashi; Yumiko Abe; Hiroki Matsui; Yoshiharu Tokita; Takayuki Saitoh; Shiomi Kanaizumi; Takatoshi Makino; Hiromitsu Shinozaki; Takehiko Yamaji; Hideomi Watanabe, 03 Mar. 2016, Journal of Interprofessional Care, 30, 2, 175, 183, Scientific journal

  DOI
• Polymorphisms of IL-10 affect the severity and prognosis of myelodysplastic syndrome, Tetsuhiro Kasamatsu; Takayuki Saitoh; Yusuke Minato; Hiroaki Shimizu; Akihiko Yokohama; Norifumi Tsukamoto; Hiroshi Handa; Toru Sakura; Hirokazu Murakami, 01 Mar. 2016, European Journal of Haematology, 96, 3, 245, 251, Scientific journal

  DOI
• Primary Plasma Cell Leukemia in the Era of Novel Agents: A Multicenter Study of the Japanese Society of Myeloma, Hirono Iriuchishima; Shuji Ozaki; Jun Konishi; Morio Matsumoto; Kayoko Murayama; Fumihiko Nakamura; Go Yamamoto; Hiroshi Handa; Takayuki Saitoh; Eiichi Nagura; Kazuyuki Shimizu; Yoshihisa Nojima; Hirokazu Murakami, 01 Feb. 2016, Acta Haematologica, 135, 2, 113, 121, Scientific journal

  DOI
• SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patients, Takeki Mitsui; Hiromi Koiso; Hirotaka Nakahashi; Akio Saitoh; Hiroaki Shimizu; Takuma Ishizaki; Yoshiyuki Ogawa; Makiko Takizawa; Akihiko Yokohama; Takayuki Saitoh; Takahiro Jinbo; Hidemi Ogura; Hiroshi Handa; Morio Sawamura; Tohru Sakura; Masamitsu Karasawa; Hirokazu Murakami; Yoshihisa Nojima; Norifumi Tsukamoto, 01 Feb. 2016, International Journal of Hematology, 103, 2, 219, 226, Scientific journal

  DOI
• Diffuse large B-cell lymphoma of the testis relapsed 16 years after achieving complete response, Isao Nagasaka; Takeki Mitsui; Takuma Ishizaki; Hiromi Koiso; Akihiko Yokohama; Takayuki Saitoh; Junko Hirato; Tadahiko Igarashi; Masaru Kojima; Norifumi Tsukamoto; Yoshihisa Nojima; Hirokazu Murakami; Hiroshi Handa, 01 Dec. 2015, [Rinshō ketsueki] The Japanese journal of clinical hematology, 56, 12, 2447, 2451, Scientific journal

  DOI
• Primary leptomeningeal B-cell lymphoma with normal pressure hydrocephalus at diagnosis, Takuma Ishizaki; Takeki Mitsui; Yuri Uchiyama; Yoshiyuki Ogawa; Hiromi Koiso; Makiko Takizawa; Akihiko Yokohama; Takayuki Saitoh; Hiroshi Handa; Norifumi Tsukamoto; Hirokazu Murakami; Yoshihisa Nojima, 01 Dec. 2015, [Rinshō ketsueki] The Japanese journal of clinical hematology, 56, 12, 2441, 2446, Scientific journal

  DOI
• 骨髄腫の診断と鑑別診断, 齋藤 貴之; 村上 博和, Dec. 2015, 33, 12
• 寛解16年後に再発した精巣原発びまん性大細胞型B細胞リンパ腫, 長坂 伊左男; 三井 健揮; 石埼 卓馬; 小磯 博美; 横濱 章彦; 齋藤 貴之; 平戸 純子; 五十嵐 忠彦; 小島 勝; 塚本 憲史; 野島 美久; 村上 博和; 半田 寛, Dec. 2015, 56, 12

  DOI
• Effect of the order of TBI and cyclophosphamide administration on the outcome of allogeneic hematopoietic stem cell transplantation, K. Motohashi; S. Fujisawa; M. Onizuka; S. Kako; E. Sakaida; K. Shono; R. Tatara; N. Doki; T. Mori; T. Sakura; N. Aotsuka; E. Fuji; N. Tomita; N. Kawai; T. Saitoh; K. Usuki; J. Taguchi; R. Watanabe; S. Kobayashi; S. Yano; H. Kanamori; S. Takahashi; S. Okamoto, 01 Nov. 2015, Bone Marrow Transplantation, 50, 11, 1476, 1479

  DOI
• Allogeneic hematopoietic stem cell transplantation for adult patients with mixed phenotype acute leukemia: Results of a matched-pair analysis, Hiroaki Shimizu; Takayuki Saitoh; Shinichiro Machida; Shinichi Kako; Noriko Doki; Takehiko Mori; Toru Sakura; Yoshinobu Kanda; Heiwa Kanamori; Shuichi Miyawaki; Shinichiro Okamoto, Nov. 2015, European Journal of Haematology, 95, 5, 455, 460, Scientific journal

  DOI
• Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed/refractory follicular lymphoma, S. Yano; T. Mori; Y. Kanda; J. Kato; C. Nakaseko; S. Fujisawa; N. Tomita; R. Sakai; K. Shono; T. Saitoh; N. Aotsuka; N. Kobayashi; T. Saito; S. Takahashi; H. Kanamori; S. Okamoto, 01 Oct. 2015, Bone Marrow Transplantation, 50, 10, 1299, 1305, Scientific journal

  DOI
• Trends of survival in patients with multiple myeloma in Japan: A multicenter retrospective collaborative study of the Japanese Society of Myeloma, S. Ozaki; H. Handa; T. Saitoh; H. Murakami; M. Itagaki; H. Asaoku; K. Suzuki; A. Isoda; M. Matsumoto; M. Sawamura; J. Konishi; K. Sunami; N. Takezako; S. Hagiwara; Y. Kuroda; T. Chou; E. Nagura; K. Shimizu, 18 Sep. 2015, Blood Cancer Journal, 5

  DOI
• 骨髄腫細胞におけるマイクロRNAとエピゲノムネットワーク, 半田 寛; 斉藤 貴之; 村上 博和, Jun. 2015, 70, 6
• Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: A prospective cohort study by the Kanto Study Group for Cell Therapy, M. Tanaka; H. Kanamori; K. Matsumoto; T. Tachibana; A. Numata; K. Ohashi; T. Kobayashi; C. Nakaseko; Y. Kanda; E. Yamazaki; S. Fujisawa; J. Ooi; T. Sakura; N. Aotsuka; M. Onoda; S. Machida; J. Kato; K. Usuki; R. Watanabe; J. Taguchi; S. Yano; T. Saito; S. Takahashi; H. Sakamaki; S. Okamoto, 08 May 2015, Bone Marrow Transplantation, 50, 5, 727, 733, Scientific journal

  DOI
• 病気の話し 多発性骨髄腫, 笠松 哲光; 齋藤 貴之; 村上 博和, May 2015, 43, 5
• High percentage of regulatory T cells before and after vitamin B12 treatment in patients with pernicious anemia, Satoru Watanabe; Norifumi Ide; Hatsue Ogawara; Akihiko Yokohama; Takeki Mitsui; Hiroshi Handa; Hiromi Koiso; Norifumi Tsukamoto; Takayuki Saitoh; Hirokazu Murakami, Apr. 2015, Acta Haematologica, 133, 1, 83, 88, Scientific journal

  DOI
• High Frequency of Hepatitis B Core and Surface Antibodies in Hepatitis C Virus-Infected Patients on the Screening Examination, Chiaki Suto; Hirokazu Murakami; Yoshino Kobayashi; Takeaki Nagamine; Takayuki Saitoh; Tetsuhiro Kasamatsu; Hatsue Ogawara; Masami Murakami, 01 Mar. 2015, Rinsho byori. The Japanese journal of clinical pathology, 63, 3, 305, 311, Scientific journal
• A new staging system to predict prognosis of patients with multiple myeloma in an era of novel therapeutic agents, Hirono Iriuchishima; Takayuki Saitoh; Hiroshi Handa; Atsushi Isoda; Morio Matsumoto; Morio Sawamura; Atsushi Iwasaki; Chiaki Ushie; Hikaru Hattori; Yoshiko Sasaki; Takeki Mitsui; Akihiko Yokohama; Norifumi Tsukamoto; Hirokazu Murakami; Yoshihisa Nojima, 01 Feb. 2015, European Journal of Haematology, 94, 2, 145, 151, Scientific journal

  DOI
• [Immunomodulatory effects of lenalidomide], Hiroshi Handa; Takayuki Saitoh; Hirokazu Murakami, 01 Jan. 2015, Nihon rinsho. Japanese journal of clinical medicine, 73, 1, 156, 161, Scientific journal
• レナリドミドの免疫調整作用, 半田 寛; 斉藤 貴之; 村上 博和, Jan. 2015, 73, 1
• Successful Treatment with Recombinant Thrombomodulin for a Case of Adult Onset Kasabach-Merritt Syndrome Caused by Left Thigh Hemangioma, Ogawa Yoshiyuki; Handa Hiroshi; Tsukamoto Norifumi; Murakami Hirokazu; Nojima Yoshihisa; Yanagisawa Kunio; Uchiumi Hideki; Ishizaki Takuma; Mitsui Takeki; Takizawa Makiko; Koiso Hiromi; Yokohama Akihiko; Saitoh Takayuki, 2015, The Kitakanto Medical Journal, 65, 3, 187, 191

  DOI
• XRCC1 Arg194Trp and XRCC1 Arg399Gln polymorphisms affect clinical features and prognosis of myelodysplastic syndromes, Batchimeg Norjmaa; Takayuki Saitoh; Tetsuhiro Kasamatsu; Yusuke Minato; Hirokazu Murakami, 2015, Kitakanto Medical Journal, 65, 1, 11, 19, Scientific journal

  DOI
• Does the hematopoietic cell transplantation specific comorbidity index (HCT-CI) predict transplantation outcomes? A Prospective multicenter validation study of the kanto study group for cell therapy, Aya Nakaya; Takehiko Mori; Masatsugu Tanaka; Naoto Tomita; Chiaki Nakaseko; Shingo Yano; Shin Fujisawa; Hisashi Sakamaki; Nobuyuki Aotsuka; Akira Yokota; Yoshinobu Kanda; Toru Sakura; Yasuhito Nanya; Takayuki Saitoh; Heiwa Kanamori; Satoshi Takahashi; Shinichiro Okamoto, 01 Oct. 2014, Biology of Blood and Marrow Transplantation, 20, 10, 1553, 1559, Scientific journal

  DOI
• Problems in the practice for elderly myeloma patients, 半田 寛; 斉藤 貴之; 村上 博和, Oct. 2014, 69, 4, 484, 490
• 再発または難治性骨髄腫を有する高齢患者に対するbortezomib+DEXの週1回投与(JMSG-0902)(Weekly bortezomib + DEX for elderly patients with relapsed or refractory myeloma(JMSG-0902)), Ozaki Shuji; Hata Hiroyuki; Abe Masahiro; Saito Takayuki; Hanamura Ichiro; Yano Hiroki; Sunami Kazutaka; Kosugi Hiroshi; Sawamura Morio; Nakazato Tomonori; Masunari Taro; Mori Mayumi; Takagi Toshiyuki; Shimizu Kazuyuki; The Japanese Society of Myeloma, Sep. 2014, 臨床血液, 55, 9, 1293, 1293
• Survival of multiple myeloma patients aged 65-70 years in the era of novel agents and autologous stem cell transplantation, Shuji Ozaki; Takeshi Harada; Takayuki Saitoh; Chihiro Shimazaki; Mitsuhiro Itagaki; Hideki Asaoku; Yoshiaki Kuroda; Takaaki Chou; Yumiko Yoshiki; Kenshi Suzuki; Hirokazu Murakami; Kunihiko Hayashi; Roberto Mina; Antonio Palumbo; Kazuyuki Shimizu, Aug. 2014, Acta Haematologica, 132, 2, 211, 219, Scientific journal

  DOI
• 多発性骨髄腫および類縁疾患．, 村上 博和; 齋藤 貴之; 笠松 哲光, Aug. 2014
• [Successful treatment with dasatinib for polycythemia vera patient emerging BCR-ABL positive clone during 13 years of treatment]., Makiko Takizawa; Akihiko Yokohama; Tomomi Sekigami; Hiromi Koiso; Takuma Ishizaki; Takeki Mitsui; Yoshiyuki Ogawa; Takayuki Saitoh; Hiroshi Handa; Norifumi Tsukamoto; Hirokazu Murakami; Yoshihisa Nojima, Jun. 2014, [Rinshō ketsueki] The Japanese journal of clinical hematology, 55, 6, 687, 691, Scientific journal
• 白血病と言われたら, 齋藤貴之; 村上博和, Jun. 2014
• マイクロRNAと多発性骨髄腫, 半田 寛; 斉藤 貴之; 村上 博和, Jun. 2014, 68, 6
• DNA修復と血液疾患, 齋藤 貴之, May 2014, 64, 2

  DOI
• Leukemia-like onset of bone marrow metastasis from anaplastic oligodendroglioma after 17 years of dormancy: an autopsy case report, Yuko Tanaka; Sumihito Nobusawa; Hayato Ikota; Hideaki Yokoo; Junko Hirato; Hideaki Ito; Tatsuhiro Saito; Hidemi Ogura; Yoichi Nakazato, Apr. 2014, BRAIN TUMOR PATHOLOGY, 31, 2, 131, 136, Scientific journal

  DOI
• A newly diagnosed CML-CP HBV carrier was safely treated with Dasatinib and Entecavir, Hisashi Takei; Takeki Mitsui; Naru Sato; Akio Saito; Takumi Hoshino; Hiromi Koiso; Makiko Takizawa; Akihiko Yokohama; Takayuki Saito; Norifumi Tsukamoto; Kazuhiro Murakami; Hiroshi Handa; Yoshihisa Nojima, Apr. 2014, Kitakanto Medical Journal, 64, 1, 51, 55, Scientific journal

  DOI
• 移植非適応骨髄腫の治療 高齢者治療の問題点, 齋藤貴之; 村上博和; 半田寛, Mar. 2014, 7
• [Relapsed primary intraocular lymphoma treated with intravitreal methotrexate and high-dose chemotherapy followed by autologous stem cell rescue]., Tadashi Kamio; Akihiko Yokohama; Toshimasa Hayashi; Kotaro Toyama; Hiroko Koya; Takumi Hoshino; Takayuki Saitoh; Naoto Hanyuda; Ryou Mukai; Hiroshi Handa; Hirokazu Murakami; Norifumi Tsukamoto; Yoshihisa Nojima, Feb. 2014, [Rinshō ketsueki] The Japanese journal of clinical hematology, 55, 2, 244, 248, Scientific journal
• Introduction to IPE Training Course at Gunma University, TOKITA Yoshiharu; TOZATO Fusae; SHINOZAKI Hiromitsu; WATANABE Hideomi; KANAIZUMI Shiomi; SAITOH Takayuki; MAKINO Takatoshi; MATSUI Hiroki; KURURI Nana; LEE Bumsuk; ABE Yumiko; ASAKAWA Yasuyoshi, 2014, The Journal of Interprofessional Collaboration in Health and Social Care, 7, 2, 126, 130

  DOI
• 形質細胞腫瘍～特異な病型～ 1．骨の孤発性形質細胞腫, 齋藤貴之; 笠松哲光; 村上博和, 2014
• Relapsed primary intraocular lymphoma treated with intravitreal methotrexate and high-dose chemotherapy followed by autologous stem cell rescue, KAMIO Tadashi; HANDA Hiroshi; MURAKAMI Hirokazu; TSUKAMOTO Norifumi; NOJIMA Yoshihisa; YOKOHAMA Akihiko; HAYASHI Toshimasa; TOYAMA Kotaro; KOYA Hiroko; HOSHINO Takumi; SAITOH Takayuki; HANYUDA Naoto; MUKAI Ryou, 2014, Rinsho Ketsueki, 55, 2, 244, 248

  DOI
• Successful treatment with dasatinib for polycythemia vera patient emerging BCR-ABL positive clone during 13 years of treatment, TAKIZAWA Makiko; TSUKAMOTO Norifumi; MURAKAMI Hirokazu; NOJIMA Yoshihisa; YOKOHAMA Akihiko; SEKIGAMI Tomomi; KOISO Hiromi; ISHIZAKI Takuma; MITSUI Takeki; OGAWA Yoshiyuki; SAITOH Takayuki; HANDA Hiroshi, 2014, Rinsho Ketsueki, 55, 6, 687, 691

  DOI
• Regulatory T cells percentage in peripheral blood before and after eradication of Helicobacter pylori, Yuka Satoh; Hatsue Ogawara; Osamu Kawamura; Yasuyuki Shimoyama; Motoyasu Kusano; Akihiko Yokohama; Takayuki Saitoh; Hiroshi Handa; Norifumi Tsukamoto; Hirokazu Murakami, 2014, Health, 6, 4

  DOI
• DNMT3B7 expression related to MENT expression and its promoter methylation in human lymphomas, Lobna Alkebsi; Hiroshi Handa; Yoshiko Sasaki; Yohei Osaki; Kunio Yanagisawa; Yoshiaki Ogawa; Akihiko Yokohama; Hikaru Hattori; Hiromi Koiso; Takayuki Saitoh; Takeki Mitsui; Norifumi Tsukamoto; Yoshihisa Nojima; Hirokazu Murakami, Dec. 2013, Leukemia Research, 37, 12, 1662, 1667, Scientific journal

  DOI
• Characterization of CD56⁺ dendritic-like cells: A normal counterpart of blastic plasmacytoid dendritic cell neoplasm?, Yohei Osaki; Akihiko Yokohama; Akio Saito; Kenichi Tahara; Kunio Yanagisawa; Yoshiyuki Ogawa; Takuma Ishizaki; Takeki Mitsui; Hiromi Koiso; Makiko Takizawa; Hideki Uchiumi; Takayuki Saitoh; Hiroshi Handa; Hirokazu Murakami; Norifumi Tsukamoto; Yoshihisa Nojima, 29 Nov. 2013, PLoS ONE, 8, 11, e81722, Scientific journal

  DOI
• Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia, Hiroaki Shimizu; Takayuki Saitoh; Nahoko Hatsumi; Satoru Takada; Hiroshi Handa; Takahiro Jimbo; Toru Sakura; Shuichi Miyawaki; Yoshihisa Nojima, Nov. 2013, Leukemia Research, 37, 11, 1477, 1481, Scientific journal

  DOI
• Genetic differences between Asian and Caucasian chronic lymphocytic leukemia, Norihiko Kawamata; Chimene Moreilhon; Takayuki Saitoh; Masamitsu Karasawa; Brian K. Bernstein; Aiko Sato-Otsubo; Seishi Ogawa; Sophie Raynaud; H. Phillip Koeffler, Aug. 2013, International Journal of Oncology, 43, 2, 561, 565, Scientific journal

  DOI
• Development of IgG4-related disease 10 years after chemotherapy for diffuse large B cell lymphoma and longstanding bronchial asthma, Takeki Mitsui; Akihiko Yokohama; Hiromi Koiso; Takuma Ishizaki; Hideki Uchiumi; Takayuki Saitoh; Hiroshi Handa; Junko Hirato; Masamitsu Karasawa; Hirokazu Murakami; Masaru Kojima; Yoshihisa Nojima; Norifumi Tsukamoto, Jul. 2013, International Journal of Hematology, 98, 1, 122, 128, Scientific journal

  DOI
• 血漿タンパクの異常 クリオグロブリン血症, 村上博和; 齋藤貴之; 半田寛, May 2013
• 多発性骨髄腫に対するプロテアソーム阻害薬治療, 村上 博和; 齋藤 貴之; 半田 寛, May 2013, 40, 5
• [I. Proteasome inhibitor for treatment of multiple myeloma]., Hirokazu Murakami; Takayuki Saito; Hiroshi Handa, May 2013, Gan to kagaku ryoho. Cancer & chemotherapy, 40, 5, 583, 588, Scientific journal
• Distinctive disease subgroups according to differentiation stages in adult patients with T-cell acute lymphoblastic leukemia, Hiroaki Shimizu; Hiroshi Handa; Nahoko Hatsumi; Satoru Takada; Takayuki Saitoh; Toru Sakura; Shuichi Miyawaki; Yoshihisa Nojima, Apr. 2013, European Journal of Haematology, 90, 4, 301, 307, Scientific journal

  DOI
• 多発性骨髄腫に多く見られる感染症, 齋藤貴之; 村上博和, Mar. 2013, 2
• 血縁者間同種造血幹細胞移植後にドナー由来のHLA抗体が出現し, 血小板輸血不応を来した急性骨髄性白血病, 内山 由理; 星野 匠臣; 三原 正大; 三井 健揮; 小磯 博美; 滝沢 牧子; 横濱 章彦; 斉藤 貴之; 内海 英貴; 半田 寛; 塚本 憲史; 村上 博和; 野島 美久, Feb. 2013, 54, 2

  DOI
• [Emergence of donor-derived anti-HLA antibody and subsequent transfusion-refractory thrombocytopenia after allogeneic hematopoietic stem cell transplantation from an HLA-matched sibling donor in a patient with acute myeloid leukemia]., Yuri Uchiyama; Takumi Hoshino; Masahiro Mihara; Takeki Mitsui; Hiromi Koiso; Makiko Takizawa; Akihiko Yokohama; Takayuki Saitoh; Hideki Uchiumi; Hiroshi Handa; Norifumi Tsukamoto; Hirokazu Murakami; Yoshihisa Nojima, Feb. 2013, [Rinsho ketsueki] The Japanese journal of clinical hematology, 54, 2, 214, 8, Scientific journal

  DOI
• Prognostic importance of the soluble form of IL-2 receptorα (sIL-2Rα) and its relationship with surface expression of IL-2Rα (CD25) of lymphoma cells in diffuse large B-cell lymphoma treated with CHOP-like regimen with or without rituximab: a retrospective analysis of 338 cases, Yoko Hashimoto; Akihiko Yokohama; Akio Saitoh; Hirotaka Nakahashi; Kohtaro Toyama; Takeki Mitsui; Hiromi Koiso; Takayuki Saitoh; Hiroshi Handa; Hideki Uchiumi; Takahiro Jinbo; Kayoko Murayama; Morio Matsumoto; Morio Sawamura; Masamitsu Karasawa; Hirokazu Murakami; Junko Hirato; Yoshihisa Nojima; Masaru Kojima; Norifumi Tsukamoto, 2013, Journal of clinical and experimental hematopathology : JCEH, 53, 3, 197, 205, Scientific journal

  DOI
• Characterization of CD56(+) Dendritic-Like Cells: A Normal Counterpart of Blastic Plasmacytoid Dendritic Cell Neoplasm?, Osaki, Yohei;Yokohama, Akihiko;Saito, Akio;Tahara, Kenichi;Yanagisawa, Kunio;Ogawa, Yoshiyuki;Ishizaki, Takuma;Mitsui, Takeki;Koiso, Hiromi;Takizawa, Makiko;Uchiumi, Hideki;Saitoh, Takayuki;Handa, Hiroshi;Murakami, Hirokazu;Tsukamoto, Norifumi;Nojima, Yoshihisa, 2013, PLOS ONE, 8, 11

  DOI
• Distinctive disease subgroups according to differentiation stages in adult patients with T-cell acute lymphoblastic leukemia, Shimizu, Hiroaki;Handa, Hiroshi;Hatsumi, Nahoko;Takada, Satoru;Saitoh, Takayuki;Sakura, Toru;Miyawaki, Shuichi;Nojima, Yoshihisa, 2013, EUROPEAN JOURNAL OF HAEMATOLOGY, 90, 4, 301, 307

  DOI
• Development of IgG4-related disease 10 years after chemotherapy for diffuse large B cell lymphoma and longstanding bronchial asthma, Mitsui, Takeki;Yokohama, Akihiko;Koiso, Hiromi;Ishizaki, Takuma;Uchiumi, Hideki;Saitoh, Takayuki;Handa, Hiroshi;Hirato, Junko;Karasawa, Masamitsu;Murakami, Hirokazu;Kojima, Masaru;Nojima, Yoshihisa;Tsukamoto, Norifumi, 2013, INTERNATIONAL JOURNAL OF HEMATOLOGY, 98, 1, 122, 128

  DOI
• Genetic differences between Asian and Caucasian chronic lymphocytic leukemia, Kawamata, Norihiko;Moreilhon, Chimene;Saitoh, Takayuki;Karasawa, Masamitsu;Bernstein, Brian K.;Sato-Otsubo, Aiko;Ogawa, Seishi;Raynaud, Sophie;Koeffler, H. Phillip, 2013, INTERNATIONAL JOURNAL OF ONCOLOGY, 43, 2, 561, 565

  DOI
• DNMT3B7 expression related to MENT expression and its promoter methylation in human lymphomas, Alkebsi, Lobna;Handa, Hiroshi;Sasaki, Yoshiko;Osaki, Yohei;Yanagisawa, Kunio;Ogawa, Yoshiaki;Yokohama, Akihiko;Hattori, Hikaru;Koiso, Hiromi;Saitoh, Takayuki;Mitsui, Takeki;Tsukamoto, Norifumi;Nojima, Yoshihisa;Murakami, Hirokazu, 2013, LEUKEMIA RESEARCH, 37, 12, 1662, 1667

  DOI
• Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma, H. Shimizu; T. Saitoh; M. Tanaka; T. Mori; T. Sakura; N. Kawai; Y. Kanda; C. Nakaseko; S. Yano; H. Fujita; S. Fujisawa; S. Miyawaki; H. Kanamori; S. Okamoto, Dec. 2012, Leukemia, 26, 12, 2469, 2473, Scientific journal

  DOI
• Age-related epstein-barr virus-positive lymphoproliferative disorders of the orbit and maxillary sinus, Mitsui T; Mitsui T; Mawatari M; Koiso H; Yokohama A; Uchiumi H; Saitoh T; Handa H; Hirato J; Murakami H; Kojima M; Nakamura S; Nakamura S; Nojima Y; Kanamori H; Tsukamoto N, Oct. 2012, J Clin Exp Hematop, 52, 3
• Clinical significance of granulocytic sarcoma in adult patients with acute myeloid leukemia, Hiroaki Shimizu; Takayuki Saitoh; Nahoko Hatsumi; Satoru Takada; Akihiko Yokohama; Hiroshi Handa; Tkahiro Jimbo; Toru Sakura; Norifumi Tsukamoto; Hirokazu Murakami; Shuichi Miyawaki; Yoshihisa Nojima, Aug. 2012, Cancer Science, 103, 8, 1513, 1517, Scientific journal

  DOI
• Follicular lymphoma presenting with marked splenomegaly: Report of three cases, Hiromi Koiso; Akihiko Yokohama; Takeki Mitsui; Takayuki Saitoh; Hiroshi Handa; Hirokazu Murakami; Junko Hirato; Masaru Kojima; Yoshihisa Nojima; Norifumi Tsukamoto, Jun. 2012, Acta Haematologica, 128, 1, 48, 52, Scientific journal

  DOI
• Clinical significance of granulocytic sarcoma in adult patients with acute myeloid leukemia, Shimizu H; Saitoh T; Hatsumi N; Takada S; Yokohama A; Handa H; Jimbo T; Sakura T; Tsukamoto N; Murakami H; Miyawaki S; Nojima Y, May 2012, Cancer Sci., 103, 8
• Retrospective survey on the clinical features of non-Hodgkin lymphomas in Gunma Prefecture, Japan, Hashimoto Y; Yokohama A; Saitoh A; Nakahashi H; Toyama K; Mitsui T; Koiso H; Saitoh T; Handa H; Uchiumi H; Jinbo T; Murayama K; Tamaki Y; Matsumoto M; Sawamura M; Karasawa M; Murakami H; Hirato J; Nojima Y; Kojima M; Tsukamoto N, May 2012, Rinsho Ketsueki, 3
• Follicular lymphoma presenting with marked splenomegaly: report of three cases, Koiso H; Yokohama A; Mitsui T; Saitoh T; Handa H; Murakami H; Hirato J; Kojima M; Nojima Y; Tsukamoto N, May 2012, Acta Haematol, 128, 1
• Circulating plasmacytoid dendritic cells in patients with primary and Helicobacter pylori-associated immune thrombocytopenia, Akio Saito; Akihiko Yokohama; Yohei Osaki; Yoshiyuki Ogawa; Hirotaka Nakahashi; Kohtaro Toyama; Takeki Mitsui; Yoko Hashimoto; Hiromi Koiso; Hideki Uchiumi; Takayuki Saitoh; Hiroshi Handa; Morio Sawamura; Masamitsu Karasawa; Hirokazu Murakami; Norifumi Tsukamoto; Yoshihisa Nojima, Apr. 2012, European Journal of Haematology, 88, 4, 340, 349, Scientific journal

  DOI
• [Diagnosis and prognostic factors in patients with multiple myeloma]., Hirokazu Murakami; Akihiko Yokohama; Takayuki Saitoh; Norifumi Tsukamoto; Hiroshi Handa, Apr. 2012, Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 2, 584, 588, Scientific journal
• Diagnosis and prognostic factors in patients with multiple myeloma, Murakami H; Yokohama A; Saitoh T; Tsukamoto N; Handa H, Apr. 2012, Nihon Rinsho Nihon Rinsho, 2
• [Retrospective survey on the clinical features of non-Hodgkin lymphomas in Gunma Prefecture, Japan]., Yoko Hashimoto; Akihiko Yokohama; Akio Saitoh; Hirotaka Nakahashi; Kohtaro Toyama; Takeki Mitsui; Hiromi Koiso; Takayuki Saitoh; Hiroshi Handa; Hideki Uchiumi; Takahiro Jinbo; Kayoko Murayama; Yoshio Tamaki; Morio Matsumoto; Morio Sawamura; Masamitsu Karasawa; Hirokazu Murakami; Junko Hirato; Yoshihisa Nojima; Masaru Kojima; Norifumi Tsukamoto, Mar. 2012, [Rinshō ketsueki] The Japanese journal of clinical hematology, 53, 3, 329, 336, Scientific journal
• Allogeneic hematopoietic stem cell transplantation for primary and secondary myelofibrosis: a retrospective, multicenter study of the Kanto Study Group for Cell Therapy (KSGCT), Takeuchi M; Nakaseko C; Ohwada C; Sato Y; Ohashi K; Kakihana K; Mori T; Aisa Y; Kanda Y; Takahashi S; Yokota A; Kawaguchi T; Saitoh T; Hatsumi N; Taguchi J; Takasaki H; Kanamori H; Maruta A; Sakamaki H; Okamoto S, Feb. 2012, Journal of Hematopoietic cell transplantation 1(1), 15-23, 2012., 1, 1, 15, 23

  DOI
• TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients, Akihiko Yokohama; Akio Saitoh; Hirotaka Nakahashi; Takeki Mitsui; Hiromi Koiso; Yoshitora Kim; Hideki Uchiumi; Takayuki Saitoh; Hiroshi Handa; Takahiro Jimbo; Kayoko Murayama; Tohru Sakura; Hirokazu Murakami; Masamitsu Karasawa; Yoshihisa Nojima; Norifumi Tsukamoto, Jan. 2012, INTERNATIONAL JOURNAL OF HEMATOLOGY, 95, 1, 77, 85, Scientific journal

  DOI
• TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients, Akihiko Yokohama; Akio Saitoh; Hirotaka Nakahashi; Takeki Mitsui; Hiromi Koiso; Yoshitora Kim; Hideki Uchiumi; Takayuki Saitoh; Hiroshi Handa; Takahiro Jimbo; Kayoko Murayama; Tohru Sakura; Hirokazu Murakami; Masamitsu Karasawa; Yoshihisa Nojima; Norifumi Tsukamoto, Jan. 2012, International Journal of Hematology, 95, 1, 77, 85, International conference proceedings

  DOI
• Age-related Epstein-Barr Virus-positive lymphoproliferative disorders of the orbit and maxillary sinus : a case report., Takeki Mitsui; Momoko Mawatari; Hiromi Koiso; Akihiko Yokohama; Hideki Uchiumi; Takayuki Saitoh; Hiroshi Handa; Junko Hirato; Masamitsu Karasawa; Hirokazu Murakami; Masaru Kojima; Shigeo Nakamura; Yoshihisa Nojima; Norifumi Tsukamoto, 2012, Journal of clinical and experimental hematopathology : JCEH, 52, 3, 205, 209, Scientific journal

  DOI
• Der(2)t(2; 11)(p21; q23), a variant form of t(2; 11), in biphenotypic acute leukemia with T lymphoid lineage and myeloid lineage differentiation, Yuri Miyazawa; Hiroyuki Irisawa; Takafumi Matsushima; Takeki Mitsui; Hideki Uchiumi; Takayuki Saitoh; Hiroshi Handa; Masamitsu Karasawa; Hirokazu Murakami; Norifumi Tsukamoto; Yoshihisa Nojima, 2012, Kitakanto Medical Journal, 62, 3, 287, 290, Scientific journal

  DOI
• TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients, Yokohama, Akihiko;Saitoh, Akio;Nakahashi, Hirotaka;Mitsui, Takeki;Koiso, Hiromi;Kim, Yoshitora;Uchiumi, Hideki;Saitoh, Takayuki;Handa, Hiroshi;Jimbo, Takahiro;Murayama, Kayoko;Sakura, Tohru;Murakami, Hirokazu;Karasawa, Masamitsu;Nojima, Yoshihisa;Tsukamoto, Norifumi, 2012, INTERNATIONAL JOURNAL OF HEMATOLOGY, 95, 1, 77, 85

  DOI
• Does the Hematopoietic Cell Transplantation Specific Comorbidity Index (HCT-CI) Predict Transplant Outcomes?: A Prospective Multicenter Validation Study of the Kanto Study Group for Cell Therapy (KSGCT), Nakaya, Aya;Mori, Takehiko;Tanaka, Masatsugu;Tomita, Naoto;Nakaseko, Chiaki;Yano, Shingo;Fujisawa, Shin;Sakamaki, Hisashi;Aotsuka, Nobuyuki;Yokota, Akira;Kanda, Yoshinobu;Sakura, Toru;Nannya, Yasuhito;Saitoh, Takayuki;Kanamori, Heiwa;Takahashi, Satoshi;Okamoto, Shinichiro, 2012, BLOOD, 120, 21
• The Cytokine Polymorphisms Affect the Severity of Thrombocytopenia at Diagnosis in Chronic Immune Thrombocytopenia, Saitoh, Takayuki;Ushie, Chiaki;Iwasaki, Atsushi;Moriyama, Norihiko;Takani, Tomonori;Hikaru, Hattori;Handa, Hiroshi;Koiso, Hiromi;Yokohama, Akihiko;Tsukamoto, Norifumi;Ogawara, Hatsue;Murakami, Hirokazu, 2012, BLOOD, 120, 21
• Novel Agents and Autologous Stem Cell Transplantation Improve Survival of Multiple Myeloma Patients with Ages 65-70 Years: A Multicenter Retrospective Collaborative Study Between Japanese Society of Myeloma and European Myeloma Network, Ozaki, Shuji;Harada, Takeshi;Saitoh, Takayuki;Shimazaki, Chihiro;Itagaki, Mitsuhiro;Asaoku, Hideki;Kuroda, Yoshiaki;Chou, Takaaki;Yoshiki, Yumiko;Suzuki, Kenshi;Murakami, Hirokazu;Hayashi, Kunihiko;Palumbo, Antonio;Shimizu, Kazuyuki, 2012, BLOOD, 120, 21
• Polymorphisms of IL-10, IL-17A, IL-17F and IL-18 Affect the Clinical Features of Multiple Myeloma in Japanese Patients, Iwasaki, Atsushi;Saitoh, Takayuki;Ushie, Chiaki;Moriyama, Norihiko;Takani, Tomonori;Hattori, Hikaru;Handa, Hiroshi;Matsumoto, Morio;Isoda, Jun;Sawamura, Morio;Ogawara, Hatsue;Murakami, Hirokazu, 2012, BLOOD, 120, 21
• Long-term follow-up of EBV-positive lymphoproliferative disorders in a patient with systemic lupus erythematosus, Norifumi Tsukamoto; Hiroshi Handa; Akihiko Yokohama; Takeki Mitsui; Takayuki Saitoh; Hiromi Koiso; Hideki Uchiumi; Takumi Hoshino; Masamitsu Karasawa; Hirokazu Murakami; Masaru Kojima; Yoshihisa Nojima, Dec. 2011, Medical Molecular Morphology, 44, 4, 237, 241, Scientific journal

  DOI
• Long-term follow-up of EBV-positive lymphoproliferative disorders in a patient with systemic lupus erythematosus., Tsukamoto N; Handa H; Yokohama A; Mitsui T; Saitoh T; Koiso H; Uchiumi H; Hoshino T; Karasawa M; Murakami H; Kojima M; Nojima Y, Dec. 2011, Med Mol Morphol, 44, 4
• Discrepancy in EBV-DNA load between peripheral blood and cerebrospinal fluid in a patient with isolated CNS post-transplant lymphoproliferative disorder, Hiroaki Shimizu; Takayuki Saitoh; Hiroko Koya; Akinori Yuzuriha; Takumi Hoshino; Nahoko Hatsumi; Satoru Takada; Tomohito Nagaki; Yoshihisa Nojima; Toru Sakura, Nov. 2011, INTERNATIONAL JOURNAL OF HEMATOLOGY, 94, 5, 495, 498, Scientific journal

  DOI
• Discrepancy in EBV-DNA load between peripheral blood and cerebrospinal fluid in a patient with isolated CNS post-transplant lymphoproliferative disorder, Hiroaki Shimizu; Takayuki Saitoh; Hiroko Koya; Akinori Yuzuriha; Takumi Hoshino; Nahoko Hatsumi; Satoru Takada; Tomohito Nagaki; Yoshihisa Nojima; Toru Sakura, Nov. 2011, International Journal of Hematology, 94, 5, 495, 498, Scientific journal

  DOI
• Differences in the JAK2 and MPL mutation status in the cell lineages of the bcr/abl-negative chronic myeloproliferative neoplasm subtypes, Toyama K; Karasawa M; Yokohama A; Mitsui T; Uchiumi H; Saitoh T; Handa H; Murakami H; Nojima Y; Tsukamoto N, Nov. 2011, Intern Med., 50, 21
• Interleukin-10 gene polymorphism reflects the severity of chronic immune thrombocytopenia in Japanese patients, T. Saitoh; T. Kasamatsu; M. Inoue; T. Mitsui; H. Koiso; A. Yokohama; H. Handa; T. Matsushima; N. Tsukamoto; M. Karasawa; H. Ogawara; Y. Nojima; H. Murakami, Oct. 2011, International Journal of Laboratory Hematology, 33, 5, 526, 532, Scientific journal

  DOI
• Interleukin-17F gene polymorphism in patients with chronic immune thrombocytopenia, Takayuki Saitoh; Norifumi Tsukamoto; Hiromi Koiso; Takeki Mitsui; Akihiko Yokohama; Hiroshi Handa; Masamitsu Karasawa; Hatsue Ogawara; Yoshihisa Nojima; Hirokazu Murakami, Sep. 2011, European Journal of Haematology, 87, 3, 253, 258, Scientific journal

  DOI
• Successful treatment of autoimmune hemolytic anemia associated with multicentric castleman disease by anti-interleukin-6 Receptor antibody (tocilizumab) therapy, Akinori Yuzuriha; Takayuki Saitoh; Hiromi Koiso; Takeki Mitsui; Hideki Uchiumi; Akihiko Yokohama; Hiroshi Handa; Masaru Kojima; Norifumi Tsukamoto; Masamitsu Karaswa; Hirokazu Murakami; Yoshihisa Nojima, Sep. 2011, Acta Haematologica, 126, 3, 147, 150, Scientific journal

  DOI
• Pure red cell aplasia induced only by intravenous administration of recombinant human erythropoietin, Hiroaki Shimizu; Takayuki Saitoh; Fumie Ota; Takahiro Jimbo; Yoshito Tsukada; Hirokazu Murakami; Yoshihisa Nojima, Aug. 2011, Acta Haematologica, 126, 2, 114, 118, Scientific journal

  DOI
• [Glossitis by mixed infection of cytomegalovirus and herpes simplex virus during therapy for pure red cell aplasia complicated with Good syndrome]., Hiroko Koya; Akihiko Yokohama; Ayaka Miura; Takumi Hoshino; Takeki Mitsui; Hiromi Koiso; Takayuki Saitoh; Hideki Uchiumi; Hiroshi Handa; Jyunko Hirato; Keijyu Hiromura; Masamitsu Karasawa; Hirokazu Murakami; Norifumi Tsukamoto; Yoshihisa Nojima, Aug. 2011, [Rinshō ketsueki] The Japanese journal of clinical hematology, 52, 8, 708, 712, Scientific journal
• [Glossitis by mixed infection of cytomegalovirus and herpes simplex virus during therapy for pure red cell aplasia complicated with Good syndrome]., Koya H; Yokohama A; Miura A; Hoshino T; Mitsui T; Koiso H; Saitoh T; Uchiumi H; Handa H; Hirato J; Hiromura K; Karasawa M; Murakami H; Tsukamoto N; Nojima Y, Aug. 2011, Rinsho Ketsueki, 52, 8
• Fludarabine、rituximab併用療法によりCoombs陰性AIHAを来したCLL, 神尾 直; 林 俊誠; 斉藤 明生; 星野 匠臣; 三井 健揮; 内海 英貴; 半田 寛; 野島 美久; 横濱 章彦; 小磯 博美; 斉藤 貴之; 塚本 憲史; 亀崎 豊実, Aug. 2011, 52, 8, 726, 726
• Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation, Chiaki Nakaseko; Shinichi Ozawa; Emiko Sakaida; Miwa Sakai; Yoshinobu Kanda; Kumi Oshima; Mineo Kurokawa; Satoshi Takahashi; Jun Ooi; Takayuki Shimizu; Akira Yokota; Fumiaki Yoshiba; Katsumichi Fujimaki; Heiwa Kanamori; Rika Sakai; Takayuki Saitoh; Tohru Sakura; Atsuo Maruta; Hisashi Sakamaki; Shinichiro Okamoto, Mar. 2011, International Journal of Hematology, 93, 3, 375, 382, Scientific journal

  DOI
• Pure Red Cell Aplasia Induced Only by Intravenous Administration of Recombinant Human Erythropoietin, Hiroaki Shimizu; Takayuki Saitoh; Fumie Ota; Takahiro Jimbo; Yoshito Tsukada; Hirokazu Murakami; Yoshihisa Nojima, 2011, ACTA HAEMATOLOGICA, 126, 2, 114, 118, Scientific journal

  DOI
• Successful Treatment of Autoimmune Hemolytic Anemia Associated with Multicentric Castleman Disease by Anti-Interleukin-6 Receptor Antibody (Tocilizumab) Therapy, Akinori Yuzuriha; Takayuki Saitoh; Hiromi Koiso; Takeki Mitsui; Hideki Uchiumi; Akihiko Yokohama; Hiroshi Handa; Masaru Kojima; Norifumi Tsukamoto; Masamitsu Karaswa; Hirokazu Murakami; Yoshihisa Nojima, 2011, ACTA HAEMATOLOGICA, 126, 3, 147, 150, Scientific journal

  DOI
• Differences in the JAK2 and MPL mutation status in the cell lineages of the bcr/abl-negative chronic myeloproliferative neoplasm subtypes, Kohtaro Toyama; Masamitsu Karasawa; Akihiko Yokohama; Takeki Mitsui; Hideki Uchiumi; Takayuki Saitoh; Hiroshi Handa; Hirokazu Murakami; Yoshihisa Nojima; Norifumi Tsukamoto, 2011, Internal Medicine, 50, 21, 2557, 2561, Scientific journal

  DOI
• 赤芽球癆治療中にサイトメガロウイルスと単純ヘルペスウイルスの混合感染による舌炎を発症したGood症候群., 小屋紘子; 横濱章彦; 三浦あやか; 星野匠臣; 三井健揮; 小磯博美; 斉藤貴之; 内海英貴; 半田 寛; 平戸純子; 広村桂樹; 唐沢正光; 村上博和; 塚本憲史; 野島美久, 2011, 52, 708, 12

  DOI
• Interleukin-17F gene polymorphism in patients with chronic immune thrombocytopenia, Saitoh, Takayuki;Tsukamoto, Norifumi;Koiso, Hiromi;Mitsui, Takeki;Yokohama, Akihiko;Handa, Hiroshi;Karasawa, Masamitsu;Ogawara, Hatsue;Nojima, Yoshihisa;Murakami, Hirokazu, 2011, EUROPEAN JOURNAL OF HAEMATOLOGY, 87, 3, 253, 258

  DOI
• Discrepancy in EBV-DNA load between peripheral blood and cerebrospinal fluid in a patient with isolated CNS post-transplant lymphoproliferative disorder, Shimizu, Hiroaki;Saitoh, Takayuki;Koya, Hiroko;Yuzuriha, Akinori;Hoshino, Takumi;Hatsumi, Nahoko;Takada, Satoru;Nagaki, Tomohito;Nojima, Yoshihisa;Sakura, Toru, 2011, INTERNATIONAL JOURNAL OF HEMATOLOGY, 94, 5, 495, 498

  DOI
• Long-term follow-up of EBV-positive lymphoproliferative disorders in a patient with systemic lupus erythematosus, Tsukamoto, Norifumi;Handa, Hiroshi;Yokohama, Akihiko;Mitsui, Takeki;Saitoh, Takayuki;Koiso, Hiromi;Uchiumi, Hideki;Hoshino, Takumi;Karasawa, Masamitsu;Murakami, Hirokazu;Kojima, Masaru;Nojima, Yoshihisa, 2011, MEDICAL MOLECULAR MORPHOLOGY, 44, 4, 237, 241

  DOI
• Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation, Nakaseko, Chiaki;Ozawa, Shinichi;Sakaida, Emiko;Sakai, Miwa;Kanda, Yoshinobu;Oshima, Kumi;Kurokawa, Mineo;Takahashi, Satoshi;Ooi, Jun;Shimizu, Takayuki;Yokota, Akira;Yoshiba, Fumiaki;Fujimaki, Katsumichi;Kanamori, Heiwa;Sakai, Rika;Saitoh, Takayuki;Sakura, Tohru;Maruta, Atsuo;Sakamaki, Hisashi;Okamoto, Shinichiro, 2011, INTERNATIONAL JOURNAL OF HEMATOLOGY, 93, 3, 375, 382

  DOI
• Differences in the JAK2 and MPL Mutation Status in the Cell Lineages of the bcr/abl-negative Chronic Myeloproliferative Neoplasm Subtypes, Toyama, Kohtaro;Karasawa, Masamitsu;Yokohama, Akihiko;Mitsui, Takeki;Uchiumi, Hideki;Saitoh, Takayuki;Handa, Hiroshi;Murakami, Hirokazu;Nojima, Yoshihisa;Tsukamoto, Norifumi, 2011, INTERNAL MEDICINE, 50, 21, 2557, 2561

  DOI
• 赤芽球癆治療中にサイトメガロおよびヘルペスウイルス混合感染による舌炎を発症したGood症候群, 三浦 あやか; 横濱 章彦; 小屋 紘子; 星野 匠臣; 斉藤 貴之; 半田 寛; 平戸 純子; 廣村 桂樹; 塚本 憲史; 野島 美久, Sep. 2010, 574回, 49, 49
• Impact of discontinuing fluoroquinolone prophylaxis on early mortality after allogeneic marrow or peripheral blood SCT with myeloablative conditioning, J. Kanda; T. Ichinohe; T. Saito; K. Yamashita; T. Kondo; T. Ishikawa; S. Ichiyama; T. Uchiyama, Aug. 2010, BONE MARROW TRANSPLANTATION, 45, 8, 1369, 1371

  DOI
• Flow cytometric detection of human telomerase reverse transcriptase (hTERT) expression in a subpopulation of bone marrow cells, Hiroshi Handa; Takafumi Matsushima; Natsumi Nishimoto; Madoka Inoue; Takayuki Saitoh; Akihiko Yokohama; Norifumi Tsukamoto; Takeki Mitsui; Hirotaka Nakahashi; Kotaro Toyama; Masamitsu Karasawa; Hatsue Ogawara; Yoshihisa Nojima; Hirokazu Murakami, Feb. 2010, Leukemia Research, 34, 2, 177, 183, Scientific journal

  DOI
• Flow cytometric detection of human telomerase reverse transcriptase (hTERT) expression in a subpopulation of bone marrow cells., Handa H; Matsushima T; Nishimoto N; Inoue M; Saitoh T; Yokohama A; Tsukamoto N; Mitsui T; Nakahashi H; Toyama K; Karasawa M; Ogawara H; Nojima Y; Murakami H, Feb. 2010, Leuk Res, 34
• Association of Interleukin-18 Gene Polymorphism with Severity of Chronic Immune Thrombocytopenia (ITP), Saitoh, Takayuki;Moriyama, Norihiko;Takani, Tomonori;Mitsui, Takeki;Hoshino, Takumi;Koiso, Hiromi;Yokohama, Akihiko;Handa, Hiroshi;Karasawa, Masamitsu;Ogawara, Hatsue;Tsukamoto, Norifumi;Murakami, Hirokazu, 2010, BLOOD, 116, 21, 1515, 1515
• Hairy cell leukemia-related disorders consistently show low CD27 expression, Yoko Hashimoto; Norifumi Tsukamoto; Hirotaka Nakahashi; Akihiko Yokohama; Takayuki Saitoh; Hiroshi Handa; Takafumi Matsushima; Hirokazu Murakami; Yoshihisa Nojima; Masamitsu Karasawa, Dec. 2009, Pathology and Oncology Research, 15, 4, 615, 621, Scientific journal

  DOI
• IgM-lambda multiple myeloma presenting with systemic amyloidosis, Daisuke Higeta; Akihiko Yokohama; Youhei Osaki; Kenichi Tahara; Momoko Mawatari; Tomomi Sekigami; Hiromi Koiso; Takayuki Saito; Hideki Uchiumi; Hiroshi Handa; Masamitsu Karasawa; Hirokazu Murakami; Jyunko Hirato; Norifumi Tsukamoto; Yoshihisa Nojima, Dec. 2009, [Rinshō ketsueki] The Japanese journal of clinical hematology, 50, 12, 1711, 1714, Scientific journal

  DOI
• Hairy cell leukemia-related disorders consistently show low CD27 expression., Hashimoto Y; Tsukamoto N; Nakahashi H; Yokohama A; Saitoh T; Handa H; Matsushima T; Murakami H; Nojima Y; Karasawa M, Dec. 2009, Pathol Oncol Res., 15
• Hairy cell leukemia-related disorders consistently show low CD27 expression, Hashimoto Y; Tsukamoto N; Nakahashi H; Yokohama A; Saitoh T; Handa H; Matsushima T; Murakami H; Nojima Y; Karasawa M, Dec. 2009, Pathol Onocol Research, 15, 4
• Successful treatment with reduced-intensity stem cell transplantation for secondary myelofibrosis following polycythemia vera., Kenichi TAHARA; Akihiko YOKOHAMA; Hiroshi HANDA; Takayuki SAITOH; Hideki UCHIUMI; Tomomi SEKIGAMI; Kohtaro TOYAMA; Momoko MAWATARI; Yohei OSAKI; Takafumi MATSUSHIMA; Masamitsu KARASAWA; Hirokazu MURAKAMI; Norifumi TSUKAMOTO; Yoshihisa NOJIMA, Nov. 2009, [Rinshō ketsueki] The Japanese journal of clinical hematology, 50, 11, 1630, 1634, Scientific journal

  DOI
• Successful treatment with reduced-intensity stem cell transplantation for secondary myelofibrosis following polycythemia vera, TAHARA K; YOKOHAMA A; HANDA H; SAITOH T; UCHIUMI H; SEKIGAMI T; TOYAMA K; MAWATARI M; OSAKI Y; MATSUSHIMA T; KARASAWA M; MURAKAMI H; TSUKAMOTO N; NOJIMA Y, Nov. 2009, Rinsho Ketsueki, 50, 11
• Autologous peripheral blood stem cell transplantation to treat CHOP-refractory aggressive subcutaneous panniculitis-like T cell lymphoma, Hirotaka Nakahashi; Norifumi Tsukamoto; Arito Yamane; Takayuki Saitoh; Hideki Uchiumi; Hiroshi Handa; Masamitsu Karasawa; Hirokazu Murakami; Masaru Kojima; Yoshihisa Nojima, Jul. 2009, Acta Haematologica, 121, 4, 239, 242, Scientific journal

  DOI
• Autologous peripheral blood stem cell transplantation to treat CHOP-refractory aggressive subcutaneous panniculitis-like T cell lymphoma., Nakahashi H; Tsukamoto N; Yamane A; Saitoh T; Uchiumi H; Handa H; Karasawa M; Murakami H; Kojima M; Nojima Y, Jun. 2009, Acta Haematol, 121
• Low burden of a JAK2-V617F mutated clone in monoclonal haematopoiesis in a Japanese woman with Budd-Chiari syndrome, Kohtaro Toyama; Masamitsu Karasawa; Arito Yamane; Hiromi Koiso; Akihiko Yokohama; Hideki Uchiumi; Takayuki Saitoh; Hiroshi Handa; Ken Sato; Hitoshi Takagi; Shuichi Miyawaki; Hirokazu Murakami; Yoshihisa Nojima; Norifumi Tsukamoto, May 2009, International Journal of Hematology, 89, 4, 517, 522, Scientific journal

  DOI
• Low burden of a JAK2-V617F mutated clone in monoclonal haematopoiesis in a Japanese woman with Budd-Chiari syndrome., Toyama K; Karasawa M; Yamane A; Koiso H; Yokohama A; Uchiumi H; Saitoh T; Handa H; Sato K; Takagi H; Miyawaki S; Murakami H; Nojima Y; Tsukamoto N, May 2009, Int J Hematol., 89, 4
• Characterization of immunoglobulin heavy and light chain gene expression in chronic lymphocytic leukemia and related disorders., Nakahashi H; Tsukamoto N; Hashimoto Y; Koiso H; Yokohama A; Saitoh T; Uchiumi H; Handa H; Murakami H; Nojima Y; Karasawa M, Apr. 2009, Cancer Sci, 100
• Development of an extramedullary plasmacytoma despite disappearing M protein in multiple myeloma by bortezomib treatment, Hiromi Koiso; Kenichi Tahara; Yohei Osaki; Momoko Mawatari; Tomomi Sekigami; Akihiko Yokohama; Takayuki Saitoh; Hideki Uchiumi; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Yoshihisa Nojima; Hirokazu Murakami, Feb. 2009, [Rinshō ketsueki] The Japanese journal of clinical hematology, 50, 2, 78, 82, Scientific journal
• [Development of an extramedullary plasmacytoma despite disappearing M protein in multiple myeloma by bortezomib treatment], Koiso H; Tahara K; Osaki Y; Mawatari M; Sekigami T; Yokohama A; Saitoh T; Uchiumi H; Handa H; Tsukamoto N; Karasawa M; Nojima Y; Murakami H, Feb. 2009, Rinsho Ketsueki, 50, 2
• Characterization of immunoglobulin heavy and light chain gene expression in chronic lymphocytic leukemia and related disorders, Hirotaka Nakahashi; Norifumi Tsukamoto; Yoko Hashimoto; Hiromi Koiso; Akihiko Yokohama; Takayuki Saitoh; Hideki Uchiumi; Hiroshi Handa; Hirokazu Murakami; Yoshihisa Nojima; Masamitsu Karasawa, 2009, Cancer Science, 100, 4, 671, 677, Scientific journal

  DOI
• Successful treatment by all-trans retinoic acid in a patient with acute promyelocytic leukemia complicated by liver cirrhosis and polycystic kidney, Arito Yamane; Norifumi Tsukamoto; Takayuki Saitoh; Hideki Uchiumi; Hiroshi Handa; Masamitsu Karasawa; Yoshihisa Nojima; Hirokazu Murakami, 2009, Internal Medicine, 48, 18, 1691, 1694, Scientific journal

  DOI
• Successful treatment by all-trans retinoic acid in a patient with acute promyelocytic leukemia complicated by liver cirrhosis and polycystic kidney., Yamane A; Tsukamoto N; Saitoh T; Uchiumi H; Handa H; Karasawa M; Nojima Y; Murakami H, 2009, Intern Med., 48, 1691-1694
• Successful treatment with reduced-intensity stem cell transplantation for secondary myelofibrosis following polycythemia vera., Tahara K; Yokohma A; Hand H; Saitoh T; Uchiuumi H; Sekigami T; Toyama K; Mawatari M; Osaki Y; Matsushima T; Karasawa M; MurakamiI H; Tsukamoto N; Nojima Y, 2009, Rinsho Ketsueki, 50
• Low burden of a JAK2-V617F mutated clone in monoclonal haematopoiesis in a Japanese woman with Budd-Chiari syndrome, Toyama, Kohtaro;Karasawa, Masamitsu;Yamane, Arito;Koiso, Hiromi;Yokohama, Akihiko;Uchiumi, Hideki;Saitoh, Takayuki;Handa, Hiroshi;Sato, Ken;Takagi, Hitoshi;Miyawaki, Shuichi;Murakami, Hirokazu;Nojima, Yoshihisa;Tsukamoto, Norifumi, 2009, INTERNATIONAL JOURNAL OF HEMATOLOGY, 89, 4, 517, 522

  DOI
• Autologous Peripheral Blood Stem Cell Transplantation to Treat CHOP-Refractory Aggressive Subcutaneous Panniculitis-Like T Cell Lymphoma, Nakahashi, Hirotaka;Tsukamoto, Norifumi;Yamane, Arito;Saitoh, Takayuki;Uchiumi, Hideki;Handa, Hiroshi;Karasawa, Masamitsu;Murakami, Hirokazu;Kojima, Masaru;Nojima, Yoshihisa, 2009, ACTA HAEMATOLOGICA, 121, 4, 239, 242

  DOI
• Successful Treatment by All-Trans Retinoic Acid in a Patient with Acute Promyelocytic Leukemia Complicated by Liver Cirrhosis and Polycystic Kidney, Yamane, Arito;Tsukamoto, Norifumi;Saitoh, Takayuki;Uchiumi, Hideki;Handa, Hiroshi;Karasawa, Masamitsu;Nojima, Yoshihisa;Murakami, Hirokazu, 2009, INTERNAL MEDICINE, 48, 18, 1691, 1694

  DOI
• Clinical Significance of Granulocytic Sarcoma in Patients with Acute Myeloid Leukemia, Shimizu, Hiroaki;Saitoh, Takayuki;Hoshino, Takumi;Hatsumi, Naoko;Takada, Satoru;Irisawa, Hiroyuki;Yokohama, Akihiko;Jimbo, Takahiro;Handa, Hiroshi;Matsushima, Takafumi;Sakura, Toru;Tsukamoto, Norifumi;Karasawa, Masamitsu;Miyawaki, Shuichi, 2009, BLOOD, 114, 22, 1207, 1207
• T cell large granular lymphocyte (LGL) leukemia associated with Behcet's disease: High expression of sFasL and IL-18 of CD8 LGL, Takayuki Saitoh; Takafumi Matsushima; Yoriaki Kaneko; Akihiko Yokohama; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Yoshihisa Nojima; Hirokazu Murakami, Jul. 2008, Annals of Hematology, 87, 7, 585, 586

  DOI
• Impaired response to GM-CSF and G-CSF, and enhanced apoptosis in C/EBP [beta]-deficient hematopoietic cells, Akagi T; Saitoh T; O'Kelly J; Akira S; Gombart AF; Koeffler HP, May 2008, Blood, 111, 6
• Impaired response to GM-CSF and G-CSF, and enhanced apoptosis in C/EBP ²-deficient hematopoietic cells, Tadayuki Akagi; Takayuki Saitoh; James O'Kelly; Shizuo Akira; Adrian F. Gombart; H. Phillip Koeffler, 15 Mar. 2008, Blood, 111, 6, 2999, 3004, Scientific journal

  DOI
• Hodgkin lymphoma presenting with various immunologic abnormalities, including autoimmune hepatitis, Hashimoto's thyroiditis, autoimmune hemolytic anemia, and immune thrombocytopenia, Takayuki Saitoh; Takafumi Matsushima; Yasuyuki Saito; Arito Yamane; Akihiko Yokohama; Hiroyuki Irisawa; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Masaru Kojima; Yoshihisa Nojima; Hirokazu Murakami, Feb. 2008, Clinical Lymphoma and Myeloma, 8, 1, 62, 64, Scientific journal

  DOI
• Successful treatment of azole-refractory Candida guilliermondii fungemia with a combination therapy of micafungin and liposomal amphotericin B, Takayuki Saitoh; Takafumi Matsushima; Hiroyuki Shimizu; Yohei Osaki; Arito Yamane; Hiroyuki Irisawa; Akihiko Yokohama; Hideki Uchiumi; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Yoshihisa Nojima; Hirokazu Murakami, Feb. 2008, [Rinshō ketsueki] The Japanese journal of clinical hematology, 49, 2, 94, 98, Scientific journal
• HLA full matchの造血幹細胞移植を受けるも、約半年の経過で死亡した骨髄異形成症候群の55歳の症例, 高士祐一; 加藤恵理子; 大石琢磨; 横尾英明; 大崎洋平; 斉藤貴之, Feb. 2008, 715
• Hodgkin lymphoma presenting with various immunologic abnormalities, including autoimmune hepatitis, Hashimoto's thyroiditis, autoimmune hemolytic anemia, and immune thrombocytopenia, Takayuki Saitoh; Takafumi Matsushima; Yasuyuki Saito; Arito Yamane; Akihiko Yokohama; Hiroyuki Irisawa; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Masaru Kojima; Yoshihisa Nojima; Hirokazu Murakami, Feb. 2008, CLINICAL LYMPHOMA & MYELOMA, 8, 1, 62, 64, Scientific journal
• Successful treatment of Azole-refractory Candida guilliermondii fungemia with combination therapy with liposomal amphotericin B and micafungin, Saitoh T; Matsushima T; Shmizu H; Osaki Y; Yamane A; Irisawa H; Yokohama A; Uchiumi H; Handa H; Tsukamoto N; Karasawa M; Nojima Y; Murakami H, Feb. 2008, Rinsho Ketsueki, 49, 2
• T-Cell Large Granular Lymphocyte (LGL) Leukemia Associated with Behcet's Disease: High Expression of sFasL and IL-18 of CD8 LGL, Saitoh T; Matsushima T; Irisawa H; Yokohama A; Handa H; Tsukamoto N; Karasawa M; Nojima Y; Murakami H, Jan. 2008, Ann Hematol, 87, 7
• The Influence of Polymorphisms of Interleukin-17F Genes on the Susceptibility and Clinical Significanse of Chronic Idiopathic Thrombocytopenic Purpura, Saitoh, Takayuki;Kasamatsu, Tetsuhiro;Yokohama, Akihiko;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Ogawara, Hatsue;Nojima, Yoshihisa;Murakami, Hirokazu, 2008, BLOOD, 112, 11, 1175, 1175
• T cell large granular lymphocyte (LGL) leukemia associated with Behcet's disease: high expression of sFasL and IL-18 of CD8 LGL, Saitoh, Takayuki;Matsushima, Takafumi;Kaneko, Yoriaki;Yokohama, Akihiko;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Nojima, Yoshihisa;Murakami, Hirokazu, 2008, ANNALS OF HEMATOLOGY, 87, 7, 585, 586

  DOI
• Hodgkin lymphoma presenting with various immunologic abnormalities, including autoimmune hepatitis, Hashimoto's thyroiditis, autoimmune hemolytic anemia, and immune thrombocytopenia, Saitoh, Takayuki;Matsushima, Takafumi;Saito, Yasuyuki;Yamane, Arito;Yokohama, Akihiko;Irisawa, Hiroyuki;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Kojima, Masaru;Nojima, Yoshihisa;Murakami, Hirokazu, 2008, CLINICAL LYMPHOMA & MYELOMA, 8, 1, 62, 64
• Diagnosis and management guideline for multiple myeloma, Hirokazu Murakami; Hiroshi Handa; Takayuki Saitoh, Dec. 2007, Nippon rinsho. Japanese journal of clinical medicine, 65, 12, 2167, 2176
• 多発性骨髄腫の診断と治療のガイドライン, 村上博和; 半田寛; 斉藤貴之, Dec. 2007, 65, 12
• JAK2-V617F mutation analysis of granulocytes and platelets from patients with chronic myeloproliferative disorders: Advantage of studying platelets, Kohtaro Toyama; Masamitsu Karasawa; Arito Yamane; Hiroyuki Irisawa; Akihiko Yokohama; Takayuki Saitoh; Hiroshi Handa; Takafumi Matsushima; Morio Sawamura; Shuichi Miyawaki; Hirokazu Murakami; Yoshihisa Nojima; Norifumi Tsukamoto, Oct. 2007, British Journal of Haematology, 139, 1, 64, 69, Scientific journal

  DOI
• JAK2-V617F mutation analysis of granulocytes and platelets from patients with chronic myeloproliferative disorders: advantage of studying platelets., Toyama K; Karasawa M; Yamane A; Irisawa H; Yokohama A; Saitoh T; Handa H; Matsushima T; Sawamura M; Miyawaki S; Murakami H; Nojima Y; Tsukamoto N, Oct. 2007, Br J Haematol., 139, 1
• Successful treatment with voriconazole of Aspergillus meningitis in a patient with acute myeloid leukemia [6], Takayuki Saitoh; Takafumi Matsushima; Hiroaki Shimizu; Akihiko Yokohama; Hiroyuki Irisawa; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Yoshihisa Nojima; Hirokazu Murakami, Sep. 2007, Annals of Hematology, 86, 9, 697, 698

  DOI
• The usefulness of ¹⁸F-fluorodeoxyglucose positron emission tomography (¹⁸F-FDG-PET) and a comparison of ¹⁸F-FDG-PET with ⁶⁷gallium scintigraphy in the evaluation of lymphoma: Relation to histologic subtypes based on the World Health Organization classification, Norifumi Tsukamoto; Masaru Kojima; Masatoshi Hasegawa; Noboru Oriuchi; Takafumi Matsushima; Akihiko Yokohama; Takayuki Saitoh; Hiroshi Handa; Keigo Endo; Hirokazu Murakami, 01 Aug. 2007, Cancer, 110, 3, 652, 659, Scientific journal

  DOI
• Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation, Hideki Uchiumi; Takafumi Matsushima; Arito Yamane; Noriko Doki; Hiroyuki Irisawa; Takayuki Saitoh; Tohru Sakura; Takahiro Jimbo; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Shuichi Miyawaki; Hirokazu Murakami; Yoshihisa Nojima, Aug. 2007, International Journal of Hematology, 86, 2, 137, 142, Scientific journal

  DOI
• The usefulness of F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG-PET) and a comparison of F-18-FDG-PET with (67)gallium scintigraphy in the evaluation of lymphoma - Relation to histologic subtypes-based on the World Health Organization Classification, Norifumi Tsukamoto; Masaru Kojima; Masatoshi Hasegawa; Noboru Oriuchi; Takafumi Matsushima; Akihiko Yokohama; Takayuki Saitoh; Hiroshi Handa; Keigo Endo; Hirokazu Murakami, Aug. 2007, CANCER, 110, 3, 652, 659, Scientific journal

  DOI
• Polyclonal B-cell lymphocytosis with hairy cell appearance: hairy B-cell lymphoproliferative disorder, Hirotaka Nakahashi; Yoko Hashimoto; Arito Yamane; Hiroyuki Irisawa; Akihiko Yokohama; Takayuki Saitoh; Hiroshi Hanada; Takafumi Matsushima; Norifumi Tsukamoto; Masamitsu Karasawa; Hirokazu Murakamai; Yoshihisa Nojima, Aug. 2007, [Rinshō ketsueki] The Japanese journal of clinical hematology, 48, 8, 647, 651, Scientific journal

  DOI
• [Polyclonal B-cell lymphocytosis with hairy cell appearance: hairy B-cell lymphoproliferative disorder], Nakahashi H; Hashimoto Y; Yamane A; Irisawa H; Yokohama A; Saitoh T; Hanada H; Matsushima T; Tsukamoto N; Karasawa M; Murakamai H; Nojima Y, Aug. 2007, Rinsho Ketsueki., 48
• Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation., Uchiumi H; Matsushima T; Yamane A; Doki N; Irisawa H; Saitoh T; Sakura T; Jimbo T; Handa H; Tsukamoto N; Karasawa M; Miyawaki S; Murakami H; Nojima Y, Aug. 2007, 86, 2
• Acquired hemophilia A developed at relapse of minimal change nephrotic syndrome, Hiroaki Shimizu; Takayuki Saitoh; Yohei Osaki; Arito Yamane; Fumito Gohda; Hiroyuki Irisawa; Akihiko Yokohama; Hideki Uchiumi; Hiroshi Handa; Takafumi Matsushima; Norifumi Tsukamoto; Masamitsu Karasawa; Hirokazu Murakami; Yoshihisa Nojima, Jun. 2007, [Rinshō ketsueki] The Japanese journal of clinical hematology, 48, 6, 514, 517, Scientific journal
• [Acquired hemophilia A developed at relapse of minimal change nephrotic syndrome], Shimizu H; Saitoh T; Osaki Y; Yamane A; Gohda F; Irisawa H; Yokohama A; Uchiumi H; Handa H; Matsushima T; Tsukamoto N; Karasawa M; Murakami H; Nojima Y, Jun. 2007, Rinsho Ketsueki., 48, 6
• Hodgkin lymphoma accompanied by aplastic anemia and polyclonal expansion of large granular lymphocytes, Takayuki Saitoh; Takafumi Matsushima; Arito Yamane; Masataka Sakuraya; Hiroyuki Irisawa; Akihiko Yokohama; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Yoshihisa Nojima; Hirokazu Murakami, May 2007, Acta Haematologica, 117, 4, 238, 241, Scientific journal

  DOI
• Small-bowel perforation accompanied by Aspergillus endocarditis in a patient with angioimmunoblastic T-cell lymphoma [5], Takayuki Saitoh; Takafumi Matsushima; Asuka Matsuo; Akihiko Yokohama; Hiroyuki Irisawa; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Yoshihisa Nojima; Hirokazu Murakami, Jan. 2007, Annals of Hematology, 86, 1, 71, 73

  DOI
• 臍帯血移植を施行し寛解を継続している予宮原発granulocytic sarcoma(GS), 清水啓明; 斉藤貴之; 関上智美; 入澤寛之; 横濱章彦; 内海英貴; 半田寛; 松島孝文; 塚本憲史; 野島美久; 山根有人; 唐沢正光; 半田寛; 村上博和; 星野匠臣; 神保貴宏, 2007, 57, 3
• Successful treatment with voriconazole of Aspergillus meningitis in a patient with acute myeloid leukemia, Saitoh T; Matsushima T; Shimizu H; Yokohama A; Irisawa H; Handa H; Tsukamoto N; Karasawa M; Nojima Y; Murakami H, 2007, Ann Hematol
• Hodgkin Lymphoma Accompanied by Aplastic Anemia and Polyclonal Expansion of Large Granular Lymphocytes, Saitoh T; Matsushima T; Yamane A; Sakuraya M; Irisawa H; Yokohama A; Handa H; Tsukamoto N; Karasawa M; Nojima Y; Murakami H, 2007, Acta Haematol., 117
• Successful treatment with voriconazole of Aspergillus meningitis in a patient with acute myeloid leukemia, Saitoh, Takayuki;Matsushima, Takafumi;Shimizu, Hiroaki;Yokohama, Akihiko;Irisawa, Hiroyuki;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Nojima, Yoshihisa;Murakami, Hirokazu, 2007, ANNALS OF HEMATOLOGY, 86, 9, 697, 698

  DOI
• JAK2-V617F mutation analysis of granulocytes and platelets from patients with chronic myeloproliferative disorders: advantage of studying platelets, Toyama, Kohtaro;Karasawa, Masamitsu;Yamane, Arito;Irisawa, Hiroyuki;Yokohama, Akihiko;Saitoh, Takayuki;Handa, Hiroshi;Matsushima, Takafumi;Sawamura, Morio;Miyawaki, Shuichi;Murakami, Hirokazu;Nojima, Yoshihisa;Tsukamoto, Norifumi, 2007, BRITISH JOURNAL OF HAEMATOLOGY, 139, 1, 64, 69

  DOI
• The usefulness of F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG-PET) and a comparison of F-18-FDG-PET with (67)gallium scintigraphy in the evaluation of lymphoma - Relation to histologic subtypes-based on the World Health Organization Classification, Tsukamoto, Norifumi;Kojima, Masaru;Hasegawa, Masatoshi;Oriuchi, Noboru;Matsushima, Takafumi;Yokohama, Akihiko;Saitoh, Takayuki;Handa, Hiroshi;Endo, Keigo;Murakami, Hirokazu, 2007, CANCER, 110, 3, 652, 659

  DOI
• Small-bowel perforation accompanied by Aspergillus endocarditis in a patient with angioimmunoblastic T-cell lymphoma, Saitoh, Takayuki;Matsushima, Takafumi;Matsuo, Asuka;Yokohama, Akihiko;Irisawa, Hiroyuki;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Nojima, Yoshihisa;Murakami, Hirokazu, 2007, ANNALS OF HEMATOLOGY, 86, 1, 71, 73

  DOI
• Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation, Uchiumi, Hideki;Matsushima, Takafumi;Yamane, Arito;Doki, Noriko;Irisawa, Hiroyuki;Saitoh, Takayuki;Sakura, Tohru;Jimbo, Takahiro;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Miyawaki, Shuichi;Murakami, Hirokazu;Nojima, Yoshihisa, 2007, INTERNATIONAL JOURNAL OF HEMATOLOGY, 86, 2, 137, 142

  DOI
• Interleukin-10 gene polymorphism reflects the severity of chronic idiopathic thrombocytopenic purpura, Saitoh, Takayuki;Kasamatsu, Tetsuhiro;Inoue, Madoka;Al-ma'Quol, W. H. S.;Yokohama, Akihiko;Handa, Hiroshi;Matsushima, Takafumi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Ogawara, Hatsue;Nojima, Yoshihisa;Murakami, Hirokazu, 2007, BLOOD, 110, 11, 629A, 629A
• Presentation of extramedullary Philadelphia chromosome-positive biphenotypic acute leukemia as testicular mass: Response to imatinib-combined chemotherapy [9], Takayuki Saitoh; Takafumi Matsushima; Hirono Iriuchishima; Arito Yamane; Hiroyuki Irisawa; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Yoshihisa Nojima; Hirokazu Murakami, Dec. 2006, Leukemia and Lymphoma, 47, 12, 2667, 2669

  DOI
• Sacroiliitis as an initial manifestation of acute myelogenous leukemia, Takumi Hoshino; Takafumi Matsushima; Yasuyuki Saitoh; Arito Yamane; Makiko Takizawa; Hiroyuki Irisawa; Takayuki Saitoh; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Hirokazu Murakami; Yoshihisa Nojima, Dec. 2006, International Journal of Hematology, 84, 5, 421, 424, Scientific journal

  DOI
• Copper deficiency pancytopenia with infectious complications after hemolytic anemia [4], Takayuki Saitoh; Takafumi Matsushima; Kohtaro Toyama; Aarito Yamane; Hiroyuki Irisawa; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Yoshihisa Nojima; Hirokazu Murakami, Dec. 2006, Annals of Hematology, 85, 12, 881, 882

  DOI
• Sacroiliitis as an initial manifestation of acute myelogenous leukemia., Takumi Hoshino; Takafumi Matsushima; Yasuyuki Saitoh; Arito Yamane; Makiko Takizawa; Hiroyuki Irisawa; Takayuki Saitoh; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Hirokazu Murakami; Yoshihisa Nojima, Dec. 2006, International journal of hematology, 84, 5, 421, 4, Scientific journal
• Copper deficiency pancytopenia with infectious complications after hemolytic anemia., Saitoh T; Matsushima T; Toyama K; Yamane A; Irisawa H; Handa H; Tsukamoto N; Karasawa M; Nojima Y; Murakami H, Dec. 2006, Ann Hematol, 85, 12
• X-linked agammaglobulinemia diagnosed in adulthood: A case report, Takeki Mitsui; Norifumi Tsukamoto; Hirokazu Kanegane; Kazunaga Agematsu; Tomomi Sekigami; Hiroyuki Irisawa; Takayuki Saitoh; Hideki Uchiumi; Hiroshi Handa; Takafumi Matsushima; Masamitsu Karasawa; Hirokazu Murakami; Toshio Miyawaki; Yoshihisa Nojima, Aug. 2006, International Journal of Hematology, 84, 2, 154, 157, Scientific journal

  DOI
• PC-SPES down-regulates COX-2 via inhibition of NF-κB and C/EBPβ in non-small cell lung cancer cells, Takayuki Ikezoe; Yang Yang; Takayuki Saitoh; David Heber; Robert McKenna; Hirokuni Taguchi; H. Phillip Koeffler, Aug. 2006, International Journal of Oncology, 29, 2, 453, 461, Scientific journal

  DOI
• PC-SPES down-regulates COX-2 via inhibition of NF-kappa B and C/EBP beta in non-small cell lung cancer cells, Takayuki Ikezoe; Yang Yang; Takayuki Saitoh; David Heber; Robert McKenna; Hirokuni Taguchi; H. Phillip Koeffler, Aug. 2006, INTERNATIONAL JOURNAL OF ONCOLOGY, 29, 2, 453, 461, Scientific journal
• Deep vein thrombosis and pulmonary embolism in a patient with multiple myeloma treated with thalidomide and dexamethasone, Yuri Miyazawa; Hiroyuki Irisawa; Hideki Uchiumi; Takayuki Saitoh; Hiroshi Handa; Takafumi Matsushima; Norifumi Tsukamoto; Masamitsu Karasawa; Hirokazu Murakami; Yoshihisa Nojima, Jul. 2006, [Rinshō ketsueki] The Japanese journal of clinical hematology, 47, 7, 656, 660, Scientific journal
• Reversible posterior leukoencephalopathy syndrome probably caused by L-asparaginase., Miyazawa Y; Irisawa H; Matsushima T; Mitsui T; Uchiumi H; Saitoh T; Handa H; Karasawa M; Murakami H; Tsukamoto N; Nojima Y, Jun. 2006, 47, 6
• 当科における同種造血幹細胞移植症例の検討, 入沢寛之; 小野口裕乃; 宮澤悠里; 石埼卓馬; 内海英貴; 斉藤貴之; 松島孝文; 塚本憲史; 野島美久; 唐沢正光; 半田寛; 村上博和, 2006, 56, 3
• X-linked agammaglobulinemia diagnosed in adulthood: a case report., Mitsui T; Tsukamoto N; Kanegane H; Agematsu K; Sekigami T; Irisawa H; Saitoh T; Uchiumi H; Handa H; Matsushima T; Karasawa M; Murakami H; Miyawaki T; Nojima Y, 2006, Int J Hematol., 84
• Sacroiliitis as an initial manifestation of acute myelogenons leukemia, Hoshino, Takumi;Matsushima, Takafumi;Saitoh, Yasuyuki;Yamane, Arito;Takizawa, Makiko;Irisawa, Hiroyuki;Saitoh, Takayuki;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Murakami, Hirokazu;Nojima, Yoshihisa, 2006, INTERNATIONAL JOURNAL OF HEMATOLOGY, 84, 5, 421, 424

  DOI
• Copper deficiency pancytopenia with infectious complications after hemolytic anemia, Saitoh, Takayuki;Matsushima, Takafumi;Toyama, Kohtaro;Yamane, Aarito;Irisawa, Hiroyuki;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Nojima, Yoshihisa;Murakami, Hirokazu, 2006, ANNALS OF HEMATOLOGY, 85, 12, 881, 882

  DOI
• Presentation of extramedullary Philadelphia chromosome-positive biphenotypic acute leukemia as testicular mass: Response to imatinib-combined chemotherapy, Saitoh, Takayuki;Matsushima, Takafumi;Iriuchishima, Hirono;Yamane, Arito;Irisawa, Hiroyuki;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Nojima, Yoshihisa;Murakami, Hirokazu, 2006, LEUKEMIA & LYMPHOMA, 47, 12, 2667, 2669

  DOI
• HLA-DRB1 analysis in hairy B-cell lymphoproliferative disorder (HBLD): a Japanese type of benign persistent polyclonal B-cell lymphocytosis., Nakahashi, Hirotaka;Karasawa, Masamitsu;Hashimoto, Yoko;Frisawa, Hiroyuki;Yokohama, Akihiko;Saitoh, Takayuki;Handa, Hiroshi;Matsushima, Takalumi;Murakami, Hirokazu;Tsukamoto, Norifurni;Nojima, Yosihisa, 2006, BLOOD, 108, 11, 182B, 182B
• Utility of FDG-PET and comparison of FDG-PET and Ga-67 scintigraphy in evaluation of B-cell indolent lymphoma., Tsukamoto, Norifumi;Yokohama, Akihiko;Irisawa, Hiroyuki;Saitoh, Takayuki;Uchiumi, Hideki;Matsushima, Takafumi;Nojima, Yoshihisa;Karasawa, Masamitsu;Handa, Hiroshi;Murakami, Hirokazu, 2006, BLOOD, 108, 11, 234B, 234B
• JAK2 mutation in granulocytes and platelets and X-chromosome gene-based clonal analysis in chronic myeloproliferative disorders., Toyama, Kohtaro;Tsukamoto, Norifurni;Hiroyuki, Irisawa;Yokohama, Akihiko;Saitoh, Takayuki;Handa, Hiroshi;Matsushima, Takafumi;Murakami, Hirokazu;Miyawaki, Shuichi;Nojima, Yoshihisa;Karasawa, Masamitsu, 2006, BLOOD, 108, 11, 310B, 310B
• X-linked agammaglobulinemia diagnosed in adulthood: A case report, Mitsui, Takeki;Tsukamoto, Norifumi;Kanegane, Hirokazu;Agematsu, Kazunaga;Sekigami, Tomomi;Irisawa, Hiroyuki;Saitoh, Takayuki;Uchiumi, Hideki;Handa, Hiroshi;Matsushima, Takafumi;Karasawa, Masamitsu;Murakami, Hirokazu;Miyawaki, Toshio;Nojima, Yoshihisa, 2006, INTERNATIONAL JOURNAL OF HEMATOLOGY, 84, 2, 154, 157

  DOI
• Up-regulated of DMT1 in the Duodenum may be responsible for Iron Deposition in the Liver in TfR2 Mutant Mice., Kawabata, H; Fleming, R.E; Gui, D; Moon, S.Y; Saitoh, T; O'Kelly, J; Umehara, Y; Wano, Y; Said, J.W; Koeffler, H.P, Dec. 2005, Blood
• imatinib併用化学療法が有効であったPhiladelphia染色体陽性Biphenotypic Acute Leukemiaの1例, 太田 昌樹; 竝川 昌司; 小野口 裕乃; 入澤 寛之; 斉藤 貴之; 廣村 桂樹; 松島 孝文; 塚本 憲史; 野島 美久, Dec. 2005, 532回, 22, 22
• 骨髄球の分化誘導転写因子C/EBPαの他臓器での癌抑制機能, 熊谷 隆志; 高井 教行; 小松 直樹; 斉藤 貴之; 川又 紀彦; 久保 文人; 鈴木 隆之; 北野 あさ子; 今井 康文; Koeffler H.Phillip, Sep. 2005, 67回・47回, 887, 887
• HDAC阻害剤,Suberoylanilide Hydroxamic Acid(SAHA)とValproic Acid(VPA)のリンパ腫に対する抗腫瘍効果, 坂尻 さくら; 熊谷 隆志; 川又 紀彦; 斉藤 貴之; 久保 文人; 鈴木 隆之; 北野 あさ子; 今井 康文; Koeffler H. Phillip, Sep. 2005, 67回・47回, 768, 768
• Mucosa-associated lymphoid tissue lymphoma of the extrahepatic bile duct, T Shimura; H Kuwano; K Kashiwabara; M Kojima; N Masuda; H Suzuki; K Kanoh; T Saitoh; T Asao, Mar. 2005, HEPATO-GASTROENTEROLOGY, 52, 62, 360, 362, Scientific journal
• Dimeric transthyretin variant assembles into spherical neurotoxins., Matsubara K; Mizuguchi M; Igarashi K; Shinohara Y; Takeuchi M; Matsuura A; Saitoh T; Mori Y; Shinoda H; Kawano K, Mar. 2005, Biochemistry, 44, 9, 3280, 3288

  DOI
• Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis, Hiroshi Kawabata; Robert E. Fleming; Dorina Gui; Seo Y. Moon; Takayuki Saitoh; James O'Kelly; Yutaka Umehara; Yuji Wano; Jonathan W. Said; H. Phillip Koeffler, 01 Jan. 2005, Blood, 105, 1, 376, 381, Scientific journal

  DOI
• Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis, H Kawabata; RE Fleming; D Gui; SY Moon; T Saitoh; J O'Kelly; Y Umehara; Y Wano; JW Said; HP Koeffler, Jan. 2005, BLOOD, 105, 1, 376, 381, Scientific journal

  DOI
• Critical regions for assembly of vertebrate nonmuscle myosin II., Nakasawa T; Takahashi M; Matsuzawa F; Aikawa S; Togashi Y; Saitoh T; Yamagishi A; Yazawa M, Jan. 2005, Biochemistry, 44, 1, 174, 183

  DOI
• Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines, Sakura Sakajiri; Takashi Kumagai; Norihiko Kawamata; Takayuki Saitoh; Jonathan W. Said; H. Phillip Koeffler, Jan. 2005, Experimental Hematology, 33, 1, 53, 61, Scientific journal

  DOI
• Contribution of cellular contractility to spatial and temporal variations in cellular stiffness, M Nagayama; H Haga; M Takahashi; T Saitoh; K Kawabata, Nov. 2004, EXPERIMENTAL CELL RESEARCH, 300, 2, 396, 405, Scientific journal

  DOI
• C/EBP-alpha and -beta: Apposing affects in lymphoma cells., T Saitoh; AF Gombart; AM Chumakov; S De Vos; D Gui; JW Said; HP Koeffler, Nov. 2003, BLOOD, 102, 11, 159B, 159B
• Suppressive activities of OGG1 and MYH proteins against G:C to T:A mutations caused by 8-hydroxyguanine but not by benzo[a]pyrene diol epoxide in human cells in vivo, Arito Yamane; Kazuya Shinmura; Noriaki Sunaga; Takayuki Saitoh; Satoru Yamaguchi; Yumi Shinmura; Kimio Yoshimura; Hirokazu Murakami; Yoshihisa Nojima; Takashi Kohno; Jun Yokota, 01 Jun. 2003, Carcinogenesis, 24, 6, 1031, 1037

  DOI
• Suppressive activities of OGG1 and MYH proteins against G : C to T : A mutations caused by 8-hydroxyguanine but not by benzo[a]pyrene diol epoxide in human cells in vivo, A Yamane; K Shinmura; N Sunaga; T Saitoh; S Yamaguchi; Y Shinmura; K Yoshimura; H Murakami; Y Nojima; T Kohno; J Yokota, Jun. 2003, CARCINOGENESIS, 24, 6, 1031, 1037, Scientific journal

  DOI
• Vitamin D3 analogs stimulate hair growth in nude mice, Vijaya Vegesna; James O'Kelly; Milan Uskokovic; Jonathan Said; Nathan Lemp; Takayuki Saitoh; Takayuki Ikezoe; Lise Binderup; H. Phillip Koeffler, 01 Nov. 2002, Endocrinology, 143, 11, 4389, 4396, Scientific journal

  DOI
• Ribosome-lamella complex of leukemic cells in a patient with aggressive NK cell leukemia, Nahoko Hatsumi; Takayuki Saitoh; Akihiko Yokohama; Hideki Uchiumi; Takafumi Matsushima; Norifumi Tsukamoto; Yoshihisa Nojima; Masamitsu Karasawa; Hiroshi Handa; Hatsue Ogawara; Hirokazu Murakami, Nov. 2002, Ultrastructural Pathology, 26, 6, 415, 417, Scientific journal

  DOI
• Decreased myelopoiesis in C/EBP beta-/- mice in response to GM-CSF., T Saitoh; AF Gombart; HP Koeffler, Nov. 2002, BLOOD, 100, 11, 523A, 523A
• Vitamin D-3 analogs stimulate hair growth in nude mice, Vegesna, V; J O'Kelly; M Uskokovic; J Said; N Lemp; T Saitoh; T Ikezoe; L Binderup; HP Koeffler, Nov. 2002, ENDOCRINOLOGY, 143, 11, 4389, 4396, Scientific journal

  DOI
• A single nucleotide polymorphism at the splice donor site of the human MYH base excision repair gene results in reduced translation efficiency of its transcripts, Satoru Yamaguchi; Kazuya Shinmura; Takayuki Saitoh; Seiichi Takenoshita; Hiroyuki Kuwano; Jun Yokota, 2002, Genes to Cells, 7, 5, 461, 474, Scientific journal

  DOI
• Ribosome-lamella complex of leukemic cells in a patient with aggressive NK cell leukemia, Hatsumi, N; Saitoh, T; Yokohama, A; Uchiumi, H; Matsushima, T; Tsukamoto, N; Nojima, Y; Karasawa, M; Handa, H; Ogawara, H; Murakami, H, 2002, Ultrastruct Pathol, 26
• The magnitude of a staging system for multiple myeloma based on clinically available prognostic factors., H Murakami; T Kawada; T Saitoh; H Uchiumi; K Moridaira; T Matsushima; N Tsukamoto; K Morita; M Sawamura; M Karasawa; SI Miyawaki; S Shinonome; S Shimano; S Sato; H Ogawara; Y Nojima; R Ohno, Nov. 2001, BLOOD, 98, 11, 302B, 302B
• Enhancement of OGG1 protein AP lyase activity by increase of APEX protein, Takayuki Saitoh; Kazuya Shinmura; Satoru Yamaguchi; Masachika Tani; Shuji Seki; Hirokazu Murakami; Yoshihisa Nojima; Jun Yokota, 05 Jun. 2001, Mutation Research - DNA Repair, 486, 1, 31, 40, Scientific journal

  DOI
• Somatic mutations and single nucleotide polymorphisms of base excision repair genes involved in the repair of 8-hydroxyguanine in damaged DNA, Kazuya Shinmura; Satoru Yamaguchi; Takayuki Saitoh; Takashi Kohno; Jun Yokota, 10 May 2001, Cancer Letters, 166, 1, 65, 69, Scientific journal

  DOI
• OGG1 protein suppresses G:C→T: A mutation in a shuttle vector containing 8-hydroxyguanine in human cells, Noriaki Sunaga; Takashi Kohno; Kazuya Shinmura; Takayuki Saitoh; Tomonari Matsuda; Ryusei Saito; Jun Yokota, 2001, Carcinogenesis, 22, 9, 1355, 1362, Scientific journal

  DOI
• Effect of cytokines on growth and differentiation of leukaemic cells with translocation t(6;9)(p23;q34), Takafumi Matsushima; Takayuki Saitoh; Masamitsu Karasawa; Makiko Takizawa; Shuichi Miyawaki; Yoshihisa Nojima; Hirokazu Murakami, 2001, British Journal of Haematology, 115, 4, 812, 816, Scientific journal

  DOI
• Risk factors for early death in patients undergoing treatment for multiple myeloma, H. Murakami; K. Hayashi; N. Hatsumi; T. Saitoh; A. Yokohama; T. Matsushima; N. Tsukamoto; K. Morita; M. Karasawa; H. Ogawara; M. Sawamura; Y. Nojima, 2001, Annals of Hematology, 80, 8, 452, 455, Scientific journal

  DOI
• Adenine excisional repair function of MYH protein on the adenine : 8-hydroxyguanine base pair in double-stranded DNA, A Shinmura; S Yamaguchi; T Saitoh; M Takeuchi-Sasaki; Kim, SR; T Nohmi; J Yokota, Dec. 2000, NUCLEIC ACIDS RESEARCH, 28, 24, 4912, 4918, Scientific journal
• Regulation of cell surface expression of CTLA-4 by secretion of CTLA-4-containing lysosomes upon activation of CD4(+) T cells, T Iida; H Ohno; C Nakaseko; M Sakuma; M Takeda-Ezaki; H Arase; E Kominami; T Fujisawa; T Saito, Nov. 2000, JOURNAL OF IMMUNOLOGY, 165, 9, 5062, 5068, Scientific journal
• Improvement of extrathymic T cell type of large granular lymphocyte (LGL) leukemia by cyclosporin A: the serum level of Fas ligand is a marker of LGL leukemia activity, T Saitoh; M Karasawa; M Sakuraya; N Norio; T Junko; K Shirakawa; T Matsushima; N Tsukamoto; Y Nojima; H Murakami, Oct. 2000, EUROPEAN JOURNAL OF HAEMATOLOGY, 65, 4, 272, 275, Scientific journal
• Detection of VP-16-treated HL-60 cell apoptosis by TUNEL electron microscopy, T Saitoh; H Murakami; N Hatsumi; T Matsushima; T Naruse, Mar. 2000, ULTRASTRUCTURAL PATHOLOGY, 24, 2, 99, 103, Scientific journal
• Multiple myeloma presenting high fever and high serum levels of lactic dehydrogenase, CRP, and interleukin-6, Hirokazu Murakami; Satoru Takada; Nahoko Hatsumi; Akihiko Yokohama; Takayuki Saitoh; Hideki Uchiumi; Tadashi Maehara; Takafumi Matsushima; Norifumi Tsukamoto; Kimio Morita; Jun'ichi Tamura; Morio Sawamura; Masamitsu Karasawa, 2000, American Journal of Hematology, 64, 1, 76, 77, Scientific journal

  DOI
• Detection of VP-16-treated HL-60 cell, apoptosis by TUNEL electron microscopy, Takayuki Saitoh; Hirokazu Murakami; Nahoko Hatsumi; Takafumi Matsushima; Takuji Naruse, 2000, Ultrastructural Pathology, 24, 2, 99, 103, Scientific journal

  DOI
• Improvement of extrathymic T cell type of large granular lymphocyte (LGL) leukemia by cyclosporin A: The serum level of Fas ligand is a marker of LGL leukemia activity, Takayuki Saitoh; Masamitsu Karasawa; Masataka Sakuraya; Nakamura Norio; Tohma Junko; Kamon Shirakawa; Takafumi Matsushima; Norifumi Tsukamoto; Ju N.Ichi Tamura; Takuji Naruse; Hirokazu Murakami, 2000, European Journal of Haematology, 65, 4, 272, 275, Scientific journal

  DOI
• Two cases of chronic graft-versus-host disease with elevated levels of soluble Fas ligand in serum, Satoru Takada; Nahoko Hatsumi; Takayuki Saito; Takahumi Matsushima; Toru Sakura; Junich Tamura; Masamitu Karasawa; Shuichi Miyawaki, 2000, American Journal of Hematology, 64, 2, 133, 136, Scientific journal

  DOI
• Intermediate grade非ホジキンリンパ腫に対するCOPBLAM/MEVMP療法の治療成績., 塚本憲史; 斉藤貴之; 前原忠史; 松島孝文; 小倉秀充; 田村遵一; 成清卓二; 唐沢正光; 森田公夫; 村上博和; 土屋純; 佐藤貞夫; 島野俊一; 宮脇修一; 東雲正剛; 沢村守夫; 平林久美; 小島勝, 2000, 50
• Intermediate grade非ホジキンリンパ腫に対するCOPBLAM/MEVMP療法の治療成績., 斉藤 貴之, 2000, 50: 99-104
• Rhabdomyosarcoma in a patient with mosaic Klinefelter syndrome and transformation of immature teratoma, T Yamamoto; J Tamura; S Orima; T Saitoh; M Sakuraya; T Maehara; A Shirota; A Maezawa; Y Nojima; T Naruse, Jul. 1999, JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 27, 4, 196, 200, Scientific journal
• Electron microscopical analysis of myeloperoxidase of leukemic cells in CD7+stem cell leukemia lymphoma, H Murakami; N Hatsumi; T Saitoh; T Mitsui; T Matsushima; N Tsukamoto; K Morita; J Tamura; M Karasawa, May 1999, EUROPEAN JOURNAL OF HAEMATOLOGY, 62, 5, 350, 351
• Three AML patients with existing or pre-existing intracerebral granulocytic sarcomas who were successfully treated with allogeneic bone marrow transplantations, S Takada; K Ito; T Sakura; N Hatsumi; M Sato; T Saito; H Shiozaki; T Matsushima; S Miyawaki, Apr. 1999, BONE MARROW TRANSPLANTATION, 23, 7, 731, 734, Scientific journal
• Immunomodulation by vitamin B12: augmentation of CD8(+) T lymphocytes and natural killer (NK) cell activity in vitamin B12-deficient patients by methyl-B12 treatment, J Tamura; K Kubota; H Murakami; M Sawamura; T Matsushima; T Tamura; T Saitoh; H Kurabayshi; T Naruse, Apr. 1999, CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 116, 1, 28, 32, Scientific journal
• Myelodysplastic syndromes with nephrotic syndrome, T Saitoh; H Murakami; H Uchiumi; K Moridaira; T Maehara; T Matsushima; N Tsukamoto; J Tamura; M Karasawa; T Naruse; J Tsuchiya, Mar. 1999, AMERICAN JOURNAL OF HEMATOLOGY, 60, 3, 200, 204, Scientific journal
• A staging system for multiple myeloma based on the morphology of myeloma cells, H Murakami; T Kawada; T Saitoh; H Uchiumi; K Moridaira; T Matsushima; N Tsukamoto; J Tamura; K Morita; M Sawamura; M Karasawa; S Miyawaki; S Shinonome; S Shimano; S Sato; H Ogawara; J Tsuchiya, Jan. 1999, EUROPEAN JOURNAL OF HAEMATOLOGY, 62, 1, 63, 67, Scientific journal
• Primary nonsecretory plasma cell leukemia: a rare variant of multiple myeloma, E Kawada; S Shinonome; T Saitoh; J Tamura; M Karasawa; M Sawamura; H Murakami, Jan. 1999, ANNALS OF HEMATOLOGY, 78, 1, 25, 27, Scientific journal
• Primary nonsecretory plasma cell leukemia: A rare variant of multiple myeloma, Etsuo Kawada; S. Shinonome; T. Saitoh; J. Tamura; M. Karasawa; M. Sawamura; H. Murakami, Jan. 1999, Annals of Hematology, 78, 1, 25, 27, Scientific journal

  DOI
• A staging system for multiple myeloma based on the morphology of myeloma cells, Hirokazu Murakami; Tomoyuki Kawada; Takayuki Saitoh; Hideki Uchiumi; Kazuaki Moridaira; Takafumi Matsushima; Norifumi Tsukamoto; Jun'ichi Tamura; Kimio Morita; Morio Sawamura; Masamitsu Karasawa; Shuichi Miyawaki; Shogo Shinonome; Shunichi Shimano; Sadao Sato; Hatsue Ogawara; Jun Tsuchiya, 1999, European Journal of Haematology, 62, 1, 63, 67, Scientific journal

  DOI
• Rhabdomyosarcoma in a patient with mosaic Klinefelter syndrome and transformation of immature teratoma, T. Yamamoto; J. Tamura; S. Orima; T. Saitoh; M. Sakuraya; T. Maehara; A. Shirota; A. Maezawa; Y. Nojima; T. Naruse, 1999, Journal of International Medical Research, 27, 4, 196, 200, Scientific journal

  DOI
• Electron microscopical analysis of myeloperoxidase of leukemic cells in CD7 + stem cell leukemia/lymphoma [2], H. Murakami; N. Hatsumi; T. Saitoh; T. Mitsui; T. Matsushima; N. Tsukamoto; K. Morita; J. Tamura; M. Karasawa, 1999, European Journal of Haematology, 62, 5, 350, 351

  DOI
• Three AML patients with existing or pre-existing intracerebral granulocytic sarcomas who were successfully treated with allogeneic bone marrow transplantations, S. Takada; K. Ito; T. Sakura; N. Hatsumi; M. Sato; T. Saito; H. Shiozaki; T. Matsushima; S. Miyawaki, 1999, Bone Marrow Transplantation, 23, 7, 731, 734, Scientific journal

  DOI
• Myelodysplastic syndromes with nephrotic syndrome, Takayuki Saitoh; Hirokazu Murakami; Hideki Uchiumi; Kazuaki Moridaira; Tadashi Maehara; Takafumi Matsushima; Norifumi Tsukamoto; Jun'ichi Tamura; Masamitsu Karasawa; Takuji Naruse; Jun Tsuchiya, 1999, American Journal of Hematology, 60, 3, 200, 204, Scientific journal

  DOI
• Immunomodulation by vitamin B12: Augmentation of CD8⁺ T lymphocytes and natural killer (NK) cell activity in vitamin B12-deficient patients by methyl-B12 treatment, J. Tamura; K. Kubota; H. Murakami; M. Sawamura; T. Matsushima; T. Tamura; T. Saitoh; H. Kurabayshi; T. Naruse, 1999, Clinical and Experimental Immunology, 116, 1, 28, 32, Scientific journal

  DOI
• Fulminant, CMV-associated, haemophagocytic syndrome following unrelated bone marrow transplantation, M Sato; T Matsushima; S Takada; N Hatsumi; K Kim; M Sakuraya; T Saito; J Tamura; M Karasawa; H Murakami; T Naruse, Dec. 1998, BONE MARROW TRANSPLANTATION, 22, 12, 1219, 1222, Scientific journal
• Coincidental occurrence of pernicious anemia and mycosis fungoides in two elderly males, Takayuki Saitoh; Hirokazu Murakami; Kumiko Hayashi; Takafumi Matsushima; Jun'ichi Tamura; Masamitsu Karasawa; Takuji Naruse; Jun Tsuchiya, Jun. 1998, American Journal of Hematology, 58, 2, 127, 129, Scientific journal

  DOI
• Ultrastructural abnormalities of bone marrow erythroblasts in refractory anemia, T Sakura; H Murakami; T Saitoh; T Naruse; J Tsuchiya, May 1998, ULTRASTRUCTURAL PATHOLOGY, 22, 3, 173, 180, Scientific journal
• Ultrastructural abnormalities of bone marrow erythroblasts in refractory anemia, Tohru Sakura; Hirokazu Murakami; Takayuki Saitoh; Takuji Naruse; Jun Tsuchiya, 1998, Ultrastructural Pathology, 22, 3, 173, 180, Scientific journal

  DOI
• Non-Hodgkin's lymphoma following acute myeloid leukemia in complete remission, Kazuaki Moridaira; Jun'ichi Tamura; Takayuki Saitoh; Mitsuyasu Kanai; Katsuhiko Itoh; Toshimasa Uchiyama; Tokio Takeuchi; Sadao Sato; Takafumi Matsushima; Hirokazu Murakami; Takuji Naruse; Jun Tsuchiya, 1998, Acta Haematologica, 100, 2, 97, 98, Scientific journal

  DOI
• Non-Hodgkin's lymphoma following acute myeloid leukemia in complete remission, K Moridaira; J Tamura; T Saitoh; M Kanai; K Itoh; T Uchiyama; T Takeuchi; S Sato; T Matsushima; H Murakami; T Naruse; J Tsuchiya, 1998, ACTA HAEMATOLOGICA, 100, 2, 97, 98, Scientific journal
• Fulminant, CMV-associated, haemophagocytic syndrome following unrelated bone marrow transplantation, M. Sato; T. Matsushima; S. Takada; N. Hatsumi; K. Kim; M. Sakuraya; T. Saito; J. Tamura; M. Karasawa; H. Murakami; T. Naruse, 1998, Bone Marrow Transplantation, 22, 12, 1219, 1222, Scientific journal

  DOI
• Scabies in a patient with acute myelogenous leukemia, Fumito Iwai; Takayuki Saitoh; Hirokazu Murakami; Hideki Uchiumi; Hirotaka Sakai; Takafumi Matsushima; Tadashi Maehara; Norifumi Tsukamoto; Jun’ichi Tamura; Kimio Morita; Masamitsu Karasawa; Takuji Naruse, 1998, Kitakanto Medical Journal, 48, 4, 297, 299, Scientific journal

  DOI
• Successful treatment of multiple myeloma with autologous peripheral blood stem cell transplantation: A case report, S. Kobayashi; T. Matsushima; H. Koiso; K. Kim; T. Saitoh; H. Sakai; H. Ogura; J. Tamura; M. Karasawa; H. Murakami; T. Naruse, 1998, Kitakanto Medical Journal, 48, 3, 223, 227, Scientific journal

  DOI
• Serum beta-2-microglobulin in patients with multiple myeloma treated with alpha interferon, Hirokazu Murakami; Hatsue Ogawara; Kimio Morita; Takayuki Saitoh; Takafumi Matsushima; Jun'ichi Tamura; Morio Sawamura; Masamitsu Karasawa; Shuichi Miyawaki; Shunichi Schimano; Sadao Satoh; Jun Tsuchiya, 1997, Journal of Medicine, 28, 5-6, 311, 318, Scientific journal
• Eosinophilic gastroenteritis presenting with acute pancreatitis, Akito Maeshima; Hirokazu Murakami; Hiroto Sadakata; Takayuki Saitoh; Takafumi Matsushima; Jun'ichi Tamura; Masamitsu Karasawa; Takuji Naruse, 1997, Journal of Medicine, 28, 3-4, 265, 272, Scientific journal
• Immunological abnormalities in splenic marginal zone cell lymphoma, Hirokazu Murakami; Hiroyuki Irisawa; Takayuki Saitoh; Takafumi Matsushima; Jun'ichi Tamura; Morio Sawamura; Masamitsu Karasawa; Yasuo Hosomura; Masaru Kojima, 1997, American Journal of Hematology, 56, 3, 173, 178, Scientific journal

  DOI
• Deep vein thrombosis and pulmonary embolism in a patient with multiple myeloma treated with thalidomide and dexamethasone, MIYAZAWA Yuri;IRISAWA Hiroyuki;UCHIUMI Hideki;SAITOH Takayuki;HANDA Hiroshi;MATSUSHIMA Takafumi;TSUKAMOTO Norifumi;KARASAWA Masamitsu;MURAKAMI Hirokazu;NOJIMA Yoshihisa, Jul. 2006, 47, 7, 656, 660
• Clinical Benefits of Preconditioning Intervention in Patients with Relapsed or Refractory Acute Myelogenous Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A Kanto Study of Group for Cell Therapy Multicenter Analysis., Tachibana T; Kanda J; Ishizaki T; Najima Y; Tanaka M; Doki N; Fujiwara SI; Kimura SI; Onizuka M; Takahashi S; Saito T; Mori T; Fujisawa S; Sakaida E; Kanto Study Group for Cell Therapy (KSGCT), Sep. 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 27, 1, 70.e1-70.e8, Scientific journal

  DOI
• 多発性骨髄腫におけるDNAポリメラーゼの発現, 須永 征伸; 山根 瑛子; 石原 領; 村上 有希; 渡辺 早貴; 浅尾 優太; 後藤 七海; 笠松 哲光; 齋藤 貴之; 半田 寛, Jun. 2019, 20, 学術集会, S88, S88
• リンパ形質細胞性リンパ腫におけるホルマリン固定パラフィン包埋標本を用いた遺伝子変異の検出および検体の評価, 粟田 真彩; 横濱 章彦; 橋本 菜央; 後藤 七海; 笠松 哲光; 斉藤 明生; 磯田 淳; 齋藤 貴之; 半田 寛; 塚本 憲史, Jun. 2019, 20, 学術集会, S114, S114
• 多発性骨髄腫におけるc-MAFおよびMAFBの発現, 山根 瑛子; 須永 征伸; 石原 領; 村上 有希; 渡辺 早貴; 浅尾 優太; 後藤 七海; 笠松 哲光; 齋藤 貴之; 半田 寛, Jun. 2019, 20, 学術集会, S118, S118
• 多発性骨髄腫におけるProgrammed Cell Death Ligand-1(PD-L1)およびPD-L2の発現, 浅尾 優太; 村上 有希; 山根 瑛子; 須永 征伸; 石原 領; 渡辺 早貴; 後藤 七海; 笠松 哲光; 齋藤 貴之; 半田 寛, Jun. 2019, 20, 学術集会, S119, S119
• MYCは腫瘍抑制性TP53-micro RNA 34経路を遮断し骨髄腫の進行に関与する(MYC involves myeloma progression by abolishing tumor suppressive function of p53-miRNA 34 axis), 村上 有希; 増田 恵; 小田 司; 増田 裕太; 服部 光; 石原 領; 本間 和貴; 渡辺 早貴; 黒田 裕子; 小林 宣彦; 齋藤 貴之; 入内島 裕乃; 小磯 博美; 石埼 卓馬; 清水 啓明; 大崎 洋平; 横濱 章彦; 塚本 憲史; 後藤 七海; 笠松 哲光; 村上 博和; 半田 寛, Sep. 2018, 臨床血液, 59, 9, 1603, 1603
• TNF-α-857C/T多型は骨髄異形成症候群の重症度に影響する(TNF-α-857C/T polymorphism affects the severity of myelodysplastic syndromes), 相馬 佳奈; 齋藤 貴之; 後藤 七海; 北村 裕也; 高橋 範行; 須永 征伸; 山根 瑛子; 小田 司; 笠松 哲光; 清水 啓明; 滝沢 牧子; 佐倉 徹; 横濱 章彦; 塚本 憲史; 半田 寛; 村上 博和, Sep. 2018, 臨床血液, 59, 9, 1645, 1645
• PNA clamp PCR法を用いたリンパ形質細胞性リンパ種におけるCXCR4遺伝子変異の同定(Detection of CXCR4 mutation by PNA clamp PCR method on FFPE samples of lymphoplasmacytic lymphoma), 粟田 真彩; 横濱 章彦; 金井 敬海; 村田 圭祐; 後藤 七海; 笠松 哲光; 斉藤 明生; 磯田 淳; 齋藤 貴之; 半田 寛; 村上 博和; 塚本 憲史, Sep. 2018, 臨床血液, 59, 9, 1655, 1655
• 多発性骨髄腫における新規治療標的としての塩基除去修復の役割(The role of base excision repair as a potential therapeutic target in multiple myeloma), 後藤 七海; 齋藤 貴之; 井野 瑠美; 高橋 範行; 小田 司; 粟田 真彩; 石原 領; 大圃 真純; 金井 敬海; 村田 圭祐; 村上 有希; 渡辺 早貴; 笠松 哲光; 清水 啓明; 滝沢 牧子; 松本 守生; 澤村 守夫; 横濱 章彦; 塚本 憲史; 半田 寛; 村上 博和, Sep. 2018, 臨床血液, 59, 9, 1669, 1669
• 慢性骨髄性白血病を発症した本態性血小板血症患者でのシングルコロニー遺伝子解析(Genetic analysis of single colonies from secondary CML of MPN patients), 村田 圭祐; 滝沢 牧子; 粟田 真彩; 大圃 真純; 金井 敬海; 後藤 七海; 笠松 哲光; 横濱 章彦; 半田 寛; 齋藤 貴之; 村上 博和, Sep. 2018, 臨床血液, 59, 9, 1708, 1708
• TNF-α-857C/Tは特発性血小板減少性紫斑病の発症リスクを上昇させる, 相馬 佳奈; 齋藤 貴之; 北村 裕也; 石原 領; 村上 有希; 渡辺 早貴; 後藤 七海; 笠松 哲光; 半田 寛; 村上 博和, Jun. 2018, 19, 学術集会, S134, S134
• 本態性血小板血症から移行したPh陰性B細胞性急性リンパ性白血病の一症例, 永井 清絵; 齋藤 貴之; 松井 直紀; 齋藤 貴子; 中山 雅彦; 後藤 七海; 笠松 哲光; 高田 覚; 村上 博和, Jun. 2018, 19, 学術集会, S143, S143
• 多発性骨髄腫におけるlong non-cording RNA MALAT1とNEAT1およびNEAT1_2の発現, 渡辺 早貴; 石原 領; 村上 有希; 増田 裕太; 後藤 七海; 笠松 哲光; 齋藤 貴之; 村上 博和; 半田 寛, Jun. 2018, 19, 学術集会, S157, S157
• 多発性骨髄腫における髄外形質細胞腫とMatrix metalloproteinase(MMP)及びtissue inhibitor of metalloproteinases(TIMP)の発現, 石原 領; 村上 有希; 渡辺 早貴; 増田 裕太; 後藤 七海; 笠松 哲光; 齋藤 貴之; 村上 博和; 半田 寛, Jun. 2018, 19, 学術集会, S158, S158
• 多発性骨髄腫細胞株におけるmicroRNA-29,34 familyの発現制御機構, 村上 有希; 石原 領; 渡辺 早貴; 増田 裕太; 後藤 七海; 笠松 哲光; 齋藤 貴之; 村上 博和; 半田 寛, Jun. 2018, 19, 学術集会, S158, S158
• 骨髄異形成症候群の白血病化とPARP1 V762A遺伝子多型の関連について, 後藤 七海; 齋藤 貴之; 北村 裕也; 相馬 佳奈; 石原 領; 村上 有希; 渡辺 早貴; 笠松 哲光; 半田 寛; 村上 博和, Jun. 2018, 19, 学術集会, S179, S179
• 多発性骨髄腫におけるPD-1、PD-L1およびCTLA-4遺伝子多型解析, 笠松 哲光; 粟田 真彩; 金井 敬海; 村田 圭祐; 後藤 七海; 松本 守生; 澤村 守夫; 滝沢 牧子; 横濱 章彦; 半田 寛; 塚本 憲史; 齊藤 貴之; 村上 博和, May 2018, 8, 2, 137, 137
• 骨髄異形成症候群におけるPARP1V762A多型の解析, 後藤 七海; 齋藤 貴之; 笠松 哲光; 村上 博和, Oct. 2017, 65, 補冊, 275, 275
• 遺伝子組み換えヒトエリスロポエチン製剤の末梢血中CD69発現B細胞に対する影響, 粟田 真彩; 横濱 章彦; 金井 敬海; 村田 圭祐; 長嶋 友海; 後藤 七海; 笠松 哲光; 半田 寛; 齋藤 貴之; 村上 博和, Jun. 2017, 18, 学術集会, S165, S165
• IFN-γ+874T/A遺伝子多型は低リスク骨髄異形成症候群の病態に関与する, 大圃 真純; 齋藤 貴之; 井野 瑠美; 北村 裕也; 本間 和貴; 高橋 範行; 後藤 七海; 笠松 哲光; 半田 寛; 村上 博和, Jun. 2017, 18, 学術集会, S185, S185
• 多発性骨髄腫患者における免疫チェックポイント遺伝子の多型解析, 金井 敬海; 笠松 哲光; 粟田 真彩; 村田 圭祐; 長嶋 友海; 増田 裕太; 後藤 七海; 半田 寛; 齋藤 貴之; 村上 博和, Jun. 2017, 18, 学術集会, S195, S195
• 多発性骨髄腫におけるlong non-cording RNA NEAT1とMALAT1の発現, 渡辺 早貴; 石原 領; 村上 有希; 本間 和貴; 増田 裕太; 後藤 七海; 笠松 哲光; 齋藤 貴之; 村上 博和; 半田 寛, Jun. 2017, 18, 学術集会, S195, S195
• 多発性骨髄腫におけるMatrix metalloproteinase(MMP)及びtissue inhibitor of metalloproteinases(TIMP)の発現, 石原 領; 村上 有希; 渡辺 早貴; 本間 和貴; 増田 裕太; 後藤 七海; 笠松 哲光; 齋藤 貴之; 村上 博和; 半田 寛, Jun. 2017, 18, 学術集会, S196, S196
• 多発性骨髄腫細胞株におけるc-Myc作用阻害によるmicroRNA-29発現の変化, 村上 有希; 石原 領; 渡辺 早貴; 本間 和貴; 増田 裕太; 後藤 七海; 笠松 哲光; 齋藤 貴之; 村上 博和; 半田 寛, Jun. 2017, 18, 学術集会, S196, S196
• 多発性骨髄腫におけるc-MycとLong non coding RNA PVT1の発現, 本間 和貴; 半田 寛; 石原 領; 村上 有希; 渡辺 早貴; 増田 裕太; 後藤 七海; 笠松 哲光; 齋藤 貴之; 村上 博和, Jun. 2017, 18, 学術集会, S197, S197
• 急性骨髄性白血病患者における多機能蛋白APE1遺伝子多型解析, 後藤 七海; 齋藤 貴之; 大圃 真純; 井野 瑠美; 北村 裕也; 本間 和貴; 高橋 範行; 笠松 哲光; 半田 寛; 村上 博和, Jun. 2017, 18, 学術集会, S209, S209
• Th2サイトカイン多型のIL-4-590CCとIL-10RB K47EはITPの治療反応性に関与する, 北村 裕也; 齋藤 貴之; 大圃 真純; 井野 瑠美; 本間 和貴; 高橋 範行; 後藤 七海; 笠松 哲光; 半田 寛; 村上 博和, Jun. 2017, 18, 学術集会, S217, S217
• PD-1およびCTLA-4遺伝子多型は慢性免疫性血小板減少症の発症および症状に関与する, 井野 瑠美; 笠松 哲光; 北村 裕也; 本間 和貴; 長嶋 友海; 高橋 範行; 後藤 七海; 半田 寛; 齋藤 貴之; 村上 博和, Jun. 2017, 18, 学術集会, S218, S218
• Prognostic Value of Chromosomal Abnormalities for Follicular Lymphoma in the Rituximab-Era, Takeki Mitsui; Akihiko Yokohama; Hiromi Koiso; Akio Saito; Kohtaro Toyama; Hiroaki Shimizu; Takuma Ishizaki; Hiroyuki Irisawa; Takayuki Saito; Kayoko Murayama; Morio Matsumoto; Hiroshi Handa; Hirokazu Murakami; Norifumi Tsukamoto, Dec. 2016, BLOOD, 128, 22
• POLYMORPHISM OF IL-10 RECEPTOR. AFFECTS THE PROGNOSIS OF MULTIPLE MYELOMA PATIENTS TREATED WITH THALIDOMIDE AND/OR BORTEZOMIB, T. Kasamatsu; T. Saitoh; R. Ino; Y. Kitamura; K. Honma; N. Gotoh; H. Handa; M. Matsumoto; M. Sawamura; A. Yokohama; N. Tsukamoto; H. Murakami, Jun. 2016, HAEMATOLOGICA, 101, 780, 780
• LONG NON-CODING RNA MALAT1 WAS ASSOCIATED WITH PROGRESSION OF MULTIPLE MYELOMA AND INDUCED BY CELLULAR STRESS, H. Handa; Y. Kuroda; K. Kimura; A. Yamane; Y. Masuda; T. Kasamatsu; T. Saitoh; K. Tahara; N. Kobayashi; H. Shimizu; N. Tsukamoto; A. Yokohama; T. Mitsui; T. Ishizaki; H. Koiso; M. Takizawa; H. Murakami, Jun. 2016, HAEMATOLOGICA, 101, 513, 514
• 心腔内病変を有する悪性リンパ腫3例の治療経験, 小林 宣彦; 三井 健揮; 飯野 宏允; 野口 紘幸; 内藤 千晶; 三原 正大; 田原 研一; 清水 啓明; 柳澤 邦雄; 石埼 卓馬; 小川 孔幸; 小磯 博美; 滝沢 牧子; 横濱 章彦; 斉藤 貴之; 塚本 憲史; 村上 博和; 半田 寛, Jun. 2016, 57, 6, 778, 779
• MUTATION OF THE SF3B1 PREDICT A POOR PROGNOSIS IN JAPANESE CLL PATIENTS, Takeki Mitsui; Hiromi Koiso; Hirotaka Namahashi; Akio Saito; Takuma Ishizaki; Makiko TAakizawa; Akihiko Yokohama; Takayuki Saito; Takahiro Jinbo; Hidemi Ogura; Hiroshi Handa; Morio Sawamura; Tohru Sakura; Masamitsu Karasawa; Hirokazu Murakami; Yoshihisa Nojima; Norifumi Tsukamoto, Sep. 2015, EXPERIMENTAL HEMATOLOGY, 43, 9, S81, S81
• Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation., Kanda J; Mizumoto C; Ichinohe T; Kawabata H; Saito T; Yamashita K; Kondo T; Takakura S; Ichiyama S; Uchiyama T; Ishikawa T, Feb. 2011, BONE MARROW TRANSPLANTATION, 46, 2, 208, 216, Scientific journal

  DOI
• The 30th Meeting of the Gunma Association for Organ Transplantation, 田原 研一; 横濱 章彦; 関上 智美; 馬渡 桃子; 大崎 洋平; 斎藤 貴之; 半田 寛; 松島 孝文; 塚本 憲史; 野島 美久, 01 Feb. 2009, The KITAKANTO medical journal, 59, 1, 75, 76

  DOI
• Clinical significance of Th1/Th2 ratio in patients with myelodysplastic syndrome, Hatsue Ogawara; Wedad Hamdi; Tetsuhiro Kasamatsu; Madoka Inoue; Hiroshi Handa; Takayuki Saito; Takafumi Matsushima; Norifumi Tsukamoto; Yoshihisa Nojima; Hirokazu Murakami, Jun. 2007, INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 29, 93, 93
• Flow cytometric detection of human telomerase reverse mranscriptase expression in CD34 positive precursor fraction in myelodysplastic syndrome bone marrow., Hiroshi Handa; Takafumi Matsushima; Norifumi Tsukamoto; Masamitsu Karasawa; Hiroyuki Irisawa; Takayuki Saito; Akihiko Yokohama; Arito Yamane; Hirokazu Murakami, Nov. 2006, BLOOD, 108, 11, 153B, 153B
• Reversible posterior leukoencephalopathy syndrome probably caused by L-asparaginase, MIYAZAWA Yuri;IRISAWA Hiroyuki;MATSUSHIMA Takafumi;MITSUI Takeki;UCHIUMI Hideki;SAITOH Takayuki;HANDA Hiroshi;KARASAWA Masamitsu;MURAKAMI Hirokazu;TSUKAMOTO Norifumi;NOJIMA Yoshihisa, Jun. 2006, Rinsho Ketsueki, 47, 6, 531, 535
• Sacroiliitis as an Initial Manifestation of Acute Myelogenous Leukemia, HOSHINO Takumi;MATSUSHIMA Takafumi;SAITOH Yasuyuki;YAMANE Arito;TAKIZAWA Makiko;IRISAWA Hiroyuki;SAITOH Takayuki;HANDA Hiroshi;TSUKAMOTO Norifumi;KARASAWA Masamitsu;MURAKAMI Hirokazu;NOJIMA Yoshihisa, Dec. 2006, 84, 5, 421, 424
• X-Linked Agammaglobulinemia Diagnosed in Adulthood : A Case Report, MITSUI Takeki;TSUKAMOTO Norifumi;KANEGANE Hirokazu;AGEMATSU Kazunaga;SEKIGAMI Tomomi;IRISAWA Hiroyuki;SAITOH Takayuki;UCHIUMI Hideki;HANDA Hiroshi;MATSUSHIMA Takafumi;KARASAWA Masamitsu;MURAKAMI Hirokazu;MIYAWAKI Toshio;NOJIMA Yoshihisa, Aug. 2006, Int. J. Hematol., 84, 2, 154, 157
• Polyclonal B-cell lymphocytosis with hairy cell appearance : hairy B-cell lymphoproliferative disorder, NAKAHASHI Hirotaka;HASHIMOTO Yoko;YAMANE Arito;IRISAWA Hiroyuki;YOKOHAMA Akihiko;SAITOH Takayuki;HANADA Hiroshi;MATSUSHIMA Takafumi;TSUKAMOTO Norifumi;KARASAWA Masamitsu;MURAKAMAI Hirokazu;NOJIMA Yoshihisa, Aug. 2007, 48, 8, 647, 651
• Prevalence and Clinical Characteristics of Acute Myeloid Leukemia Associated with Disseminated Intravascular Coagulation, UCHIUMI Hideki;MATSUSHIMA Takafumi;YAMANE Arito;DOKI Noriko;IRISAWA Hiroyuki;SAITOH Takayuki;SAKURA Tohru;JIMBO Takahiro;HANDA Hiroshi;TSUKAMOTO Norifumi;KARASAWA Masamitsu;MIYAWAKI Shuichi;MURAKAMI Hirokazu;NOJIMA Yoshihisa, Aug. 2007, 86, 2, 137, 142
• Successful treatment of azole-refractory Candida guilliermondii fungemia with a combination therapy with micafungin and liposomal amphotericin B, SAITOH Takayuki;MATSUSHIMA Takafumi;SHIMIZU Hiroyuki;OSAKI Yohei;YAMANE Arito;IRISAWA Hiroyuki;YOKOHAMA Akihiko;UCHIUMI Hideki;HANDA Hiroshi;TSUKAMOTO Norifumi;KARASAWA Masamitsu;NOJIMA Yoshihisa;MURAKAMI Hirokazu, Feb. 2008, Rinsho Ketsueki, 49, 2, 94, 98
• Development of an extramedullary plasmacytoma despite disappearing M protein in multiple myeloma by bortezomib treatment, KOISO Hiromi;TAHARA Kenichi;OSAKI Yohei;MAWATARI Momoko;SEKIGAMI Tomomi;YOKOHAMA Akihiko;SAITOH Takayuki;UCHIUMI Hideki;HANDA Hiroshi;TSUKAMOTO Norifumi;KARASAWA Masamitsu;NOJIMA Yoshihisa;MURAKAMI Hirokazu, Feb. 2009, Rinsho Ketsueki, 50, 2, 78, 82
• Characterization of immunoglobulin heavy and light chain gene expression in chronic lymphocytic leukemia and related disorders, NAKAHASHI Hirotaka;TSUKAMOTO Norifumi;HASHIMOTO Yoko;KOISO Hiromi;YOKOHAMA Akihiko;SAITOH Takayuki;UCHIUMI Hideki;HANDA Hiroshi;MURAKAMI Hirokazu;NOJIMA Yoshihisa;KARASAWA Masamitsu, Apr. 2009, Cancer Sci, 100, 4, 671, 677
• Low burden of a JAK2-V617F mutated clone in monoclonal haematopoiesis in a Japanese woman with Budd-Chiari syndrome, TOYAMA Kohtaro;KARASAWA Masamitsu;YAMANE Arito;KOISO Hiromi;YOKOHAMA Akihiko;UCHIUMI Hideki;SAITOH Takayuki;HANDA Hiroshi;SATO Ken;TAKAGI Hitoshi;MIYAWAKI Shuichi;MURAKAMI Hirokazu;NOJIMA Yoshihisa;TSUKAMOTO Norifumi, May 2009, 89, 4, 517, 522
• Successful treatment with reduced-intensity stem cell transplantation for secondary myelofibrosis following polycythemia vera, TAHARA Kenichi;YOKOHAMA Akihiko;HANDA Hiroshi;SAITOH Takayuki;UCHIUMI Hideki;SEKIGAMI Tomomi;TOYAMA Kohtaro;MAWATARI Momoko;OSAKI Yohei;MATSUSHIMA Takafumi;KARASAWA Masamitsu;MURAKAMI Hirokazu;TSUKAMOTO Norifumi;NOJIMA Yoshihisa, Nov. 2009, The Japanese journal of clinical hematology, 50, 11, 1630, 1634
• Successful Treatment by All-Trans Retinoic Acid in a Patient with Acute Promyelocytic Leukemia Complicated by Liver Cirrhosis and Polycystic Kidney, Yamane Arito;Tsukamoto Norifumi;Saitoh Takayuki;Uchiumi Hideki;Handa Hiroshi;Karasawa Masamitsu;Nojima Yoshihisa;Murakami Hirokazu, 2009, Internal Medicine, 48, 18, 1691, 1694
• Deep vein thrombosis and pulmonary embolism in a patient with multiple myeloma treated with thalidomide and dexamethasone, MIYAZAWA Yuri;NOJIMA Yoshihisa;IRISAWA Hiroyuki;UCHIUMI Hideki;SAITOH Takayuki;HANDA Hiroshi;MATSUSHIMA Takafumi;TSUKAMOTO Norifumi;KARASAWA Masamitsu;MURAKAMI Hirokazu, 2006, Rinsho Ketsueki, 47, 7, 656, 660
• Acquired hemophilia A developed at relapse of minimal change nephrotic syndrome, SHIMIZU Hiroaki;MATSUSHIMA Takafumi;TSUKAMOTO Norifumi;KARASAWA Masamitsu;MURAKAMI Hirokazu;NOJIMA Yoshihisa;SAITOH Takayuki;OSAKI Yohei;YAMANE Arito;GOHDA Fumito;IRISAWA Hiroyuki;YOKOHAMA Akihiko;UCHIUMI Hideki;HANDA Hiroshi, 2007, Rinsho Ketsueki, 48, 6, 514, 517
• Polyclonal B-cell lymphocytosis with hairy cell appearance: hairy B-cell lymphoproliferative disorder, NAKAHASHI Hirotaka;KARASAWA Masamitsu;MURAKAMAI Hirokazu;NOJIMA Yoshihisa;HASHIMOTO Yoko;YAMANE Arito;IRISAWA Hiroyuki;YOKOHAMA Akihiko;SAITOH Takayuki;HANADA Hiroshi;MATSUSHIMA Takafumi;TSUKAMOTO Norifumi, 2007, Rinsho Ketsueki, 48, 8, 647, 651
• Successful treatment with reduced-intensity stem cell transplantation for secondary myelofibrosis following polycythemia vera, TAHARA Kenichi;MATSUSHIMA Takafumi;KARASAWA Masamitsu;MURAKAMI Hirokazu;TSUKAMOTO Norifumi;NOJIMA Yoshihisa;YOKOHAMA Akihiko;HANDA Hiroshi;SAITOH Takayuki;UCHIUMI Hideki;SEKIGAMI Tomomi;TOYAMA Kohtaro;MAWATARI Momoko;OSAKI Yohei, 2009, Rinsho Ketsueki, 50, 11, 1630, 1634
• IL-10 promoter region-592A/C genotype increases the risk of multiple myeloma in Japanese patients., Saitoh, Takayuki;Kasamatsu, Tetsuhiro;Matsuoka, Hitomi;Endoh, Miyuki;Inoue, Madoka;Yamane, Arito;Irisawa, Hiroyuki;Handa, Hiroshi;Matsushima, Takafumi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Ogawara, Hatsue;Nojima, Yoshihisa;Murakami, Hirokazu, 2006, BLOOD, 108, 11, 342B, 342B
• Hodgkin lymphoma accompanied by aplastic anemia and polyclonal expansion of large granular lymphocytes, Saitoh, Takayuki;Matsushima, Takafumi;Yamane, Arito;Sakuraya, Masataka;Irisawa, Hiroyuki;Yokohama, Akihiko;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Nojima, Yoshihisa;Murakami, Hirokazu, 2007, ACTA HAEMATOLOGICA, 117, 4, 238, 241

  DOI
• IL-10-592 polymorphism predicts the clinical outcome of Japanese patients with multiple myeloma and MGUS, Kasamatsu, Tetsuhiro;Saitoh, Takayuki;Handa, Hiroshi;Matsushima, Takafumi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Ogawara, Hatsue;Sawamura, Morio;Nojima, Yohihisa;Murakami, Hirokazu, 2007, BLOOD, 110, 11, 263B, 263B
• The Influence of Polymorphisms of Interleukin-17F Genes on the Susceptibility and Clinical Significanse of Chronic Idiopathic Thrombocytopenic Purpura, Saitoh, Takayuki;Kasamatsu, Tetsuhiro;Yokohama, Akihiko;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Ogawara, Hatsue;Nojima, Yoshihisa;Murakami, Hirokazu, 2008, BLOOD, 112, 11, 1175, 1175
• Characterization of immunoglobulin heavy and light chain gene expression in chronic lymphocytic leukemia and related disorders, Nakahashi, Hirotaka;Tsukamoto, Norifumi;Hashimoto, Yoko;Koiso, Hiromi;Yokohama, Akihiko;Saitoh, Takayuki;Uchiumi, Hideki;Handa, Hiroshi;Murakami, Hirokazu;Nojima, Yoshihisa;Karasawa, Masamitsu, 2009, CANCER SCIENCE, 100, 4, 671, 677

  DOI
• The Influence of Polymorphisms of Interleukin-17F Genes On the Susceptibility and Clinical Outcome of Multiple Myeloma., Saitoh, Takayuki;Kasamatsu, Tetsuhiro;Yokohama, Akihiko;Handa, Hiroshi;Tsukamoto, Norifumi;Karasawa, Masamitsu;Ogawara, Hatsue;Nojima, Yoshihisa;Murakami, Hirokazu, 2009, BLOOD, 114, 22, 709, 710
• Hairy Cell Leukemia-Related Disorders Consistently Show Low CD27 Expression, Hashimoto, Yoko;Tsukamoto, Norifumi;Nakahashi, Hirotaka;Yokohama, Akihiko;Saitoh, Takayuki;Handa, Hiroshi;Matsushima, Takafumi;Murakami, Hirokazu;Nojima, Yoshihisa;Karasawa, Masamitsu, 2009, PATHOLOGY & ONCOLOGY RESEARCH, 15, 4, 615, 621

  DOI
• Flow cytometric detection of human telomerase reverse transcriptase (hTERT) expression in a subpopulation of bone marrow cells, Handa, Hiroshi;Matsushima, Takafumi;Nishimoto, Natsumi;Inoue, Madoka;Saitoh, Takayuki;Yokohama, Akihiko;Tsukamoto, Norifumi;Mitsui, Takeki;Nakahashi, Hirotaka;Toyama, Kotaro;Karasawa, Masamitsu;Ogawara, Hatsue;Nojima, Yoshihisa;Murakami, Hirokazu, 2010, LEUKEMIA RESEARCH, 34, 2, 177, 183

  DOI
• THE INFLUENCE OF POLYMORPHISMS OF INTERLEUKIN-17F GENES ON THE SUSCEPTIBILITY AND CLINICAL OUTCOME OF MULTIPLE MYELOMA, Saitoh, Takayuki;Tsukamoto, Norifumi;Koiso, Hiromi;Murakami, Hirokazu, 2010, ANNALS OF ONCOLOGY, 21, 17, 17
• Significantly Reduced Circulating Plasmacytoid Dendritic Cells In Patients with Primary and Helicobacter Pylori-Associated Immune Thrombocytopenia., Saito, Akio;Yokohama, Akihiko;Osaki, Yohei;Ogawa, Yoshiyuki;Mitsui, Takeki;Uchiumi, Hideki;Saitoh, Takayuki;Handa, Hiroshi;Sawamura, Morio;Karasawa, Masamitsu;Murakami, Hirokazu;Nojima, Yoshihisa;Tsukamoto, Norifumi, 2010, BLOOD, 116, 21, 1048, 1049
• Pure Red Cell Aplasia Induced Only by Intravenous Administration of Recombinant Human Erythropoietin, Shimizu, Hiroaki;Saitoh, Takayuki;Ota, Fumie;Jimbo, Takahiro;Tsukada, Yoshito;Murakami, Hirokazu;Nojima, Yoshihisa, 2011, ACTA HAEMATOLOGICA, 126, 2, 114, 118

  DOI
• Successful Treatment of Autoimmune Hemolytic Anemia Associated with Multicentric Castleman Disease by Anti-Interleukin-6 Receptor Antibody (Tocilizumab) Therapy, Yuzuriha, Akinori;Saitoh, Takayuki;Koiso, Hiromi;Mitsui, Takeki;Uchiumi, Hideki;Yokohama, Akihiko;Handa, Hiroshi;Kojima, Masaru;Tsukamoto, Norifumi;Karaswa, Masamitsu;Murakami, Hirokazu;Nojima, Yoshihisa, 2011, ACTA HAEMATOLOGICA, 126, 3, 147, 150

  DOI
• Circulating plasmacytoid dendritic cells in patients with primary and Helicobacter pylori-associated immune thrombocytopenia, Saito, Akio;Yokohama, Akihiko;Osaki, Yohei;Ogawa, Yoshiyuki;Nakahashi, Hirotaka;Toyama, Kohtaro;Mitsui, Takeki;Hashimoto, Yoko;Koiso, Hiromi;Uchiumi, Hideki;Saitoh, Takayuki;Handa, Hiroshi;Sawamura, Morio;Karasawa, Masamitsu;Murakami, Hirokazu;Tsukamoto, Norifumi;Nojima, Yoshihisa, 2012, EUROPEAN JOURNAL OF HAEMATOLOGY, 88, 4, 340, 349

  DOI
• Follicular Lymphoma Presenting with Marked Splenomegaly: Report of Three Cases, Koiso, Hiromi;Yokohama, Akihiko;Mitsui, Takeki;Saitoh, Takayuki;Handa, Hiroshi;Murakami, Hirokazu;Hirato, Junko;Kojima, Masaru;Nojima, Yoshihisa;Tsukamoto, Norifumi, 2012, ACTA HAEMATOLOGICA, 128, 1, 47, 52

  DOI
• Clinical significance of granulocytic sarcoma in adult patients with acute myeloid leukemia, Shimizu, Hiroaki;Saitoh, Takayuki;Hatsumi, Nahoko;Takada, Satoru;Yokohama, Akihiko;Handa, Hiroshi;Jimbo, Tkahiro;Sakura, Toru;Tsukamoto, Norifumi;Murakami, Hirokazu;Miyawaki, Shuichi;Nojima, Yoshihisa, 2012, CANCER SCIENCE, 103, 8, 1513, 1517

  DOI
• Biological Features and Plasticity of CD56-Positive Dendritic-Like Cells: relationship to Blastic Plasmacytoid Dendritic Cell Neoplasm, Osaki, Yohei;Yokohama, Akihiko;Saitoh, Akio;Tahara, Kenichi;Yanagisawa, Kunio;Ogawa, Yoshiyuki;Ishizaki, Takuma;Mitsui, Takeki;Koiso, Hiromi;Takizawa, Makiko;Uchiumi, Hideki;Murakami, Hirokazu;Saitoh, Takayuki;Tsukamoto, Norifumi;Handa, Hiroshi;Nojima, Yoshihisa, 2012, BLOOD, 120, 21
• Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia, Shimizu, Hiroaki;Saitoh, Takayuki;Hatsumi, Nahoko;Takada, Satoru;Handa, Hiroshi;Jimbo, Takahiro;Sakura, Toru;Miyawaki, Shuichi;Nojima, Yoshihisa, 2013, LEUKEMIA RESEARCH, 37, 11, 1477, 1481

  DOI
• Survival of Multiple Myeloma Patients Aged 65-70 Years in the Era of Novel Agents and Autologous Stem Cell Transplantation, Ozaki, Shuji;Harada, Takeshi;Saitoh, Takayuki;Shimazaki, Chihiro;Itagaki, Mitsuhiro;Asaoku, Hideki;Kuroda, Yoshiaki;Chou, Takaaki;Yoshiki, Yumiko;Suzuki, Kenshi;Murakami, Hirokazu;Hayashi, Kunihiko;Mina, Roberto;Palumbo, Antonio;Shimizu, Kazuyuki;Japanese Soc Myeloma;European Myeloma Network, 2014, ACTA HAEMATOLOGICA, 132, 2, 211, 219

  DOI
• Does the Hematopoietic Cell Transplantation Specific Comorbidity Index (HCT-CI) Predict Transplantation Outcomes? A Prospective Multicenter Validation Study of the Kanto Study Group for Cell Therapy, Nakaya, Aya;Mori, Takehiko;Tanaka, Masatsugu;Tomita, Naoto;Nakaseko, Chiaki;Yano, Shingo;Fujisawa, Shin;Sakamaki, Hisashi;Aotsuka, Nobuyuki;Yokota, Akira;Kanda, Yoshinobu;Sakura, Toru;Nanya, Yasuhito;Saitoh, Takayuki;Kanamori, Heiwa;Takahashi, Satoshi;Okamoto, Shinichiro, 2014, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20, 10, 1553, 1559

  DOI
• High Percentage of Regulatory T Cells before and after Vitamin B-12 Treatment in Patients with Pernicious Anemia, Watanabe, Satoru;Ide, Norifumi;Ogawara, Hatsue;Yokohama, Akihiko;Mitsui, Takeki;Handa, Hiroshi;Koiso, Hiromi;Tsukamoto, Norifumi;Saitoh, Takayuki;Murakami, Hirokazu, 2015, ACTA HAEMATOLOGICA, 133, 1, 83, 88

  DOI
• Primary Plasma Cell Leukemia in the Era of Novel Agent: Report of Multicenter Study from Japanese Society of Myeloma, Iriuchishima, Hirono;Murakami, Hirokazu;Ozaki, Shuji;Handa, Hiroshi;Saitoh, Takayuki;Nagura, Eiichi;Shimizu, Kazuyuki, 2014, BLOOD, 124, 21
• Methylation and Hydroxymethylation Status of Tumor Suppressor Genes and Common Fragile Sites Genes in Acute Myeloid Leukemia, Handa, Hiroshi;Suda, Itsumi;Kaneko, Ayaka;Masuda, Yuta;Kimura, Kei;Kuroda, Yuko;Kasamatsu, Tetsuhiro;Minato, Yusuke;Tahara, Kenichi;Shimizu, Hiroaki;Ishizaki, Takuma;Mitsui, Takeki;Yokohama, Akihiko;Koiso, Hiromi;Takizawa, Makiko;Saitoh, Takayuki;Hatsumi, Naoko;Takada, Satoru;Sakura, Toru;Tsukamoto, Norifumi;Nojima, Yoshihisa;Murakami, Hirokazu, 2014, BLOOD, 124, 21
• BCL6 Dose Not Negatively Regulate DNA Damage Response Genes in Multiple Myeloma Cells, Tahara, Kenichi;Takizawa, Makiko;Handa, Hiroshi;Masuda, Yuta;Kaneko, Ayaka;Suda, Itsumi;Kimura, Kei;Kuroda, Yuko;Atsushi, Isoda;Matsumoto, Morio;Koiso, Hiromi;Takuma, Ishizaki;Mitsui, Takeki;Yokohama, Akihiko;Saitoh, Takayuki;Tsukamoto, Norifumi;Murakami, Hirokazu, 2014, BLOOD, 124, 21
• Clinical Significance of Additional Cytogenetic Abnormalities (ACA) Acquired at the First Relapse in Adult Acute Myeloid Leukemia (AML) Patients, Shimizu, Hiroaki;Yokohama, Akihiko;Hatsumi, Nahoko;Takada, Satoru;Saitoh, Takayuki;Handa, Hiroshi;Sakura, Toru;Nojima, Yoshihisa, 2014, BLOOD, 124, 21
• Survival of Multiple Myeloma Patients in the Era of Novel Agents and Autologous Stem Cell Transplantation: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma, Ozaki, Shuji;Handa, Hiroshi;Saitoh, Takayuki;Murakami, Hirokazu;Itagaki, Mitsuhiro;Asaoku, Hideki;Suzuki, Kenshi;Isoda, Atsushi;Sawamura, Morio;Konishi, Jun;Sunami, Kazutaka;Takezako, Naoki;Hagiwara, Shotaro;Kuroda, Yoshiaki;Chou, Takaaki;Shibata, Eiko;Shimizu, Kazuyuki;Nagura, Eiichi, 2014, BLOOD, 124, 21
• A new staging system to predict prognosis of patients with multiple myeloma in an era of novel therapeutic agents, Iriuchishima, Hirono;Saitoh, Takayuki;Handa, Hiroshi;Isoda, Atsushi;Matsumoto, Morio;Sawamura, Morio;Iwasaki, Atsushi;Ushie, Chiaki;Hattori, Hikaru;Sasaki, Yoshiko;Mitsui, Takeki;Yokohama, Akihiko;Tsukamoto, Norifumi;Murakami, Hirokazu;Nojima, Yoshihisa, 2015, EUROPEAN JOURNAL OF HAEMATOLOGY, 94, 2, 145, 151

  DOI
• Allogeneic hematopoietic stem cell transplantation for adult patients with mixed phenotype acute leukemia: results of a matched-pair analysis, Shimizu, Hiroaki;Saitoh, Takayuki;Machida, Shinichiro;Kako, Shinichi;Doki, Noriko;Mori, Takehiko;Sakura, Toru;Kanda, Yoshinobu;Kanamori, Heiwa;Miyawaki, Shuichi;Okamoto, Shinichiro;KSGCT, 2015, EUROPEAN JOURNAL OF HAEMATOLOGY, 95, 5, 455, 460

  DOI
• Long Non-Coding RNA MALAT1 Is Associated with the Progression of Multiple Myeloma and Induced By Cellular Stress, Kuroda, Yuko;Kimura, Kei;Masuda, Yuta;Yamane, Arito;Hattori, Hikaru;Tahara, Kenichi;Kaneko, Ayaka;Suda, Itsumi;Takahashi, Noriyuki;Nanami, Gotoh;Nagai, Kie;Nagashima, Tomomi;Takizawa, Makiko;Koiso, Hiromi;Ishizaki, Takuma;Mitsui, Takeki;Iriuchishima, Hirono;Saitoh, Takayuki;Shimizu, Hiroaki;Yokohama, Akihiko;Tsukamoto, Norifumi;Kasamatsu, Tetsuhiro;Minato, Yusuke;Nojima, Yoshihisa;Murakami, Hirokazu;Handa, Hiroshi, 2015, BLOOD, 126, 23
• Prognostic Impact of Cytogenetic Abnormalities in Adult Patients with Philadelphia-Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL) Who Underwent Allogeneic Stem Cell Transplant (allo-SCT), Shimizu, Hiroaki;Saitoh, Takayuki;Okamoto, Shinichiro;Kanda, Yoshinobu;Kanamori, Heiwa;Takahashi, Satoshi;Ohashi, Kazuteru;Usuki, Kensuke;Nakaseko, Chiaki;Onizuka, Makoto;Sakura, Toru;Goto, Moritaka;Yano, Shingo;Fujisawa, Shin;Watanabe, Reiko;Aotsuka, Nobuyuki;Taguchi, Jun;Tomita, Naoto;Wakita, Hisashi;Nannya, Yasuhito, 2015, BLOOD, 126, 23
• Th1 Polarization of Cytokine and Cytokine Receptor Polymorphisms Affect the Susceptibility and Severity of ITP, Takahashi, Noriyuki;Saitoh, Takayuki;Gotoh, Nanami;Kimura, Kei;Kuroda, Yuko;Nagai, Kie;Nagashima, Tomomi;Kasamatsu, Tetsuhiro;Minato, Yusuke;Shimizu, Hiroaki;Ishizaki, Takuma;Yokohama, Akihiko;Takizawa, Makiko;Koiso, Hiromi;Mitsui, Takeki;Tsukamoto, Norifumi;Handa, Hiroshi;Murakami, Hirokazu, 2015, BLOOD, 126, 23
• Loop Regulation Between microRNAs and Epigenetics Underlie microRNA Dysregulation in Multiple Myeloma and Is Associated with the Disease Progression, Kimura, Kei;Kuroda, Yuko;Masuda, Yuta;Yamane, Arito;Hattori, Hikaru;Tahara, Kenichi;Kaneko, Ayaka;Suda, Itsumi;Takahashi, Noriyuki;Gotoh, Nanami;Nagai, Kie;Nagashima, Tomomi;Saitoh, Takayuki;Iriuchishima, Hirono;Takizawa, Makiko;Koiso, Hiromi;Ishizaki, Takuma;Mitsui, Takeki;Shimizu, Hiroaki;Yokohama, Akihiko;Tsukamoto, Norifumi;Kasamatsu, Tetsuhiro;Minato, Yusuke;Nojima, Yoshihisa;Murakami, Hirokazu;Handa, Hiroshi, 2015, BLOOD, 126, 23
• A Revised International Staging System of Multiple Myeloma in the Era of Novel Agents and Autologous Stem Cell Transplantation in Japan: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma, Ozaki, Shuji;Saitoh, Takayuki;Handa, Hiroshi;Murakami, Hirokazu;Suzuki, Kenshi;Takezako, Naoki;Konishi, Jun;Sunami, Kazutaka;Kuroda, Yoshiaki;Itagaki, Mitsuhiro;Asaoku, Hideki;Nagura, Eiichi;Shimizu, Kazuyuki, 2015, BLOOD, 126, 23
• SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patients, Mitsui, Takeki;Koiso, Hiromi;Nakahashi, Hirotaka;Saitoh, Akio;Shimizu, Hiroaki;Ishizaki, Takuma;Ogawa, Yoshiyuki;Takizawa, Makiko;Yokohama, Akihiko;Saitoh, Takayuki;Jinbo, Takahiro;Ogura, Hidemi;Handa, Hiroshi;Sawamura, Morio;Sakura, Tohru;Karasawa, Masamitsu;Murakami, Hirokazu;Nojima, Yoshihisa;Tsukamoto, Norifumi, 2016, INTERNATIONAL JOURNAL OF HEMATOLOGY, 103, 2, 219, 226

  DOI
• Polymorphisms of IL-10 affect the severity and prognosis of myelodysplastic syndrome, Kasamatsu, Tetsuhiro;Saitoh, Takayuki;Minato, Yusuke;Shimizu, Hiroaki;Yokohama, Akihiko;Tsukamoto, Norifumi;Handa, Hiroshi;Sakura, Toru;Murakami, Hirokazu, 2016, EUROPEAN JOURNAL OF HAEMATOLOGY, 96, 3, 245, 251

  DOI
• Primary Plasma Cell Leukemia in the Era of Novel Agents: A Multicenter Study of the Japanese Society of Myeloma, Iriuchishima, Hirono;Ozaki, Shuji;Konishi, Jun;Matsumoto, Morio;Murayama, Kayoko;Nakamura, Fumihiko;Yamamoto, Go;Handa, Hiroshi;Saitoh, Takayuki;Nagura, Eiichi;Shimizu, Kazuyuki;Nojimaa, Yoshihisa;Murakami, Hirokazu, 2016, ACTA HAEMATOLOGICA, 135, 2, 113, 121

  DOI
• The polymorphisms of XRCC1 Arg194Trp and the XRCC1Arg399Gln affect the clinical features and the prognosis of MDS, Norjmaa, Batchimeg;Saitoh, Takayuki;Kasamatsu, Tetsuhiro;Minato, Yusuke;Sunaga, Noriaki;Murakami, Hirokazu, 2015, CANCER RESEARCH, 75

  DOI
• Professional identity acquisition process model in interprofessional education using structural equation modelling: 10-year initiative survey, Kururi, Nana;Tozato, Fusae;Lee, Bumsuk;Kazama, Hiroko;Katsuyama, Shiori;Takahashi, Maiko;Abe, Yumiko;Matsui, Hiroki;Tokita, Yoshiharu;Saitoh, Takayuki;Kanaizumi, Shiomi;Makino, Takatoshi;Shinozaki, Hiromitsu;Yamaji, Takehiko;Watanabe, Hideomi, 2016, JOURNAL OF INTERPROFESSIONAL CARE, 30, 2, 175, 183

  DOI
• Reduced frequency treatment with bortezomib plus dexamethasone for elderly patients with relapsed and/or refractory multiple myeloma: a phase 2 study of the Japanese Myeloma Study Group (JMSG-0902), Ozaki, Shuji;Hata, Hiroyuki;Abe, Masahiro;Saitoh, Takayuki;Hanamura, Ichiro;Yano, Hiroki;Sunami, Kazutaka;Kosugi, Hiroshi;Sawamura, Morio;Nakazato, Tomonori;Masunari, Taro;Mori, Mayumi;Takagi, Toshiyuki;Murakami, Hirokazu;Shimizu, Kazuyuki, 2016, ANNALS OF HEMATOLOGY, 95, 6, 921, 929

  DOI
• A plan for embedding an interprofessional education initiative into an existing programme in a Southeast Asian university, Lee, Bumsuk;Shinozaki, Hiromitsu;Bouphavanh, Ketsomsouk;Tokita, Yoshiharu;Makino, Takatoshi;Matsui, Hiroki;Saitoh, Takayuki;Tozato, Fusae;Watanabe, Hideomi, 2016, JOURNAL OF INTERPROFESSIONAL CARE, 30, 3, 401, 403

  DOI
• Chromosome 16q genes CDH1, CDH13 and ADAMTS18 are correlated and frequently methylated in human lymphoma, Alkebsi, Lobna;Handa, Hiroshi;Yokohama, Akihiko;Saitoh, Takayuki;Tsukamoto, Norifumi;Murakami, Hirokazu, 2016, ONCOLOGY LETTERS, 12, 5, 3523, 3530

  DOI
• Th2 Cytokine Polymorphisms, IL-4-590 CC Genotype and IL-10RB K47E, Increase the Requirement of Second-Line Treatment for Chronic ITP, Kitamura, Yuya;Saitoh, Takayuki;Ino, Rumi;Honma, Kazuki;Nagashima, Tomomi;Takahashi, Noriyuki;Gotoh, Nanami;Kasamatsu, Tetsuhiro;Ishizaki, Takuma;Takizawa, Makiko;Yokohama, Akihiko;Shimizu, Hiroaki;Handa, Hiroshi;Tsukamoto, Norifumi;Murakami, Hirokazu, 2016, BLOOD, 128, 22
• Base Excision Repair Gene OGG1 Affects the Relapse Risk of Acute Myeloid Leukemia, Gotoh, Nanami;Saitoh, Takayuki;Takahashi, Noriyuki;Ino, Rumi;Kitamura, Yuya;Honma, Kazuki;Nagashima, Tomomi;Kasamatsu, Tetsuhiro;Hoshino, Takumi;Sakura, Toru;Takizawa, Makiko;Yokohama, Akihiko;Shimizu, Hiroaki;Handa, Hiroshi;Tsukamoto, Norifumi;Murakami, Hirokazu, 2016, BLOOD, 128, 22
• Risk Factors and Clinical Impact of Chronic Kidney Disease (CKD) after Allogeneic Stem Cell Transplant (allo-SCT), Shimizu, Hiroaki;Ishizaki, Takuma;Hatsumi, Nahoko;Takada, Satoru;Yokohama, Akihiko;Saitoh, Takayuki;Nojima, Yoshihisa;Handa, Hiroshi, 2016, BLOOD, 128, 22
• One-Time Administration of Recombinant Human Erythropoietin Decreases B Cell in Human Peripheral Blood, Nagashima, Tomomi;Yokohama, Akihiko;Nagai, Kie;Ino, Rumi;Takahashi, Noriyuki;Kasamatsu, Tetsuhiro;Sekigami, Tomomi;Iriuchishima, Hirono;Takizawa, Makiko;Handa, Hiroshi;Saitoh, Takayuki;Murakami, Hirokazu, 2016, BLOOD, 128, 22
• The cytokine polymorphisms affecting Th1/Th2 increase the susceptibility to, and severity of, chronic ITP, Takahashi, Noriyuki;Saitoh, Takayuki;Gotoh, Nanami;Nitta, Yasuhiro;Alkebsi, Lobna;Kasamatsu, Tetsuhiro;Minato, Yusuke;Yokohama, Akihiko;Tsukamoto, Norifumi;Handa, Hiroshi;Murakami, Hirokazu, 2017, BMC IMMUNOLOGY, 18

  DOI
• PROGRAMMED CELL DEATH 1 GENE POLYMORPHISMS ASSOCIATED WITH THE CLINICAL FEATURES OF MULTIPLE MYELOMA, Kasamatsu, Tetsuhiro;Awata, Maaya;Kanai, Yukihiro;Murata, Keisuke;Matsumoto, Morio;Sawamura, Morio;Takizawa, Makiko;Yokohama, Akihiko;Gotoh, Nanami;Handa, Hiroshi;Saitoh, Takayuki;Murakami, Hirokazu, 2017, INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 39, 52, 52
• Overexpression of B-cell lymphoma 6 alters gene expression profile in a myeloma cell line and is associated with decreased DNA damage response, Tahara, Kenichi;Takizawa, Makiko;Yamane, Arito;Osaki, Yohei;Ishizaki, Takuma;Mitsui, Takeki;Yokohama, Akihiko;Saitoh, Takayuki;Tsukamoto, Norifumi;Matsumoto, Morio;Murakami, Hirokazu;Nojima, Yoshihisa;Handa, Hiroshi, 2017, CANCER SCIENCE, 108, 8, 1556, 1564

  DOI
• The bridge treatment selected at the decision for transplantation did not affect the outcomes in patients with MDS, Kako, Shinichi;Kanda, Yoshinobu;Kato, Jun;Yamamoto, Wataru;Kato, Seiko;Onizuka, Makoto;Yokota, Akira;Tatara, Raine;Yokoyama, Hiroki;Hagihara, Maki;Usuki, Kensuke;Gotoh, Moritaka;Watanabe, Reiko;Kawai, Nobutaka;Saitoh, Takayuki;Kanamori, Heiwa;Takahashi, Satoshi;Okamoto, Shinichiro, 2017, HEMATOLOGICAL ONCOLOGY, 35, 3, 341, 349

  DOI
• Recurrent alterations of the WW domain containing oxidoreductase gene spanning the common fragile site FRA16D in multiple myeloma and monoclonal gammopathy of undetermined significance, Handa, Hiroshi;Sasaki, Yoshiko;Hattori, Hikaru;Alkebsi, Lobna;Kasamatsu, Tetsuhiro;Saitoh, Takayuki;Mitsui, Takeki;Yokohama, Akihiko;Tsukamoto, Norifumi;Matsumoto, Morio;Murakami, Hirokazu, 2017, ONCOLOGY LETTERS, 14, 4, 4372, 4378

  DOI
• PDCD1 and CTLA4 polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia, Kasamatsu, Tetsuhiro;Ino, Rumi;Takahashi, Noriyuki;Gotoh, Nanami;Minato, Yusuke;Takizawa, Makiko;Yokohama, Akihiko;Handa, Hiroshi;Saitoh, Takayuki;Tsukamoto, Norifumi;Murakami, Hirokazu, 2018, BRITISH JOURNAL OF HAEMATOLOGY, 180, 5, 705, 714

  DOI
• IL17A and IL23R gene polymorphisms affect the clinical features and prognosis of patients with multiple myeloma, Kasamatsu, Tetsuhiro;Kimoto, Mari;Takahashi, Noriyuki;Minato, Yusuke;Gotoh, Nanami;Takizawa, Makiko;Matsumoto, Morio;Sawamura, Morio;Yokohama, Akihiko;Handa, Hiroshi;Tsukamoto, Norifumi;Saitoh, Takayuki;Murakami, Hirokazu, 2018, HEMATOLOGICAL ONCOLOGY, 36, 1, 196, 201

  DOI
• Polymorphism of IL-10 receptor beta affects the prognosis of multiple myeloma patients treated with thalidomide and/or bortezomib, Kasamatsu, Tetsuhiro;Saitoh, Takayuki;Ino, Rumi;Gotoh, Nanami;Mitsui, Takeki;Shimizu, Hiroaki;Matsumoto, Morio;Sawamura, Morio;Yokohama, Akihiko;Handa, Hiroshi;Tsukamoto, Norifumi;Murakami, Hirokazu, 2017, HEMATOLOGICAL ONCOLOGY, 35, 4, 711, 718

  DOI
• Short-term administration of recombinant human erythropoietin decreases B cell number in human peripheral blood, Nagashima, Tomomi;Yokohama, Akihiko;Nagai, Kie;Kasamatsu, Tetsuhiro;Gotoh, Nanami;Iriuchishima, Hirono;Sekigami, Tomomi;Saitoh, Takayuki;Handa, Hiroshi;Tsukamoto, Norifumi;Murakami, Hirokazu, 2018, TRANSFUSION AND APHERESIS SCIENCE, 57, 2, 208, 214

  DOI
• Association between OGG1 S326C CC genotype and elevated relapse risk in acute myeloid leukemia, Gotoh, Nanami;Saitoh, Takayuki;Takahashi, Noriyuki;Kasamatsu, Tetsuhiro;Minato, Yusuke;Lobna, Alkebsi;Oda, Tsukasa;Hoshino, Takumi;Sakura, Toru;Shimizu, Hiroaki;Takizawa, Makiko;Handa, Hiroshi;Yokohama, Akihiko;Tsukamoto, Norifumi;Murakami, Hirokazu, 2018, INTERNATIONAL JOURNAL OF HEMATOLOGY, 108, 3, 246, 253

  DOI
• Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma, Kasamatsu, Tetsuhiro;Ozaki, Shuji;Saitoh, Takayuki;Konishi, Jun;Sunami, Kazutaka;Itagaki, Mitsuhiro;Asaoku, Hideki;Cho, Takaaki;Handa, Hiroshi;Hagiwara, Shotaro;Wakayama, Toshio;Negoro, Akiko;Takezako, Naoki;Harada, Naoko;Kuroda, Yoshiaki;Nakaseko, Chiaki;Miyake, Takaaki;Inoue, Nobumasa;Hata, Hiroyuki;Shimazaki, Chihiro;Ohno, Tatsuharu;Kuroda, Junya;Murayama, Tohru;Kobayashi, Takahiro;Abe, Masahiro;Ishida, Tadao;Nagura, Eiich;Shimizu, Kazuyuki, 2018, HEMATOLOGICAL ONCOLOGY, 36, 5, 792, 800

  DOI
• Long Non-Coding A NEAT1 Is Upregulated By Heat Shock Factor 1 (HSF1) and Associated with Multiple Myeloma Progression, Watanabe, Saki;Oda, Tsukasa;Kuroda, Yuko;Homma, Kazuki;Murakami, Yuki;Ishihara, Rei;Yamane, Eiko;Sunaga, Masanobu;Kobayashi, Nobuhiko;Osaki, Yohei;Ishizaki, Takuma;Shimizu, Hiroaki;Koiso, Hiromi;Iriuchishima, Hirono;Takizawa, Makiko;Yokohama, Akihiko;Tsukamoto, Norifumi;Nanami, Gotoh;Ino, Rumi;Saitoh, Takayuki;Murakami, Hirokazu;Handa, Hiroshi, 2018, BLOOD, 132

  DOI
• Malignancy-Associated Hypercalcemia Related with Receptor Activator of NF-kappa B Ligand (RANKL) Expression in T-Cell Acute Lymphoblastic Leukemia, Tahara, Kenichi;Koiso, Hiromi;Osaki, Yo-hei;Sekigami, Tomomi;Yokohama, Akihiko;Saitoh, Takayuki;Tsukamoto, Norifumi;Murakami, Hirokazu;Abe, Masahiro;Handa, Hiroshi, 2019, ACTA HAEMATOLOGICA, 141, 3, 135, 137

  DOI
• Activin A: a novel urinary biomarker of renal impairment in multiple myeloma, Iriuchishima, Hirono;Maeshima, Akito;Takahashi, Shunsuke;Ishizaki, Takuma;Yokohama, Akihiko;Tsukamoto, Norifumi;Saitoh, Takayuki;Murakami, Hirokazu;Handa, Hiroshi, 2019, BIOSCIENCE REPORTS, 39

  DOI
• PARP1 V762A polymorphism affects the prognosis of myelodysplastic syndromes, Gotoh, Nanami;Minato, Yusuke;Saitoh, Takayuki;Takahashi, Noriyuki;Kasamatsu, Tetsuhiro;Souma, Kana;Oda, Tsukasa;Hoshino, Takumi;Sakura, Toru;Ishizaki, Takuma;Shimizu, Hiroaki;Takizawa, Makiko;Yokohama, Akihiko;Tsukamoto, Norifumi;Handa, Hiroshi;Murakami, Hirokazu, 2020, EUROPEAN JOURNAL OF HAEMATOLOGY, 104, 6, 526, 537

  DOI
• Th1 Cytokine Polymorphism Gene: TNF-Alpha-857C/T Affects the Pathogenesis and Progression of Acute Myeloid Leukemia, Soma, Kana;Nanami, Gotoh;Kasamatsu, Tetsuhiro;Murakami, Yuki;Ishihara, Rei;Awata, Maaya;Yamane, Eiko;Sunaga, Masanobu;Asao, Yuta;Hashimoto, Nao;Ogawa, Yoshiyuki;Shimizu, Hiroaki;Ishizaki, Takuma;Yokohama, Akihiko;Tsukamoto, Norifumi;Handa, Hiroshi;Sakura, Toru;Takada, Satoru;Saitoh, Takayuki, 2019, BLOOD, 134

  DOI
• Impact of Continuous and Maintenance Therapy on Survival Outcome in Patients with Newly Diagnosed Multiple Myeloma: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma, Ozaki, Shuji;Handa, Hiroshi;Saitoh, Takayuki;Sunami, Kazutaka;Ishida, Tadao;Suzuki, Kenshi;Narita, Tomoko;Iida, Shinsuke;Nakamura, Yuichi;Suzuki, Kazuhito;Nishimura, Noriko;Murakami, Hirokazu;Shimizu, Kazuyuki, 2019, BLOOD, 134

  DOI
• P53 Pathway Activation Mediated High c-MAF Expression Is Associated with Overall and Post-Progression Survival in Multiple Myeloma, Yamane, Eiko;Oda, Tsukasa;Sunaga, Masanobu;Murakami, Yuki;Ishihara, Rei;Asao, Yuta;Masuda, Yuta;Watanabe, Saki;Kobayashi, Nobuhiko;Takei, Hisashi;Osaki, Yohei;Nanami, Gotoh;Kasamatsu, Tetsuhiro;Shimizu, Hiroaki;Ishizaki, Takuma;Koiso, Hiromi;Takizawa, Makiko;Ogawa, Yoshiyuki;Yokohama, Akihiko;Tsukamoto, Norifumi;Saitoh, Takayuki;Murakami, Hirokazu;Handa, Hiroshi, 2019, BLOOD, 134

  DOI
• DNA Polymerases Pol theta/Pol eta Involved in Error-Prone DNA Repair Are Highly Expressed in Multiple Myeloma and Upregulated By DNA Damage, Sunaga, Masanobu;Oda, Tsukasa;Yamane, Eiko;Ishihara, Rei;Murakami, Yuki;Watanabe, Saki;Asao, Yuta;Masuda, Yuta;Takei, Hisashi;Kobayashi, Nobuhiko;Osaki, Yohei;Nanami, Gotoh;Kasamatsu, Tetsuhiro;Koiso, Hiromi;Takizawa, Makiko;Shimizu, Hiroaki;Ishizaki, Takuma;Ogawa, Yoshiyuki;Yokohama, Akihiko;Tsukamoto, Norifumi;Saitoh, Takayuki;Murakami, Hirokazu;Handa, Hiroshi, 2019, BLOOD, 134

  DOI
• Extramedullary Relapses after Allogeneic Stem Cell Transplant (allo-SCT) in Adult Patients with Acute Lymphoblastic Leukemia (ALL), Shimizu, Hiroaki;Ishizaki, Takuma;Hatsumi, Nahoko;Takada, Satoru;Yokohama, Akihiko;Saitoh, Takayuki;Sakura, Toru;Handa, Hiroshi, 2019, BLOOD, 134

  DOI
• Long Noncoding RNA PVT1 Is Regulated by Bromodomain Protein BRD4 in Multiple Myeloma and Is Associated with Disease Progression, Handa, Hiroshi;Honma, Kazuki;Oda, Tsukasa;Kobayashi, Nobuhiko;Kuroda, Yuko;Kimura-Masuda, Kei;Watanabe, Saki;Ishihara, Rei;Murakami, Yuki;Masuda, Yuta;Tahara, Ken-ichi;Takei, Hisashi;Kasamatsu, Tetsuhiro;Saitoh, Takayuki;Murakami, Hirokazu, 2020, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 21, 19, Scientific journal

  DOI
• DNA-double strand breaks enhance the expression of major histocompatibility complex class II through the ATM-NF-kappa Beta-IRF1-CIITA pathway, Oda, Tsukasa;Nakamura, Ruri;Kasamatsu, Tetsuhiro;Gotoh, Nanami;Okuda, Keiko;Saitoh, Takayuki;Handa, Hiroshi;Murakami, Hirokazu;Yamashita, Takayuki, 2022, CANCER GENE THERAPY, 29, 2, 225, 240

  DOI
• Clonal evolution detected with conventional cytogenetic analysis is a potent prognostic factor in adult patients with relapsed Philadelphia chromosome-negative acute lymphoblastic leukemia, Shimizu, Hiroaki;Yokohama, Akihiko;Ishizaki, Takuma;Hatsumi, Nahoko;Takada, Satoru;Saitoh, Takayuki;Sakura, Toru;Handa, Hiroshi, 2021, LEUKEMIA RESEARCH, 103

  DOI
• Propensity-score matched analysis of the efficacy of maintenance/continuous therapy in newly diagnosed patients with multiple myeloma: a multicenter retrospective collaborative study of the Japanese Society of Myeloma, Ozaki, Shuji;Handa, Hiroshi;Koiso, Hiromi;Saitoh, Takayuki;Sunami, Kazutaka;Ishida, Tadao;Suzuki, Kenshi;Narita, Tomoko;Iida, Shinsuke;Nakamura, Yuichi;Suzuki, Kazuhito;Nishimura, Noriko;Murakami, Hirokazu;Shimizu, Kazuyuki, 2022, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 148, 1, 191, 203, Scientific journal

  DOI
• Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation, NAKASEKO Chiaki;OZAWA Shinichi;SAKAIDA Emiko;SAKAI Miwa;KANDA Yoshinobu;OSHIMA Kumi;KUROKAWA Mineo;TAKAHASHI Satoshi;OOI Jun;SHIMIZU Takayuki;YOKOTA Akira;YOSHIBA Fumiaki;FUJIMAKI Katsumichi;KANAMORI Heiwa;SAKAI Rika;SAITOH Takayuki;SAKURA Tohru;MARUTA Atsuo;SAKAMAKI Hisashi;OKAMOTO Shinichiro, Mar. 2011, Int J Hematol, 93, 3, 375, 382
• Glossitis by mixed infection of cytomegalovirus and herpes simplex virus during therapy for pure red cell aplasia complicated with Good syndrome, KOYA Hiroko;YOKOHAMA Akihiko;MIURA Ayaka;HOSHINO Takumi;MITSUI Takeki;KOISO Hiromi;SAITOH Takayuki;UCHIUMI Hideki;HANDA Hiroshi;HIRATO Jyunko;HIROMURA Keijyu;KARASAWA Masamitsu;MURAKAMI Hirokazu;TSUKAMOTO Norifumi;NOJIMA Yoshihisa, 2011, Rinsho Ketsueki, 52, 8, 708, 712
• Discrepancy in EBV-DNA load between peripheral blood and cerebrospinal fluid in a patient with isolated CNS post-transplant lymphoproliferative disorder, SHIMIZU Hiroaki;SAITOH Takayuki;KOYA Hiroko;YUZURIHA Akinori;HOSHINO Takumi;HATSUMI Nahoko;TAKADA Satoru;NAGAKI Tomohito;NOJIMA Yoshihisa;SAKURA Toru, Nov. 2011, 94, 5, 495, 498
• TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients, YOKOHAMA Akihiko;SAITOH Akio;NAKAHASHI Hirotaka;MITSUI Takeki;KOISO Hiromi;KIM Yoshitora;UCHIUMI Hideki;SAITOH Takayuki;HANDA Hiroshi;JIMBO Takahiro;MURAYAMA Kayoko;SAKURA Tohru;MURAKAMI Hirokazu;KARASAWA Masamitsu;NOJIMA Yoshihisa;TSUKAMOTO Norifumi, Jan. 2012, 95, 1, 77, 85
• Long-term follow-up of EBV-positive lymphoproliferative disorders in a patient with systemic lupus erythematosus, TSUKAMOTO Norifumi;HANDA Hiroshi;YOKOHAMA Akihiko;MITSUI Takeki;SAITOH Takayuki;KOISO Hiromi;UCHIUNI Hideki;HOSHINO Takumi;KARASAWA Masamitsu;MURAKAMI Hirokazu;KOJIMA Masaru;NOJIMA Yoshihisa, Dec. 2011, 44, 4, 237, 241
• Retrospective survey on the clinical features of non-Hodgkin lymphomas in Gunma Prefecture, Japan, HASHIMOTO Yoko;YOKOHAMA Akihiko;SAITOH Akio;NAKAHASHI Hirotaka;TOYAMA Kohtaro;MITSUI Takeki;KOISO Hiromi;SAITOH Takayuki;HANDA Hiroshi;UCHIUMI Hideki;JINBO Takahiro;MURAYAMA Kayoko;TAMAKI Yoshio;MATSUMOTO Morio;SAWAMURA Morio;KARASAWA Masamitsu;MURAKAMI Hirokazu;HIRATO Junko;NOJIMA Yoshihisa;KOJIMA Masaru;TSUKAMOTO Norifumi, 2012, Rinsho Ketsueki, 53, 3, 329, 336
• Age-Related Epstein-Barr Virus-Positive Lymphoproliferative Disorders of the Orbit and Maxillary Sinus : A Case Report, Mitsui Takeki;Mawatari Momoko;Koiso Hiromi;Yokohama Akihiko;Uchiumi Hideki;Saitoh Takayuki;Handa Hiroshi;Hirato Junko;Karasawa Masamitsu;Murakami Hirokazu;Kojima Masaru;Nakamura Shigeo;Nojima Yoshihisa;Tsukamoto Norifumi, 2012, Journal of Clinical and Experimental Hematopathology, 52, 3, 205, 209
• Emergence of donor-derived anti-HLA antibody and subsequent transfusion-refractory thrombocytopenia after allogeneic hematopoietic stem cell transplantation from an HLA-matched sibling donor in a patient with acute myeloid leukemia, UCHIYAMA Yuri;HOSHINO Takumi;MIHARA Masahiro;MITSUI Takeki;KOISO Hiromi;TAKIZAWA Makiko;YOKOHAMA Akihiko;SAITOH Takayuki;UCHIUMI Hideki;HANDA Hiroshi;TSUKAMOTO Norifumi;MURAKAMI Hirokazu;NOJIMA Yoshihisa, 2013, Rinsho Ketsueki, 54, 2, 214, 218
• Development of IgG4-related fisease 10 years after chemotherapy for diffuse large B cell lymphoma and longstanding bronchial asthma, MITSUI Takeki;YOKOHAMA Akihiko;KOISO Hiromi;ISHIZAKI Takuma;UCHIUMI Hideki;SAITOH Takayuki;HANDA Hiroshi;HIRATO Junko;KARASAWA Hirokazu;MURAKAMI Hirokazu;KOJIMA MASARU;NOJIMA Yoshihisa;TSUKAMOTO Norifumi, Jul. 2013, 98, 1, 122, 128
• Ribosome-lamella complex of leukemic cells in a patient with aggressive NK cell leukemia., Hatsumi Nahoko;Saitoh Takayuki;Yokohama Akihiko;Uchiumi Hideki;Matsushima Takafumi;Tsukamoto Norifumi;Nojima Yoshihisa;Karasawa Masamitsu;Handa Hiroshi;Ogawara Hatsue;Murakami Hirokazu, Ultrastructural pathology, 26, 6

  DOI
• Sunitinib Induced Immune Thrombocytopenia, Matsumoto Kumiko;Handa Hiroshi;Yuzuriha Akinori;Toyama Kohtarou;Mitsui Takeki;Hashimoto Yoko;Koiso Hiromi;Saitoh Takayuki;Uchiumi Hideki;Murakami Hirokazu;Matsui Hiroshi;Suzuki Kazuhiro;Tsukamoto Norifumi;Nojima Yoshihisa, 2011, The Kitakanto Medical Journal, 61, 2, 175, 177
• Successful Treatment of Multiple Myeloma with Autologous Peripheral Blood Stem Cell Transplantation: A Case Report., Kobayashi Satsuki;Murakami Hirokazu;Naruse Takuji;Matsushima Takafumi;Koiso Hiromi;Kim Kaho;Saitoh Takayuki;Sakai Hirotaka;Ogura Hidemi;Tamura Jun'ichi;Karasawa Masamitsu, 1998, The Kitakanto Medical Journal, 48, 3, 223, 227
• Scabies in a Patient with Acute Myelogenous Leukemia., Iwai Fumito;Morita Kimio;Karasawa Masamitsu;Naruse Takuji;Saitoh Takayuki;Murakami Hirokazu;Uchiumi Hideki;Sakai Hirotaka;Matsushima Takafumi;Maehara Tadashi;Tsukamoto Norifumi;Tamura Jun'ichi, 1998, The Kitakanto Medical Journal, 48, 4, 297, 299
• COPBLAM/MEVMP Regimen for Intermediate-Grade Non-Hodgkin's Lymphoma., Tsukamoto Norifumi;Murakami Hirokazu;Tsuchiya Jun;Sato Sadao;Shimano Shun'ichi;Miyawaki Shuichi;Shinonome Shougo;Sawamura Morio;Hirabayashi Hisami;Kojima Masaru;Saito Takayuki;Maehara Tadashi;Matsushima Takafumi;Ogura Hidemi;Tamura Jun'ichi;Naruse Takuji;Karasawa Masamitsu;Morita Kimio, 2000, The Kitakanto Medical Journal, 50, 2, 99, 105
• Differences in the JAK2 and MPL Mutation Status in the Cell Lineages of the bcr/abl-negative Chronic Myeloproliferative Neoplasm Subtypes, Toyama Kohtaro;Karasawa Masamitsu;Yokohama Akihiko;Mitsui Takeki;Uchiumi Hideki;Saitoh Takayuki;Handa Hiroshi;Murakami Hirokazu;Nojima Yoshihisa;Tsukamoto Norifumi, 2011, Internal Medicine, 50, 21, 2557, 2561
• Allogeneic hematopoietic stem cell transplantation for primary and secondary myelofibrosis, Takeuchi Masahiro;Nakaseko Chiaki;Ohwada Chikako;Sato Yasunori;Ohashi Kazuteru;Kakihana Kazuhiko;Mori Takehiko;Aisa Yoshinobu;Kanda Yoshinobu;Takahashi Satoshi;Yokota Akira;Kawaguchi Takeharu;Saitoh Takayuki;Hatsumi Nahoko;Taguchi Jun;Takasaki Hirotaka;Kanamori Heiwa;Maruta Atsuo;Sakamaki Hisashi;Okamoto Shinichiro, 2012, Journal of Hematopoietic Cell Transplantation, 1, 1, 15, 23
• Acyclovir encephalopathy developed after autologous peripheral blood stem cell transplantation in a patient with multiple myeloma, Mihara Masahiro;Hoshino Takumi;Uchiyama Yuri;Saitoh Akio;Mitsui Takeki;Koiso Hiromi;Yokohama Akihiko;Saitoh Takayuki;Uchiumi Hideki;Handa Hiroshi;Tsukamoto Norifumi;Murakamii Hirokazu;Nojima Yoshihisa, 2012, Journal of Hematopoietic Cell Transplantation, 1, 3, 93, 97
• Prognostic Importance of the Soluble Form of IL-2 Receptorα (sIL-2Rα) and its Relationship with Surface Expression of IL-2Rα (CD25) of Lymphoma Cells in Diffuse Large B-cell Lymphoma Treated with CHOP-like Regimen with or without Rituximab : A Retrospective Analysis of 338 Cases, Hashimoto Yoko;Yokohama Akihiko;Saitoh Akio;Nakahashi Hirotaka;Toyama Kohtaro;Mitsui Takeki;Koiso Hiromi;Saitoh Takayuki;Handa Hiroshi;Uchiumi Hideki;Jinbo Takahiro;Murayama Kayoko;Matsumoto Morio;Sawamura Morio;Karasawa Masamitsu;Murakami Hirokazu;Hirato Junko;Nojima Yoshihisa;Kojima Masaru;Tsukamoto Norifumi, 2013, Journal of Clinical and Experimental Hematopathology, 53, 3, 197, 205
• Reversible posterior leukoencephalopathy syndrome probably caused by L-asparaginase, MIYAZAWA Yuri;TSUKAMOTO Norifumi;NOJIMA Yoshihisa;IRISAWA Hiroyuki;MATSUSHIMA Takafumi;MITSUI Takeki;UCHIUMI Hideki;SAITOH Takayuki;HANDA Hiroshi;KARASAWA Masamitsu;MURAKAMI Hirokazu, 2006, Rinsho Ketsueki, 47, 6, 531, 535
• Retrospective survey on the clinical features of non-Hodgkin lymphomas in Gunma Prefecture, Japan, HASHIMOTO Yoko;YOKOHAMA Akihiko;SAITOH Akio;NAKAHASHI Hirotaka;TOYAMA Kohtaro;MITSUI Takeki;KOISO Hiromi;SAITOH Takayuki;HANDA Hiroshi;UCHIUMI Hideki;JINBO Takahiro;MURAYAMA Kayoko;TAMAKI Yoshio;MATSUMOTO Morio;SAWAMURA Morio;KARASAWA Masamitsu;MURAKAMI Hirokazu;HIRATO Junko;NOJIMA Yoshihisa;KOJIMA Masaru;TSUKAMOTO Norifumi, 2012, Rinsho Ketsueki, 53, 3, 329, 336
• Successful treatment with dasatinib for polycythemia vera patient emerging BCR-ABL positive clone during 13 years of treatment, TAKIZAWA Makiko;YOKOHAMA Akihiko;SEKIGAMI Tomomi;KOISO Hiromi;ISHIZAKI Takuma;MITSUI Takeki;OGAWA Yoshiyuki;SAITOH Takayuki;HANDA Hiroshi;TSUKAMOTO Norifumi;MURAKAMI Hirokazu;NOJIMA Yoshihisa, 2014, Rinsho Ketsueki, 55, 6, 687, 691
• Polycythemia Vera Terminating in Refractory Ascites, Toyama Kohtaro;Mitsui Takeki;Yokohama Akihiko;Saitoh Takayuki;Uchiumi Hideki;Handa Hiroshi;Sakuraya Masataka;Murakami Hirokazu;Nojima Yoshihisa;Tsukamoto Norifumi, 2012, The Kitakanto Medical Journal, 62, 2, 159, 162
• Der(2)t(2 ; 11)(p21 ; q23), a Variant form of t(2 ; 11), in Biphenotypic Acute Leukemia with T Lymphoid Lineage and Myeloid Lineage Differentiation, Miyazawa Yuri;Irisawa Hiroyuki;Matsushima Takafumi;Mitsui Takeki;Uchiumi Hideki;Saitoh Takayuki;Handa Hiroshi;Karasawa Masamitsu;Murakami Hirokazu;Tsukamoto Norifumi;Nojima Yoshihisa, 2012, The Kitakanto Medical Journal, 62, 3, 287, 290
• DNA Repair System in Hematology, Saitoh Takayuki, 2014, The Kitakanto Medical Journal, 64, 2, 217, 218
• Relapsed primary intraocular lymphoma treated with intravitreal methotrexate and high-dose chemotherapy followed by autologous stem cell rescue, KAMIO Tadashi;YOKOHAMA Akihiko;HAYASHI Toshimasa;TOYAMA Kotaro;KOYA Hiroko;HOSHINO Takumi;SAITOH Takayuki;HANYUDA Naoto;MUKAI Ryou;HANDA Hiroshi;MURAKAMI Hirokazu;TSUKAMOTO Norifumi;NOJIMA Yoshihisa, 2014, Rinsho Ketsueki, 55, 2, 244, 248
• XRCC1 Arg194Trp and XRCC1 Arg399Gln Polymorphisms Affect Clinical Features and Prognosis of Myelodysplastic Syndromes, Norjmaa Batchimeg;Saitoh Takayuki;Kasamatsu Tetsuhiro;Minato Yusuke;Murakami Hirokazu, 2015, The Kitakanto Medical Journal, 65, 1, 11, 19
• Successful Treatment with Recombinant Thrombomodulin for a Case of Adult Onset Kasabach-Merritt Syndrome Caused by Left Thigh Hemangioma, Ogawa Yoshiyuki;Yanagisawa Kunio;Uchiumi Hideki;Ishizaki Takuma;Mitsui Takeki;Takizawa Makiko;Koiso Hiromi;Yokohama Akihiko;Saitoh Takayuki;Handa Hiroshi;Tsukamoto Norifumi;Murakami Hirokazu;Nojima Yoshihisa, 2015, The Kitakanto Medical Journal, 65, 3, 187, 191
• Primary leptomeningeal B-cell lymphoma with normal pressure hydrocephalus at diagnosis, ISHIZAKI Takuma;MITSUI Takeki;UCHIYAMA Yuri;OGAWA Yoshiyuki;KOISO Hiromi;TAKIZAWA Makiko;YOKOHAMA Akihiko;SAITOH Takayuki;HANDA Hiroshi;TSUKAMOTO Norifumi;MURAKAMI Hirokazu;NOJIMA Yoshihisa, 2015, Rinsho Ketsueki, 56, 12, 2441, 2446
• Diffuse large B-cell lymphoma of the testis relapsed 16 years after achieving complete response, NAGASAKA Isao;MITSUI Takeki;ISHIZAKI Takuma;KOISO Hiromi;YOKOHAMA Akihiko;SAITOH Takayuki;HIRATO Junko;IGARASHI Tadahiko;KOJIMA Masaru;TSUKAMOTO Norifumi;NOJIMA Yoshihisa;MURAKAMI Hirokazu;HANDA Hiroshi, 2015, Rinsho Ketsueki, 56, 12, 2447, 2451
• XRCC1 Arg194Trp and XRCC1 Arg399Gln Polymorphisms Affect Clinical Features and Prognosis of Myelodysplastic Syndromes, Norjmaa Batchimeg;Saitoh Takayuki;Kasamatsu Tetsuhiro;Minato Yusuke;Murakami Hirokazu, 2017, The Kitakanto Medical Journal, 67, 1, 93, 94
• Clinical management and outcomes of completely resected stage I follicular lymphoma, Yokohama Akihiko;Hashimoto Yoko;Takizawa Makiko;Shimizu Hiroaki;Miyazawa Yuri;Saitoh Akio;Toyama Kohtaro;Ishizaki Takuma;Mitsui Takeki;Hiromi;Koiso;Saitoh Takayuki;Murayama Kayoko;Matsumoto Morio;Sawamura Morio;Murakami Hirokazu;Hirato Junko;Kojima Masaru;Nojima Yoshihisa;Handa Hiroshi;Tsukamoto Norifumi, 2018, Journal of Clinical and Experimental Hematopathology, 58, 1, 10, 16
• Efficacy and Safety of Intermediate dose Etoposide for Mobilization of Peripheral Blood Stem Cells in Hematopoietic Tumors, Ishizaki Takuma;Yokohama Akihiko;Shimizu Hiroaki;Yanagisawa Kunio;Ogawa Yoshiyuki;Mitsui Takeki;Koiso Hiromi;Takizawa Makiko;Saitoh Takayuki;Murakami Hirokazu;Tsukamoto Norifumi;Handa Hiroshi, 2018, The Kitakanto Medical Journal, 68, 1, 43, 47
• A Survey on Chronic Obstructive Pulmonary Disease Action Plans at Visiting Nursing Stations in Gunma Prefecture, Nashiki Emiko;Uchida Yoko;Saitoh Takayuki, Feb. 2019, The Kitakanto Medical Journal, 69, 1, 7, 15
• Thyroid storm and exacerbation of autoimmune hemolytic anemia following childbirth, SUGISAKI Manato;ISHIZAKI Takuma;IRIUCHISHIMA Hirono;SHIMIZU Hiroaki;YANAGISAWA Kunio;OGAWA Yoshiyuki;YOKOHAMA Akihiko;SAITOH Takayuki;TSUKAMOTO Norifumi;HANDA Hiroshi, 2019, Rinsho Ketsueki, 60, 8, 924, 928
• Introduction to IPE Training Course at Gunma University, TOKITA Yoshiharu;KANAIZUMI Shiomi;SAITOH Takayuki;MAKINO Takatoshi;MATSUI Hiroki;KURURI Nana;LEE Bumsuk;ABE Yumiko;ASAKAWA Yasuyoshi;TOZATO Fusae;SHINOZAKI Hiromitsu;WATANABE Hideomi, 2014, The Journal of Interprofessional Collaboration in Health and Social Care, 7, 2, 126, 130
• The Evaluation of an International Symposium using Skype, Shimoda Kaori;Sanjmyatav Bulganchimeg;Murano Maika;Sakamoto Masaaki;Tozato Fusae;Mori Yosie;Khulan Gaalan;Kikuchi Senichiro;Tsuchiya Kenji;Noguchi Naoto;Ochi Takako;Saitoh Takayuki, Aug. 2019, The Kitakanto Medical Journal, 69, 3, 195, 203
• 2 Cases of Refractory Idiopathic Thrombocytopenic Purpura in Pregnancy, Osaki Yohei;Ogawa Yoshiyuki;Morita Akihito;Higeta Daisuke;Shimizu Hiroaki;Yanagisawa Kunio;Ishizaki Takuma;Saitoh Takayuki;Tsukamoto Norifumi;Kameda Takashi;Handa Hiroshi, Aug. 2019, The Kitakanto Medical Journal, 69, 3, 227, 232
• The International Student Exchange Programs of Gunma University Showa Campus, Saitoh Takayuki;Kishi Mikiko;Koibuchi Noriyuki;Koyama Hiroshi;Sakamoto Masaaki;Ishizaki Yasuki, Aug. 2019, The Kitakanto Medical Journal, 69, 3, 263, 265
• [Deep vein thrombosis and pulmonary embolism in a patient with multiple myeloma treated with thalidomide and dexamethasone]., Miyazawa Yuri;Irisawa Hiroyuki;Uchiumi Hideki;Saitoh Takayuki;Handa Hiroshi;Matsushima Takafumi;Tsukamoto Norifumi;Karasawa Masamitsu;Murakami Hirokazu;Nojima Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 47, 7
• X-linked agammaglobulinemia diagnosed in adulthood: a case report., Mitsui Takeki;Tsukamoto Norifumi;Kanegane Hirokazu;Agematsu Kazunaga;Sekigami Tomomi;Irisawa Hiroyuki;Saitoh Takayuki;Uchiumi Hideki;Handa Hiroshi;Matsushima Takafumi;Karasawa Masamitsu;Murakami Hirokazu;Miyawaki Toshio;Nojima Yoshihisa, International journal of hematology, 84, 2

  DOI
• Sacroiliitis as an initial manifestation of acute myelogenous leukemia., Hoshino Takumi;Matsushima Takafumi;Saitoh Yasuyuki;Yamane Arito;Takizawa Makiko;Irisawa Hiroyuki;Saitoh Takayuki;Handa Hiroshi;Tsukamoto Norifumi;Karasawa Masamitsu;Murakami Hirokazu;Nojima Yoshihisa, International journal of hematology, 84, 5

  DOI
• Hodgkin lymphoma accompanied by aplastic anemia and polyclonal expansion of large granular lymphocytes., Saitoh Takayuki;Matsushima Takafumi;Yamane Arito;Sakuraya Masataka;Irisawa Hiroyuki;Yokohama Akihiko;Handa Hiroshi;Tsukamoto Norifumi;Karasawa Masamitsu;Nojima Yoshihisa;Murakami Hirokazu, 23 Feb. 2007, Acta haematologica, 117, 4

  DOI
• The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification., Tsukamoto Norifumi;Kojima Masaru;Hasegawa Masatoshi;Oriuchi Noboru;Matsushima Takafumi;Yokohama Akihiko;Saitoh Takayuki;Handa Hiroshi;Endo Keigo;Murakami Hirokazu, Cancer, 110, 3

  DOI
• [Acquired hemophilia A developed at relapse of minimal change nephrotic syndrome]., Shimizu Hiroaki;Saitoh Takayuki;Osaki Yohei;Yamane Arito;Gohda Fumito;Irisawa Hiroyuki;Yokohama Akihiko;Uchiumi Hideki;Handa Hiroshi;Matsushima Takafumi;Tsukamoto Norifumi;Karasawa Masamitsu;Murakami Hirokazu;Nojima Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 48, 6
• JAK2-V617F mutation analysis of granulocytes and platelets from patients with chronic myeloproliferative disorders: advantage of studying platelets., Toyama Kohtaro;Karasawa Masamitsu;Yamane Arito;Irisawa Hiroyuki;Yokohama Akihiko;Saitoh Takayuki;Handa Hiroshi;Matsushima Takafumi;Sawamura Morio;Miyawaki Shuichi;Murakami Hirokazu;Nojima Yoshihisa;Tsukamoto Norifumi, British journal of haematology, 139, 1

  DOI
• [Polyclonal B-cell lymphocytosis with hairy cell appearance: hairy B-cell lymphoproliferative disorder]., Nakahashi Hirotaka;Hashimoto Yoko;Yamane Arito;Irisawa Hiroyuki;Yokohama Akihiko;Saitoh Takayuki;Hanada Hiroshi;Matsushima Takafumi;Tsukamoto Norifumi;Karasawa Masamitsu;Murakamai Hirokazu;Nojima Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 48, 8
• Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation., Uchiumi Hideki;Matsushima Takafumi;Yamane Arito;Doki Noriko;Irisawa Hiroyuki;Saitoh Takayuki;Sakura Tohru;Jimbo Takahiro;Handa Hiroshi;Tsukamoto Norifumi;Karasawa Masamitsu;Miyawaki Shuichi;Murakami Hirokazu;Nojima Yoshihisa, International journal of hematology, 86, 2

  DOI
• [Diagnosis and management guideline for multiple myeloma]., Murakami Hirokazu;Handa Hiroshi;Saitoh Takayuki, Nihon rinsho. Japanese journal of clinical medicine, 65, 12
• [Successful treatment of azole-refractory Candida guilliermondii fungemia with a combination therapy of micafungin and liposomal amphotericin B]., Saitoh Takayuki;Matsushima Takafumi;Shimizu Hiroyuki;Osaki Yohei;Yamane Arito;Irisawa Hiroyuki;Yokohama Akihiko;Uchiumi Hideki;Handa Hiroshi;Tsukamoto Norifumi;Karasawa Masamitsu;Nojima Yoshihisa;Murakami Hirokazu, [Rinsho ketsueki] The Japanese journal of clinical hematology, 49, 2
• Hodgkin lymphoma presenting with various immunologic abnormalities, including autoimmune hepatitis, Hashimoto's thyroiditis, autoimmune hemolytic anemia, and immune thrombocytopenia., Saitoh Takayuki;Matsushima Takafumi;Saito Yasuyuki;Yamane Arito;Yokohoma Akihiko;Irisawa Hiroyuki;Handa Hiroshi;Tsukamoto Norifumi;Karasawa Masamitsu;Kojima Masaru;Nojima Yoshihisa;Murakami Hirokazu, Clinical lymphoma & myeloma, 8, 1

  DOI
• Characterization of immunoglobulin heavy and light chain gene expression in chronic lymphocytic leukemia and related disorders., Nakahashi Hirotaka;Tsukamoto Norifumi;Hashimoto Yoko;Koiso Hiromi;Yokohama Akihiko;Saitoh Takayuki;Uchiumi Hideki;Handa Hiroshi;Murakami Hirokazu;Nojima Yoshihisa;Karasawa Masamitsu, 10 Feb. 2009, Cancer science, 100, 4

  DOI
• [Development of an extramedullary plasmacytoma despite disappearing M protein in multiple myeloma by bortezomib treatment]., Koiso Hiromi;Tahara Kenichi;Osaki Yohei;Mawatari Momoko;Sekigami Tomomi;Yokohama Akihiko;Saitoh Takayuki;Uchiumi Hideki;Handa Hiroshi;Tsukamoto Norifumi;Karasawa Masamitsu;Nojima Yoshihisa;Murakami Hirokazu, [Rinsho ketsueki] The Japanese journal of clinical hematology, 50, 2
• Hairy cell leukemia-related disorders consistently show low CD27 expression., Hashimoto Yoko;Tsukamoto Norifumi;Nakahashi Hirotaka;Yokohama Akihiko;Saitoh Takayuki;Handa Hiroshi;Matsushima Takafumi;Murakami Hirokazu;Nojima Yoshihisa;Karasawa Masamitsu, 20 Mar. 2009, Pathology oncology research : POR, 15, 4

  DOI
• Low burden of a JAK2-V617F mutated clone in monoclonal haematopoiesis in a Japanese woman with Budd-Chiari syndrome., Toyama Kohtaro;Karasawa Masamitsu;Yamane Arito;Koiso Hiromi;Yokohama Akihiko;Uchiumi Hideki;Saitoh Takayuki;Handa Hiroshi;Sato Ken;Takagi Hitoshi;Miyawaki Shuichi;Murakami Hirokazu;Nojima Yoshihisa;Tsukamoto Norifumi, 24 Mar. 2009, International journal of hematology, 89, 4

  DOI
• Autologous peripheral blood stem cell transplantation to treat CHOP-refractory aggressive subcutaneous panniculitis-like T cell lymphoma., Nakahashi Hirotaka;Tsukamoto Norifumi;Yamane Arito;Saitoh Takayuki;Uchiumi Hideki;Handa Hiroshi;Karasawa Masamitsu;Murakami Hirokazu;Kojima Masaru;Nojima Yoshihisa, 29 Jun. 2009, Acta haematologica, 121, 4

  DOI
• Flow cytometric detection of human telomerase reverse transcriptase (hTERT) expression in a subpopulation of bone marrow cells., Handa Hiroshi;Matsushima Takafumi;Nishimoto Natsumi;Inoue Madoka;Saitoh Takayuki;Yokohama Akihiko;Tsukamoto Norifumi;Mitsui Takeki;Nakahashi Hirotaka;Toyama Kotaro;Karasawa Masamitsu;Ogawara Hatsue;Nojima Yoshihisa;Murakami Hirokazu, 14 Jul. 2009, Leukemia research, 34, 2

  DOI
• Successful treatment by all-trans retinoic acid in a patient with acute promyelocytic leukemia complicated by liver cirrhosis and polycystic kidney., Yamane Arito;Tsukamoto Norifumi;Saitoh Takayuki;Uchiumi Hideki;Handa Hiroshi;Karasawa Masamitsu;Nojima Yoshihisa;Murakami Hirokazu, 15 Sep. 2009, Internal medicine (Tokyo, Japan), 48, 18

  DOI
• Successful treatment with reduced-intensity stem cell transplantation for secondary myelofibrosis following polycythemia vera., TAHARA Kenichi;YOKOHAMA Akihiko;HANDA Hiroshi;SAITOH Takayuki;UCHIUMI Hideki;SEKIGAMI Tomomi;TOYAMA Kohtaro;MAWATARI Momoko;OSAKI Yohei;MATSUSHIMA Takafumi;KARASAWA Masamitsu;MURAKAMI Hirokazu;TSUKAMOTO Norifumi;NOJIMA Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 50, 11
• 【多発性骨髄腫の最新情報I】骨髄腫の診断と鑑別診断　診断基準の変遷を踏まえて, ;, Dec. 2015, 33, 12, 47
• 寛解16年後に再発した精巣原発びまん性大細胞型B細胞リンパ腫, ;;;;;;;;;;;;, Dec. 2015, 56, 12, 2447
• 2大学間における学生のチーム医療に対する態度について横断的比較解析と教育効果の検討, ;;;;;;;;;;;;;;;, Mar. 2016, 9, 1, 86
• 骨髄線維症を合併した多発性骨髄腫, ;;;;;;;, Apr. 2016, 6, 2, 88
• 疾患と検査値の推移　多発性骨髄腫, ;;, Jul. 2017, 45, 7, 758
• DNA修復に着眼した多発性骨髄腫の耐性機構の解明, 齋藤 貴之, Aug. 2017, 32, 9, 908
• 多発性骨髄腫治療における免疫チェックポイント分子の意義, ;;, Aug. 2017, 32, 9, 917
• 【慢性疾患となった骨髄腫-どのように診断するか?　どのように付き合っていくか?】骨髄腫治療薬の温故知新　アルキル化薬とステロイド, ;;;, Oct. 2017, 120, 4, 865
• 遺伝子組み換えヒトエリスロポエチン製剤の末梢血中CD69発現B細胞に対する影響, ;;;;;;;;;, Jun. 2017, 18, 学術集会, S165
• IFN-γ+874T/A遺伝子多型は低リスク骨髄異形成症候群の病態に関与する, ;;;;;;;;;, Jun. 2017, 18, 学術集会, S185
• 多発性骨髄腫患者における免疫チェックポイント遺伝子の多型解析, ;;;;;;;;;, Jun. 2017, 18, 学術集会, S195
• 多発性骨髄腫におけるlong non-cording RNA NEAT1とMALAT1の発現, ;;;;;;;;;, Jun. 2017, 18, 学術集会, S195
• 多発性骨髄腫におけるMatrix metalloproteinase(MMP)及びtissue inhibitor of metalloproteinases(TIMP)の発現, ;;;;;;;;;, Jun. 2017, 18, 学術集会, S196
• 多発性骨髄腫細胞株におけるc-Myc作用阻害によるmicroRNA-29発現の変化, ;;;;;;;;;, Jun. 2017, 18, 学術集会, S196
• 多発性骨髄腫におけるc-MycとLong non coding RNA PVT1の発現, ;;;;;;;;;, Jun. 2017, 18, 学術集会, S197
• 急性骨髄性白血病患者における多機能蛋白APE1遺伝子多型解析, ;;;;;;;;;, Jun. 2017, 18, 学術集会, S209
• Th2サイトカイン多型のIL-4-590CCとIL-10RB K47EはITPの治療反応性に関与する, ;;;;;;;;;, Jun. 2017, 18, 学術集会, S217
• PD-1およびCTLA-4遺伝子多型は慢性免疫性血小板減少症の発症および症状に関与する, ;;;;;;;;;, Jun. 2017, 18, 学術集会, S218
• 血小板数維持に難渋した妊娠合併特発性血小板減少症の2例, ;;;;;;;;;, Jun. 2017, 18, 学術集会, S218
• 自然軽快と再燃を繰り返した後天性von Willebrand症候群(AvWS)の1例, ;;;;;;;;;;, Apr. 2017, 28, 2, 201
• 病因・病態・予後　IgM型多発性骨髄腫　日本骨髄腫学会多施設共同後方視的調査研究, ;;;;;;;;;;;;;, Apr. 2017, 7, 1, 37
• PD-1およびPD-L1遺伝子多型は多発性骨髄腫の髄外病変の合併および重症度に関与する, ;;;;;;;;;;;;, Aug. 2017, 67, 3, 267
• Th1サイトカイン多型は骨髄異形成症候群の重症度に関与する, ;;;;;;;;;;;;;;;, Aug. 2017, 67, 3, 267
• PARP1V762A多型は骨髄異形成症候群の白血病化と関連する, ;;;;;;;;;;;;;;;, Aug. 2017, 67, 3, 268
• 末梢血CD69陽性B細胞はrecombinant human erythropoietinの投与によって減少する, ;;;;;;;;;;;;;, Aug. 2017, 67, 3, 276
• Th1サイトカインTNF-α-857C/Tは特発性血小板減少性紫斑病の発症リスクに関与する, ;;;;;;;;;;;;;;, Aug. 2017, 67, 3, 276
• 慢性免疫性血小板減少症における免疫チェックポイント遺伝子多型解析, ;;;;;;;;;;;;;;, Aug. 2017, 67, 3, 277
• 【地域・在宅の拡がるIPEの新たな取り組み】群馬大学のInterprofessional education(IPE)の取り組み, ;;;;;;;;;;;;;;;;, Oct. 2017, 10, 2, 119
• 骨髄線維症を合併した形質細胞性腫瘍の5症例, ;;;;;;;;;;, Oct. 2017, 65, 補冊, 151
• 骨髄異形成症候群におけるPARP1V762A多型の解析, ;;;, Oct. 2017, 65, 補冊, 275
• DNA架橋剤メラファランは多発性骨髄腫細胞株において主要組織適合抗原クラスII(MHC II)の転写活性化因子CIITAの発現を促進する, ;;;;;;;;;, Dec. 2017, 2017年度, [2P
• TNF-α-857C/Tは特発性血小板減少性紫斑病の発症リスクを上昇させる, ;;;;;;;;;, Jun. 2018, 19, 学術集会, S134
• 多発性骨髄腫におけるlong non-cording RNA MALAT1とNEAT1およびNEAT1_2の発現, ;;;;;;;;, Jun. 2018, 19, 学術集会, S157
• 多発性骨髄腫における髄外形質細胞腫とMatrix metalloproteinase(MMP)及びtissue inhibitor of metalloproteinases(TIMP)の発現, ;;;;;;;;, Jun. 2018, 19, 学術集会, S158
• 多発性骨髄腫細胞株におけるmicroRNA-29,34 familyの発現制御機構, ;;;;;;;;, Jun. 2018, 19, 学術集会, S158
• 骨髄異形成症候群の白血病化とPARP1 V762A遺伝子多型の関連について, ;;;;;;;;;, Jun. 2018, 19, 学術集会, S179
• Etoposide中等量療法による末梢血幹細胞採取, ;;;;;;;;;;;, Feb. 2018, 68, 1, 43
• 【進化するIPE　地域包括ケアシステムが求める多職種連携教育の今】(Part3-1)導入事例　大学の特色を生かしたIPE　全人的医療とチーム医療に貢献できる人材の育成を目指して　群馬大学の多職種連携教育, ;;;;;;;;;;, Jul. 2018, 43, 9, 0842
• 白血病細胞の眼内浸潤を認めた成人T細胞白血病の1例, ;;;;;;, Sep. 2018, 72, 9, 1235
• 成人Ph陰性ALLにおける診断時に染色体異常により同定されたクローン不均一性の臨床的意義(Clonal heterogeneity detected with metaphase cytogenetics at diagnosis in adult Ph-negative ALL), ;;;;;;;;, Sep. 2018, 59, 9, 1535
• Long non-coding RNA NEAT1はHSF1によって制御され骨髄腫の進行に関与する(Long non-coding RNA NEAT1 is upregulated by HSF1 and associated with myeloma progression), ;;;;;;;;;;;;;;;;;;;, Sep. 2018, 59, 9, 1603
• MYCは腫瘍抑制性TP53-micro RNA 34経路を遮断し骨髄腫の進行に関与する(MYC involves myeloma progression by abolishing tumor suppressive function of p53-miRNA 34 axis), ;;;;;;;;;;;;;;;;;;;;;, Sep. 2018, 59, 9, 1603
• マトリックスメタロプロテーゼとその阻害因子は骨髄腫の進行と髄外形質細胞腫形成に関係する(MMP and TIMP is associated with multiple myeloma progression and extramedullary plasmacytoma), ;;;;;;;;;;;;;;;;;;, Sep. 2018, 59, 9, 1604
• TNF-α-857C/T多型は骨髄異形成症候群の重症度に影響する(TNF-α-857C/T polymorphism affects the severity of myelodysplastic syndromes), ;;;;;;;;;;;;;;;, Sep. 2018, 59, 9, 1645
• PNA clamp PCR法を用いたリンパ形質細胞性リンパ種におけるCXCR4遺伝子変異の同定(Detection of CXCR4 mutation by PNA clamp PCR method on FFPE samples of lymphoplasmacytic lymphoma), ;;;;;;;;;;;, Sep. 2018, 59, 9, 1655
• 多発性骨髄腫における新規治療標的としての塩基除去修復の役割(The role of base excision repair as a potential therapeutic target in multiple myeloma), ;;;;;;;;;;;;;;;;;;;;, Sep. 2018, 59, 9, 1669
• プレリキサフォルで動員された末梢血幹細胞の特徴(Features of blood graft contents mobilized by G-CSF plus chemotherapy with or without plerixafor), ;;;;;;;;;, Sep. 2018, 59, 9, 1677
• 慢性骨髄性白血病を発症した本態性血小板血症患者でのシングルコロニー遺伝子解析(Genetic analysis of single colonies from secondary CML of MPN patients), ;;;;;;;;;;, Sep. 2018, 59, 9, 1708
• 大気micro-PIXE法を用いた急性前骨髄性白血病細胞内微量元素の動態解析　アントラサイクリン系抗腫瘍薬とDNAメチル基転移酵素阻害剤が急性前骨髄性白血病細胞に及ぼす影響, ;;;;;;;, Oct. 2018, 55回, 179
• 多発性骨髄腫におけるIDO1およびIDO2の遺伝子多型の意義, ;;;;;;;;;, Jun. 2019, 20, 学術集会, S87
• 多発性骨髄腫においてlong non-coding RNA NEAT1はDNA損傷応答に関与する, ;;;;;;;;, Jun. 2019, 20, 学術集会, S87
• 多発性骨髄腫におけるDNAポリメラーゼの発現, ;;;;;;;;;, Jun. 2019, 20, 学術集会, S88
• リンパ形質細胞性リンパ腫におけるホルマリン固定パラフィン包埋標本を用いた遺伝子変異の検出および検体の評価, ;;;;;;;;;, Jun. 2019, 20, 学術集会, S114
• 多発性骨髄腫におけるc-MAFおよびMAFBの発現, ;;;;;;;;;, Jun. 2019, 20, 学術集会, S118
• 多発性骨髄腫における髄外形質細胞腫とMMP及びTIMP発現異常の解析, ;;;;;;;;, Jun. 2019, 20, 学術集会, S118
• 多発性骨髄腫におけるProgrammed Cell Death Ligand-1(PD-L1)およびPD-L2の発現, ;;;;;;;;;, Jun. 2019, 20, 学術集会, S119
• Th1サイトカインTNF-α-857C>Tは急性骨髄性白血病の発症リスク、臨床背景、予後に関与する, ;;;;;, Jun. 2019, 20, 学術集会, S157
• MTH1 V83M多型VV型は骨髄異形成症候群の発症リスクとなる, ;;;;;;;;;;;;;;;;;;, Aug. 2018, 68, 3, 200
• 多発性骨髄腫細胞株におけるmicroRNA-29、34 familyの発現制御機構, ;;;;;;;;;;;;;;;;;, Aug. 2018, 68, 3, 201
• Th1サイトカインTNF-α-857C/Tは急性骨髄性白血病の発症リスク、臨床背景、予後に関与する, ;;;;;;;;;;;;;;, Aug. 2018, 68, 3, 209
• 多発性骨髄腫における髄外形質細胞腫とMatrix metalloproteinase(MMP)及びtissue inhibitor of metalloproteinases(TIMP)の発現, ;;;;;;;;;;;;;;;;;, Aug. 2018, 68, 3, 213
• 多発性骨髄腫におけるlong non-cording RNA MALAT1とNEAT1およびNEAT1_2の発現, ;;;;;;;;;;;;;;;;;, Aug. 2018, 68, 3, 213
• 群馬県の訪問看護ステーションにおけるCOPDアクションプランに関する調査, ;;, Feb. 2019, 69, 1, 7
• 群馬県市町村国保における特定健診等の分析(第1報)　実態調査結果の全国との比較, ;;;;;;, Oct. 2019, 78回, 344
• 群馬県市町村国保における特定健診等の分析(第2報)　実施率上位自治体へのヒアリング, ;;;;;;;, Oct. 2019, 78回, 345
• 多発性骨髄腫の分子病態とその臨床応用, 齋藤 貴之, Feb. 2020, 21, 1, 1
• Skypeを活用して開催した国際シンポジウムの評価　モンゴル国のリハビリテーションの発展を目指して, ;;;;;;;;;;;, Aug. 2019, 69, 3, 195
• 治療抵抗性妊娠合併特発性血小板減少性紫斑病の2例, ;;;;;;;;;;, Aug. 2019, 69, 3, 227
• Skypeを活用して開催した国際シンポジウムの評価　モンゴル国のリハビリテーションの発展を目指して, ;;;;;;;;;;;, Aug. 2019, 69, 3, 290
• DNA損傷修復応答に関与するDNAポリメラーゼPOLQとPOLHの多発性骨髄腫における発現, ;;;;;;;;;;;;;;;;;;;;;;;;;, Aug. 2019, 69, 3, 296
• 末梢血幹細胞採取におけるSphingosine-1-phosphateの関与, ;;;;;;;;;;;;, Aug. 2019, 69, 3, 300
• 次世代シーケンサーを用いた原発性マクログロブリン血症およびIgG産生型リンパ形質細胞性リンパ腫における遺伝子変異の解析, ;;;;;;;, Aug. 2019, 69, 3, 301
• Th1サイトカイン遺伝子多型は慢性免疫性血小板減少症(cITP)の重症度に影響する, ;;;;;;;;;, Aug. 2019, 69, 3, 301
• 多発性骨髄腫におけるc-MAF、MAFB発現とp53, ;;;;;;;;;;;;;;;;;;;;;;;;;, Aug. 2019, 69, 3, 302
• 多発性骨髄腫におけるCD47の発現, ;;;;;;;;, Jun. 2020, 21, 学術集会, S230
• 多発性骨髄腫におけるmicroRNA-145の発現とその制御機構, ;;;;;;;;, Aug. 2021, 22, 学術集会, S165
• 多発性骨髄腫の髄外進展におけるTIMP1の影響, ;;;;;;;;, Aug. 2021, 22, 学術集会, S165
• 健常者T細胞における薬剤誘導性細胞老化の検討, ;;;;;;;;;, Aug. 2021, 22, 学術集会, S187
• 海外研修がinternational postureに与える影響, ;;, Sep. 2021, 55回, PR, Scientific journal
• 健常者T細胞における薬剤誘導性細胞老化の検討(Melphalan and doxorubicin induce cellular senescence in T cells of healthy subjects), ;;;;;;;;;;;, Sep. 2021, 83回, PS, Scientific journal
• 中枢神経再発高リスクび漫性大細胞型B細胞リンパ腫に対する中枢神経再発予防効果の単施設解析(A single-center analysis of central nervous system prophylaxis for diffuse large B cell lymphoma), ;;;;;;;, Sep. 2021, 83, OS1, Scientific journal
• TCR beta constant region 1に対する抗体を用いた成熟細胞腫瘍のクローナリティーの検討(Immunophenotypic detection of monoclonality in mature T-cell malignancy using anti TCR Cb1 antibody), ;;;;;;;;;;;, Sep. 2021, 83回, BPA, Research society
• 急性骨髄性白血病の発症リスクおよび予後不良因子としてのNFKB1遺伝子多型および発現について, ;;;;;;;;;;, Aug. 2021, 71, 3, 259
• アレムツズマブを投与した再発難治CD52陽性T細胞性前リンパ球性白血病(T-PLL), ;;;;;;;;;;;;, May 2022, 63, 5, 504, Scientific journal
• 慢性リンパ性白血病と異なるクローンから発生したリヒター症候群の1例, ;;;;;;;;;, May 2022, 63, 5, 507, Scientific journal
• Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation., Nakaseko Chiaki;Ozawa Shinichi;Sakaida Emiko;Sakai Miwa;Kanda Yoshinobu;Oshima Kumi;Kurokawa Mineo;Takahashi Satoshi;Ooi Jun;Shimizu Takayuki;Yokota Akira;Yoshiba Fumiaki;Fujimaki Katsumichi;Kanamori Heiwa;Sakai Rika;Saitoh Takayuki;Sakura Tohru;Maruta Atsuo;Sakamaki Hisashi;Okamoto Shinichiro, 19 Mar. 2011, International journal of hematology, 93, 3

  DOI
• Interleukin-17F gene polymorphism in patients with chronic immune thrombocytopenia., Saitoh Takayuki;Tsukamoto Norifumi;Koiso Hiromi;Mitsui Takeki;Yokohama Akihiko;Handa Hiroshi;Karasawa Masamitsu;Ogawara Hatsue;Nojima Yoshihisa;Murakami Hirokazu, 31 Jul. 2011, European journal of haematology, 87, 3

  DOI
• Successful treatment of autoimmune hemolytic anemia associated with multicentric Castleman disease by anti-interleukin-6 receptor antibody (tocilizumab) therapy., Yuzuriha Akinori;Saitoh Takayuki;Koiso Hiromi;Mitsui Takeki;Uchiumi Hideki;Yokohama Akihiko;Handa Hiroshi;Kojima Masaru;Tsukamoto Norifumi;Karaswa Masamitsu;Murakami Hirokazu;Nojima Yoshihisa, 14 Jul. 2011, Acta haematologica, 126, 3

  DOI
• [Glossitis by mixed infection of cytomegalovirus and herpes simplex virus during therapy for pure red cell aplasia complicated with Good syndrome]., Koya Hiroko;Yokohama Akihiko;Miura Ayaka;Hoshino Takumi;Mitsui Takeki;Koiso Hiromi;Saitoh Takayuki;Uchiumi Hideki;Handa Hiroshi;Hirato Jyunko;Hiromura Keijyu;Karasawa Masamitsu;Murakami Hirokazu;Tsukamoto Norifumi;Nojima Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 52, 8
• Differences in the JAK2 and MPL mutation status in the cell lineages of the bcr/abl-negative chronic myeloproliferative neoplasm subtypes., Toyama Kohtaro;Karasawa Masamitsu;Yokohama Akihiko;Mitsui Takeki;Uchiumi Hideki;Saitoh Takayuki;Handa Hiroshi;Murakami Hirokazu;Nojima Yoshihisa;Tsukamoto Norifumi, 01 Nov. 2011, Internal medicine (Tokyo, Japan), 50, 21

  DOI
• Long-term follow-up of EBV-positive lymphoproliferative disorders in a patient with systemic lupus erythematosus., Tsukamoto Norifumi;Handa Hiroshi;Yokohama Akihiko;Mitsui Takeki;Saitoh Takayuki;Koiso Hiromi;Uchiumi Hideki;Hoshino Takumi;Karasawa Masamitsu;Murakami Hirokazu;Kojima Masaru;Nojima Yoshihisa, 17 Dec. 2011, Medical molecular morphology, 44, 4

  DOI
• TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients., Yokohama Akihiko;Saitoh Akio;Nakahashi Hirotaka;Mitsui Takeki;Koiso Hiromi;Kim Yoshitora;Uchiumi Hideki;Saitoh Takayuki;Handa Hiroshi;Jimbo Takahiro;Murayama Kayoko;Sakura Tohru;Murakami Hirokazu;Karasawa Masamitsu;Nojima Yoshihisa;Tsukamoto Norifumi, 23 Dec. 2011, International journal of hematology, 95, 1

  DOI
• Circulating plasmacytoid dendritic cells in patients with primary and Helicobacter pylori-associated immune thrombocytopenia., Saito Akio;Yokohama Akihiko;Osaki Yohei;Ogawa Yoshiyuki;Nakahashi Hirotaka;Toyama Kohtaro;Mitsui Takeki;Hashimoto Yoko;Koiso Hiromi;Uchiumi Hideki;Saitoh Takayuki;Handa Hiroshi;Sawamura Morio;Karasawa Masamitsu;Murakami Hirokazu;Tsukamoto Norifumi;Nojima Yoshihisa, 02 Feb. 2012, European journal of haematology, 88, 4

  DOI
• [Retrospective survey on the clinical features of non-Hodgkin lymphomas in Gunma Prefecture, Japan]., Hashimoto Yoko;Yokohama Akihiko;Saitoh Akio;Nakahashi Hirotaka;Toyama Kohtaro;Mitsui Takeki;Koiso Hiromi;Saitoh Takayuki;Handa Hiroshi;Uchiumi Hideki;Jinbo Takahiro;Murayama Kayoko;Tamaki Yoshio;Matsumoto Morio;Sawamura Morio;Karasawa Masamitsu;Murakami Hirokazu;Hirato Junko;Nojima Yoshihisa;Kojima Masaru;Tsukamoto Norifumi, [Rinsho ketsueki] The Japanese journal of clinical hematology, 53, 3
• Follicular lymphoma presenting with marked splenomegaly: report of three cases., Koiso Hiromi;Yokohama Akihiko;Mitsui Takeki;Saitoh Takayuki;Handa Hiroshi;Murakami Hirokazu;Hirato Junko;Kojima Masaru;Nojima Yoshihisa;Tsukamoto Norifumi, 17 May 2012, Acta haematologica, 128, 1

  DOI
• [Diagnosis and prognostic factors in patients with multiple myeloma]., Murakami Hirokazu;Yokohama Akihiko;Saitoh Takayuki;Tsukamoto Norifumi;Handa Hiroshi, Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 2
• Age-related Epstein-Barr Virus-positive lymphoproliferative disorders of the orbit and maxillary sinus : a case report., Mitsui Takeki;Mawatari Momoko;Koiso Hiromi;Yokohama Akihiko;Uchiumi Hideki;Saitoh Takayuki;Handa Hiroshi;Hirato Junko;Karasawa Masamitsu;Murakami Hirokazu;Kojima Masaru;Nakamura Shigeo;Nojima Yoshihisa;Tsukamoto Norifumi, Journal of clinical and experimental hematopathology : JCEH, 52, 3

  DOI
• Distinctive disease subgroups according to differentiation stages in adult patients with T-cell acute lymphoblastic leukemia., Shimizu Hiroaki;Handa Hiroshi;Hatsumi Nahoko;Takada Satoru;Saitoh Takayuki;Sakura Toru;Miyawaki Shuichi;Nojima Yoshihisa, 26 Feb. 2013, European journal of haematology, 90, 4

  DOI
• [Emergence of donor-derived anti-HLA antibody and subsequent transfusion-refractory thrombocytopenia after allogeneic hematopoietic stem cell transplantation from an HLA-matched sibling donor in a patient with acute myeloid leukemia]., Uchiyama Yuri;Hoshino Takumi;Mihara Masahiro;Mitsui Takeki;Koiso Hiromi;Takizawa Makiko;Yokohama Akihiko;Saitoh Takayuki;Uchiumi Hideki;Handa Hiroshi;Tsukamoto Norifumi;Murakami Hirokazu;Nojima Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 54, 2
• Development of IgG4-related disease 10 years after chemotherapy for diffuse large B cell lymphoma and longstanding bronchial asthma., Mitsui Takeki;Yokohama Akihiko;Koiso Hiromi;Ishizaki Takuma;Uchiumi Hideki;Saitoh Takayuki;Handa Hiroshi;Hirato Junko;Karasawa Masamitsu;Murakami Hirokazu;Kojima Masaru;Nojima Yoshihisa;Tsukamoto Norifumi, 12 May 2013, International journal of hematology, 98, 1

  DOI
• Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia., Shimizu Hiroaki;Saitoh Takayuki;Hatsumi Nahoko;Takada Satoru;Handa Hiroshi;Jimbo Takahiro;Sakura Toru;Miyawaki Shuichi;Nojima Yoshihisa, 05 Sep. 2013, Leukemia research, 37, 11

  DOI
• DNMT3B7 expression related to MENT expression and its promoter methylation in human lymphomas., Alkebsi Lobna;Handa Hiroshi;Sasaki Yoshiko;Osaki Yohei;Yanagisawa Kunio;Ogawa Yoshiaki;Yokohama Akihiko;Hattori Hikaru;Koiso Hiromi;Saitoh Takayuki;Mitsui Takeki;Tsukamoto Norifumi;Nojima Yoshihisa;Murakami Hirokazu, 21 Sep. 2013, Leukemia research, 37, 12

  DOI
• Characterization of CD56+ dendritic-like cells: a normal counterpart of blastic plasmacytoid dendritic cell neoplasm?, Osaki Yohei;Yokohama Akihiko;Saito Akio;Tahara Kenichi;Yanagisawa Kunio;Ogawa Yoshiyuki;Ishizaki Takuma;Mitsui Takeki;Koiso Hiromi;Takizawa Makiko;Uchiumi Hideki;Saitoh Takayuki;Handa Hiroshi;Murakami Hirokazu;Tsukamoto Norifumi;Nojima Yoshihisa, 29 Nov. 2013, PloS one, 8, 11

  DOI
• Prognostic importance of the soluble form of IL-2 receptorα (sIL-2Rα) and its relationship with surface expression of IL-2Rα (CD25) of lymphoma cells in diffuse large B-cell lymphoma treated with CHOP-like regimen with or without rituximab: a retrospective analysis of 338 cases., Hashimoto Yoko;Yokohama Akihiko;Saitoh Akio;Nakahashi Hirotaka;Toyama Kohtaro;Mitsui Takeki;Koiso Hiromi;Saitoh Takayuki;Handa Hiroshi;Uchiumi Hideki;Jinbo Takahiro;Murayama Kayoko;Matsumoto Morio;Sawamura Morio;Karasawa Masamitsu;Murakami Hirokazu;Hirato Junko;Nojima Yoshihisa;Kojima Masaru;Tsukamoto Norifumi, Journal of clinical and experimental hematopathology : JCEH, 53, 3

  DOI
• [Relapsed primary intraocular lymphoma treated with intravitreal methotrexate and high-dose chemotherapy followed by autologous stem cell rescue]., Kamio Tadashi;Yokohama Akihiko;Hayashi Toshimasa;Toyama Kotaro;Koya Hiroko;Hoshino Takumi;Saitoh Takayuki;Hanyuda Naoto;Mukai Ryou;Handa Hiroshi;Murakami Hirokazu;Tsukamoto Norifumi;Nojima Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 55, 2
• [Successful treatment with dasatinib for polycythemia vera patient emerging BCR-ABL positive clone during 13 years of treatment]., Takizawa Makiko;Yokohama Akihiko;Sekigami Tomomi;Koiso Hiromi;Ishizaki Takuma;Mitsui Takeki;Ogawa Yoshiyuki;Saitoh Takayuki;Handa Hiroshi;Tsukamoto Norifumi;Murakami Hirokazu;Nojima Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 55, 6
• A new staging system to predict prognosis of patients with multiple myeloma in an era of novel therapeutic agents., Iriuchishima Hirono;Saitoh Takayuki;Handa Hiroshi;Isoda Atsushi;Matsumoto Morio;Sawamura Morio;Iwasaki Atsushi;Ushie Chiaki;Hattori Hikaru;Sasaki Yoshiko;Mitsui Takeki;Yokohama Akihiko;Tsukamoto Norifumi;Murakami Hirokazu;Nojima Yoshihisa, 24 Jul. 2014, European journal of haematology, 94, 2

  DOI
• Does the hematopoietic cell transplantation specific comorbidity index (HCT-CI) predict transplantation outcomes? A prospective multicenter validation study of the Kanto Study Group for Cell Therapy., Nakaya Aya;Mori Takehiko;Tanaka Masatsugu;Tomita Naoto;Nakaseko Chiaki;Yano Shingo;Fujisawa Shin;Sakamaki Hisashi;Aotsuka Nobuyuki;Yokota Akira;Kanda Yoshinobu;Sakura Toru;Nanya Yasuhito;Saitoh Takayuki;Kanamori Heiwa;Takahashi Satoshi;Okamoto Shinichiro, 15 Jul. 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 20, 10

  DOI
• Allogeneic hematopoietic stem cell transplantation for adult patients with mixed phenotype acute leukemia: results of a matched-pair analysis., Shimizu Hiroaki;Saitoh Takayuki;Machida Shinichiro;Kako Shinichi;Doki Noriko;Mori Takehiko;Sakura Toru;Kanda Yoshinobu;Kanamori Heiwa;Miyawaki Shuichi;Okamoto Shinichiro; , 13 Mar. 2015, European journal of haematology, 95, 5

  DOI
• Polymorphisms of IL-10 affect the severity and prognosis of myelodysplastic syndrome., Kasamatsu Tetsuhiro;Saitoh Takayuki;Minato Yusuke;Shimizu Hiroaki;Yokohama Akihiko;Tsukamoto Norifumi;Handa Hiroshi;Sakura Toru;Murakami Hirokazu, 26 May 2015, European journal of haematology, 96, 3

  DOI
• Primary Plasma Cell Leukemia in the Era of Novel Agents: A Multicenter Study of the Japanese Society of Myeloma., Iriuchishima Hirono;Ozaki Shuji;Konishi Jun;Matsumoto Morio;Murayama Kayoko;Nakamura Fumihiko;Yamamoto Go;Handa Hiroshi;Saitoh Takayuki;Nagura Eiichi;Shimizu Kazuyuki;Nojima Yoshihisa;Murakami Hirokazu, 28 Oct. 2015, Acta haematologica, 135, 2

  DOI
• SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patients., Mitsui Takeki;Koiso Hiromi;Nakahashi Hirotaka;Saitoh Akio;Shimizu Hiroaki;Ishizaki Takuma;Ogawa Yoshiyuki;Takizawa Makiko;Yokohama Akihiko;Saitoh Takayuki;Jinbo Takahiro;Ogura Hidemi;Handa Hiroshi;Sawamura Morio;Sakura Tohru;Karasawa Masamitsu;Murakami Hirokazu;Nojima Yoshihisa;Tsukamoto Norifumi, 20 Nov. 2015, International journal of hematology, 103, 2

  DOI
• The bridge treatment selected at the decision for transplantation did not affect the outcomes in patients with MDS., Kako Shinichi;Kanda Yoshinobu;Kato Jun;Yamamoto Wataru;Kato Seiko;Onizuka Makoto;Yokota Akira;Tatara Raine;Yokoyama Hiroki;Hagihara Maki;Usuki Kensuke;Gotoh Moritaka;Watanabe Reiko;Kawai Nobutaka;Saitoh Takayuki;Kanamori Heiwa;Takahashi Satoshi;Okamoto Shinichiro, 08 Dec. 2015, Hematological oncology, 35, 3

  DOI
• Primary leptomeningeal B-cell lymphoma with normal pressure hydrocephalus at diagnosis., Ishizaki Takuma;Mitsui Takeki;Uchiyama Yuri;Ogawa Yoshiyuki;Koiso Hiromi;Takizawa Makiko;Yokohama Akihiko;Saitoh Takayuki;Handa Hiroshi;Tsukamoto Norifumi;Murakami Hirokazu;Nojima Yoshihisa, [Rinsho ketsueki] The Japanese journal of clinical hematology, 56, 12

  DOI
• Professional identity acquisition process model in interprofessional education using structural equation modelling: 10-year initiative survey., Kururi Nana;Tozato Fusae;Lee Bumsuk;Kazama Hiroko;Katsuyama Shiori;Takahashi Maiko;Abe Yumiko;Matsui Hiroki;Tokita Yoshiharu;Saitoh Takayuki;Kanaizumi Shiomi;Makino Takatoshi;Shinozaki Hiromitsu;Yamaji Takehiko;Watanabe Hideomi, 01 Mar. 2016, Journal of interprofessional care, 30, 2

  DOI
• Reduced frequency treatment with bortezomib plus dexamethasone for elderly patients with relapsed and/or refractory multiple myeloma: a phase 2 study of the Japanese Myeloma Study Group (JMSG-0902)., Ozaki Shuji;Hata Hiroyuki;Abe Masahiro;Saitoh Takayuki;Hanamura Ichiro;Yano Hiroki;Sunami Kazutaka;Kosugi Hiroshi;Sawamura Morio;Nakazato Tomonori;Masunari Taro;Mori Mayumi;Takagi Toshiyuki;Murakami Hirokazu;Shimizu Kazuyuki, 05 Apr. 2016, Annals of hematology, 95, 6

  DOI
• A plan for embedding an interprofessional education initiative into an existing programme in a Southeast Asian university., Lee Bumsuk;Shinozaki Hiromitsu;Bouphavanh Ketsomsouk;Tokita Yoshiharu;Makino Takatoshi;Matsui Hiroki;Saitoh Takayuki;Tozato Fusae;Watanabe Hideomi, Journal of interprofessional care, 30, 3

  DOI
• Polymorphism of IL-10 receptor β affects the prognosis of multiple myeloma patients treated with thalidomide and/or bortezomib., Kasamatsu Tetsuhiro;Saitoh Takayuki;Ino Rumi;Gotoh Nanami;Mitsui Takeki;Shimizu Hiroaki;Matsumoto Morio;Sawamura Morio;Yokohama Akihiko;Handa Hiroshi;Tsukamoto Norifumi;Murakami Hirokazu, 13 Jul. 2016, Hematological oncology, 35, 4

  DOI
• Chromosome 16q genes CDH1, CDH13 and ADAMTS18 are correlated and frequently methylated in human lymphoma., Alkebsi Lobna;Handa Hiroshi;Yokohama Akihiko;Saitoh Takayuki;Tsukamoto Norifumi;Murakami Hirokazu, 09 Sep. 2016, Oncology letters, 12, 5

  DOI
• Clonal evolution detected with conventional cytogenetic analysis is a potent prognostic factor in adult patients with relapsed AML., Shimizu Hiroaki;Yokohama Akihiko;Ishizaki Takuma;Hatsumi Nahoko;Takada Satoru;Saitoh Takayuki;Sakura Toru;Nojima Yoshihisa;Handa Hiroshi, 04 Apr. 2017, Hematological oncology, 36, 1

  DOI
• The cytokine polymorphisms affecting Th1/Th2 increase the susceptibility to, and severity of, chronic ITP., Takahashi Noriyuki;Saitoh Takayuki;Gotoh Nanami;Nitta Yasuhiro;Alkebsi Lobna;Kasamatsu Tetsuhiro;Minato Yusuke;Yokohama Akihiko;Tsukamoto Norifumi;Handa Hiroshi;Murakami Hirokazu, 16 May 2017, BMC immunology, 18, 1

  DOI
• Overexpression of B-cell lymphoma 6 alters gene expression profile in a myeloma cell line and is associated with decreased DNA damage response., Tahara Kenichi;Takizawa Makiko;Yamane Arito;Osaki Yohei;Ishizaki Takuma;Mitsui Takeki;Yokohama Akihiko;Saitoh Takayuki;Tsukamoto Norifumi;Matsumoto Morio;Murakami Hirokazu;Nojima Yoshihisa;Handa Hiroshi, 25 Jun. 2017, Cancer science, 108, 8

  DOI
• IL17A and IL23R gene polymorphisms affect the clinical features and prognosis of patients with multiple myeloma., Kasamatsu Tetsuhiro;Kimoto Mari;Takahashi Noriyuki;Minato Yusuke;Gotoh Nanami;Takizawa Makiko;Matsumoto Morio;Sawamura Morio;Yokohama Akihiko;Handa Hiroshi;Tsukamoto Norifumi;Saitoh Takayuki;Murakami Hirokazu, 07 Aug. 2017, Hematological oncology, 36, 1

  DOI
• Recurrent alterations of the WW domain containing oxidoreductase gene spanning the common fragile site FRA16D in multiple myeloma and monoclonal gammopathy of undetermined significance., Handa Hiroshi;Sasaki Yoshiko;Hattori Hikaru;Alkebsi Lobna;Kasamatsu Tetsuhiro;Saitoh Takayuki;Mitsui Takeki;Yokohama Akihiko;Tsukamoto Norifumi;Matsumoto Morio;Murakami Hirokazu, 26 Jul. 2017, Oncology letters, 14, 4

  DOI
• Health science students' attitudes towards healthcare teams: A comparison between two universities., Makino Takatoshi;Lee Bumsuk;Matsui Hiroki;Tokita Yoshiharu;Shinozaki Hiromitsu;Kanaizumi Shiomi;Abe Yumiko;Saitoh Takayuki;Tozato Fusae;Igarashi Ayako;Sato Mika;Ohtake Shigeki;Tabuchi Noriko;Inagaki Michiko;Kama Akinori;Watanabe Hideomi, 21 Nov. 2017, Journal of interprofessional care, 32, 2

  DOI
• A Rare Case of Chronic Active Epstein-Barr Virus (EBV) Infection Accompanied by the Infiltration of EBV-infected CD8+ T Cells into the Muscle., Kobayashi Nobuhiko;Mitsui Takeki;Ogawa Yoshiyuki;Iriuchishima Hirono;Takizawa Makiko;Yokohama Akihiko;Saitoh Takayuki;Koiso Hiromi;Tsukamoto Norifumi;Murakami Hirokazu;Nojima Yoshihisa;Handa Hiroshi, Journal of pediatric hematology/oncology, 40, 3

  DOI
• PDCD1 and CTLA4 polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia., Kasamatsu Tetsuhiro;Ino Rumi;Takahashi Noriyuki;Gotoh Nanami;Minato Yusuke;Takizawa Makiko;Yokohama Akihiko;Handa Hiroshi;Saitoh Takayuki;Tsukamoto Norifumi;Murakami Hirokazu, 23 Jan. 2018, British journal of haematology, 180, 5

  DOI
• Clinical management and outcomes of completely resected stage I follicular lymphoma., Yokohama Akihiko;Hashimoto Yoko;Takizawa Makiko;Shimizu Hiroaki;Miyazawa Yuri;Saitoh Akio;Toyama Kohtaro;Ishizaki Takuma;Mitsui Takeki; ; ;Saitoh Takayuki;Murayama Kayoko;Matsumoto Morio;Sawamura Morio;Murakami Hirokazu;Hirato Junko;Kojima Masaru;Nojima Yoshihisa;Handa Hiroshi;Tsukamoto Norifumi, 08 Feb. 2018, Journal of clinical and experimental hematopathology : JCEH, 58, 1

  DOI
• Short-term administration of recombinant human erythropoietin decreases B cell number in human peripheral blood., Nagashima Tomomi;Yokohama Akihiko;Nagai Kie;Kasamatsu Tetsuhiro;Gotoh Nanami;Iriuchishima Hirono;Sekigami Tomomi;Saitoh Takayuki;Handa Hiroshi;Tsukamoto Norifumi;Murakami Hirokazu, 02 Feb. 2018, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 57, 2

  DOI
• Association between OGG1 S326C CC genotype and elevated relapse risk in acute myeloid leukemia., Gotoh Nanami;Saitoh Takayuki;Takahashi Noriyuki;Kasamatsu Tetsuhiro;Minato Yusuke;Lobna Alkebsi;Oda Tsukasa;Hoshino Takumi;Sakura Toru;Shimizu Hiroaki;Takizawa Makiko;Handa Hiroshi;Yokohama Akihiko;Tsukamoto Norifumi;Murakami Hirokazu, 08 May 2018, International journal of hematology, 108, 3

  DOI
• Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma., Kasamatsu Tetsuhiro;Ozaki Shuji;Saitoh Takayuki;Konishi Jun;Sunami Kazutaka;Itagaki Mitsuhiro;Asaoku Hideki;Cho Takaaki;Handa Hiroshi;Hagiwara Shotaro;Wakayama Toshio;Negoro Akiko;Takezako Naoki;Harada Naoko;Kuroda Yoshiaki;Nakaseko Chiaki;Miyake Takaaki;Inoue Nobumasa;Hata Hiroyuki;Shimazaki Chihiro;Ohno Tatsuharu;Kuroda Junya;Murayama Tohru;Kobayashi Takahiro;Abe Masahiro;Ishida Tadao;Nagura Eiich;Shimizu Kazuyuki, 19 Sep. 2018, Hematological oncology, 36, 5

  DOI
• Tumor long-axis diameter and SUVmax predict long-term responders in 90Y-ibritumomab tiuxetan monotherapy., Tsukamoto Norifumi;Yokohama Akihiko;Higuchi Tetsuya;Mitsui Takeki;Koiso Hiromi;Takizawa Makiko;Shimizu Hiroaki;Ishizaki Takuma;Matsumoto Morio;Toyama Kohtaro;Sakura Tohru;Ogura Hidemi;Saitoh Takayuki;Ishida Fumihiro;Murakami Hirokazu;Tsushima Yoshito;Handa Hiroshi, 10 Sep. 2018, International journal of hematology, 109, 1

  DOI
• Prognostic impact of trisomy 21 in follicular lymphoma., Mitsui Takeki;Yokohama Akihiko;Koiso Hiromi;Saito Akio;Toyama Kohtaro;Shimizu Hiroaki;Ishizaki Takuma;Irisawa Hiroyuki;Takizawa Makiko;Saitoh Takayuki;Murayama Kayoko;Matsumoto Morio;Handa Hiroshi;Hirato Junko;Kojima Masaru;Murakami Hirokazu;Tsukamoto Norifumi, 12 Nov. 2018, British journal of haematology, 184, 4

  DOI
• Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation., Takamatsu Hiroyuki;Yamashita Takeshi;Kurahashi Shingo;Saitoh Takayuki;Kondo Tadakazu;Maeda Takeshi;Nakazawa Hideyuki;Murata Makoto;Narita Tomoko;Kuroda Junya;Hashimoto Hisako;Kawamura Koji;Miyamoto Toshihiro;Honda Sumihisa;Ichinohe Tatsuo;Atsuta Yoshiko;Sunami Kazutaka, 10 Nov. 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 25, 3

  DOI
• Malignancy-Associated Hypercalcemia Related with Receptor Activator of NF-κB Ligand (RANKL) Expression in T-Cell Acute Lymphoblastic Leukemia., Tahara Kenichi;Koiso Hiromi;Osaki Yo-Hei;Sekigami Tomomi;Yokohama Akihiko;Saitoh Takayuki;Tsukamoto Norifumi;Murakami Hirokazu;Abe Masahiro;Handa Hiroshi, 15 Feb. 2019, Acta haematologica, 141, 3

  DOI
• Human telomerase reverse transcriptase expression in a CD34-positive hematopoietic progenitor of myelodysplastic syndrome and acute myelogenous leukemia., Handa Hiroshi;Nishimoto Natsumi;Inoue Madoka;Yokohama Akihiko;Tsukamoto Norifumi;Saitoh Takayuki;Murakami Hirokazu, 30 May 2019, Hematological oncology, 37, 4

  DOI
• Evaluation of the Revised International Staging System (R-ISS) in Japanese patients with multiple myeloma., Ozaki Shuji;Handa Hiroshi;Saitoh Takayuki;Murakami Hirokazu;Itagaki Mitsuhiro;Asaoku Hideki;Suzuki Kenshi;Isoda Atsushi;Matsumoto Morio;Sawamura Morio;Sunami Kazutaka;Takezako Naoki;Hagiwara Shotaro;Kuroda Yoshiaki;Chou Takaaki;Nagura Eiichi;Shimizu Kazuyuki, 02 May 2019, Annals of hematology, 98, 7

  DOI
• Activin A: a novel urinary biomarker of renal impairment in multiple myeloma., Iriuchishima Hirono;Maeshima Akito;Takahashi Shunsuke;Ishizaki Takuma;Yokohama Akihiko;Tsukamoto Norifumi;Saitoh Takayuki;Murakami Hirokazu;Handa Hiroshi, 31 May 2019, Bioscience reports, 39, 5

  DOI
• Key factors affecting the integration of interprofessional education into human resources for health reform: a Lao People's Democratic Republic case study., Lee Bumsuk;Phrasisombath Ketkesone;Shinozaki Hiromitsu;Vangkonevilay Phouthone;Bouphavanh Ketsomsouk;Prabouasone Khamphanh;Sounthavong Outhip;Tokita Yoshiharu;Makino Takatoshi;Matsui Hiroki;Saitoh Takayuki;Tozato Fusae;Kama Akinori;Watanabe Hideomi, 21 Aug. 2019, Journal of interprofessional care, 33, 4

  DOI
• [Thyroid storm and exacerbation of autoimmune hemolytic anemia following childbirth]., Sugisaki Manato;Ishizaki Takuma;Iriuchishima Hirono;Shimizu Hiroaki;Yanagisawa Kunio;Ogawa Yoshiyuki;Yokohama Akihiko;Saitoh Takayuki;Tsukamoto Norifumi;Handa Hiroshi, [Rinsho ketsueki] The Japanese journal of clinical hematology, 60, 8

  DOI
• PDCD1 and PDCD1LG1 polymorphisms affect the susceptibility to multiple myeloma., Kasamatsu Tetsuhiro;Awata Maaya;Ishihara Rei;Murakami Yuki;Gotoh Nanami;Matsumoto Morio;Sawamura Morio;Yokohama Akihiko;Handa Hiroshi;Tsukamoto Norifumi;Saitoh Takayuki;Murakami Hirokazu, 16 Oct. 2019, Clinical and experimental medicine, 20, 1

  DOI
• IgG4-related Disease with a Cardiac Mass., Matsumura Ikuko;Mitsui Takeki;Tahara Kenichi;Shimizu Hiroaki;Yanagisawa Kunio;Ishizaki Takuma;Koiso Hiromi;Takizawa Makiko;Yokohama Akihiko;Saitoh Takayuki;Hirato Junko;Murakami Hirokazu;Handa Hiroshi;Tsukamoto Norifumi, 17 Jan. 2020, Internal medicine (Tokyo, Japan), 59, 9

  DOI
• Clonal evolution detected with conventional cytogenetic analysis is a potent prognostic factor in adult patients with relapsed Philadelphia chromosome-negative acute lymphoblastic leukemia., Shimizu Hiroaki;Yokohama Akihiko;Ishizaki Takuma;Hatsumi Nahoko;Takada Satoru;Saitoh Takayuki;Sakura Toru;Handa Hiroshi, 14 Feb. 2021, Leukemia research, 103

  DOI
• 慢性疾患となった骨髄腫-どのように診断するか?　どのように付き合っていくか? 骨髄腫治療薬の温故知新 アルキル化薬とステロイド, 村上 博和;笠松 哲光;齋藤 貴之;半田 寛, Oct. 2017, 120, 4, 865, 869
• NFKB1-94ins/delATTGは急性骨髄性白血病のリスクと予後不良に関連する(NFKB1-94 ins/del ATTG is associated with the risk of AML and poor prognosis), ;;;;;;;;;;;;, Sep. 2021, 83回, PS
• 健常者T細胞における薬剤誘導性細胞老化の検討(Melphalan and doxorubicin induce cellular senescence in T cells of healthy subjects), ;;;;;;;;;;;, Sep. 2021, 83回, PS
• 中枢神経再発高リスクび漫性大細胞型B細胞リンパ腫に対する中枢神経再発予防効果の単施設解析(A single-center analysis of central nervous system prophylaxis for diffuse large B cell lymphoma), ;;;;;;;, Sep. 2021, 83回, OS1
• TCR beta constant region 1に対する抗体を用いた成熟細胞腫瘍のクローナリティーの検討(Immunophenotypic detection of monoclonality in mature T-cell malignancy using anti TCR Cb1 antibody), ;;;;;;;;;;;, Sep. 2021, 83回, BPA
• Tissue inhibitor of metalloproteinase 1(TIMP1)は骨髄腫の進行と線維芽細胞の浸潤能に関与する(Tissue inhibitor of metalloproteinase 1(TIMP1) is associated with myeloma progression and fibroblast invasive capacity), 石原 領;小田 司;村上 有希;松村 郁子;渡辺 早貴;浅尾 優太;後藤 七海;笠松 哲光;武井 寿史;小林 宣彦;齋藤 貴之;村上 博和;半田 寛, May 2022, 12, 3, 157, Scientific journal
• 多発性骨髄腫におけるHuman Endogenous Retrovirus-K(HERV-K)の発現とその役割の検討, ;;;;;;;, Jul. 2022, 23, 学術集会, S130, Scientific journal
• 当院におけるT細胞リンパ腫の中枢再発に対する検討, 金谷 秀平;梶田 樹矢;塚田 明彦;内藤 千晶;石川 哲也;小林 宜彦;大崎 洋平;宮澤 悠里;滝沢 牧子;齋藤 貴之;横濱 章彦;塚本 憲史;半田 寛, Jun. 2022, 62, 102, Scientific journal
• Long non-coding RNA NEAT1はHSF1によって制御され骨髄腫の進行に関与する(Long non-coding RNA NEAT1 is upregulated by HSF1 and associated with myeloma progression), 渡辺 早貴; 小田 司; 黒田 裕子; 村上 有希; 石原 領; 須永 征伸; 山根 瑛子; 小林 宣彦; 大崎 洋平; 石埼 卓馬; 清水 啓明; 小磯 博美; 入内島 裕乃; 後藤 七海; 笠松 哲光; 横濱 章彦; 齋藤 貴之; 村上 博和; 塚本 憲史; 半田 寛, Sep. 2018, 臨床血液, 59, 9, 1603, 1603
• マトリックスメタロプロテーゼとその阻害因子は骨髄腫の進行と髄外形質細胞腫形成に関係する(MMP and TIMP is associated with multiple myeloma progression and extramedullary plasmacytoma), 石原 領; 村上 有希; 渡辺 早貴; 小田 司; 須永 征伸; 山根 瑛子; 小林 宣彦; 大崎 洋平; 石埼 卓馬; 清水 啓明; 小磯 博美; 入内島 裕乃; 後藤 七海; 笠松 哲光; 横濱 章彦; 齋藤 貴之; 村上 博和; 塚本 憲史; 半田 寛, Sep. 2018, 臨床血液, 59, 9, 1604, 1604
• Sub-lethal doses of chemotherapeutic agents induce senescence in T cells and upregulation of PD-1 expression., Tetsuhiro Kasamatsu; Maaya Awata-Shiraiwa; Rei Ishihara; Yuki Murakami; Yuta Masuda; Nanami Gotoh; Tsukasa Oda; Akihiko Yokohama; Ikuko Matsumura; Hiroshi Handa; Norifumi Tsukamoto; Hirokazu Murakami; Takayuki Saitoh, Oct. 2023, Clinical and experimental medicine, 23, 6, 2695, 2703, Scientific journal

  DOI
• Myeloma Microenvironmental TIMP1 Induces the Invasive Phenotype in Fibroblasts to Modulate Disease Progression., Rei Ishihara; Tsukasa Oda; Yuki Murakami; Ikuko Matsumura; Saki Watanabe; Yuta Asao; Yuta Masuda; Nanami Gotoh; Tetsuhiro Kasamatsu; Hisashi Takei; Nobuhiko Kobayashi; Nobuo Sasaki; Takayuki Saitoh; Hirokazu Murakami; Hiroshi Handa, 22 Jan. 2023, International journal of molecular sciences, 24, 3, Scientific journal

  DOI
• Chronic left ventricular apical thrombosis complicating isolated left ventricular noncompaction in a patient with human immunodeficiency virus infection., Toshimitsu Kato; Norimichi Koitabashi; Yukie Sano; Kunio Yanagisawa; Yoshiyuki Ogawa; Takayuki Saitoh; Hideki Ishii, 21 Jan. 2023, Journal of medical ultrasonics (2001), 50, 2, 255, 257, Scientific journal

  DOI
• DNA damage-induced cellular senescence is regulated by 53BP1 accumulation in the nuclear foci and phase separation., Tsukasa Oda; Nanami Gotoh; Tetsuhiro Kasamatsu; Hiroshi Handa; Takayuki Saitoh; Nobuo Sasaki, 15 Jan. 2023, Cell proliferation, 56, 6, e13398, 964, Scientific journal

  DOI
• MYC Causes Multiple Myeloma Progression via Attenuating TP53-Induced MicroRNA-34 Expression., Yuki Murakami; Kei Kimura-Masuda; Tsukasa Oda; Ikuko Matsumura; Yuta Masuda; Rei Ishihara; Saki Watanabe; Yuko Kuroda; Tetsuhiro Kasamatsu; Nanami Gotoh; Hisashi Takei; Nobuhiko Kobayashi; Takayuki Saitoh; Hirokazu Murakami; Hiroshi Handa, 29 Dec. 2022, Genes, 14, 1, Scientific journal

  DOI
• Clinical significance of human endogenous retrovirus K (HERV-K) in multiple myeloma progression., Yuta Masuda; Rei Ishihara; Yuki Murakami; Saki Watanabe; Yuta Asao; Nanami Gotoh; Tetsuhiro Kasamatsu; Hisashi Takei; Nobuhiko Kobayashi; Takayuki Saitoh; Hirokazu Murakami; Hiroshi Handa, 16 Dec. 2022, International journal of hematology, 117, 4, 563, 577, Scientific journal

  DOI
• Waldenström Macroglobulinemia and Non-IgM-Type Lymphoplasmacytic Lymphoma Are Genetically Similar., Maaya Awata-Shiraiwa; Akihiko Yokohama; Yukihiro Kanai; Nanami Gotoh; Tetsuhiro Kasamatsu; Hiroshi Handa; Takayuki Saitoh; Hirokazu Murakami; Junko Hirato; Hayato Ikota; Norifumi Tsukamoto, 2023, Acta haematologica, 146, 5, 384, 390, Scientific journal

  DOI
• DNA損傷修復応答に関与するDNAポリメラーゼPOLQとPOLHの多発性骨髄腫における発現, 須永 征伸; 小田 司; 山根 瑛子; 石原 領; 村上 有希; 浅尾 優太; 武井 寿史; 小林 宜彦; 大崎 洋平; 松本 守生; 後藤 七海; 笠松 哲光; 清水 啓明; 石埼 卓馬; 小磯 博美; 滝沢 牧子; 入内島 裕乃; 関上 智美; 横濱 章彦; 塚本 憲史; 増田 裕太; 栗田 真彩; 相馬 佳奈; 橋本 菜央; 齋藤 貴之; 半田 寛, Aug. 2019, 69, 3, 296, 297
• 末梢血幹細胞採取におけるSphingosine-1-phosphateの関与, 橋本 菜央; 横濱 章彦; 粟田 真彩; 浅尾 優太; 須永 征伸; 相馬 佳奈; 山根 瑛子; 石原 領; 村上 有希; 後藤 七海; 笠松 哲光; 半田 寛; 齋藤 貴之, Aug. 2019, 69, 3, 300, 301
• 次世代シーケンサーを用いた原発性マクログロブリン血症およびIgG産生型リンパ形質細胞性リンパ腫における遺伝子変異の解析, 粟田 真彩; 横濱 章彦; 橋本 菜央; 後藤 七海; 笠松 哲光; 齋藤 貴之; 半田 寛; 塚本 憲史, Aug. 2019, 69, 3, 301, 301
• Th1サイトカイン遺伝子多型は慢性免疫性血小板減少症(cITP)の重症度に影響する, 相馬 佳奈; 後藤 七海; 笠松 哲光; 須永 征伸; 山根 瑛子; 村上 有希; 石原 領; 粟田 真彩; 半田 寛; 齋藤 貴之, Aug. 2019, 69, 3, 301, 301
• 多発性骨髄腫におけるc-MAF、MAFB発現とp53, 山根 瑛子; 小田 司; 須永 征伸; 村上 有希; 石原 領; 浅尾 優太; 武井 寿史; 小林 宜彦; 大崎 洋平; 松本 守生; 後藤 七海; 笠松 哲光; 清水 啓明; 石埼 卓馬; 小磯 博美; 滝沢 牧子; 入内島 裕乃; 関上 智美; 横濱 章彦; 塚本 憲史; 増田 裕太; 粟田 真彩; 相馬 佳奈; 橋本 菜央; 齋藤 貴之; 半田 寛, Aug. 2019, 69, 3, 302, 303
• PD-1およびPD-L1遺伝子多型は多発性骨髄腫の髄外病変の合併および重症度に関与する, 金井 敬海; 笠松 哲光; 粟田 真彩; 村田 圭祐; 井野 瑠美; 北村 裕也; 本間 和貴; 後藤 七海; 滝沢 牧子; 横濱 章彦; 半田 寛; 齋藤 貴之; 村上 博和, Aug. 2017, 67, 3, 267, 267
• Th1サイトカイン多型は骨髄異形成症候群の重症度に関与する, 高橋 佳子; 齋藤 貴之; 小島 裕里; 黒岩 希美; 相馬 佳奈; 茂木 美佑奈; 簗島 由樹; 井野 瑠美; 北村 裕也; 中村 瑠里; 松田 美弥子; 高橋 範行; 後藤 七海; 笠松 哲光; 半田 寛; 村上 博和, Aug. 2017, 67, 3, 267, 267
• PARP1V762A多型は骨髄異形成症候群の白血病化と関連する, 後藤 七海; 齋藤 貴之; 粟田 真彩; 石原 領; 大圃 真純; 金井 敬海; 村上 有希; 村田 圭祐; 渡辺 早貴; 井野 瑠美; 北村 裕也; 本間 和貴; 高橋 範行; 笠松 哲光; 半田 寛; 村上 博和, Aug. 2017, 67, 3, 268, 268
• 末梢血CD69陽性B細胞はrecombinant human erythropoietinの投与によって減少する, 粟田 真彩; 横濱 章彦; 金井 敬海; 村田 圭祐; 石原 領; 村上 有希; 渡辺 早貴; 高橋 範行; 後藤 七海; 笠松 哲光; 滝沢 牧子; 半田 寛; 齋藤 貴之; 村上 博和, Aug. 2017, 67, 3, 276, 276
• Th1サイトカインTNF-α-857C/Tは特発性血小板減少性紫斑病の発症リスクに関与する, 簗島 由樹; 齋藤 貴之; 小島 裕里; 黒岩 希美; 相馬 佳奈; 茂木 美佑奈; 高橋 佳子; 井野 瑠美; 北村 裕也; 本間 和貴; 高橋 範行; 後藤 七海; 笠松 哲光; 半田 寛; 村上 博和, Aug. 2017, 67, 3, 276, 276
• 慢性免疫性血小板減少症における免疫チェックポイント遺伝子多型解析, 村田 圭祐; 笠松 哲光; 井野 瑠美; 粟田 真彩; 金井 敬海; 大圃 真純; 中村 瑠里; 松田 美弥子; 高橋 範行; 後藤 七海; 滝沢 牧子; 横濱 章彦; 半田 寛; 齋藤 貴之; 村上 博和, Aug. 2017, 67, 3, 277, 277
• 多機能蛋白APE1の急性骨髄性白血病発症リスクへの関与と治療標的としての可能性, 笠原 渉; 後藤 七海; 齋藤 貴之; 大圃 真純; 松井 文香; 山田 晴加; 井野 瑠美; 北村 裕也; 本間 和貴; 長嶋 友海; 高橋 範行; 笠松 哲光; 清水 啓明; 石埼 卓馬; 横濱 章彦; 滝沢 牧子; 小磯 博美; 三井 健揮; 塚本 憲史; 佐倉 徹; 半田 寛; 野島 美久; 村上 博和, Aug. 2016, 66, 3, 253, 253
• Th1ケモカインのCXCL10-1447A/G多型はITPの重症度に関与する, 松井 文香; 齋藤 貴之; 大圃 真純; 笠原 渉; 山田 晴加; 井野 瑠美; 北村 裕也; 本間 和貴; 長嶋 友海; 高橋 範行; 後藤 七海; 笠松 哲光; 清水 啓明; 石埼 卓馬; 横濱 章彦; 滝沢 牧子; 小磯 博美; 三井 健揮; 塚本 憲史; 半田 寛; 野島 美久; 村上 博和, Aug. 2016, 66, 3, 254, 254
• IFN-γ+874T/A多型non-AA型は低リスクMDSの予後不良因子となる, 大圃 真純; 齋藤 貴之; 笠原 渉; 松井 文香; 山田 晴加; 井野 瑠美; 北村 裕也; 本間 和貴; 長嶋 友海; 高橋 範行; 後藤 七海; 笠松 哲光; 清水 啓明; 石埼 卓馬; 横濱 章彦; 滝沢 牧子; 小磯 博美; 三井 健揮; 塚本 憲史; 佐倉 徹; 半田 寛; 野島 美久; 村上 博和, Aug. 2016, 66, 3, 254, 255
• Th2ケモカインのCCL2-2518G/A GG(高産生)型はMDSの発症リスクを増加させる, 山田 晴加; 齋藤 貴之; 大圃 真純; 笠原 渉; 松井 文香; 井野 瑠美; 北村 裕也; 本間 和貴; 長嶋 友海; 高橋 範行; 後藤 七海; 笠松 哲光; 清水 啓明; 石埼 卓馬; 横濱 章彦; 滝沢 牧子; 小磯 博美; 三井 健揮; 塚本 憲史; 佐倉 徹; 半田 寛; 野島 美久; 村上 博和, Aug. 2016, 66, 3, 255, 255
• OGG1 S326C多型低活性型が急性骨髄性白血病の再発リスクとなる, 後藤 七海; 齋藤 貴之; 高橋 範行; 井野 瑠美; 北村 裕也; 本間 和貴; 長嶋 友海; 笠松 哲光; 半田 寛; 村上 博和, Jul. 2016, 17, 学術集会, S142, S142
• 多発性骨髄腫におけるIL-10遺伝子多型解析, 井野 瑠美; 齋藤 貴之; 北村 裕也; 後藤 七海; 高橋 範行; 本間 和貴; 長嶋 友海; 笠松 哲光; 半田 寛; 村上 博和, Jul. 2016, 17, 学術集会, S155, S155
• IL-10レセプター多型は特発性血小板減少性紫斑病(ITP)の重症度に影響する, 北村 裕也; 齋藤 貴之; 井野 瑠美; 後藤 七海; 高橋 範行; 本間 和貴; 長嶋 友海; 笠松 哲光; 半田 寛; 村上 博和, Jul. 2016, 17, 学術集会, S161, S161
• IL23R Q3H遺伝子多型は多発性骨髄腫の臨床像に影響を与える, 高橋 範行; 齋藤 貴之; 木元 麻里; 井野 瑠美; 北村 裕也; 長嶋 友海; 後藤 七海; 笠松 哲光; 半田 寛; 村上 博和, Jul. 2016, 17, 学術集会, S182, S182
• IL-10RB遺伝子多型はサリドマイド/ボルテゾミブ治療患者の予後に影響する, 笠松 哲光; 井野 瑠美; 北村 裕也; 本間 和貴; 長嶋 友海; 後藤 七海; 高橋 範之; 松本 守生; 澤村 守夫; 半田 寛; 齋藤 貴之; 村上 博和, Apr. 2016, 6, 2, 63, 63
• IL-10RB遺伝子多型はサリドマイド/ボルテゾミブ治療患者の予後に影響する, 笠松 哲光; 井野 瑠美; 北村 裕也; 本間 和貴; 長嶋 友海; 後藤 七海; 高橋 範之; 松本 守生; 澤村 守夫; 半田 寛; 齋藤 貴之; 村上 博和, Apr. 2016, 6, 2, 75, 75
• 大気micro-PIXE法を用いた骨髄異形成症候群(MDS)における赤血球内微量元素の測定(Distribution Equality Study of Healthcare Resources in Indonesia Using Gini Index), 永井 清絵; 長嶋 友海; 木村 恵; 黒田 裕子; 後藤 七海; 山田 尚人; 江夏 昌志; 佐藤 隆博; 神谷 富裕; 笠松 哲光; 湊 雄介; 半田 寛; 齋藤 貴之; 長嶺 竹明; 村上 博和, Aug. 2015, 65, 3, 276, 276
• 悪性リンパ腫におけるR-CHOP療法によるT細胞サブセットの変動(第3報), 永井 清絵; 長嶋 友海; 後藤 七海; 高橋 範行; 笠松 哲光; 湊 雄介; 小磯 博美; 半田 寛; 齋藤 貴之; 村上 博和, Jun. 2015, 16, 学術集会, S114, S114
• 慢性特発性血小板減少性紫斑病におけるTh1、Th2サイトカイン遺伝子の多型解析, 高橋 範行; 齋藤 貴之; 後藤 七海; 新田 恭浩; 長嶋 友海; 永井 清絵; 笠松 哲光; 湊 雄介; 半田 寛; 村上 博和, Jun. 2015, 16, 学術集会, S122, S122
• 急性骨髄性白血病における塩基除去修復遺伝子OGG1およびMUTYHの多型解析, 後藤 七海; 高橋 範行; 長嶋 友海; 永井 清絵; 笠松 哲光; 湊 雄介; 佐倉 徹; 半田 寛; 齋藤 貴之; 村上 博和, Jun. 2015, 16, 学術集会, S162, S162
• 遺伝子組み換えヒトエリスロポエチン製剤のヒト白血球サブセットに対する影響, 長嶋 友海; 永井 清絵; 後藤 七海; 高橋 範行; 笠松 哲光; 湊 雄介; 横濱 章彦; 半田 寛; 齋藤 貴之; 村上 博和, Jun. 2015, 16, 学術集会, S173, S173
• 急性骨髄性白血病における塩基除去修復遺伝子APE1、XRCC1遺伝子多型の解析, 後藤 七海; 斉藤 貴之; 岩崎 篤史; 新田 恭浩; ノルジマー・バトチメグ; 湊 雄介; 笠松 哲光; 佐倉 徹; 半田 寛; 村上 博和, Jun. 2014, 15, 学術集会, S181, S181
• Chronic left ventricular apical thrombosis complicating isolated left ventricular noncompaction in a patient with human immunodeficiency virus infection, Kato, Toshimitsu;Koitabashi, Norimichi;Sano, Yukie;Yanagisawa, Kunio;Ogawa, Yoshiyuki;Saitoh, Takayuki;Ishii, Hideki, 2023, JOURNAL OF MEDICAL ULTRASONICS

  DOI
• 過去6ヵ月以内に増悪したCOPD療養者がいる訪問看護ステーションの背景と増悪時に向けた対応の特徴 増悪の早期発見と終末期を見据えた対応に焦点をあてて, 梨木 恵実子; 内田 陽子; 伊東 美緒; 齋藤 貴之, Nov. 2023, 73, 4, 285, 292

MISC

• 多発性骨髄腫におけるmicroRNA-145の発現とその制御機構, 村上 有希; 小田 司; 石原 領; 浅尾 優太; 後藤 七海; 笠松 哲光; 齋藤 貴之; 村上 博和; 半田 寛, Aug. 2021, 22, 学術集会, S165, S165
• 多発性骨髄腫の髄外進展におけるTIMP1の影響, 石原 領; 小田 司; 村上 有希; 浅尾 優太; 後藤 七海; 笠松 哲光; 齋藤 貴之; 村上 博和; 半田 寛, Aug. 2021, 22, 学術集会, S165, S165
• 健常者T細胞における薬剤誘導性細胞老化の検討, 笠松 哲光; 白岩 真彩; 小田 司; 石原 領; 村上 有希; 佐藤 理水; 後藤 七海; 半田 寛; 村上 博和; 齋藤 貴之, Aug. 2021, 22, 学術集会, S187, S187
• 急性骨髄性白血病の発症リスクおよび予後不良因子としてのNFKB1遺伝子多型および発現について, 佐藤 理水; 後藤 七海; 小峯 梨花子; 大川 貴史; 石原 領; 村上 有希; 笠松 哲光; 横濱 章彦; 塚本 憲史; 半田 寛; 齋藤 貴之, Aug. 2021, 71, 3, 259, 260
• 多発性骨髄腫におけるCD47の発現, 浅尾 優太; 石原 領; 村上 有希; 山根 瑛子; 須永 征伸; 後藤 七海; 笠松 哲光; 齋藤 貴之; 半田 寛, Jun. 2020, 21, 学術集会, S230, S230
• DNA損傷修復応答に関与するDNAポリメラーゼPOLQとPOLHの多発性骨髄腫における発現, 須永 征伸; 小田 司; 山根 瑛子; 石原 領; 村上 有希; 浅尾 優太; 武井 寿史; 小林 宜彦; 大崎 洋平; 松本 守生; 後藤 七海; 笠松 哲光; 清水 啓明; 石埼 卓馬; 小磯 博美; 滝沢 牧子; 入内島 裕乃; 関上 智美; 横濱 章彦; 塚本 憲史; 増田 裕太; 栗田 真彩; 相馬 佳奈; 橋本 菜央; 齋藤 貴之; 半田 寛, Aug. 2019, 69, 3, 296, 297
• 末梢血幹細胞採取におけるSphingosine-1-phosphateの関与, 橋本 菜央; 横濱 章彦; 粟田 真彩; 浅尾 優太; 須永 征伸; 相馬 佳奈; 山根 瑛子; 石原 領; 村上 有希; 後藤 七海; 笠松 哲光; 半田 寛; 齋藤 貴之, Aug. 2019, 69, 3, 300, 301
• Th1サイトカイン遺伝子多型は慢性免疫性血小板減少症(cITP)の重症度に影響する, 相馬 佳奈; 後藤 七海; 笠松 哲光; 須永 征伸; 山根 瑛子; 村上 有希; 石原 領; 粟田 真彩; 半田 寛; 齋藤 貴之, Aug. 2019, 69, 3, 301, 301
• 次世代シーケンサーを用いた原発性マクログロブリン血症およびIgG産生型リンパ形質細胞性リンパ腫における遺伝子変異の解析, 粟田 真彩; 横濱 章彦; 橋本 菜央; 後藤 七海; 笠松 哲光; 齋藤 貴之; 半田 寛; 塚本 憲史, Aug. 2019, 69, 3, 301, 301
• 多発性骨髄腫におけるc-MAF、MAFB発現とp53, 山根 瑛子; 小田 司; 須永 征伸; 村上 有希; 石原 領; 浅尾 優太; 武井 寿史; 小林 宜彦; 大崎 洋平; 松本 守生; 後藤 七海; 笠松 哲光; 清水 啓明; 石埼 卓馬; 小磯 博美; 滝沢 牧子; 入内島 裕乃; 関上 智美; 横濱 章彦; 塚本 憲史; 増田 裕太; 粟田 真彩; 相馬 佳奈; 橋本 菜央; 齋藤 貴之; 半田 寛, Aug. 2019, 69, 3, 302, 303
• Skypeを活用して開催した国際シンポジウムの評価 モンゴル国のリハビリテーションの発展を目指して, 下田 佳央莉; Bulganchimeg Sanjmyatav; 村野 万伊加; 坂本 雅昭; 外里 冨佐江; 森 淑江; Gaalan Khulan; 菊地 千一郎; 土屋 謙仕; 野口 直人; 越智 貴子; 齋藤 貴之, Aug. 2019, The Kitakanto Medical Journal, 69, 3, 195, 203
• 治療抵抗性妊娠合併特発性血小板減少性紫斑病の2例, 大崎 洋平; 小川 孔幸; 森田 晶人; 日下田 大輔; 清水 啓明; 柳沢 邦雄; 石埼 卓馬; 齋藤 貴之; 塚本 憲史; 亀田 高志; 半田 寛, Aug. 2019, The Kitakanto Medical Journal, 69, 3, 227, 232
• The international student exchange programs of Gunma University Showa Campus, SAITOH Takayuki, May 2019, 2019；69：263～265, 69, 263, 265, Report scientific journal
• 群馬県の訪問看護ステーションにおけるCOPDアクションプランに関する調査, 梨木 恵実子; 内田 陽子; 齋藤 貴之, Feb. 2019, The Kitakanto Medical Journal, 69, 1, 7, 15
• Long Non-Coding A NEAT1 Is Upregulated By Heat Shock Factor 1 (HSF1) and Associated with Multiple Myeloma Progression, Saki Watanabe; Tsukasa Oda; Yuko Kuroda; Kazuki Homma; Yuki Murakami; Rei Ishihara; Eiko Yamane; Masanobu Sunaga; Nobuhiko Kobayashi; Yohei Osaki; Takuma Ishizaki; Hiroaki Shimizu; Hiromi Koiso; Hirono Iriuchishima; Makiko Takizawa; Akihiko Yokohama; Norifumi Tsukamoto; Gotoh Nanami; Rumi Ino; Takayuki Saitoh; Hirokazu Murakami; Hiroshi Handa, Nov. 2018, BLOOD, 132, Summary international conference

  DOI
• 白血病細胞の眼内浸潤を認めた成人T細胞白血病の1例, 島内 陽子; 馬郡 幹也; 鈴木 康太; 細貝 真弓; 戸所 大輔; 齋藤 貴之; 秋山 英雄, Sep. 2018, 臨床眼科, 72, 9, 1235, 1239
• 【進化するIPE 地域包括ケアシステムが求める多職種連携教育の今】 (Part3-1)導入事例 大学の特色を生かしたIPE 全人的医療とチーム医療に貢献できる人材の育成を目指して 群馬大学の多職種連携教育, 牧野 孝俊; 金泉 志保美; 篠崎 博光; 齋藤 貴之; 安部 由美子; 山路 雄彦; 佐藤 江奈; 川島 智幸; 岸 美紀子; 小松 康宏; 田中 和美, Jul. 2018, 看護展望, 43, 9, 0842, 0848
• 【進化するIPE 地域包括ケアシステムが求める多職種連携教育の今】(Part3-1)導入事例 大学の特色を生かしたIPE 全人的医療とチーム医療に貢献できる人材の育成を目指して 群馬大学の多職種連携教育, 牧野 孝俊; 金泉 志保美; 篠崎 博光; 齋藤 貴之; 安部 由美子; 山路 雄彦; 佐藤 江奈; 川島 智幸; 岸 美紀子; 小松 康宏; 田中 和美, Jul. 2018, 看護展望, 43, 9, 0842, 0848
• Etoposide中等量療法による末梢血幹細胞採取, 石埼 卓馬; 横濱 章彦; 清水 啓明; 柳澤 邦雄; 小川 孔幸; 三井 健揮; 小磯 博美; 滝沢 牧子; 齋藤 貴之; 村上 博和; 塚本 憲史; 半田 寛, Feb. 2018, The Kitakanto Medical Journal, 68, 1, 43, 47
• Cytogenetic Alterations Are Differently Associated with Disease Progression Depending on t(14;18) in Follicular Lymphoma, Akihiko Yokohama; Takeki Mitsui; Hiromi Koiso; Akio Saito; Kohtaro Toyama; Hiroaki Shimizu; Takuma Ishizaki; Yoko Hashimoto; Makiko Takizawa; Hiroyuki Irisawa; Kayoko Murayama; Morio Matsumoto; Takayuki Saito; Hiroshi Handa; Hirokazu Murakami; Norifumi Tsukamoto, Dec. 2017, BLOOD, 130, Summary international conference
• 【地域・在宅の拡がるIPEの新たな取り組み】群馬大学のInterprofessional education(IPE)の取り組み, 外里 冨佐江; 篠崎 博光; 金泉 志保美; 牧野 孝俊; 齋藤 貴之; 安部 由美子; 吉田 朋美; 松井 弘樹; 時田 佳治; 山路 雄彦; 佐藤 江奈; 李 範爽; 川島 智幸; 鎌田 英男; 岸 美紀子; 蒲 章則; 渡邊 秀臣, Oct. 2017, 保健医療福祉連携, 10, 2, 119, 127
• 【慢性疾患となった骨髄腫-どのように診断するか? どのように付き合っていくか?】骨髄腫治療薬の温故知新 アルキル化薬とステロイド, 村上 博和; 笠松 哲光; 齋藤 貴之; 半田 寛, Oct. 2017, 内科, 120, 4, 865, 869
• DNA修復に着眼した多発性骨髄腫の耐性機構の解明, 齋藤 貴之, Aug. 2017, BIO Clinica, 32, 9, 908, 911
• 多発性骨髄腫治療における免疫チェックポイント分子の意義, 笠松 哲光; 齋藤 貴之; 村上 博和, Aug. 2017, BIO Clinica, 32, 9, 917, 921
• 疾患と検査値の推移 多発性骨髄腫, 笠松 哲光; 齋藤 貴之; 村上 博和, Jul. 2017, 検査と技術, 45, 7, 758, 763
• SHORT-TERM ADMINISTRATION OF RECOMBINANT HUMAN ERYTHROPOIETIN DECREASES B CELL IN HUMAN PERIPHERAL BLOOD, T. Nagashima; A. Yokohama; M. Awata; Y. Kanai; K. Murata; R. Ino; Y. Kitamura; K. Honma; N. Gotoh; T. Kasamatsu; H. Handa; T. Saitoh; H. Murakami, Jun. 2017, HAEMATOLOGICA, 102, 651, 651, Summary international conference
• PROGRAMMED CELL DEATH 1 GENE POLYMORPHISMS ASSOCIATED WITH THE CLINICAL FEATURES OF MULTIPLE MYELOMA, Tetsuhiro Kasamatsu; Maaya Awata; Yukihiro Kanai; Keisuke Murata; Morio Matsumoto; Morio Sawamura; Makiko Takizawa; Akihiko Yokohama; Nanami Gotoh; Hiroshi Handa; Takayuki Saitoh; Hirokazu Murakami, May 2017, INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 39, 52, 52, Summary international conference
• 自然軽快と再燃を繰り返した後天性von Villebrand症候群(AvWS)の1例, 金谷秀平; 柳澤邦雄; 小川孔幸; 小川孔幸; 田原研一; 清水啓明; 三井健揮; 齋藤貴之; 尾崎司; 尾崎司; 惣宇利正善; 惣宇利正善; 一瀬白帝; 一瀬白帝; 半田寛, 01 Apr. 2017, 日本血栓止血学会誌, 28, 2, 201, 201
• A New Prognostic Scoring System for Multiple Myeloma in the Era of Novel Agents and Autologous Stem Cell Transplantation: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma, Shuji Ozaki; Takayuki Saitoh; Hiroshi Handa; Kenshi Suzuki; Naoki Takezako; Kazutaka Sunami; Yoshiaki Kuroda; Mitsuhiro Itagaki; Hideki Asaoku; Eiichi Nagura; Shimizu Kazuyuki; Hirokazu Murakami, Dec. 2016, BLOOD, 128, 22, Summary international conference
• One-Time Administration of Recombinant Human Erythropoietin Decreases B Cell in Human Peripheral Blood, Tomomi Nagashima; Akihiko Yokohama; Kie Nagai; Rumi Ino; Noriyuki Takahashi; Tetsuhiro Kasamatsu; Tomomi Sekigami; Hirono Iriuchishima; Makiko Takizawa; Hiroshi Handa; Takayuki Saitoh; Hirokazu Murakami, Dec. 2016, BLOOD, 128, 22, Summary international conference
• Base Excision Repair Gene OGG1 Affects the Relapse Risk of Acute Myeloid Leukemia, Nanami Gotoh; Takayuki Saitoh; Noriyuki Takahashi; Rumi Ino; Yuya Kitamura; Kazuki Honma; Tomomi Nagashima; Tetsuhiro Kasamatsu; Takumi Hoshino; Toru Sakura; Makiko Takizawa; Akihiko Yokohama; Hiroaki Shimizu; Hiroshi Handa; Norifumi Tsukamoto; Hirokazu Murakami, Dec. 2016, BLOOD, 128, 22, Summary international conference
• Risk Factors and Clinical Impact of Chronic Kidney Disease (CKD) after Allogeneic Stem Cell Transplant (allo-SCT), Hiroaki Shimizu; Takuma Ishizaki; Nahoko Hatsumi; Satoru Takada; Akihiko Yokohama; Takayuki Saitoh; Yoshihisa Nojima; Hiroshi Handa, Dec. 2016, BLOOD, 128, 22, Summary international conference
• Th2 Cytokine Polymorphisms, IL-4-590 CC Genotype and IL-10RB K47E, Increase the Requirement of Second-Line Treatment for Chronic ITP, Yuya Kitamura; Takayuki Saitoh; Rumi Ino; Kazuki Honma; Tomomi Nagashima; Noriyuki Takahashi; Nanami Gotoh; Tetsuhiro Kasamatsu; Takuma Ishizaki; Makiko Takizawa; Akihiko Yokohama; Hiroaki Shimizu; Hiroshi Handa; Norifumi Tsukamoto; Hirokazu Murakami, Dec. 2016, BLOOD, 128, 22, Summary international conference
• 【多発性骨髄腫学-最新の診療と基礎研究-】多発性骨髄腫診断基準と病期分類の変遷と展望, 齋藤 貴之; 笠松 哲光; 村上 博和, Jul. 2016, 日本臨床, 74, 増刊5 多発性骨髄腫学, 15, 20
• CLINICAL SIGNIFICANCE OF IMMUNOPHENOTYPIC CHANGES AT THE FIRST RELAPSE IN ADULT ACUTE MYELOID LEUKEMIA PATIENTS, H. Shimizu; T. Ishizaki; T. Mitsui; N. Hatsumi; S. Takada; T. Saitoh; A. Yokohama; T. Sakura; H. Handa, Jun. 2016, HAEMATOLOGICA, 101, 676, 676, Summary international conference
• Hematologic Malignancies/Pediatric Malignancies 血液・リンパ系腫瘍 再発・難治性造血器腫瘍の治療 新規・追加承認薬とその位置付け 多発性骨髄腫, 村上 博和; 齋藤 貴之; 笠松 哲光, May 2016, 癌と化学療法, 43, 5, 539, 544
• 2大学間における学生のチーム医療に対する態度について横断的比較解析と教育効果の検討, 牧野 孝俊; 李 範爽; 松井 弘樹; 時田 佳治; 金泉 志保美; 川島 智幸; 山路 雄彦; 安部 由美子; 齋藤 貴之; 吉田 朋美; 外里 冨佐江; 篠崎 博光; 渡邊 秀臣; 大竹 茂樹; 田淵 紀子; 稲垣 美智子, Mar. 2016, 保健医療福祉連携, 9, 1, 86, 86
• Immunostimulation During and After R-CHOP Therapy for B-Cell Lymphoma, Kie Nagai; Tetsuhiro Kasamatsu; Shiharu Ohmiya; Tomomi Nagashima; Hiromi Koiso; Akihiko Yokohama; Hiroshi Handa; Norifumi Tsukamoto; Nanami Gotoh; Lobna Alkebsi; Takayuki Saitoh; Kunihiko Hayashi; Hirokazu Murakami, 2016, Journal of Clinical & Experimental Immunology, 1, 1, 1-7.
• 【多発性骨髄腫の最新情報I】骨髄腫の診断と鑑別診断 診断基準の変遷を踏まえて, 齋藤 貴之; 村上 博和, Dec. 2015, Pharma Medica, 33, 12, 47, 51
• 寛解16年後に再発した精巣原発びまん性大細胞型B細胞リンパ腫, 長坂 伊左男; 三井 健揮; 石埼 卓馬; 小磯 博美; 横濱 章彦; 齋藤 貴之; 平戸 純子; 五十嵐 忠彦; 小島 勝; 塚本 憲史; 野島 美久; 村上 博和; 半田 寛, Dec. 2015, 臨床血液, 56, 12, 2447, 2451
• Differences in Expression Patterns of DNMTs and TSG Proteins in Lymphoid Tissue Section Play an Important Role in Their Association, Lobna Alkebsi; Hiroshi Handa; Kenichi Tahara; Hiroaki Shimizu; Takuma Ishizaki; Kunio Yanagisawa; Saitoh Takayuki; Tetsuhiro Kasamatsu; Makiko Takizawa; Hirokazu Murakami, Dec. 2015, BLOOD, 126, 23, Summary international conference
• Th1 Polarization of Cytokine and Cytokine Receptor Polymorphisms Affect the Susceptibility and Severity of ITP, Noriyuki Takahashi; Takayuki Saitoh; Nanami Gotoh; Kei Kimura; Yuko Kuroda; Kie Nagai; Tomomi Nagashima; Tetsuhiro Kasamatsu; Yusuke Minato; Hiroaki Shimizu; Takuma Ishizaki; Akihiko Yokohama; Makiko Takizawa; Hiromi Koiso; Takeki Mitsui; Norifumi Tsukamoto; Hiroshi Handa; Hirokazu Murakami, Dec. 2015, BLOOD, 126, 23, Summary international conference
• Prognostic Impact of Cytogenetic Abnormalities in Adult Patients with Philadelphia-Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL) Who Underwent Allogeneic Stem Cell Transplant (allo-SCT), Hiroaki Shimizu; Takayuki Saitoh; Shinichiro Okamoto; Yoshinobu Kanda; Heiwa Kanamori; Satoshi Takahashi; Kazuteru Ohashi; Kensuke Usuki; Chiaki Nakaseko; Makoto Onizuka; Toru Sakura; Moritaka Goto; Shingo Yano; Shin Fujisawa; Reiko Watanabe; Nobuyuki Aotsuka; Jun Taguchi; Naoto Tomita; Hisashi Wakita; Yasuhito Nannya, Dec. 2015, BLOOD, 126, 23, Summary international conference
• A Revised International Staging System of Multiple Myeloma in the Era of Novel Agents and Autologous Stem Cell Transplantation in Japan: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma, Shuji Ozaki; Takayuki Saitoh; Hiroshi Handa; Hirokazu Murakami; Kenshi Suzuki; Naoki Takezako; Jun Konishi; Kazutaka Sunami; Yoshiaki Kuroda; Mitsuhiro Itagaki; Hideki Asaoku; Eiichi Nagura; Kazuyuki Shimizu, Dec. 2015, BLOOD, 126, 23, Summary international conference
• Loop Regulation Between microRNAs and Epigenetics Underlie microRNA Dysregulation in Multiple Myeloma and Is Associated with the Disease Progression, Kei Kimura; Yuko Kuroda; Yuta Masuda; Arito Yamane; Hikaru Hattori; Kenichi Tahara; Ayaka Kaneko; Itsumi Suda; Noriyuki Takahashi; Nanami Gotoh; Kie Nagai; Tomomi Nagashima; Takayuki Saitoh; Hirono Iriuchishima; Makiko Takizawa; Hiromi Koiso; Takuma Ishizaki; Takeki Mitsui; Hiroaki Shimizu; Akihiko Yokohama; Norifumi Tsukamoto; Tetsuhiro Kasamatsu; Yusuke Minato; Yoshihisa Nojima; Hirokazu Murakami; Hiroshi Handa, Dec. 2015, BLOOD, 126, 23, Summary international conference
• 多職種連携教育における群馬大学の国際展開, 渡邊秀臣; 渡邊秀臣; 篠崎博光; 篠崎博光; 金泉志保美; 金泉志保美; 牧野孝俊; 牧野孝俊; 安部由美子; 安部由美子; 齋藤貴之; 齋藤貴之; 吉田朋美; 吉田朋美; 時田佳治; 時田佳治; 松井弘樹; 松井弘樹; 山路雄彦; 山路雄彦; 外里冨佐江; 外里冨佐江; LEE Bumsuk; LEE Bumsuk; 川島智幸; 川島智幸; 安川隆子; 安川隆子; 岸美紀子; 岸美紀子, 21 Nov. 2015, 日本国際保健医療学会学術大会プログラム・抄録集, 30th, 52 (JA),214 (EN)
• The polymorphisms of XRCC1 Arg194Trp and the XRCC1Arg399Gln affect the clinical features and the prognosis of MDS, Batchimeg Norjmaa; Takayuki Saitoh; Tetsuhiro Kasamatsu; Yusuke Minato; Noriaki Sunaga; Hirokazu Murakami, Aug. 2015, CANCER RESEARCH, 75, Summary international conference

  DOI
• HUMAN ATRIAL NATRIURETIC PEPTIDE (HANP) THERAPY IN THE EARLY PHASE AFTER ALLOGENEIC STEM CELL TRANSPLANT (ALLO-SCT) PREVENTS DEVELOPMENT OF CHRONIC KIDNEY DISEASE (CKD): RESULTS FROM A PHASE 2 STUDY, H. Shimizu; T. Ishizaki; N. Hatsumi; S. Takada; A. Yokohama; T. Saitoh; T. Sakura; H. Handa, Jun. 2015, HAEMATOLOGICA, 100, 159, 159, Summary international conference
• 高齢者再発・難治性多発性骨髄腫に対するweekly bortezomib+DEX療法(JMSG‐0902), 尾崎修治; 畑裕之; 安倍正博; 斉藤貴之; 花村一朗; 矢野寛樹; 角南一貴; 小杉浩史; 澤村守夫; 仲里朝周; 増成太郎; 森眞由美; 高木敏之; 清水一之, May 2015, Int J Myeloma (Web), 5, 2, O-19 (WEB ONLY), 60
• 病気のはなし 多発性骨髄腫, 笠松 哲光; 齋藤 貴之; 村上 博和, May 2015, 検査と技術, 43, 5, 372, 378
• 群馬大学多職種連携教育研修コース(IPE training course 2013)修了者の多職種連携教育に対する態度変化, 時田 佳治; 金泉 志保美; 牧野 孝俊; 松井 弘樹; 久留利 菜菜; 李 範爽; 内田 陽子; 安部 由美子; 齋藤 貴之; 浅川 康吉; 外里 冨佐江; 篠崎 博光; 渡邊 秀臣, Mar. 2015, 保健医療福祉連携, 8, 1, 67, 68
• 群馬大学のチーム医療教育による学部学生の多職種医療チームに対する態度(姿勢)の変化についての縦断的反復横断調査, 久留利菜菜; 牧野孝俊; 時田佳治; 松井弘樹; 李範爽; 金泉志保美; 内田陽子; 安部由美子; 齋藤貴之; 篠崎博光; 外里冨佐江; 渡邊秀臣, Mar. 2015, 保健医療福祉連携, 8, 1, 70, 70
• 学部学生と卒業生に対する多職種医療チームの態度, 牧野孝俊; 牧野孝俊; 李範爽; 李範爽; 松井弘樹; 松井弘樹; 時田佳治; 時田佳治; 久留利菜菜; 久留利菜菜; 金泉志保美; 金泉志保美; 浅川康吉; 浅川康吉; 齋藤貴之; 齋藤貴之; 安部由美子; 安部由美子; 篠崎博光; 篠崎博光; 外里冨佐江; 外里冨佐江; 渡邊秀臣; 渡邊秀臣, Mar. 2015, 保健医療福祉連携, 8, 1, 41, 41
• 大気micro‐PIXE法を用いた骨髄異形成症候群(MDS)における赤血球内微量元素の測定, 永井清絵; 長嶋友海; 木村恵; 黒田裕子; 後藤七海; 山田尚人; 江夏昌志; 佐藤隆博; 神谷富裕; 笠松哲光; 湊雄介; 半田寛; 齋藤貴之; 長嶺竹明; 村上博和, 2015, 北関東医学会総会プログラム・抄録, 62nd, 3, 26, 276
• Primary Plasma Cell Leukemia in the Era of Novel Agent: Report of Multicenter Study from Japanese Society of Myeloma, Hirono Iriuchishima; Hirokazu Murakami; Shuji Ozaki; Hiroshi Handa; Takayuki Saitoh; Eiichi Nagura; Kazuyuki Shimizu, Dec. 2014, BLOOD, 124, 21, Summary international conference
• Survival of Multiple Myeloma Patients in the Era of Novel Agents and Autologous Stem Cell Transplantation: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma, Shuji Ozaki; Hiroshi Handa; Takayuki Saitoh; Hirokazu Murakami; Mitsuhiro Itagaki; Hideki Asaoku; Kenshi Suzuki; Atsushi Isoda; Morio Sawamura; Jun Konishi; Kazutaka Sunami; Naoki Takezako; Shotaro Hagiwara; Yoshiaki Kuroda; Takaaki Chou; Eiko Shibata; Kazuyuki Shimizu; Eiichi Nagura, Dec. 2014, BLOOD, 124, 21, Summary international conference
• Clinical Significance of Additional Cytogenetic Abnormalities (ACA) Acquired at the First Relapse in Adult Acute Myeloid Leukemia (AML) Patients, Hiroaki Shimizu; Akihiko Yokohama; Nahoko Hatsumi; Satoru Takada; Takayuki Saitoh; Hiroshi Handa; Toru Sakura; Yoshihisa Nojima, Dec. 2014, BLOOD, 124, 21, Summary international conference
• BCL6 Dose Not Negatively Regulate DNA Damage Response Genes in Multiple Myeloma Cells, Kenichi Tahara; Makiko Takizawa; Hiroshi Handa; Yuta Masuda; Ayaka Kaneko; Itsumi Suda; Kei Kimura; Yuko Kuroda; Isoda Atsushi; Morio Matsumoto; Hiromi Koiso; Ishizaki Takuma; Takeki Mitsui; Akihiko Yokohama; Takayuki Saitoh; Norifumi Tsukamoto; Hirokazu Murakami, Dec. 2014, BLOOD, 124, 21, Summary international conference
• Soluble IL-2 Receptor a Is a More Sensitive Diagnostic Biomarker Than beta 2 Microglobulin and Predicts Survival in Follicular Lymphoma: Retrospective Analysis of 305 Cases, Akihiko Yokohama; Yoko Hashimoto; Shimizu Hiroaki; Akio Saito; Yuri Miyazawa; Hirono Iriujijima; Kotaro Toyama; Takuma Ishizaki; Takeki Mitsui; Hiromi Koiso; Makiko Takizawa; Takayuki Saito; Hiroshi Handa; Kayoko Murayama; Morio Matsumoto; Morio Sawamura; Hirokazu Murakami; Yoshihisa Nojima; Junko Hirato; Masaru Kojima; Norifumi Tsukamoto, Dec. 2014, BLOOD, 124, 21, Summary international conference
• 骨髄異形成症候群におけるIL-10-592遺伝子多型解析, 中重 友理香; 廣田 悠里; 笠松 哲光; 後藤 七海; 黒田 裕子; 木村 恵; 永井 清絵; 新田 恭浩; 金子 文香; 須田 いつみ; 増田 裕太; 高橋 範行; 井上 まどか; バトチメグ ノルジマー; 湊 雄介; 半田 寛; 齋藤 貴之; 村上 博和, 01 Aug. 2014, 64, 3, 299, 299
• 悪性リンパ腫におけるR-CHOP療法によるT細胞サブセットの変動-第2報-, 永井 清絵; 長嶋 友海; 木村 恵; 黒田 裕子; 後藤 七海; 笠松 哲光; 湊 雄介; 小磯 博美; 半田 寛; 齋藤 貴之; 村上 博和, 01 Aug. 2014, 64, 3, 299, 299
• 特発性血小板減少性紫斑病におけるPARP1Val762Ala遺伝子多型解析, 新田 恭浩; 齋藤 貴之; 後藤 七海; バトチメグ ノルジマー; 高橋 範行; 増田 裕太; 須田 いつみ; 金子 文香; 木村 恵; 黒田 裕子; 永井 清絵; 笠松 哲光; 湊 雄介; 半田 寛; 村上 博和, 01 Aug. 2014, 64, 3, 300, 300
• ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) WHO REQUIRE TWO COURSES OF INDUCTION THERAPY TO ACHIEVE COMPLETE REMISSION (CR) SHOULD UNDERGO ALLOGENEIC TRANSPLANT (ALLO-SCT) DURING THE FIRST CR, H. Shimizu; H. Handa; N. Hatsumi; S. Takada; A. Yokohama; T. Saitoh; T. Sakura; Y. Nojima, Jun. 2014, HAEMATOLOGICA, 99, 299, 300, Summary international conference
• 高齢者再発・難治性多発性骨髄腫に対するweekly bortezomib+dexamethasone療法(JMSG‐0902), 尾崎修治; 畑裕之; 安倍正博; 斉藤貴之; 花村一朗; 矢野寛樹; 角南一貴; 澤村守夫; 仲里朝周; 小杉浩史; 森眞由美; 高木敏之; 清水一之, May 2014, Int J Myeloma (Web), 4, 2, CS-3 (WEB ONLY), 52
• Introduction to IPE Training Course at Gunma University, TOKITA Yoshiharu; TOZATO Fusae; SHINOZAKI Hiromitsu; WATANABE Hideomi; KANAIZUMI Shiomi; SAITOH Takayuki; MAKINO Takatoshi; MATSUI Hiroki; KURURI Nana; LEE Bumsuk; ABE Yumiko; ASAKAWA Yasuyoshi, 2014, The Journal of Interprofessional Collaboration in Health and Social Care, 7, 2, 126, 130

  DOI
• Lenalidomide治療中に上腸間膜静脈-門脈血栓塞栓症を発症し広範な壊死小腸切除を要した1例, 杠明憲; 石川哲也; 林俊誠; 三原正大; 小林宣彦; 清水啓明; 入内島裕乃; 石埼卓馬; 小川孔幸; 小磯博美; 三井健揮; 滝沢牧子; 横濱章彦; 斉藤貴之; 半田寛; 塚本憲史; 村上博和; 野島美久, 2014, 55, 7
• 進行性多巣性白質脳症を発症した再発びまん性大細胞型B細胞性リンパ腫, 杠明憲; 横濱章彦; 小磯博美; 内山由里; 石川哲也; 小林宣彦; 三原正大; 清水啓明; 入内島裕乃; 石崎卓馬; 三井健揮; 滝沢牧子; 斉藤貴之; 半田寛; 村上博和; 野島美久; 塚本憲史, 2014, 54
• 治療抵抗性のランゲルハンス細胞肉腫に対して同種造血幹細胞移植を実施し完全寛解を得た1例, 杠明憲; 石川哲也; 林俊誠; 三原正大; 小林宣彦; 清水啓明; 入内島裕乃; 石埼卓馬; 石埼卓馬; 小磯博美; 三井健揮; 滝沢牧子; 横濱章彦; 斉藤貴之; 半田寛; 半田寛; 塚本憲史; 村上博和; 野島美久, 2014, 36th
• The Polymorphisms Of Base Excision Repair Genes Influence The Cytogenetic Risk Factors In Acute Myeloid Leukemia, Atsushi Iwasaki; Takayuki Saitoh; Yasuhiro Nitta; Batchimeg Norjimaa; Chiharu Omiya; Akira Kamiya; Nahoko Hatsumi; Hiroaki Shimizu; Takuma Ishizaki; Takumi Hoshino; Satoru Takada; Hiroshi Handa; Toru Sakura; Akihiko Yokohama; Norifumi Tsukamoto; Hirokazu Murakami, Nov. 2013, BLOOD, 122, 21, Summary international conference
• The Outcomes Of Allogeneic Stem Cell Transplantation In Patients With Mixed Phenotype Acute Leukemia (MPAL) Are Comparable To Those In Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL): Results Of a Matched-Pair Analysis, Hiroaki Shimizu; Takayuki Saitoh; Shinichiro Machida; Shinichi Kako; Noriko Doki; Takehiko Mori; Toru Sakura; Yoshinobu Kanda; Heiwa Kanamori; Shuichi Miyawaki; Shinichiro Okamoto, Nov. 2013, BLOOD, 122, 21, Summary international conference
• Interrelationship Of c-Myc, Micro RNA 29 and 34 Families, DNA methyltransferases and Methylation In Acute Myeloid Leukemia, Hiroshi Handa; Ayaka Kaneko; Itsumi Suda; Yuta Masuda; Nami Goto; Hikaru Hattori; Kenichi Tahara; Hiroaki Shimizu; Takuma Ishizaki; Takeki Mitsui; Akihiko Yokohama; Hiromi Koiso; Makiko Takizawa; Hirono Iriuchishima; Lobna A. Alkebsi; Naoko Hatsumi; Satoru Takada; Toru Sakura; Norifumi Tsukamoto; Takayuki Saitoh; Yoshihisa Nojima; Hirokazu Murakami, Nov. 2013, BLOOD, 122, 21, Summary international conference
• 【医療・福祉系大学における多職種連携・チーム医療教育の現在と未来】【群馬大学】群馬大学の紹介, 外里 冨佐江; 時田 佳治; 安部 由美子; 金泉 志保美; 内田 陽子; 浅川 康吉; 牧野 孝俊; 松井 弘樹; 久留利 菜菜; 李 範爽; 齋藤 貴之; 篠崎 博光; 渡邊 秀臣; 群馬大学大学院保健学研究科インタープロフェッショナル教育推進委員会, Sep. 2013, 保健医療福祉連携, 6, 1-2, 38, 40
• 【血液症候群(第2版)-その他の血液疾患を含めて-】血漿タンパクの異常 クリオグロブリン血症, 村上 博和; 齋藤 貴之; 半田 寛, May 2013, 日本臨床, 別冊, 血液症候群第2版III, 657, 665
• Hematologic Malignancies/Pediatric Malignancies 血液・リンパ腫瘍 多発性骨髄腫に対するプロテアソーム阻害薬治療, 村上 博和; 齋藤 貴之; 半田 寛, May 2013, 癌と化学療法, 40, 5, 583, 588
• Does the Hematopoietic Cell Transplantation Specific Comorbidity Index (HCT-CI) Predict Transplant Outcomes?: A Prospective Multicenter Validation Study of the Kanto Study Group for Cell Therapy (KSGCT), Aya Nakaya; Takehiko Mori; Masatsugu Tanaka; Naoto Tomita; Chiaki Nakaseko; Shingo Yano; Shin Fujisawa; Hisashi Sakamaki; Nobuyuki Aotsuka; Akira Yokota; Yoshinobu Kanda; Toru Sakura; Yasuhito Nannya; Takayuki Saitoh; Heiwa Kanamori; Satoshi Takahashi; Shinichiro Okamoto, Nov. 2012, BLOOD, 120, 21, Summary international conference
• Novel Agents and Autologous Stem Cell Transplantation Improve Survival of Multiple Myeloma Patients with Ages 65-70 Years: A Multicenter Retrospective Collaborative Study Between Japanese Society of Myeloma and European Myeloma Network, Shuji Ozaki; Takeshi Harada; Takayuki Saitoh; Chihiro Shimazaki; Mitsuhiro Itagaki; Hideki Asaoku; Yoshiaki Kuroda; Takaaki Chou; Yumiko Yoshiki; Kenshi Suzuki; Hirokazu Murakami; Kunihiko Hayashi; Antonio Palumbo; Kazuyuki Shimizu, Nov. 2012, BLOOD, 120, 21, Summary international conference
• Polymorphisms of IL-10, IL-17A, IL-17F and IL-18 Affect the Clinical Features of Multiple Myeloma in Japanese Patients, Atsushi Iwasaki; Takayuki Saitoh; Chiaki Ushie; Norihiko Moriyama; Tomonori Takani; Hikaru Hattori; Hiroshi Handa; Morio Matsumoto; Jun Isoda; Morio Sawamura; Hatsue Ogawara; Hirokazu Murakami, Nov. 2012, BLOOD, 120, 21, Summary international conference
• The Cytokine Polymorphisms Affect the Severity of Thrombocytopenia at Diagnosis in Chronic Immune Thrombocytopenia, Takayuki Saitoh; Chiaki Ushie; Atsushi Iwasaki; Norihiko Moriyama; Tomonori Takani; Hattori Hikaru; Hiroshi Handa; Hiromi Koiso; Akihiko Yokohama; Norifumi Tsukamoto; Hatsue Ogawara; Hirokazu Murakami, Nov. 2012, BLOOD, 120, 21, Summary international conference
• 15．多発性骨髄腫患者における塩基除去修復遺伝子多型解析, 岩崎 篤史; 牛江 千明; 服部 光; 齋藤 貴之; 半田 寛; 村上 博和, 01 Aug. 2012, 62, 3, 372, 372
• 18．悪性貧血のメチコバール治療前後におけるＴリンパ球サブセットの変化, 渡部 悟; 神谷 明; 大宮 千春; 齋藤 貴之; 半田 寛; 村上 博和, 01 Aug. 2012, 62, 3, 373, 373
• がん化学療法におけるチーム医療 がん化学療法における安全管理と支持療法, 齋藤 貴之; 村上 博和; 浅尾 高行; 永井 弥生; 小磯 博美; 解良 恭一; 塚本 憲史, Aug. 2012, The Kitakanto Medical Journal, 62, 3, 364, 364
• 【造血器腫瘍 白血病・リンパ腫・骨髄腫の実地診療に不可欠の最新情報とその活用】セミナー/最新の臨床的知識を活かした造血器腫瘍の実地診療の実際 骨髄腫の最近の診療のキーポイント 骨髄腫を疑う所見から専門医までの検査の進めかた, 村上 博和; 半田 寛; 齋藤 貴之, Aug. 2012, Medical Practice, 29, 8, 1323, 1326
• Higher frequency of relapses with granulocytic sarcoma after allogeneic haematopietic stem cell transplantation than with chemotherapy in adult acute myeloid leukaemia patients, H. Koya; A. Yuzuriha; N. Hatsumi; S. Takada; T. Saitoh; H. Handa; T. Sakura, Apr. 2012, BONE MARROW TRANSPLANTATION, 47, S116, S116, Summary international conference
• A meta-analysis and systemic review of thalidomide treatment in non-transplant candidates with multiple myeloma, 村上 博和; 斉藤 貴之; 半田 寛, Apr. 2012, 64, 4, 481, 486
• Acyclovir encephalopathy developed after autologous peripheral blood stem cell transplantation in a patient with multiple myeloma, Mihara Masahiro; Handa Hiroshi; Tsukamoto Norifumi; Murakamii Hirokazu; Nojima Yoshihisa; Hoshino Takumi; Uchiyama Yuri; Saitoh Akio; Mitsui Takeki; Koiso Hiromi; Yokohama Akihiko; Saitoh Takayuki; Uchiumi Hideki, 2012, Journal of Hematopoietic Cell Transplantation, 1, 3, 93, 97

  DOI
• Polycythemia Vera Terminating in Refractory Ascites, Kohtaro Toyama; Takeki Mitsui; Akihiko Yokohama; Takayuki Saitoh; Hideki Uchiumi; Hiroshi Handa; Masataka Sakuraya; Hirokazu Murakami; Yoshihisa Nojima; Norifumi Tsukamoto, 2012, Kitakanto Medical Journal, 62, 2, 159, 162

  DOI
• 群馬県における非ホジキンリンパ腫患者の実態調査, 橋本 陽子; 横濱 章彦; 斉藤 明生; 中橋 寛隆; 外山 耕太郎; 三井 健揮; 小磯 博美; 斉藤 貴之; 半田 寛; 内海 英貴; 神保 貴宏; 村山 佳予子; 玉木 義雄; 松本 守生; 澤村 守夫; 唐沢 正光; 村上 博和; 平戸 純子; 野島 美久; 小島 勝; 塚本 憲史, 2012, 53, 3, 329, 336

  DOI
• Allogeneic Hematopoietic Stem Cell Transplantation for Adult AML Patients with Granulocytic Sarcoma, Hiroaki Shimizu; Takayuki Saitoh; Masatsugu Tanaka; Takehiko Mori; Nobutaka Kawai; Toru Sakura; Yoshinobu Kanda; Chiaki Nakaseko; Shingo Yano; Hiroyuki Fujita; Shin Fujisawa; Shuichi Miyawaki; Heiwa Kanamori; Shinichiro Okamoto, Nov. 2011, BLOOD, 118, 21, 890, 891, Summary international conference
• 多発性骨髄腫におけるInterleukin-18 promoter多型解析, 高荷 智紀; 森山 紀彦; 斉藤 貴之; 村上 博和, 01 Aug. 2011, 61, 3, 466, 466
• 特発性血小板減少性紫斑病の重症度とサイトカイン多型, 森山 紀彦; 牛江 千明; 高荷 智紀; 斉藤 貴之; 村上 博和, 01 Aug. 2011, 61, 3, 466, 466
• Treatment in elderly patients with multiple myeloma, 斉藤貴之; 塚本憲史; 村上博和, 2011, 62, 3, 314, 323
• How to use the novel agents, including bortezomib, thalidomide, and lenalidomide, in patients with refractory/relapsed myeloma?, 村上博和; 斉藤貴之; 半田寛, 2011, 63, 1, 66, 74
• Sunitinib induced immune thrombocytopenia, Kumiko Matsumoto; Akihiko Yokohama; Akinori Yuzuriha; Kohtarou Toyama; Takeki Mitsui; Yoko Hashimoto; Hiromi Koiso; Takayuki Saitoh; Hideki Uchiumi; Hiroshi Handa; Masamitsu Karasawa; Hirokazu Murakami; Hiroshi Matsui; Kazuhiro Suzuki; Norifumi Tsukamoto; Yoshihisa Nojima, 2011, Kitakanto Medical Journal, 61, 2, 175, 177

  DOI
• Association of Interleukin-18 Gene Polymorphism with Severity of Chronic Immune Thrombocytopenia (ITP), Takayuki Saitoh; Norihiko Moriyama; Tomonori Takani; Takeki Mitsui; Takumi Hoshino; Hiromi Koiso; Akihiko Yokohama; Hiroshi Handa; Masamitsu Karasawa; Hatsue Ogawara; Norifumi Tsukamoto; Hirokazu Murakami, Nov. 2010, BLOOD, 116, 21, 1515, 1515, Summary international conference
• Significantly Reduced Circulating Plasmacytoid Dendritic Cells In Patients with Primary and Helicobacter Pylori-Associated Immune Thrombocytopenia., Akio Saito; Akihiko Yokohama; Yohei Osaki; Yoshiyuki Ogawa; Takeki Mitsui; Hideki Uchiumi; Takayuki Saitoh; Hiroshi Handa; Morio Sawamura; Masamitsu Karasawa; Hirokazu Murakami; Yoshihisa Nojima; Norifumi Tsukamoto, Nov. 2010, BLOOD, 116, 21, 1048, 1049, Summary international conference
• THE INFLUENCE OF POLYMORPHISMS OF INTERLEUKIN-17F GENES ON THE SUSCEPTIBILITY AND CLINICAL OUTCOME OF MULTIPLE MYELOMA, Takayuki Saitoh; Norifumi Tsukamoto; Hiromi Koiso; Hirokazu Murakami, Nov. 2010, ANNALS OF ONCOLOGY, 21, 17, 17, Summary international conference
• HUMAN TELOMERASE REVERSE TRANSCRIPTASE EXPRESSION (HTERT) DETECTED BY FLOW CYTOMETORY IN CD34 POSITIVE PROGENITOR FRACTION IN MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA, H. Handa; H. Murakami; T. Matsushima; N. Nishimoto; M. Inoue; T. Saitoh; A. Yokohama; H. Koiso; T. Mitsui; N. Tsukamoto; H. Ogawara; M. Karasawa; Y. Nojirna, Jun. 2010, HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 95, 375, 375, Summary international conference
• AUTOLOGOUS STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH RELAPSED OR PRIMARY REFRACTORY PERIPHERAL T-CELL LYMPHOMA, H. Shimizu; Y. Hshimoto; A. Yokohama; T. Saitoh; H. Handa; H. Irisawa; T. Jinbo; K. Murayama; M. Matsumoto; M. Sawamura; N. Tsukamoto; H. Murakami, Jun. 2010, HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 95, 638, 638, Summary international conference
• Molecular allelokaryotyping to identify mechanism of development of Asian chronic lymphocytic leukemia, Norihiko Kawamata; Seishi Ogawa; Motohiro Kato; Sophie Raynauld; Takayuki Saitoh; Hirotaka Nakahashi; Masamitsu Karasawa; H. Phillip Koeffler, Apr. 2010, CANCER RESEARCH, 70, Summary international conference

  DOI
• 多発性骨髄腫の最近の治療．, 村上博和; 半田寛; 斉藤貴之, 2010, 59, 8, 1835, 1837
• Clinical Significance of Granulocytic Sarcoma in Patients with Acute Myeloid Leukemia, Hiroaki Shimizu; Takayuki Saitoh; Takumi Hoshino; Naoko Hatsumi; Satoru Takada; Hiroyuki Irisawa; Akihiko Yokohama; Takahiro Jimbo; Hiroshi Handa; Takafumi Matsushima; Toru Sakura; Norifumi Tsukamoto; Masamitsu Karasawa; Shuichi Miyawaki, Nov. 2009, BLOOD, 114, 22, 1207, 1207, Summary international conference
• The Influence of Polymorphisms of Interleukin-17F Genes On the Susceptibility and Clinical Outcome of Multiple Myeloma., Takayuki Saitoh; Tetsuhiro Kasamatsu; Akihiko Yokohama; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Hatsue Ogawara; Yoshihisa Nojima; Hirokazu Murakami, Nov. 2009, BLOOD, 114, 22, 709, 710, Summary international conference
• Prognostic Importance of Soluble Form IL-2 Receptor a (sIL-2Ra) and Its Relationship with Surface Expression of IL-2Ra of Lymphoma Cell in Diffuse Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy: a Retrospective Analysis of 409 Cases, Akihiko Yokohama; Yoko Hashimoto; Akio Saito; Hirotaka Nakahashi; Kohtaro Toyama; Hiromi Koiso; Takayuki Saito; Hiroshi Handa; Hideki Uchiurni; Takahiro Jimbo; Kayoko Murayama; Morio Sawamura; Morio Matsumoto; Masamitsu Karasawa; Hirokazu Murakami; Yoshihisa Nojima; Junko Hirato; Masaru Kojima; Norifumi Tsukamoto, Nov. 2009, BLOOD, 114, 22, 767, 768, Summary international conference
• 特発性血小板減少性紫斑病におけるIL-17遺伝子の多型解析, 笠松 哲光; 斉藤 貴之; 小池 美奈; 兵藤 悠美子; 荻原 真二; 半田 寛; 塚本 憲史; 小河原 はつ江; 野島 美久; 村上 博和, Jul. 2009, 臨床病理, 57, 補冊, 278, 278
• 【がん診療update】各種のがん 造血器 多発性骨髄腫, 村上 博和; 半田 寛; 齋藤 貴之, Jun. 2009, 日本医師会雑誌, 138, 特別1, S300, S302
• 1. 再発難治性多発性骨髄腫に対するbortezomibの使用経験(第13回群馬血液疾患研究会), 中橋 寛隆; 塚本 憲史; 小磯 博美; 横濱 章彦; 斉藤 貴之; 内海 英貴; 野島 美久; 磯田 淳; 松本 守生; 澤村 守夫; 村山 佳予子; 唐沢 正光; 半田 寛; 村上 博和, 01 May 2009, 59, 2, 209, 209
• 1. 髄外腫瘤が急性骨髄性白血病の予後に与える影響の検討(第14回群馬血液疾患研究会), 清水 啓明; 斉藤 貴之; 大崎 洋平; 入沢 寛之; 横濱 章彦; 内海 英貴; 松島 孝文; 塚本 憲史; 野島 美久; 唐沢 正光; 半田 寛; 村上 博和; 星野 匠臣; 初見 菜穂子; 高田 覚; 佐倉 徹; 宮脇 修一, 01 May 2009, 59, 2, 211, 211
• 多発性骨髄腫の治療：総論, 村上博和; 半田寛; 斉藤貴之; 小河原はつ江, 2009, 64, 12, 53, 61
• Bortezomib治療中にM蛋白が消失したにもかかわらず髄外形質細胞腫が出現した多発性骨髄腫., 小磯博美; 田原研一; 大崎洋平; 馬渡桃子; 関上智美; 横濱章彦; 斉藤貴之; 内海英貴; 半田寛; 塚本憲史; 唐沢正光; 野島美久; 村上博和, 2009, 50, 78, 82

  DOI
• 多発性骨髄腫－最近の進歩―多発性骨髄腫の治療：総論．, 村上博和; 半田寛; 斉藤貴之; 小河原はつ江, 2009, 64, 12, 2525, 2533
• 特集･新時代の骨髄腫治療 ７．サリドマイド治療の実際～TERMS 遵守と副作用マネージメント～。, 村上博和; 半田寛; 斎藤貴之, 2009, 19, 8, 1245, 1253
• 特集 多発性骨髄腫. 多様な病期分類., 村上博和; 半田寛; 斉藤貴之; 小河原はつ江, 2009, 28, 3, 232, 236
• The Influence of Polymorphisms of Interleukin-17F Genes on the Susceptibility and Clinical Significanse of Chronic Idiopathic Thrombocytopenic Purpura, Takayuki Saitoh; Tetsuhiro Kasamatsu; Akihiko Yokohama; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Hatsue Ogawara; Yoshihisa Nojima; Hirokazu Murakami, Nov. 2008, BLOOD, 112, 11, 1175, 1175, Summary international conference
• 外来化学療法センター運営におけるチーム医療の現状と問題点 外来化学療法パスを通じて, 斉藤 貴之; 関本 研一; 浅尾 高行; 鹿沼 達哉, Oct. 2008, 日本癌治療学会誌, 43, 2, 782, 782
• Micafunginとliposomal amphotericin Bの併用療法が奏効したazole系薬剤不応性のCandida guilliermondii血症, 斉藤貴之; 松島孝文; 清水啓之; 大崎洋平; 山根有人; 入澤寛之; 横濱章彦; 内海英貴; 半田寛; 塚本憲史; 唐沢正光; 野島美久; 村上博和, 2008, 49, 2, 94, 98

  DOI
• 【多発性骨髄腫 分子標的治療を目指して】多発性骨髄腫の治療指針, 村上 博和; 半田 寛; 齋藤 貴之, Dec. 2007, 日本臨床, 65, 12, 2167, 2176
• IL-10-592 polymorphism predicts the clinical outcome of Japanese patients with multiple myeloma and MGUS, Tetsuhiro Kasamatsu; Takayuki Saitoh; Hiroshi Handa; Takafumi Matsushima; Norifumi Tsukamoto; Masamitsu Karasawa; Hatsue Ogawara; Morio Sawamura; Yohihisa Nojima; Hirokazu Murakami, Nov. 2007, BLOOD, 110, 11, 263B, 263B, Summary international conference
• Interleukin-10 gene polymorphism reflects the severity of chronic idiopathic thrombocytopenic purpura, Takayuki Saitoh; Tetsuhiro Kasamatsu; Madoka Inoue; W. H. S. Al-ma'Quol; Akihiko Yokohama; Hiroshi Handa; Takafumi Matsushima; Norifumi Tsukamoto; Masamitsu Karasawa; Hatsue Ogawara; Yoshihisa Nojima; Hirokazu Murakami, Nov. 2007, BLOOD, 110, 11, 629A, 629A, Summary international conference
• Relation of IL-10-592 polymorphism to the susceptibility and clinical outcome of multiple myeloma in Japanese patients, T. Saitoh; T. Kasamatsu; M. Inoue; W. H. S. Al-ma'Quol; H. Irisawa; A. Yokohama; H. Handa; T. Matsushima; N. Tsukamoto; M. Karasawa; H. Ogarawa; M. Sawamura; N. Yoshihisa; H. Murakami, Jun. 2007, HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 92, 6, 105, 105, Summary international conference
• Acquired hemophilia A developed at relapse of minimal change nephrotic syndrome, SHIMIZU Hiroaki; MATSUSHIMA Takafumi; TSUKAMOTO Norifumi; KARASAWA Masamitsu; MURAKAMI Hirokazu; NOJIMA Yoshihisa; SAITOH Takayuki; OSAKI Yohei; YAMANE Arito; GOHDA Fumito; IRISAWA Hiroyuki; YOKOHAMA Akihiko; UCHIUMI Hideki; HANDA Hiroshi, 2007, Rinsho Ketsueki, 48, 6, 514, 517

  DOI
• HLA-DRB1 analysis in hairy B-cell lymphoproliferative disorder (HBLD): a Japanese type of benign persistent polyclonal B-cell lymphocytosis., Hirotaka Nakahashi; Masamitsu Karasawa; Yoko Hashimoto; Hiroyuki Frisawa; Akihiko Yokohama; Takayuki Saitoh; Hiroshi Handa; Takalumi Matsushima; Hirokazu Murakami; Norifurni Tsukarnoto; Yosihisa Nojima, Nov. 2006, BLOOD, 108, 11, 182B, 182B, Summary international conference
• IL-10 promoter region-592A/C genotype increases the risk of multiple myeloma in Japanese patients., Takayuki Saitoh; Tetsuhiro Kasamatsu; Hitomi Matsuoka; Miyuki Endoh; Madoka Inoue; Arito Yamane; Hiroyuki Irisawa; Hiroshi Handa; Takafumi Matsushima; Norifumi Tsukamoto; Masamitsu Karasawa; Hatsue Ogawara; Yoshihisa Nojima; Hirokazu Murakami, Nov. 2006, BLOOD, 108, 11, 342B, 342B, Summary international conference
• JAK2 mutation in granulocytes and platelets and X-chromosome gene-based clonal analysis in chronic myeloproliferative disorders., Kohtaro Toyama; Norifurni Tsukamoto; Irisawa Hiroyuki; Akihiko Yokohama; Takayuki Saitoh; Hiroshi Handa; Takafumi Matsushima; Hirokazu Murakami; Shuichi Miyawaki; Yoshihisa Nojima; Masamitsu Karasawa, Nov. 2006, BLOOD, 108, 11, 310B, 310B, Summary international conference
• Utility of FDG-PET and comparison of FDG-PET and Ga-67 scintigraphy in evaluation of B-cell indolent lymphoma., Norifumi Tsukamoto; Akihiko Yokohama; Hiroyuki Irisawa; Takayuki Saitoh; Hideki Uchiumi; Takafumi Matsushima; Yoshihisa Nojima; Masamitsu Karasawa; Hiroshi Handa; Hirokazu Murakami, Nov. 2006, BLOOD, 108, 11, 234B, 234B, Summary international conference
• Deep vein thrombosis and pulmonary embolism in a patient with multiple myeloma treated with thalidomide and dexamethasone, MIYAZAWA Yuri; NOJIMA Yoshihisa; IRISAWA Hiroyuki; UCHIUMI Hideki; SAITOH Takayuki; HANDA Hiroshi; MATSUSHIMA Takafumi; TSUKAMOTO Norifumi; KARASAWA Masamitsu; MURAKAMI Hirokazu, 2006, Rinsho Ketsueki, 47, 7, 656, 660

  DOI
• Reversible posterior leukoencephalopathy syndrome probably caused by L-asparaginase, MIYAZAWA Yuri; TSUKAMOTO Norifumi; NOJIMA Yoshihisa; IRISAWA Hiroyuki; MATSUSHIMA Takafumi; MITSUI Takeki; UCHIUMI Hideki; SAITOH Takayuki; HANDA Hiroshi; KARASAWA Masamitsu; MURAKAMI Hirokazu, 2006, Rinsho Ketsueki, 47, 6, 531, 535

  DOI
• 5. 大学病院における緩和ケアチームによる取り組み ―患者・家族の満足を追求した1事例を通して―（第11回群馬緩和医療研究会）, 石田 和子; 須川 美枝子; 井上 エリ子; 伊藤 桂子; 前田 三枝子; 三國 雅彦; 田村 遵一; 井田 逸郎; 米村 公江; 小幡 英章; 伊藤 奈緒美; 中山 優子; 堤 荘一; 堀口 淳; 斉藤 貴之; 小川 淳司; 飯塚 恵子; 中林 正美; 関上 里子; 柳澤 健, 01 May 2005, 55, 2, 210, 210
• ヒト細胞においてOGG1蛋白質は8‐ヒドロキシグアニンにより生じるG:C→T:A変異を抑制する, SUNAGA NORIAKI; KONO TAKASHI; SHINMURA KAZUYA; SAITO TAKAYUKI; MATSUDA TOMONARI; SAITO RYUSEI; YOKOTA JUN, 26 Sep. 2001, 日本癌学会総会記事, 60th, 405
• 8‐ヒドロキシグアニン修復に関わるヒトMYH遺伝子のスプライス供与部位の一塩基多型は蛋白質翻訳効率を減少させる, 山口悟; 新村和也; 斉藤貴之; 桑野博行; 横田淳, 25 Nov. 2000, 23rd, 770
• ヒト細胞における銅(II)/過酸化水素及びリボフラビン/可視光による変異誘導能及び特異性の検討, 砂長則明; 河野隆志; 斉藤貴之; 新村和也; 斉藤龍生; 横田淳, 25 Nov. 2000, 23rd, 766
• 8‐ヒドロキシグアニン修復に関わるヒトOGG1蛋白質のAPEX蛋白質による修復活性の増強, 斉藤貴之; 新村和也; 山口悟; 関周司; 村上博和; 横田淳, 25 Nov. 2000, 23rd, 769
• アデニン:8‐ヒドロキシグアニン塩基対に対するMYH蛋白質のアデニン除去能の検討, 新村和也; 山口悟; 斉藤貴之; KIM S‐R; 能美健彦; 横田淳, 25 Nov. 2000, 23rd, 770
• Copblam/MEVMP regimen for intermediate-grade non-hodgkin's lymphoma, Norifumi Tsukamoto; Takayuki Saito; Tadashi Maehara; Takafumi Matsushima; Hidemi Ogura; Jun'ichi Tamura; Takuji Naruse; Masamitsu Karasawa; Kimio Morita; Hirokazu Murakami; Jun Tsuchiya; Sadao Sato; Shun'ichi Shimano; Shuichi Miyawaki; Shougo Shinonome; Morio Sawamura; Hisami Hirabayashi; Masaru Kojima, 2000, Kitakanto Medical Journal, 50, 2, 99, 105

  DOI
• Successful Treatment of Multiple Myeloma with Autologous Peripheral Blood Stem Cell Transplantation: A Case Report., Kobayashi Satsuki; Murakami Hirokazu; Naruse Takuji; Matsushima Takafumi; Koiso Hiromi; Kim Kaho; Saitoh Takayuki; Sakai Hirotaka; Ogura Hidemi; Tamura Jun'ichi; Karasawa Masamitsu, 1998, The Kitakanto Medical Journal, 48, 3, 223, 227

  DOI
• 群馬血液研究会で経験した多発性骨髄腫292例の解析., 村上 博和; 斉藤 貴之; 松島 孝文; 田村 遵一; 唐沢 正光; 成清 卓二; 小野沢 正子; 沢村 守夫; 岡本 潔; 野際 英司; 伊藤 克彦; 佐倉 徹; 宮脇 修一; 川田 悦夫; 東雲 正剛; 前川 正; 櫻谷 昌孝; 佐藤 貞夫; 土屋 純, 1996, 66,121-124
• 海外研修がinternational postureに与える影響, 下田 佳央莉; 久留利 菜菜; 齋藤 貴之, Sep. 2021, 55回, PR, 12
• NFKB1-94 ins/del ATTG is associated with the risk of AML and poor prognosis(和訳中), 佐藤 理水; 後藤 七海; 笠松 哲光; 小田 司; 大川 貴史; 石原 領; 白岩 真彩; 村上 有希; 高田 覚; 塚本 憲史; 横濱 章彦; 半田 寛; 齋藤 貴之, Sep. 2021, 日本血液学会学術集会, 83回, PS, 3
• Melphalan and doxorubicin induce cellular senescence in T cells of healthy subjects(和訳中), 笠松 哲光; 白岩 真彩; 小田 司; 大川 貴史; 佐藤 理水; 石原 領; 村上 有希; 後藤 七海; 横濱 章彦; 半田 寛; 村上 博和; 齋藤 貴之, Sep. 2021, 日本血液学会学術集会, 83回, PS, 4
• A single-center analysis of central nervous system prophylaxis for diffuse large B cell lymphoma(和訳中), 宮澤 悠里; 横濱 章彦; 石埼 卓馬; 小磯 博美; 滝沢 牧子; 齋藤 貴之; 塚本 憲史; 半田 寛, Sep. 2021, 日本血液学会学術集会, 83回, OS1, 3
• Immunophenotypic detection of monoclonality in mature T-cell malignancy using anti TCR Cb1 antibody(和訳中), 白岩 真彩; 横濱 章彦; 佐藤 理水; 大川 貴史; 石原 領; 村上 有希; 後藤 七海; 笠松 哲光; 齋藤 貴之; 伊古田 勇人; 塚本 憲史; 半田 寛, Sep. 2021, 日本血液学会学術集会, 83回, BPA, 9
• 多発性骨髄腫におけるmicroRNA-145の発現とその制御機構, 村上 有希; 小田 司; 石原 領; 浅尾 優太; 後藤 七海; 笠松 哲光; 齋藤 貴之; 村上 博和; 半田 寛, Aug. 2021, 22, 学術集会, S165, S165
• 多発性骨髄腫の髄外進展におけるTIMP1の影響, 石原 領; 小田 司; 村上 有希; 浅尾 優太; 後藤 七海; 笠松 哲光; 齋藤 貴之; 村上 博和; 半田 寛, Aug. 2021, 22, 学術集会, S165, S165
• 健常者T細胞における薬剤誘導性細胞老化の検討, 笠松 哲光; 白岩 真彩; 小田 司; 石原 領; 村上 有希; 佐藤 理水; 後藤 七海; 半田 寛; 村上 博和; 齋藤 貴之, Aug. 2021, 22, 学術集会, S187, S187
• 多発性骨髄腫の継続・維持療法の有効性に関する傾向スコアマッチング解析(Propensity-score matched analysis of the efficacy of maintenance or continuous therapy on multiple myeloma), 尾崎 修治; 半田 寛; 小磯 博美; 齋藤 貴之; 角南 一貴; 石田 禎夫; 鈴木 憲史; 成田 朋子; 飯田 真介; 中村 裕一; 鈴木 一史; 西村 倫子; 村上 博和; 清水 一之, May 2021, International Journal of Myeloma, 11, 2, 96, 96
• PD-1 AND CTLA-4 POLYMORPHISMS AFFECT THE SUSCEPTIBILITY AND CLINICAL FEATURES OF CHRONIC IMMUNE THROMBOCYTOPENIA, R. Ino; T. Kasamatsu; Y. Kitamura; K. Honma; T. Nagashima; N. Takahashi; N. Gotoh; M. Takizawa; A. Yokohama; H. Handa; T. Saitoh; H. Murakami, Jun. 2017, HAEMATOLOGICA, 102, 591, 591, Summary international conference
• Long Non-Coding RNA MALAT1 Is Associated with the Progression of Multiple Myeloma and Induced By Cellular Stress, Yuko Kuroda; Kei Kimura; Yuta Masuda; Arito Yamane; Hikaru Hattori; Kenichi Tahara; Ayaka Kaneko; Itsumi Suda; Noriyuki Takahashi; Gotoh Nanami; Kie Nagai; Tomomi Nagashima; Makiko Takizawa; Hiromi Koiso; Takuma Ishizaki; Takeki Mitsui; Hirono Iriuchishima; Takayuki Saitoh; Hiroaki Shimizu; Akihiko Yokohama; Norifumi Tsukamoto; Tetsuhiro Kasamatsu; Yusuke Minato; Yoshihisa Nojima; Hirokazu Murakami; Hiroshi Handa, Dec. 2015, BLOOD, 126, 23, Summary international conference
• 遺伝子組み換えヒトエリスロポエチン製剤のヒト白血 球サブセットに対する影響, 長嶋 友海; 永井 清絵; 後藤 七海; 木村 恵; 黒田 裕子; 笠松 哲光; 湊 雄介; 横濱 章彦; 半田 寛; 齋藤 貴之; 村上 博和, 01 Aug. 2015, 65, 3, 279, 279
• 多発性骨髄腫におけるlong non-coding RNAの発現, 黒田 裕子; 半田 寛; 木村 恵; 後藤 七海; 永井 清絵; 長嶋 友海; 笠松 哲光; 齋藤 貴之; 村上 博和, 01 Aug. 2015, 65, 3, 274, 275
• OGG1S326C C/C型が急性骨髄性白血病の再発リスクを高める, 後藤 七海; 齋藤 貴之; 高橋 範行; 井野 瑠美; 北村 裕也; 木元 麻里; 木村 恵; 黒田 裕子; 永井 清絵; 長嶋 友海; 佐倉 徹; 湊 雄介; 笠松 哲光; 半田 寛; 村上 博和, 01 Aug. 2015, 65, 3, 274, 274
• IL-10RB KK型は,特発性血小板減少性紫斑病（ITP） の重症度に影響する, 北村 裕也; 齋藤 貴之; 井野 瑠美; 木元 麻里; 長嶋 友海; 後藤 七海; 木村 恵; 黒田 裕子; 永井 清絵; 高橋 範行; 湊 雄介; 笠松 哲光; 半田 寛; 村上 博和, 01 Aug. 2015, 65, 3, 279, 279
• IL-10およびIL-10受容体遺伝子多型は多発性骨髄腫の予後に影響する, 井野 瑠美; 齋藤 貴之; 北村 裕也; 木元 麻里; 長嶋 友海; 後藤 七海; 木村 恵; 黒田 裕子; 永井 清絵; 高橋 範行; 湊 雄介; 笠松 哲光; 半田 寛; 村上 博和, 01 Aug. 2015, 65, 3, 275, 275
• 骨髄腫におけるmicroRNAの脱制御, 木村 恵; 半田 寛; 黒田 裕子; 後藤 七海; 永井 清絵; 長嶋 友海; 笠松 哲光; 齋藤 貴之; 村上 博和, 01 Aug. 2015, 65, 3, 275, 276
• 多発性骨髄腫におけるIL23RGlu3His遺伝子多型解析, 木元 麻里; 齋藤 貴之; 井野 瑠美; 北村 裕也; 後藤 七海; 長嶋 友海; 木村 恵; 黒田 裕子; 永井 清絵; 高橋 範行; 湊 雄介; 笠松 哲光; 半田 寛; 村上 博和, 01 Aug. 2015, 65, 3, 275, 275
• 同種造血幹細胞移植における移植前血清フェリチン値の臨床的意義 多施設前方視的試験の結果, 田中正嗣; 田中正嗣; 金森平和; 大橋一輝; 中世古知昭; 神田善伸; 山崎悦子; 藤澤信; 佐倉徹; 青墳信之; 小野田昌弘; 町田真一郎; 加藤淳; 臼杵憲祐; 渡部玲子; 田口淳; 矢野真吾; 斉藤貴之; 高橋聡; 坂巻壽; 岡本真一郎, 2014, 36th
• 多発性骨髄腫(MM)患者における塩基除去修復(BER)遺伝子多型解析, 岩崎 篤史; 齋藤 貴之; 新田 恭浩; バトチメグ ノルジマー; 増田 裕太; 須田 いつみ; 金子 文香; 半田 寛; 村上 博和, 01 Aug. 2013, 63, 3, 334, 335
• 多発性骨髄腫における8p11領域遺伝子FGFR1、WHSC1L1発現の検討, 増田 裕太; 半田 寛; 金子 文香; 須田 いつみ; 新田 恭浩; 岩崎 篤史; 大宮 千春; 神谷 明; 齋藤 貴之; 村上 博和, 01 Aug. 2013, 63, 3, 331, 331
• 急性骨髄性白血病におけるCommon Fragile Site遺伝子、WW domain-containing oxidoreductase(WWOX)と、RAS association domain family protein A(RASSF1A)のメチル化, 須田 いつみ; 半田 寛; 金子 文香; 増田 裕太; 岩崎 篤史; 大宮 千春; 神谷 明; 新田 恭浩; 齋藤 貴之; 村上 博和, 01 Aug. 2013, 63, 3, 330, 330
• The Association of polymorphism in DNA BER genes OGG1, XRCC1, APE1 and MUTYH with the risk/clinical characteristics of myelodysplastic syndromes (MDS) in Japanese patients, Norjmaa Batchimeg; Saitoh Takayuki; Iwasaki Atsushi; Nitta Yasuhiro; Handa Hiroshi; Murakami Hirokazu, 01 Aug. 2013, 63, 3, 335, 335
• 多発性骨髄腫(MM)患者におけるIL-10, IL-17, IL-18サイトカイン遺伝子多型解析, 新田 恭浩; 齋藤 貴之; 岩崎 篤史; バトチメグ ノルジマー; 増田 裕太; 須田 いつみ; 金子 文香; 半田 寛; 村上 博和, 01 Aug. 2013, 63, 3, 334, 334
• Biological Features and Plasticity of CD56-Positive Dendritic-Like Cells: relationship to Blastic Plasmacytoid Dendritic Cell Neoplasm, Yohei Osaki; Akihiko Yokohama; Akio Saitoh; Kenichi Tahara; Kunio Yanagisawa; Yoshiyuki Ogawa; Takuma Ishizaki; Takeki Mitsui; Hiromi Koiso; Makiko Takizawa; Hideki Uchiumi; Hirokazu Murakami; Takayuki Saitoh; Norifumi Tsukamoto; Hiroshi Handa; Yoshihisa Nojima, Nov. 2012, BLOOD, 120, 21, Summary international conference
• 多発性骨髄腫の病期分類と予後予測 (特集 多発性骨髄腫診療の新時代を迎えて--診断と治療に吹き込む「新しい風」) -- (多発性骨髄腫の診断), 斉藤 貴之; 塚本 憲史; 村上 博和, Aug. 2011, 108, 2, 221, 226
• 顎口腔再建とリハビリテーション―障害医学と社会的生命の維持―（第56回北関東医学会総会抄録 特別講演）, 横尾 聡; 斉藤 貴之; 大崎 洋平; 入沢 寛之; 横濱 章彦; 内海 英貴; 半田 寛; 松島 孝文; 唐沢 正光; 村上 博和; 塚本 憲史; 野島 美久; 星野 匠臣; 初見 菜穂子; 高田 覚; 佐倉 徹; 宮脇 修一, 01 Aug. 2009, 59, 3, 311, 311
• Reappraisal of bacterial prophylaxis in allogeneic marrow or peripheral blood stem cell transplantations after myeloablative conditionings, J. Kanda; T. Ichinohe; T. Saito; K. Yamashita; T. Kondo; T. Ishikawa; S. Ichiyama; T. Uchiyama, Mar. 2009, BONE MARROW TRANSPLANTATION, 43, S239, S239, Summary international conference
• 2.真性多血症からの二次性骨髄線維症に対しRISTを行った1例(第31回群馬移植研究会学術講演会), 田原 研一; 斉藤 貴之; 横濱 章彦; 半田 寛; 内海 英貴; 関上 智美; 外山 耕太郎; 馬渡 桃子; 大崎 洋平; 松島 孝文; 塚本 憲史; 野島 美久, 01 Feb. 2009, 59, 1, 77, 77
• 1.群馬県における悪性リンパ腫患者の病型頻度(一般演題,第12回群馬血液疾患研究会), 外山 耕太郎; 塚本 憲史; 斉藤 明生; 中橋 寛隆; 大崎 洋平; 横濱 章彦; 斉藤 貴之; 松島 孝文; 唐沢 正光; 野島 美久; 入澤 寛之; 神保 貴宏; 村山 佳予子; 松本 守生; 澤村 守夫; 半田 寛; 村上 博和, 01 May 2008, 58, 2, 239, 239
• 13. BCR/ABL陰性慢性骨髄増殖性疾患における顆粒球,血小板のJAK2遺伝子変異の検討(一般演題,第54回北関東医学会総会抄録), 外山 耕太郎; 入沢 寛之; 横濱 章彦; 内海 英貴; 斉藤 貴之; 半田 寛; 松島 孝文; 塚本 憲史; 唐沢 正光; 村上 博和; 野島 美久, 01 Aug. 2007, 57, 3, 301, 302
• 7. 転移性腎細胞癌に対しミニ移植を施行した一例(第24回群馬移植研究会学術講演会), 齊藤 泰之; 星野 匠臣; 山根 有人; 滝沢 牧子; 入沢 寛之; 斉藤 貴之; 松島 孝文; 塚本 憲史; 野島 美久; 唐沢 正光; 半田 寛; 村上 博和, 01 May 2005, 55, 2, 188, 189
• 造血器腫瘍における貪食チェックポイント分子SIRPαの遺伝子多型の解析, 堀 鮎香; 後藤 七海; 齋藤 貴之; 大西 浩史, Nov. 2022, 95回, 2P, 272
• 大腸上皮幹細胞ニッチであるDCS細胞の細胞系譜解析, 青柳 瑠南; 小田 司; 宮内 英治; 齋藤 貴之; 佐々木 伸雄, Aug. 2022, 72, 3, 320, 320
• 貪食抑制受容体SIRPαの遺伝子多型と造血器腫瘍病態との関連解析, 堀 鮎香; 後藤 七海; 齋藤 貴之; 大西 浩史, Aug. 2022, 72, 3, 321, 321
• 多発性骨髄腫におけるHuman Endogenous Retrovirus-K(HERV-K)の発現とその役割の検討, 増田 裕太; 石原 領; 村上 有希; 後藤 七海; 笠松 哲光; 齋藤 貴之; 村上 博和; 半田 寛, Jul. 2022, 23, 学術集会, S130, S130
• 当院におけるT細胞リンパ腫の中枢再発に対する検討, 金谷 秀平; 梶田 樹矢; 塚田 明彦; 内藤 千晶; 石川 哲也; 小林 宜彦; 大崎 洋平; 宮澤 悠里; 滝沢 牧子; 齋藤 貴之; 横濱 章彦; 塚本 憲史; 半田 寛, Jun. 2022, 62, 102, 102
• アレムツズマブを投与した再発難治CD52陽性T細胞性前リンパ球性白血病(T-PLL), 塚田 明彦; 小林 宣彦; 松本 彬; 梶田 樹矢; 明石 直樹; 金谷 秀平; 内藤 千晶; 石川 哲也; 宮澤 悠里; 小川 孔幸; 横濱 章彦; 齋藤 貴之; 半田 寛, May 2022, 63, 5, 504, 505
• 慢性リンパ性白血病と異なるクローンから発生したリヒター症候群の1例, 梶田 樹矢; 宮澤 悠里; 塚田 明彦; 金谷 秀平; 大崎 洋平; 小林 宣彦; 小川 孔幸; 齋藤 貴之; 横濱 章彦; 半田 寛, May 2022, 63, 5, 507, 507
• Tissue inhibitor of metalloproteinase 1(TIMP1)は骨髄腫の進行と線維芽細胞の浸潤能に関与する(Tissue inhibitor of metalloproteinase 1(TIMP1) is associated with myeloma progression and fibroblast invasive capacity), 石原 領; 小田 司; 村上 有希; 松村 郁子; 渡辺 早貴; 浅尾 優太; 後藤 七海; 笠松 哲光; 武井 寿史; 小林 宣彦; 齋藤 貴之; 村上 博和; 半田 寛, May 2022, International Journal of Myeloma, 12, 3, 157, 157
• 急性骨髄性白血病の発症リスクおよび予後不良因子としてのNFKB1遺伝子多型および発現について, 佐藤 理水; 後藤 七海; 小峯 梨花子; 大川 貴史; 石原 領; 村上 有希; 笠松 哲光; 横濱 章彦; 塚本 憲史; 半田 寛; 齋藤 貴之, Aug. 2021, 71, 3, 259, 260
• デフェロキサミンによるHIF-1安定化を介した多発性骨髄腫における遺伝子発現変動の解析, 白石 菜月; 後藤 七海; 小田 司; 笠松 哲光; 青柳 瑠南; 大森 綺音; 柳澤 宏太; 糸井 悠晏; 飯田 南美; 根岸 光; 佐々木 伸雄; 横濱 章彦; 半田 寛; 齋藤 貴之, Oct. 2023, 日本血液学会学術集会, 85回, 1177, 1177
• 大動脈弁血栓による心原性脳塞栓症を合併した急性前骨髄球性白血病, 杉崎 真人; 吉田 源也; 西連寺 由起子; 明石 直樹; 金谷 秀平; 野口 紘幸; 小林 宣彦; 大崎 洋平; 宮澤 悠里; 小川 孔幸; 横濱 章彦; 齋藤 貴之; 塚本 憲史; 半田 寛, Oct. 2023, 日本血液学会学術集会, 85回, 75, 75
• 全身性ALアミロイドーシスにおけるdaratumumab前後の治療効果に関する単施設後方視的解析, 宮澤 悠里; 金谷 秀平; 小林 宣彦; 大崎 洋平; 小川 孔幸; 横濱 章彦; 齋藤 貴之; 半田 寛, Oct. 2023, 日本血液学会学術集会, 85回, 537, 537
• 非結核性抗酸菌症合併下に同種造血幹細胞移植を行った好中球減少を主体とする高リスクの骨髄異形成症候群, 西連寺 由起子; 小林 宣彦; 杉崎 真人; 野口 紘幸; 齋藤 慧; 大崎 洋平; 宮澤 悠里; 小川 孔幸; 横濱 章彦; 齋藤 貴之; 半田 寛, Oct. 2023, 日本血液学会学術集会, 85回, 736, 736
• DNA損傷誘導性細胞老化は液-液相分離で形成される53BP1核内フォーカスにより制御される(DNA damage-induced cellular senescence is regulated by 53BP1 accumulation in the nuclear foci and phase separation), 小田 司; 後藤 七海; 笠松 哲光; 半田 寛; 齋藤 貴之; 佐々木 伸雄, Sep. 2023, 日本癌学会総会記事, 82回, 964, 964
• 造血器腫瘍および免疫性血小板減少性紫斑病における貪食チェックポイント分子SIRPαの遺伝子多型の解析(Gene polymorphism of SIRPα, a phagocytic checkpoint moleculte, in hematopoietic tumors and immune thrombocytopenic purpura), 堀 鮎香; 後藤 七海; 齋藤 貴之; 大西 浩史, Sep. 2023, 日本癌学会総会記事, 82回, 951, 951
• HIF-1αの安定化剤を用いた模擬低酸素環境下における多発性骨髄腫細胞の遺伝子発現解析, 白石 菜月; 後藤 七海; 小田 司; 笠松 哲光; 青柳 瑠南; 大森 綺音; 柳澤 宏太; 糸井 悠晏; 飯田 南美; 根岸 光; 佐々木 伸雄; 横濱 章彦; 半田 寛; 齋藤 貴之, Aug. 2023, 73, 3, 254, 254
• 大腸上皮幹細胞ニッチであるDeep Crypt Secretory(DCS)細胞の細胞系譜解析, 青柳 瑠南; 小田 司; 宮内 栄治; 齋藤 貴之; 佐々木 伸雄, Aug. 2023, 73, 3, 254, 255
• ヒト回腸由来オルガノイドを利用した胆汁酸トランスポーターASBTの発現解析, 柳澤 宏太; 齋藤 貴之; 宮内 栄治; 高島 優季; 小林 彰子; 佐々木 伸雄, Aug. 2023, 73, 3, 260, 260
• 多発性骨髄腫細胞におけるmicro-RNAのメチル化の解析, 糸井 悠晏; 笠松 哲光; 飯田 南美; 根岸 光; 大森 綺音; 松村 郁子; 後藤 七海; 半田 寛; 村上 博和; 齋藤 貴之, Jul. 2023, 24, 学術集会, S141, S141
• 多発性骨髄腫細胞株における抗腫瘍薬投与時のマイトファジー動態, 根岸 光; 笠松 哲光; 飯田 南美; 糸井 悠晏; 大森 綺音; 松村 郁子; 後藤 七海; 半田 寛; 村上 博和; 齋藤 貴之, Jul. 2023, 24, 学術集会, S199, S199
• 多発性骨髄腫細胞株におけるミトコンドリア分裂促進蛋白質DRP1の発現解析, 笠松 哲光; 樋口 柚利子; 飯田 南美; 糸井 悠晏; 根岸 光; 松村 郁子; 後藤 七海; 半田 寛; 村上 博和; 齋藤 貴之, Jul. 2023, 24, 学術集会, S199, S199
• 好中球細胞外トラップ(NETs)が多発性骨髄腫細胞の増殖に与える影響, 飯田 南美; 笠松 哲光; 糸井 悠晏; 根岸 光; 大森 綺音; 松村 郁子; 後藤 七海; 半田 寛; 村上 博和; 齋藤 貴之, Jul. 2023, 24, 学術集会, S202, S202
• 単施設における治療抵抗性・早期再発びまん性大細胞型B細胞リンパ腫に対する自家末梢血幹細胞移植併用大量化学療法の実態, 宮澤 悠里; 横濱 章彦; 小林 宣彦; 大崎 洋平; 滝沢 牧子; 齋藤 貴之; 塚本 憲史; 半田 寛, Jun. 2023, 63, 123, 123
• デフェロキサミンによるHIF-1安定化を介した多発性骨髄腫における遺伝子発現変動の解析, 白石 菜月; 後藤 七海; 小田 司; 笠松 哲光; 青柳 瑠南; 大森 綺音; 柳澤 宏太; 糸井 悠晏; 飯田 南美; 根岸 光; 佐々木 伸雄; 横濱 章彦; 半田 寛; 齋藤 貴之, Oct. 2022, 日本血液学会学術集会, 84回, 1177, 1177
• 貪食抑制受容体SIRPαの遺伝子多型と造血器腫瘍病態との関連解析, 堀 鮎香; 後藤 七海; 齋藤 貴之; 大西 浩史, Aug. 2022, 72, 3, 321, 321
• MYCは腫瘍抑制性TP53-microRNA-34経路を遮断し骨髄腫の進行に関与する(MYC involves multiple myeloma progression by attenuating tumor suppressive function of TP53-microRNA-34 axis), 村上 有希; 木村 恵[増田]; 小田 司; 増田 裕太; 石原 領; 渡辺 早貴; 黒田 裕子; 笠松 哲光; 後藤 七海; 武井 寿史; 小林 宣彦; 齊藤 貴之; 村上 博和; 半田 寛, May 2022, International Journal of Myeloma, 12, 3, 153, 153
• NFKB1-94ins/delATTGは急性骨髄性白血病のリスクと予後不良に関連する(NFKB1-94 ins/del ATTG is associated with the risk of AML and poor prognosis), 佐藤 理水; 後藤 七海; 笠松 哲光; 小田 司; 大川 貴史; 石原 領; 白岩 真彩; 村上 有希; 高田 覚; 塚本 憲史; 横濱 章彦; 半田 寛; 齋藤 貴之, Sep. 2021, 日本血液学会学術集会, 83回, PS, 3
• 健常者T細胞における薬剤誘導性細胞老化の検討(Melphalan and doxorubicin induce cellular senescence in T cells of healthy subjects), 笠松 哲光; 白岩 真彩; 小田 司; 大川 貴史; 佐藤 理水; 石原 領; 村上 有希; 後藤 七海; 横濱 章彦; 半田 寛; 村上 博和; 齋藤 貴之, Sep. 2021, 日本血液学会学術集会, 83回, PS, 4
• TCR beta constant region 1に対する抗体を用いた成熟細胞腫瘍のクローナリティーの検討(Immunophenotypic detection of monoclonality in mature T-cell malignancy using anti TCR Cb1 antibody), 白岩 真彩; 横濱 章彦; 佐藤 理水; 大川 貴史; 石原 領; 村上 有希; 後藤 七海; 笠松 哲光; 齋藤 貴之; 伊古田 勇人; 塚本 憲史; 半田 寛, Sep. 2021, 日本血液学会学術集会, 83回, BPA, 9

Books etc

• リハベーシック　生物学・生体防御学, Joint work, 10 Oct. 2023, 158, Scholarly book
• 多発性骨髄腫の診療指針 第5版, Joint work, 2020
• 日本臨床 多発性骨髄腫の診断と治療のガイドライン, 2007
• 多発性骨髄腫の治療：総論 最新医学, 2009
• がん診療update多発性骨髄腫 日本医師会雑誌, 2010
• 多発性骨髄腫-飛躍的な進歩を続ける病態解析と最新治療 多様な病期分類 カレントセラピー, 2010
• IMiDsの基礎と臨床 第Ⅱ章臨床の実際, 2010
• 総合臨床 多発性骨髄腫の最新の治療, 2010
• 血液フロンティア 血液疾患における分子標的治療 ベンダムスチンによる骨髄腫の治療, 2010
• 多発性骨髄腫update－診療の進歩と新規治療の展望 高齢者多発性骨髄腫に対する治療, 2011
• 多発性骨髄腫診療の新時代を迎えて, 2011
• 白血病リンパ腫骨髄腫 今日の診断と治療第4版, 2011
• EBM血液疾患の治療2013-2014. Ⅳ．多発性骨髄腫と類縁疾患．2．移植非適応高齢者骨髄腫の治療指針．金倉譲等編, 2012
• 特集 リンパ系腫瘍のresearch questions, 2011
• Diagnosis and prognostic factors in patients with multiple myeloma, 2012
• 多発性骨髄腫治療マニュアル 原発性アミロイドーシス, 2012
• 多発性骨髄腫 Updating 第2巻 多発性骨髄腫の症候/合併症とのその対策, 2013
• Hematologic Malignancies/pediatric Malignancies 血液・リンパ腫瘍 多発性骨髄腫に対するプロテアソーム阻害薬治療, 2013
• カルフィルゾミブ登場の意義と期待．多発性骨髄腫診療PROGRESS. 赤司浩一監修．, Single work, Nov. 2016, 80-85
• 多発性骨髄腫診断基準と病期分類の変遷と展望．多発性骨髄腫学―最新の臨床と基礎研究―, Single work, 2016, 15-20
• 多発性骨髄腫におけるmiRNA異常．造血器腫瘍アトラス改訂第5版．谷脇雅史、横田昇平、黒田純也編、, Single work, Aug. 2016, 376-383
• 多発性骨髄腫におけるエピゲノム異常とmiRNA, Single work, 2016, 684-690
• 多発性骨髄腫学 －最新の診療と基礎研究－ 高齢者骨髄腫の治療－脆弱性の評価と治療の選択・用量調節 日本臨床, Single work, 2016
• 高齢多発性骨髄腫患者に対する診療上の問題点, Single work, 2014, 484-490
• レナリドマイドの免疫調整作用, Single work, Jan. 2015, 156-161

Presentations

• 「患者さん中心の医療にむけて　「患者力とは何か？がん患者さんのリテラシー向上にむけて」, 齋藤貴之, Feb. 2024
• 災害避難者に寄り添った LoRaWANを用いたヘルスモニタリングシステムの社会実装, 齋藤貴之, 共創の場　キックオフシンポジウム, 31 Jan. 2024, 31 Jan. 2024
• DNA Polymerases Pol θ/Pol η Involved in Error-Prone DNA Repair Are Highly Expressed in Multiple Myeloma and Upregulated By DNA Damage, Masanobu Sunaga, 61th ASH meeting, 09 Dec. 2019, English
• P53 Pathway Activation Mediated High c-MAF Expression Is Associated with Overall and Post-Progression Survival in Multiple Myeloma, Eiko Yamane, 61th ASH meeting, 09 Dec. 2019, English
• Impact of Continuous and Maintenance Therapy on Survival Outcome in Patients with Newly Diagnosed Multiple Myeloma: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma, Ozaki Shuji, 61th ASH meeting, 08 Dec. 2019, English
• Th1 Cytokine Polymorphism Gene: TNF-Alpha -857C/T Affects the Pathogenesis and Progression of Acute Myeloid Leukemia, Kana Shoma, 61st ASH Annual Meeting, 07 Dec. 2019, English
• Development of a web-system for promotion of EBLM by building a clinical case bank with harmonized recording of lab data, 山根 瑛子; 小田 司; 須永 征伸; 村上 有希; 石原 領; 浅尾 優太; 武井 寿史; 小林 宜彦; 大崎 洋平; 松本 守生; 後藤 七海; 笠松 哲光; 清水 啓明; 石埼 卓馬; 小磯 博美; 滝沢 牧子; 入内島 裕乃; 関上 智美; 横濱 章彦; 塚本 憲史; 増田 裕太; 粟田 真彩; 相馬 佳奈; 橋本 菜央; 齋藤 貴之; 半田 寛, 66th KITAKANTO Medical Society, 28 Sep. 2019, Japanese
• Th1 Cytokine Polymorphisms affect the severity of cITP, 相馬 佳奈; 後藤 七海; 笠松 哲光; 須永 征伸; 山根 瑛子; 村上 有希; 石原 領; 粟田 真彩; 半田 寛; 齋藤 貴之, 66th KITAKANTO Medical Society, 27 Sep. 2019, Japanese
• Workshop for Global human resources in Gunma University, SAITOH Takayuki, 66th KITAKANTO Medical Society, 27 Sep. 2019, Japanese
• 仙腸関節炎を初発症状として発症した骨髄異形成症候群(MDS), 第67回日本血液学会 第47回日本臨床血液学会 合同総会, 2005
• フローサイトメトリーによる骨髄異形性症候群、急性骨髄性白血病におけるテロメラーゼ逆転写酵素の発現の検討, 第67回日本血液学会 第47回日本臨床血液学会 合同総会., 2005
• リンパ腫におけるC/EBPalphaにおける役割, 第67回日本血液学会 第47回日本臨床血液学会 合同総会, 2005
• 心腔内にfungus ballを形成したangioimmunoblastic T-cell lymphoma (AITL)の1例, 第526回 日本内科学会関東地方会, 2005
• Indolent type非ホジキンリンパ腫におけるFDG-PETの有用性, 内科学会総会, 2005
• 大学病院における緩和チームによる取り組み, 第11回群馬緩和医療研究会, 2005
• 寛解導入療法中に多発脳膿瘍をきたしたTEL-AML-1陽性ALLの一例, 第15回関東甲信越癌治療と日和見感染症研究会, 2005
• Imatinibを含む多剤併用化学療法が有効だったPhiladelphia Chromosome- Positive Biphenotypic Acute Leukemiaの1例, 群馬血液勉強会, 2005
• 転移性腎細胞癌に対しミニ移植を施行した一例, 第24回 群馬移植研究会, 2004
• 血液疾患と細胞シグナル, 群馬血液勉強会, 2004
• C/EBPbeta KO mouseにおけるgranulopoiesisの検討, 第66回日本血液学会 第46回日本臨床血液学会 合同総会, 2004
• 血液疾患とサイトカイン多型, 群馬血液勉強会, 2006
• 骨髄異形成症候群(MDS)における発熱症例の検討, 第66回日本血液学会 第46回日本臨床血液学会 合同総会, 2004
• 悪性リンパ腫におけるFDG-PETの有用性とその限界, 第66回日本血液学会総会 第66回日本血液学会 第46回日本臨床血液学会 合同総会, 2004
• Suppressive activities of OGG1 and MYH proteins against G:C to T:A mutations caused by 8-hydroxyguanine but not by benzo[a]pyrene diol epoxide in human cells in vivo., 第61回日本癌学会総会, 2003
• 微小変化型ネフローゼ症候群の再燃時に後天性血友病Aを合併した一症例, 第535回日本内科学会関東地方会, 2006
• 慢性腎不全および肝硬変合併APLにATRA投与を行った一例, 第4回 日本臨床腫瘍学会総会, 2006
• 骨髄非破壊的同種造血幹細胞移植後の再発に対してドナーリンパ球輸注(DLI)が有効であったホジキンリンパ腫の一例, 第27回日本造血幹細胞移植学会総会, 2004
• Identification of Candidate Tumor Suppressor Genes Silenced Epigenetically in Mantle Cell Lymphoma., American Society of Hematology 47th Annual Meeting., 2005
• Up-regulated of DMT1 in the Duodenum may be responsible for Iron Deposition in the Liver in TfR2 Mutant Mice, American Society of Hematology 45th Annual Meeting, 2003
• PC-SPES inhibits the proliferation of non-small cell lung cancer cells and down-regulates the level of cox-2, American Association for Cancer Research 94th annual meeting, 2003
• SNPs in the OGG1 and MYH base excision repair genes can be involved in lung cancer susceptibility, The 5th Joint Conference of the American Association for Cancer Research and the Japanese Cancer Association, 2001
• 硝子体細胞診をきっかけに診断されたDiffuse Large B cell Lymphoma, 日本内科学会関東地方会, 2006
• 臍帯血移植を施行し寛解を継続している子宮原発Granulocytic Sarcoma, 臨床血液, 2007
• imatinib併用化学療法が有効であったPhiladelphia染色体陽性Biphenotypic Acute Leukemiaの1例, 第532回日本内科学会関東地方会, 2005
• 慢性腎不全および肝硬変を合併した急性前骨髄性白血病にATRA投与を行った一寛解例, 第67回日本血液学会 第47回日本臨床血液学会 合同総会, 2005
• Suberoyalanilide Hydroxamic Acid(SAHA)とValproric Acid(VPA)のリンパ腫に対する抗腫瘍効果, 第67回日本血液学会 第47回日本臨床血液学会 合同総会, 2005
• 骨髄球の分化転写因子のC/EBPalphaの他臓器での癌抑制機能, 第67回日本血液学会 第47回日本臨床血液学会 合同総会, 2005
• Thalidomide, Dexamethasone併用療法で深部静脈血栓症 (DVT)、肺動脈塞栓症を発症した多発性骨髄腫の1例, 日本臨床血液学会 第153回例会, 2005
• 多発性骨髄腫におけるIL-10の多型解析, 日本検査血液学会, 2006
• 多発性骨髄腫細胞に対するサイクリン依存性キナーゼ阻害剤（CDK inhibitor) R-Roscovitineの抗腫瘍効果, 第30回日本骨髄腫研究会, 2005
• Relation of IL-10-592 polymorphism to the susceptibility and clinical outcome of multiple myeloma in Japanese patients, International MM workshop, 2007
• Relation of IL-10-592 polymorphism to the susceptibility and clinical outcome of multiple myeloma in Japanese patients, International MM workshop, 2007
• Utility of FDG-PET and Comparison of FDG-PET and Ga-67 scntigraphy in Evalution of B-Cell Indolent Lymphoma, American Society of Hematology, 2006
• JAK2 Mutation in Granulocyte and Platelets and X-Chromosome Gene- Based Clonal Analusis in Chronc Myeloproliferative Disorders, American Society of Hemalogy, 2006
• HLA-DRB1 Analysi s in Hairy B-Cell lymphoproliferative (HBLD) AJapanese Typeof Benign Persistant POlyclonal B- Cell Lymphocytes, American Society of Hematlogy, 2006
• フローサイトメトリーによる多発性骨髄腫、MGUSのけるテロメラーゼ逆転写酵素(TERT)蛋白発現の検討, 第68回日本血液学会 第48回日本臨床血液学会 合同総会, 2006
• 骨髄異形成症候群におけるTh1/Th2の臨床的意義, 第68回日本血液学会 第48回日臨床血液学会 合同総会, 2006
• 悪性リンパ腫におけるFDG-PETの有用性：SUV値と病理組織型の関係, 第68回日本血液学会 第48回日本臨床血液学会 合同総会, 2006
• 慢性骨髄増殖性疾患の顆粒球、血小板におけるJAK2遺伝子変異とX染色体遺伝子によるクローン性の解析, 第68回日本血液学会 第48回日本臨床血液学会 合同総会, 2006
• 慢性リンパ性白血病における免疫グロブリン重鎖および軽鎖遺伝子解析, 第68回日本血液学会 第48回日本臨床血液学会 合同総会, 2006
• Hair cell 様の形態を示したPolyclonal B-cell lymphocytosisの一例, 第156回 日本臨床血液学会 例会, 2006
• 間質性肺炎発症時に抗Jo-1抗体を認めた全身性Castleman病の一例, 第155回 日本臨床血液学会 例会, 2006
• IL-10-592A/C Genotype Increases the Risk of Multiple Myeloma in Japanese Patients, American society of Hematology, 2006
• R-CHOP療法中に著明な一過性グリコーゲン蓄積性肝腫を合併した悪性リンパ腫の一例, 第154回 日本臨床血液学会 例会, 2005
• C/EBP alpha and -beta: Apposing Affects in Lymphoma Cells, American Society of Hematology 45th Annual Meeting, 2003
• Decreased Myelopoiesis in C/EBPbeta-/- Mice in Responsce to GM-CSF, American Society of Hematology 44th Annual Meeting, 2002
• リンパ球増多症における細胞表面GPIアンカー型蛋白質の発現, 第67回日本血液学会 第47回日本臨床血液学会 合同総会, 2005
• 髄外腫瘤形成(granulocytic sarcoma, GS)を伴った急性骨髄性白血病(AML)における同種造血幹細胞移植の検討, 第29回日本造血細胞移植学会総会, 2007
• 細胞表面CD27 抗原陰性はHairy cell leukemia およびそのvariant に特徴的な所見である, 第67回／第47回日本血液学会臨床血液学会合同総会, 2005
• 心腔内にfungus ballを形成したangioimmunoblastic T-cell lymphoma (AITL), 第15回関東甲信越癌治療と日和見感染症研究会., 2007
• 日本人多発性骨髄腫におけるIL-10－592多型解析, 第31回 日本骨髄腫研究会総会, 2006
• 多発性骨髄腫細胞におけるCaveolin発現制御シグナルの検討, 第69回日本血液学会 第49回日本臨床血液学会 合同総会, 2007
• 当科で経験した乳癌二次性白血病の5例の検討, 第69回日本血液学会 第49回日本臨床血液学会 合同総会, 2007
• 多発性骨髄腫におけるIL-10多型解析, 第69回日本血液学会 第49回日本臨床血液学会 合同総会, 2007
• Interleukin-10 gene polymorphism reflects the severity of chronic idiopathic thrombocytopenic purpura, ASH 49th, 2007
• 特発性血小板減少性紫斑病におけるIL-10 多型解析, 第8 回日本検査血液学会学術集会, 2007
• 自家末梢血幹細胞移植後アデノウイルスによる出血性膀胱炎、腎炎、ウイルス血症および血球貪食症候群をきたしたマントル細胞リンパ腫の１例, 第546回日本内科学会関東地方会例会, 2007
• イトラコナゾールの造血器悪性腫瘍における真菌感染予防効果の検討 多発性骨髄腫における最新治療, 2007
• 本態性血小板血症の血小板におけるJAK2遺伝子変異の検討とその優位性, 第69回日本血液学会 第49回日本臨床血液学会 合同総会, 2007
• Hairy B-cell lymphoproliferative disorder(HBLD) におけるHLA-DRとVH遺伝子の解析, 第69回日本血液学会 第49回日本臨床血液学会 合同総会, 2007
• 8-ヒドロキシグアニン修復に関わるヒトOGG1蛋白質のAPEX蛋白質による修復活性の増強, 第23回日本分子生物学会年会, 2000
• 8-ヒドロキシグアニン修復に関わるヒトMYH遺伝子のスプライス供与部位の一塩基多型は蛋白質翻訳効率を減少させる, 第23回日本分子生物学会年会, 2000
• 8-ヒドロキシグアニン塩基対に対するMYH蛋白質のアデニン除去能の検討, 第23回日本分子生物学会年会, 2000
• 8-ヒドロキシグアニン修復に関わるヒトMYH遺伝子の蛋白質翻訳効率の差異を生じさせる一塩基多型の同定, 第59回日本癌学会総会, 2000
• OGG1蛋白質とAPEX蛋白質の共同作用による8-ヒドロキシグアニンの修復とAPEX蛋白質によるその活性調節, 第59回日本癌学会総会, 2000
• 8-ヒドロキシグアニン修復に関わるヒトMYH蛋白質の基質による修復活性の差異の検討, 第59回日本癌学会総会, 2000
• 8-ヒドロキシグアニン塩基対に対するMYH蛋白質のアデニン除去能の検討., WORKSHOP ON DNA REPAIR AND MUTAGENESIS, 2000
• BCR/ABL陰性慢性骨髄増殖性疾患の血球系統における遺伝子変異の差異についての検討, 第70回日本血液学学会総会, 2008
• 多発性骨髄腫に対するCelastrolの抗腫瘍効果, 第71回日本血液学会総会, 2009
• 皮膚病変出現から3年後に白血化して診断されたCD4+CD56+hemtodermic neoplasmの一例, 第70回日本血液学学会総会, 2008
• Bortezomib治療中にM蛋白が消失したにもかかわらず、髄外形質細胞腫が出現した多発性骨髄腫, 第33回日本骨髄腫研究会総会, 2008
• V4-39/D6-13/JH5再構成とIGH/BCL3転座の関連, 第71回日本血液学会, 2009
• Clinical Significance of Granulocytic Sarcoma in Patients with Acute Myeloid Leukemia, The 71th annual meeting of the Japanese Journal of Clinical Hematology, 2009
• DLBCLの細胞表面CD25発現が血中可溶性IL-2レセプター値と予後に与える影響について, 第71回日本血液学会総会, 2009
• 化学療法と放射線療法に抵抗性を示し死亡後病理解剖を行った2次性中枢神経リンパ腫4例, 第71回日本血液学会, 2009
• Familial platelet disorder with propensity to develop myeloid malignancies(FPD/MM)が考えられた1家系 Analysis of RUNX1 mutations in a new pedigree with FPD/MM, 第71回日本血液学会総会, 2009
• 特発性血小板減少性紫斑病における末梢血樹状細胞数の治療後の変化, 第71回日本血液学会総会, 2009
• 外来化学療法センターにおける外来化学療法パスによる安全性の検討, 第7回日本臨床腫瘍学会, 2009
• G-CSF産生形質細胞による好中球増加症, 第34回日本骨髄腫研究会総会, 2009
• 再発・難治PTLに対する自家末梢血幹細胞移植の検討, 第32回日本造血細胞移植学会総会, 2010
• 同種造血細胞移植での発熱の検討, 第32回日本造血細胞移植学会総会, 2010
• Shimizu H, Saitoh T, Osaki Y, Hoshino T, Hatsumi N, Tkada S, Yokohama A, Handa H, Jimbo T, Sakura T, Tsukamoto N, Karasawa M, Murakami H, Nojima Y., Annual Meeting of the Japanese Society of Hematology 72, 2010
• Relationship between circulating dendritic cells and T cell differentiation in patients with ITP, Yokohama, 2010
• Successful treatment of AIHA associated with associated with Multicentric Castleman disease by tocilizumab therapy, The 72nd Annual Meeting of the Japanese Society of Hematology, 2010
• Interkeukin-17F polymorphism in patients with chronic immune thrombocytopenic purpra, The 72nd Annual Meeting of the Japanese Society of Hematology, 2010
• Subclinical improvement of cardiac function with iron over load after chelating therapy, Yokohama, 2010
• Pneumocystis jiroveci pneumonia in patients with Hodgkin lymphoma, The 72nd Annual Meeting of the Japanese Society of Hematology, 2010
• A woman with slowly progressive EBV associated with lymphoproliferative disease had no immunosuppressant., The 72nd Annual Meeting of the Japanese Society of Hematology, 2010
• 肺炎球菌による頸椎化膿性脊椎炎を合併した多発性骨髄腫の一例, 第165回日本血液学会例会, 2011
• 髄外腫瘤を伴うAMLに対する同種造血幹細胞移植の後方視的検討―関東造血幹細胞移植共同研究グループ(KSGCT)における後方視的検討―, 第33回日本造血細胞移植学会, 2011
• 臍帯血移植を施行した抗HLA抗体陽性患者4症例の検討, 第33回日本造血細胞移植学会, 2011
• 非血縁同種骨髄移植後の消化管GVHD(stage4)に対し、ATGを投与し効果を認めた一例, 第33回日本造血細胞移植学会, 2011
• JAK2 Mutation Status in Granulocytes, Platelets and Erythrocytes Differs Between Polycythemia Vera and Essential Thrombocythemia, American Society of Hematology 50th annual meeting, 2008
• Utility of FDG-PET and Comparison of FDG-PET and Ga-67 Scintigraphy in Evaluation of B-Cell Indolent Lymphoma, American Society of Hematology 48th annual meeting, 2006
• Epo非依存性赤芽球コロニー中に少数のJAK2-V617F陽性クローンを認めたBudd-Chiari症候群の1例, 第71回日本血液学会総会, 2009
• 特発性血小板性紫斑病（ITP）における自然免疫系の関与, 第70回日本血液学学会総会, 2008
• 真性多血症からの二次性骨髄線維症に対しRISTを行った1例, 日本造血幹細胞移植学会, 2008
• フローサイトメトリーによるAML,MDSのCD34+CD38-幹細胞分画におけるテロメラーゼ逆転写酵素発現検討, 第69回日本血液学会 第49回日本臨床血液学会 合同総会, 2007
• 当科で経験した乳癌関連二次性白血病の5例の検討, 第69回日本血液学会 第49回日本臨床血液学会 合同総会, 2007
• 巨脾で発症した濾胞性リンパ腫の3症例, 第71回日本血液学会総会, 2009
• 血液疾患における好中球減少時のプロカルシトニン測定意義について, 第71回日本血液学会総会, 2010
• 血液疾患におけるカンジダ・アスペルギルス感染症の検討―当院の病理解剖例から, 第70回日本血液学学会総会, 2008
• 髄外腫瘤が急性骨髄性白血病の予後に与える影響の検討, 第70回日本血液学学会総会, 2008
• 当科での同種骨髄移植症例におけるStenotrophomonas maitophilia 菌血症の検討, 第70回日本血液学学会総会, 2008
• 低悪性度リンパ腫におけるFDG-PETの有用性およびFDG-PETとGa-67の比較, 臨床腫瘍学会, 2007
• 多発性骨髄腫におけるIL-17Fの多型, 第7回日本臨床腫瘍学会, 2010
• Prognostic Importance of Soluble Form IL-2 Receptor α (sIL-2Rα) and Its Relationship with Surface Expression of IL-2Rα of Lymphoma Cell in Diffuse Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy: a Retrospective Analysis of 405 Cases, American Society of Hematology, 2009
• Flow cytometric detection of human telomerase reverse transcriptase expression in CD34 positive precursor fraction in myelodysplastic syndrome bone marrow., American Society of Hematology, 48th Annual Meeting, 2006
• Clinical significance of Th1/Th2 ratio in patients with myelodysplastic syndrome, The XXth International Symposium on Technological Innovations in Laboratory Hematology, 2007
• 造血器腫瘍の抗真菌予防のItraconazole(ITCZ) cap.とsolutionの血中濃度と臨床像の比較検討, 日本血液学会総会, 2009
• 当院で経験したIgG4関連疾患の臨床的病理的検討について, 日本骨髄腫研究会総会, 2009
• The Influence of Polymorphisms of Interleukin-17F Genes On the Susceptibility and Clinical Outcome of Multiple Myeloma., American Society of Hematology 51th annual meeting, 2009
• Clinical Significance of Granulocytic Sarcoma in Patients with Acute Myeloid Leukemia, American Society of Hematology 51th annual meeting, 2009
• The influence of polymorphism of interleukin-17F genes on the susceptibility and clinical significance of chronic idiopathic thrombocytopenic purpura, 50th annual meeting of American Society of Hematology, 2008
• Innate Immunity in Idiopathic Thrombocytopenic Purpura (ITP), American Society of Hematology 50th annual meeting, 2008
• Human telomerase reverse transcriptase (hTERT) expression detected by flow cytometry in CD34 positive progenitor fraction in myelodysplasitc syndorme and acute myeloid leukemia, 15th Congress of the European Hematology Association, 2010
• Interleukin-10 polymorphism reflects the severity of chronic idiopahtic thrombocytopenic purupura., American Society of Hematology, 2007
• JAK2 mutation in granulocytes and platelets and X-chromosome gene-based clonal analysis in chronic myeloproliferative disorders, American Society of Hematology, 48th Annual Meeting, 2006
• 骨髄腫細胞株に対するCerastrolの抗腫瘍効果, 第56回日本臨床検査医学会学術集会, 2009
• 特発性血小板減少性紫斑病におけるIL-17遺伝子の多型解析, 第56回日本臨床検査医学会学術集会, 2009
• T-cell prolymphocytic leukemiaと診断した11例の検討, 第71回日本血液学会総会, 2009
• T細胞の異常が疑われる好酸急増多症の2例, 第70回日本血液学学会総会, 2008
• 外来化学療法センター運営におけるチーム医療の現状と問題点 外来化学療法パスを通じて, 第46回日本癌治療学会総会, 2008
• 非典型な表面形質をもったNK細胞腫瘍と考えられた2例, 日本リンパ網内径学会, 2010
• 慢性リンパ性白血病とその類縁疾患における免疫グロブリン重鎖および軽鎖遺伝子の解析, 第70回日本血液学学会総会, 2008
• CD8陽性皮膚原発T細胞リンパ腫の一例, 臨床血液, 2008
• 再発難治性多発性骨髄腫に対するbortezomibの使用経験, 日本内科学会, 2008
• B cell lymphoma の細胞表面CD25発現と血中可溶性IL-2レセプター値の関連について, 2008
• R-Roscovitineは骨髄腫細胞株をCaspase, JNK依存性、非依存性にアポトーシスを誘導する, 第69回日本血液学会 第49回日本臨床血液学会 合同総会, 2007
• 骨髄異形成症候群における制御性T細胞測定の臨床的意義, 第69回日本血液学会第49回日本臨床血液学会, 2007
• 自家末梢血幹細胞移植後アデノウイルスによる出血性膀胱炎、腎炎、ウイルス血症および血球貪食症候群を来したマントル細胞リンパ腫の1例, 第546回日本内科学会関東地方会, 2007
• Primary intraocular lymphomaの1例, 日本内科学会関東地方会544回, 2007
• 特発性血小板減少性紫斑病におけるIL-10多型解析, 第69回日本血液学会・第49回日本臨床血液学会合同総会, 2007
• 硝子体細胞診をきっかけに診断されたDiffuse Large B-cell Lymphoma 2例, 日本リンパ網内系学会, 2007
• Imatinibが効果的であったMDSからの進展が疑われるPh1陽性AMLの一例, 日本臨床血液学会, 2007
• 47, XYY症候群に発症した急性前骨髄性白血病の一例, 日本臨床血液学会 第161回例会, 2008
• B cell lymphomaの細胞表面CD25発現と血中可溶性IL－２レセプター値の関連について, 第70回日本血液学学会総会, 2008
• 芽球の増加とともに高カルシウム血症をきたしたprecursor T lymphoblastic leukemia(T-ALL)の１例, 第70回日本血液学学会総会, 2008
• Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma, American Society of Hematology 51th Annual Meeting., 2011
• Relation of IL-18 Polymorphism to the susceptibility and clinical feature of multiple myeloma in Japanese patients., International Myeoloma Workshop 13th, 2011
• Association Between Micro-RNA and Epigenetic Modifiers DNA Methyltransferases (DNMTs), Histone Deacetylases (HDACs) in Multiple Myeloma (MM) and Monoclonal Gammmopathy with Undetermined Significance (MGUS), 17th congress of European Hematology Association, 2012
• The Polymorphisms of Base Excision Repair Genes Influence the Prognosis of Multiple Myeloma, American Society of Hematology 52th, 2012
• Does the Hematopoietic Cell Transplantation Specific Comorbidity Index (HCT-CI) Predict Transplant Outcomes?: A Prospective Multicenter Validation Study of the Kanto Study Group for Cell Therapy (KSGCT), American Society of Hematology 52th, 2012
• Association Between Micro-RNA and Epigenetic Modifiers DNA Methyltransferases (DNMTs), Histone Deacetylases (HDACs) in Multiple Myeloma (MM) and Monoclonal Gammmopathy with Undetermined Significance (MGUS), American Society of Hematology 52th ., 2012
• Novel Agents and Autologous Stem Cell Transplantation Improve Survival of Multiple Myeloma Patients with Ages 65-70 Years: A Multicenter Retrospective Collaborative Study Between Japanese Society of Myeloma and European Myeloma Network, American Society of Hematology 52th, 2012
• Biological Features and Plasticity of CD56-Positive Dendritic-Like Cells: relationship to Blastic Plasmacytoid Dendritic Cell Neoplasm, American Society of Hematology 52th, 2012
• The Cytokine Polymorphisms Affect the Severity of Thrombocytopenia at Diagnosis in Chronic Immune Thrombocytopenia, American Society of Hematology 52th, 2012
• Clinical Significance of Mixed Phenotype in Adult Patients with Philadelphia Chromosome-Positive Acute Leukemia-no Prognostic Impact in the Imatinib Era., American Society of Hematology 52th, 2012
• Analysis of invasive fungal infections in patients with hematolopoietic stem cell transplantation., The17th annual Winter Meeting of the Korean Society of Blood and Marrow Transplantation, 2013
• Polymorphism of IL-10, IL-17A, IL-17F, and IL-18 affect the clinical features of multiple myeloma in Japanese patients, 14th International Myeloma Workshop, 2013
• Combination therapy with novel agents and stem cell transplantation improve survival MM patients aged 65-70 years., 14th International Myeloma Workshop, 2013
• Weekly Bortezomib plus Dexamethasone therapy for eldely patients with relapsed or refractory myeloma( JSMG-0902), 14th International Myeloma Workshop, 2013
• Suvival of unselected patients with symptomatic multiple myeloma, 14th International Myeloma Workshop, 2013
• International staging system may be not be used to predict prognosis of multiple myeloma patients in the novel agent era, 14th International Myeloma Workshop, 2013
• Distinctive subgroups according to differentiation stages in T-cell acute lymphoblastic leukemia, The 73nd Annual Meeting of the Japanese Society of Hematology, 2011
• The Clinical and Hematological Features of 5 patients with Hairy B-cell Lymphoproliferative Disorder, The 73nd Annual Meeting of the Japanese Society of Hematology, 2011
• 群馬県における非ホジキンリンパ腫治療の後方視的検討, The 73nd Annual Meeting of the Japanese Society of Hematology, 2011
• The IL-18-607A/C and -137G/C polymorphism are not associated with risk for chronic ITP, The 73nd Annual Meeting of the Japanese Society of Hematology, 2011
• Study on polymorphism of IL-18 promoter on multiple myeloma, The 73nd Annual Meeting of the Japanese Society of Hematology, 2011
• 多発性骨髄腫細胞におけるmicroRNA および DNAメチル転移酵素発現とその転嫁, The 73nd Annual Meeting of the Japanese Society of Hematology, 2011
• Common fragile site gene FHIT and WWOX expression are frequently altered in multiple myeloma, The 73nd Annual Meeting of the Japanese Society of Hematology, 2011
• A case of Hodgkin lymphoma producing granulocyte colony-stimulating factors(G-CSF), The 73nd Annual Meeting of the Japanese Society of Hematology, 2011
• The cytokine polymorphisms affect the severity of chronic immune thrombocytopenia (ITP), The 73nd Annual Meeting of the Japanese Society of Hematology, 2011
• Two cases of the patients treated with azactidine who suffering from AML converted from MDS, The 73nd Annual Meeting of the Japanese Society of Hematology, 2011
• 多発性骨髄腫における塩基除去修復遺伝子OGG1の検討, 第12回日本検査血液学会学術集会, 2011
• AITLの治療経過中に発症したEBV陽性DLBCLの一例, The 73nd Annual Meeting of the Japanese Society of Hematology, 2011
• 多発性骨髄腫細胞に対するCelastrolの抗腫瘍効果, 第12回日本検査血液学会学術集会, 2011
• 見逃してはいけない血液検査と末血像, 第48回関東甲信地区医学検査学会 招待講演, 2011
• Polymorphism of OGG1 Ser326Cys affects clinical feature of multiple myeloma, 第37回日本骨髄腫学会 口演, 2012
• 多発性骨髄腫患者における塩基除去修復遺伝子多型解析, 第13回日本検査血液学会, 2012
• 多発性骨髄腫患者におけるIL-18遺伝子promoterの多型解析, 第13回日本検査血液学会, 2012
• 多発性骨髄腫患者における塩基除去修復遺伝子多型解析, 第59回北関東医学会総会, 2012
• 多発性骨髄腫におけるmicroRNAおよびDNAメチル基転移酵素発現とその関連, 第13回日本検査血液学会, 2012
• 悪性貧血のメチコバール治療前後におけるT リンパ球サブセットの変化, 第13回日本検査血液学会, 2012
• 外来化学療法におけるチームワーク医療 安全管理と支持療法, 第59回北関東医学会総会 シンポジウム, 2012
• 発熱性好中球減少症とG-CSFガイドラインについて, 群馬県病院薬剤師会学術講演会, 2013
• 特発性血小板減少性紫斑病（ITP）におけるPARP1 Val762Ala遺伝子多型解析, 第14回日本検査血液学会, 2013
• 多発性骨髄腫における8p11領域遺伝子FGFR1およびWHSC1L1発現の検討, 第14回日本検査血液学会, 2013
• 急性骨髄性白血病におけるmicroRNA-29 familyとその前駆体primary microRNA29およびMcl-1の発現, 第14回日本検査血液学会, 2013
• 急性骨髄性白血病におけるCommon Fragile Site遺伝子WWOXとRASSF1Aのメチル化, 第14回日本検査血液学会, 2013
• 血球減少患者におけるXE_5000 による末梢血球解析とフローサイトメトリーによる骨髄細胞解析の有用性の検討, 第14回日本検査血液学会, 2013
• Analysis of invasive fungal infections in patients with hematolopoietic stem cell transplantation, The 74th Annual Meeting of the Japanese Society of Hematology oral, 2012
• DNMT3B7 expression related MENT expression and its promoter methylation in human lymphoma., The 74th Annual Meeting of the Japanese Society of Hematology, 2012
• Immunological analysis of relapsed or refractory low grade lymphoma treated with bendamustine, The 74th Annual Meeting of the Japanese Society of Hematology, 2012
• Two cases of granulocytic sarcoma development during azacitidine treatment for MDS, The 74th Annual Meeting of the Japanese Society of Hematology, 2012
• A newly diagnosed CML-CP HBV carrier was safely treated with dasatinib and entecavir, The 74th Annual Meeting of the Japanese Society of Hematology, 2012
• Base excision repair protein genen polymorphisms affect the clinical course of multiple myeloma, The 74th Annual Meeting of the Japanese Society of Hematology, 2012
• Association between CD 138 expression of myeloma cells and patients, The 74th Annual Meeting of the Japanese Society of Hematology, 2012
• Azacitidine therapy for patients with MDS and AML following in our institute., The 74th Annual Meeting of the Japanese Society of Hematology, 2012
• 多発性骨髄腫におけるWWOX・FHITのメチル化と発現の検討, 第12回日本検査血液学会学術集会, 2011
• 急性骨髄性白血病（AML）の染色体異常における遺伝子発現およびDNAメチル化の検討, 第12回日本検査血液学会学術集会, 2011
• Donor-derived HLA antibodies in a patient after hematopoietic stem cell transplantation, The 74th Annual Meeting of the Japanese Society of Hematology, 2012
• 同種造血幹細胞移植における深在性真菌症の検討, 群馬造血幹細胞移植研究会 口演, 2013
• . EBV-associated T cell lymphoproliferative disoreder after autologous blood stem cell transplantation, The 74th Annual Meeting of the Japanese Society of Hematology, 2012
• ACV encephalopathy developed anto-PBSCT in a patients with multiple myeloma, The 74th Annual Meeting of the Japanese Society of Hematology, 2012
• Association of Interleukin-18 Gene Polymorphism with Severity of Chronic Immune Thrombocytopenia (ITP), 52nd ASH Annual Meeting, 2010
• Identification of Candidate Tumor Suppressor Genes Silenced Epigenetically in Mantle Cell Lymphoma., American Society of Hematology 47th Annual Meeting., 2005
• Up-regulated of DMT1 in the Duodenum may be responsible for Iron Deposition in the Liver in TfR2 Mutant Mice, American Society of Hematology 45th Annual Meeting, 2003
• PC-SPES inhibits the proliferation of non-small cell lung cancer cells and down-regulates the level of cox-2, American Association for Cancer Research 94th annual meeting, 2003
• SNPs in the OGG1 and MYH base excision repair genes can be involved in lung cancer susceptibility, The 5th Joint Conference of the American Association for Cancer Research and the Japanese Cancer Association, 2001
• Relation of IL-10-592 polymorphism to the susceptibility and clinical outcome of multiple myeloma in Japanese patients, International MM workshop, 2007
• Relation of IL-10-592 polymorphism to the susceptibility and clinical outcome of multiple myeloma in Japanese patients, International MM workshop, 2007
• Utility of FDG-PET and Comparison of FDG-PET and Ga-67 scntigraphy in Evalution of B-Cell Indolent Lymphoma, American Society of Hematology, 2006
• JAK2 Mutation in Granulocyte and Platelets and X-Chromosome Gene- Based Clonal Analusis in Chronc Myeloproliferative Disorders, American Society of Hemalogy, 2006
• HLA-DRB1 Analysi s in Hairy B-Cell lymphoproliferative (HBLD) AJapanese Typeof Benign Persistant POlyclonal B- Cell Lymphocytes, American Society of Hematlogy, 2006
• IL-10-592A/C Genotype Increases the Risk of Multiple Myeloma in Japanese Patients, American society of Hematology, 2006
• C/EBP alpha and -beta: Apposing Affects in Lymphoma Cells, American Society of Hematology 45th Annual Meeting, 2003
• Decreased Myelopoiesis in C/EBPbeta-/- Mice in Responsce to GM-CSF, American Society of Hematology 44th Annual Meeting, 2002
• Interleukin-10 gene polymorphism reflects the severity of chronic idiopathic thrombocytopenic purpura, ASH 49th, 2007
• Clinical Significance of Granulocytic Sarcoma in Patients with Acute Myeloid Leukemia, The 71th annual meeting of the Japanese Journal of Clinical Hematology, 2009
• Shimizu H, Saitoh T, Osaki Y, Hoshino T, Hatsumi N, Tkada S, Yokohama A, Handa H, Jimbo T, Sakura T, Tsukamoto N, Karasawa M, Murakami H, Nojima Y., Annual Meeting of the Japanese Society of Hematology 72, 2010
• Relationship between circulating dendritic cells and T cell differentiation in patients with ITP, Yokohama, 2010
• Successful treatment of AIHA associated with associated with Multicentric Castleman disease by tocilizumab therapy, The 72nd Annual Meeting of the Japanese Society of Hematology, 2010
• Interkeukin-17F polymorphism in patients with chronic immune thrombocytopenic purpra, The 72nd Annual Meeting of the Japanese Society of Hematology, 2010
• Subclinical improvement of cardiac function with iron over load after chelating therapy, Yokohama, 2010
• Pneumocystis jiroveci pneumonia in patients with Hodgkin lymphoma, The 72nd Annual Meeting of the Japanese Society of Hematology, 2010
• A woman with slowly progressive EBV associated with lymphoproliferative disease had no immunosuppressant., The 72nd Annual Meeting of the Japanese Society of Hematology, 2010
• JAK2 Mutation Status in Granulocytes, Platelets and Erythrocytes Differs Between Polycythemia Vera and Essential Thrombocythemia, American Society of Hematology 50th annual meeting, 2008
• Utility of FDG-PET and Comparison of FDG-PET and Ga-67 Scintigraphy in Evaluation of B-Cell Indolent Lymphoma, American Society of Hematology 48th annual meeting, 2006
• Prognostic Importance of Soluble Form IL-2 Receptor α (sIL-2Rα) and Its Relationship with Surface Expression of IL-2Rα of Lymphoma Cell in Diffuse Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy: a Retrospective Analysis of 405 Cases, American Society of Hematology, 2009
• Flow cytometric detection of human telomerase reverse transcriptase expression in CD34 positive precursor fraction in myelodysplastic syndrome bone marrow., American Society of Hematology, 48th Annual Meeting, 2006
• Clinical significance of Th1/Th2 ratio in patients with myelodysplastic syndrome, The XXth International Symposium on Technological Innovations in Laboratory Hematology, 2007
• The Influence of Polymorphisms of Interleukin-17F Genes On the Susceptibility and Clinical Outcome of Multiple Myeloma., American Society of Hematology 51th annual meeting, 2009
• Clinical Significance of Granulocytic Sarcoma in Patients with Acute Myeloid Leukemia, American Society of Hematology 51th annual meeting, 2009
• The influence of polymorphism of interleukin-17F genes on the susceptibility and clinical significance of chronic idiopathic thrombocytopenic purpura, 50th annual meeting of American Society of Hematology, 2008
• Innate Immunity in Idiopathic Thrombocytopenic Purpura (ITP), American Society of Hematology 50th annual meeting, 2008
• Human telomerase reverse transcriptase (hTERT) expression detected by flow cytometry in CD34 positive progenitor fraction in myelodysplasitc syndorme and acute myeloid leukemia, 15th Congress of the European Hematology Association, 2010
• Interleukin-10 polymorphism reflects the severity of chronic idiopahtic thrombocytopenic purupura., American Society of Hematology, 2007
• JAK2 mutation in granulocytes and platelets and X-chromosome gene-based clonal analysis in chronic myeloproliferative disorders, American Society of Hematology, 48th Annual Meeting, 2006
• Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma, American Society of Hematology 51th Annual Meeting., 2011
• Relation of IL-18 Polymorphism to the susceptibility and clinical feature of multiple myeloma in Japanese patients., International Myeoloma Workshop 13th, 2011
• Association Between Micro-RNA and Epigenetic Modifiers DNA Methyltransferases (DNMTs), Histone Deacetylases (HDACs) in Multiple Myeloma (MM) and Monoclonal Gammmopathy with Undetermined Significance (MGUS), 17th congress of European Hematology Association, 2012
• The Polymorphisms of Base Excision Repair Genes Influence the Prognosis of Multiple Myeloma, American Society of Hematology 52th, 2012
• Does the Hematopoietic Cell Transplantation Specific Comorbidity Index (HCT-CI) Predict Transplant Outcomes?: A Prospective Multicenter Validation Study of the Kanto Study Group for Cell Therapy (KSGCT), American Society of Hematology 52th, 2012
• Association Between Micro-RNA and Epigenetic Modifiers DNA Methyltransferases (DNMTs), Histone Deacetylases (HDACs) in Multiple Myeloma (MM) and Monoclonal Gammmopathy with Undetermined Significance (MGUS), American Society of Hematology 52th ., 2012
• Novel Agents and Autologous Stem Cell Transplantation Improve Survival of Multiple Myeloma Patients with Ages 65-70 Years: A Multicenter Retrospective Collaborative Study Between Japanese Society of Myeloma and European Myeloma Network, American Society of Hematology 52th, 2012
• Biological Features and Plasticity of CD56-Positive Dendritic-Like Cells: relationship to Blastic Plasmacytoid Dendritic Cell Neoplasm, American Society of Hematology 52th, 2012
• The Cytokine Polymorphisms Affect the Severity of Thrombocytopenia at Diagnosis in Chronic Immune Thrombocytopenia, American Society of Hematology 52th, 2012
• Clinical Significance of Mixed Phenotype in Adult Patients with Philadelphia Chromosome-Positive Acute Leukemia-no Prognostic Impact in the Imatinib Era., American Society of Hematology 52th, 2012
• Analysis of invasive fungal infections in patients with hematolopoietic stem cell transplantation., The17th annual Winter Meeting of the Korean Society of Blood and Marrow Transplantation, 2013
• Polymorphism of IL-10, IL-17A, IL-17F, and IL-18 affect the clinical features of multiple myeloma in Japanese patients, 14th International Myeloma Workshop, 2013
• Combination therapy with novel agents and stem cell transplantation improve survival MM patients aged 65-70 years., 14th International Myeloma Workshop, 2013
• Weekly Bortezomib plus Dexamethasone therapy for eldely patients with relapsed or refractory myeloma( JSMG-0902), 14th International Myeloma Workshop, 2013
• Suvival of unselected patients with symptomatic multiple myeloma, 14th International Myeloma Workshop, 2013
• International staging system may be not be used to predict prognosis of multiple myeloma patients in the novel agent era, 14th International Myeloma Workshop, 2013
• Distinctive subgroups according to differentiation stages in T-cell acute lymphoblastic leukemia, The 73nd Annual Meeting of the Japanese Society of Hematology, 2011
• The Clinical and Hematological Features of 5 patients with Hairy B-cell Lymphoproliferative Disorder, The 73nd Annual Meeting of the Japanese Society of Hematology, 2011
• The IL-18-607A/C and -137G/C polymorphism are not associated with risk for chronic ITP, The 73nd Annual Meeting of the Japanese Society of Hematology, 2011
• Study on polymorphism of IL-18 promoter on multiple myeloma, The 73nd Annual Meeting of the Japanese Society of Hematology, 2011
• Common fragile site gene FHIT and WWOX expression are frequently altered in multiple myeloma, The 73nd Annual Meeting of the Japanese Society of Hematology, 2011
• A case of Hodgkin lymphoma producing granulocyte colony-stimulating factors(G-CSF), The 73nd Annual Meeting of the Japanese Society of Hematology, 2011
• The cytokine polymorphisms affect the severity of chronic immune thrombocytopenia (ITP), The 73nd Annual Meeting of the Japanese Society of Hematology, 2011
• Two cases of the patients treated with azactidine who suffering from AML converted from MDS, The 73nd Annual Meeting of the Japanese Society of Hematology, 2011
• Analysis of invasive fungal infections in patients with hematolopoietic stem cell transplantation, The 74th Annual Meeting of the Japanese Society of Hematology oral, 2012
• DNMT3B7 expression related MENT expression and its promoter methylation in human lymphoma., The 74th Annual Meeting of the Japanese Society of Hematology, 2012
• Immunological analysis of relapsed or refractory low grade lymphoma treated with bendamustine, The 74th Annual Meeting of the Japanese Society of Hematology, 2012
• Two cases of granulocytic sarcoma development during azacitidine treatment for MDS, The 74th Annual Meeting of the Japanese Society of Hematology, 2012
• A newly diagnosed CML-CP HBV carrier was safely treated with dasatinib and entecavir, The 74th Annual Meeting of the Japanese Society of Hematology, 2012
• Base excision repair protein genen polymorphisms affect the clinical course of multiple myeloma, The 74th Annual Meeting of the Japanese Society of Hematology, 2012
• Association between CD 138 expression of myeloma cells and patients, The 74th Annual Meeting of the Japanese Society of Hematology, 2012
• Azacitidine therapy for patients with MDS and AML following in our institute., The 74th Annual Meeting of the Japanese Society of Hematology, 2012
• Donor-derived HLA antibodies in a patient after hematopoietic stem cell transplantation, The 74th Annual Meeting of the Japanese Society of Hematology, 2012
• . EBV-associated T cell lymphoproliferative disoreder after autologous blood stem cell transplantation, The 74th Annual Meeting of the Japanese Society of Hematology, 2012
• ACV encephalopathy developed anto-PBSCT in a patients with multiple myeloma, The 74th Annual Meeting of the Japanese Society of Hematology, 2012
• Association of Interleukin-18 Gene Polymorphism with Severity of Chronic Immune Thrombocytopenia (ITP), 52nd ASH Annual Meeting, 2010
• 多発性骨髄腫におけるサイクリン依存性キナーゼ阻害剤(CDK inhibitor) R-Roscovitineの抗腫瘍効果, 井上まどか; 半田寛; 松島孝文; 入澤寛之; 斉藤貴之; 山根有人; 塚本憲史; 唐沢正光; 小河原はつ江; 野島美久; 村上博和, 第68回日本血液学会 第48回日本臨床血液学会 合同総会, 08 Oct. 2006
• 血球減少例のCD45 blast gatingを用いた骨髄細胞の評価, 松島孝文; 入澤寛之; 横濱章彦; 斉藤貴之; 塚本憲史; 内海英貴; 山根有人; 唐沢正光; 半田寛; 村上博和, 第68回日本血液学会 第48回日本臨床血液学会 合同総会, 08 Oct. 2006
• 造血器腫瘍の抗真菌予防のItraconazole(ITCZ) cap.とsolution の血中濃度と臨床像の比較検討, 斉藤貴之; 塚本憲史; 田原研一; 大崎洋平; 馬渡桃子; 三井健揮; 小磯博美; 横濱章彦; 半田寛; 唐沢正光; 野島美久; 村上博和, 日本血液学会総会, Oct. 2009
• 世界で活躍するグローバル人材の育成, 齋藤貴之; 鯉淵典之; 村上正巳; 岡 美智代; 李範爽; 篠崎博光, 第66回北関東医学会総会, 27 Sep. 2019

Awards

• 2007
• 2008
• 2011
• 2011
• Travel Award of KSBMT, 2013

Research Projects

• 01 Aug. 2021, 31 Mar. 2022, Principal investigator
• Drug resistance in multiple myeloma using DNA damage repair, SAITOH Takayuki, Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C), Grant-in-Aid for Scientific Research (C), Gunma University, 01 Apr. 2017, 31 Mar. 2020, Principal investigator, We examined the expression of DNA repair genes, including base excision repair (BER) genes of multiple myeloma (MM) cell lines.The expression of OGG1, APE1, MUTYH, POLB, PARP, and XRCC1 in BER of MM cells was higher than peripheral blood mononuclear cell. We have made several BER knockdown MM cells using lentivirus.OGG1 knockdown and APE1 knockdown (KD) cells showed decreased proliferation. APE1 KD cells showed higher level of double strand DNA breaks compared to control, suggesting the role of APE1 for anti-myeloma effect by DNA repair system.Furthermore, APE1 inhibitor; Methoxyamine and E3330 showed decreased proliferation of MM cell lines. Thus, APE1 may be a target gene of MM therapy., Competitive research funding, 17K09003

  対象リソースIRI
• Competitive research funding

  対象リソースIRI
• Development of a web-system for promotion of EBLM by building a clinical case bank with harmonized recording of lab data., ICHIHARA Kiyoshi, Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (A), Grant-in-Aid for Scientific Research (A), Yamaguchi University, 01 Apr. 2016, 31 Mar. 2020, As source data for use in the practice of evidence-based laboratory medicine (EBLM), healthy reference values (RVs) of major laboratory tests and clinical and laboratory information for major diseases were accumulated by international collaboration. For the former, 18,000 healthy volunteers were recruited since 2011 through a global study on RVs by collaboration of 19 countries. Standardized test results for 50 major lab tests were put into database (DB) together with personal information obtained from a common health-status questionnaire. For the latter, as a model DB, collagen diseases and hematological malignancies were targeted. By international collaboration, clinical and laboratory findings of well-defined cases (dermatomyositis 358, systemic sclerosis 416, multiple myeloma 456, malignant lymphoma 599) were accumulated. Both DBs were placed in a newly created EBLM web system so that evidence for laboratory diagnosis can be explored by specifying various conditions., Competitive research funding, 16H02771

  対象リソースIRI
• Longitudinal study on the effect of interprofessional education delivered by two institutions on the basis of collaboration with WHO, Watanabe Hideomi, Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B), Grant-in-Aid for Scientific Research (B), Gunma University, 01 Apr. 2015, 31 Mar. 2020, WHO launched a transformative educational guidelines for health professionals in 2013. Interprofessional education (IPE) is described as one of the 11 recommendations, although the effect is conditional. To respond to the background, as a WHO Collaborating Centre (WHOCC), the present study focused on the comparison of the IPE programs between two universities implementing comprehensive IPE. While the programs were distinct, the effects on the attitudinal change of the student were similar. On the other hand, several universities in Lao PDR, Thailand and Philippines succeeded delivery of their own IPE programs in collaboration with the WOOCC and showed significant outcomes. Furthermore, several educational elements required for collaboration in patient safety were elucidated., Competitive research funding, 15H04749

  対象リソースIRI
• Analysis of base excision repair in multiple myeloma, Saitoh Takayuki; Murakami Hirokazu; Minato Yusuke; Kasamatsu Tetsuhiro; Gotoh Nanami, Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C), Grant-in-Aid for Scientific Research (C), Gunma University, 01 Apr. 2013, 31 Mar. 2016, Principal investigator, Polymorphism studies of base excision repair (BER) genes, including OGG1, XRCC1, APE1, MUTYH,and PARPI, showed that multiple myeloma （MM) patients with OGG1 Cys/Cys (low activity type) or PARP-1 non Val/Val (low activity type) were increased than health controls. Furthermore, mRNA expression of BER genes, incuding OGG1, APE1, and PARP-1 ,was increased in MM patiets. In additon, new generation PARP-1 inhibitor was effective in MM cell lines, suggesting inhibition of BER pathway may be a treatment opition in the future., Competitive research funding, 25460673

  対象リソースIRI
• The expression of Toll-like receptor in myelodysplastic syndrome, MURAKAMI Hirokazu; SAITO Takayuki; HANDA Hiroshi, Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C), Grant-in-Aid for Scientific Research (C), Gunma University, 2010, 2012, Myelodysplastic syndrome (MDS) is a clonal disease, characterized by ineffective hematopoiesis due to apoptosis of blood cells, progression to acute leukemia, and high frequency of autoimmune disease complications. Toll-like receptors (TLR) is reported to be involved in apoptosis, tumor immunity, and autoimmune disease. According to these, it is suspected that TLRs are associated with the pathogenesis of MDS. Twenty-one patients with MDS are included in this study. TLRs may be associated with the apoptosis of blood cells in high-risk MDS patients; however not be involved in the progression of MDS to leukemia., Competitive research funding, 22590515

  対象リソースIRI
• Principal investigator, Competitive research funding

  対象リソースIRI
• Polymorpshism study in Hematology, The Other Research Programs, Competitive research funding
• Elucidation of the dynamics of trace elements in blood cells of myelodysplastic syndrome by micro-PIXE and development of new therapeutic agents, Murakami Hirokazu, Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C), Grant-in-Aid for Scientific Research (C), Gunma University, 01 Apr. 2017, 31 Mar. 2021, Objective: To elucidate the mechanism of ineffective erythropoiesis and leukemia progression of myelodysplastic syndrome, we analyzed trace element dynamics in tumor cells using the micro-PIXE method. Subjects and methods: A single-ended accelerator from Takasaki Quantum Applied Laboratories was used for intracellular trace element measurement. The intracellular trace elements of the leukemia cell line and the myeloma cell line (control) were compared, and the effect of doxorubicin (DXR) was measured. Results: (1) The leukemia cell line had a higher K peak than the myeloma cell line. (2) The peak of K was lower in the DXR-treated leukemia cell line than in the untreated leukemia cell line. Discussion: The addition of DXR reduced the K concentration in leukemia cell lines, suggesting that DXR directly or indirectly affects the K concentration and is involved in cell death., 17K09055

  対象リソースIRI
• Examination of multiple myeloma prognosis predictive biomarkers based on analysis of PD-1 polymorphisms, Kasamatsu Tetsuhiro; MURAKAMI hirokazu; SAITOH takayuki, Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research Grant-in-Aid for Young Scientists (B), Grant-in-Aid for Young Scientists (B), Gunma University, 01 Apr. 2016, 31 Mar. 2019, We investigated the impact of PDCD1 (3 single nucleotide polymorphisms; SNPs), PDCD1LG1 (2 SNPs), CTLA4 (4 SNPs), IDO1 (1 SNPs) and IDO2 (1 SNPs) polymorphisms on susceptibility and clinical features of multiple myeloma (MM) patients. The PDCD1 high-expression type and IDO2 high-activity type were associated with the susceptibility of MM. In addition, the higher frequencies of patients with CTLA4 and PDCDLG1 high-expression types were observed in more malignant clinical variables. However, there were no significant differences between all polymorphisms and overall survival., 16K19190

  対象リソースIRI
• Measurement of trace elements with micro-PIXE method in myeloma cells and development of novel drugs, Murakami Hirokazu, Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C), Grant-in-Aid for Scientific Research (C), Gunma University, 01 Apr. 2014, 31 Mar. 2017, We introduced an in-air micro-PIXE (micro-PIXE) method in the measurement of trace elements in cultured myeloma cells and analyzed the change of trace elements before and after the treatment with bortezomib (proteasome inhibitor) and melphalan (alkylating agent). The cells were gathered on polycarbonate film with cytocentrifuge and measured with micro-PIXE. We established the micro-PIXE method to analyze trace elements in free cultured cells. Phosphate and Calcium changed by high-dose bortezomib treatment, but not by melphalan., 26460720

  対象リソースIRI
• Mar. 2021, Mar. 2026
• Mechanism of drug resistance by microRNA-DNA repair in multiple myeloma, Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C), Grant-in-Aid for Scientific Research (C), Gunma University, 01 Apr. 2021, 31 Mar. 2024, 21K07312

  対象リソースIRI
• Understanding mechanism of next generation stem cell mobilization method through the conventional method., Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C), Grant-in-Aid for Scientific Research (C), Gunma University, 01 Apr. 2021, 31 Mar. 2025, 21K07386

  対象リソースIRI
• 01 Apr. 2022, 31 Mar. 2025, 22K07412

  対象リソースIRI

Academic Contribution

• Peer review etc, 02 Jul. 2021, 02 Jul. 2021
• Peer review etc, 14 Jun. 2021, 14 Jun. 2021
• review of journal "cancers", Peer review etc, 08 Jun. 2021, 10 Jun. 2021

Educational Activities

Teaching Experience

• Bio-defence studies, Apr. 2013, 9999
• Laboratory Hematology 1, Apr. 2019, 9999
• Team work training, Apr. 2022, 9999
• Laboratory Hematology training, Apr. 2019, 9999
• Basic Science 1, Apr. 2015, 9999
• Bio-defence training, Apr. 2013, 9999
• Teamwork training, Apr. 2012, Mar. 2021

Awards

• Best Teacher Award 2022 Health Science, Introduction to non-technical skill, 20 Sep. 2022, Others

Social Contribution

Social Contribution

• 医療安全教育手法に基づく 多職種人材育成共同利用拠点 設置記念シンポジウム, 04 Feb. 2024, Seminar　(Target:　Teachers, Researchers)
• 国立大学法人群馬大学創基150周年記念事業　春の散歩道, 25 Mar. 2023, 25 Mar. 2023　(Target:　Guardians, General)
• 群馬大学｢性の多様性｣相談対応スーパーバイズ, 14 Mar. 2023, 14 Mar. 2023　(Target:　Teachers)
• English Cafe 昭和, 17 May 2022, 20 Jan. 2023, EnglishCafe　(Target:　College students, Graduate students, Others)
• English Cafe 昭和, 17 May 2021, 13 Jan. 2022
• English Cafe 昭和　, 18 May 2020, 22 Jan. 2021　(Target:　College students, Graduate students)
• 群馬大学X富岡市 外国人に選ばれる街つくりプロジェクト 2019, 02 Nov. 2019, 04 Nov. 2019　(Target:　College students, General, Governmental agency)
• 性の多様性 講演会, 04 Oct. 2019, 04 Oct. 2019
• 性の多様性ガイドラインWGメンバー, Apr. 2018, Mar. 2019
• EnglishCafe 昭和地区, Apr. 2018, 9999
• 群馬大学 SOGIの理解促進のための講演会 「アンコンシャス・バイアスについて〜SOGI理解促進のために」, 04 Feb. 2022, 04 Feb. 2022, SOGI講演会ポスター（メール添付用）.jpg, No password

  添付ファイルのURL
• 北関東医学会総会, 30 Sep. 2021, 9999, 20210930_第68回北関東医学会ポスター.pdf, No password

  添付ファイルのURL
• 群馬県骨髄ドナー登録推進会議, 2022, 9999
• 群馬大学｢性の多様性｣相談対応スーパーバイズ, 18 Mar. 2024, 18 Mar. 2024　(Target:　Teachers)

Academic Contribution

• 群馬血液疾患研究会, Academic society etc, 01 Apr. 2022, 31 Mar. 2023
• 北関東医学会　編集委員, Review, 01 Apr. 2022, 31 Mar. 2023

Media Coverage

• 医療教育の発信拠点に 群大が記念シンポ, Other than myself, 05 Feb. 2024, Paper
• 医療情報講座に群大院に設置, 15 Apr. 2023, Paper